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To my Dad, who i know would be proud of me. 
And to my Mum who is proud of me. 
But that is the sort of thing we can expect from the Abstract Owl, the 
dried-up western descendant of the Confucianist, Desiccated Scholar, who, 
unlike his Noble but rather unimaginative ancestor thinks he has some sort 
of monopoly on - 
"What's that?" Pooh interrupted. 
"What's what?" I asked. 
"What you just said - the Confucianist, Desiccated Scholar". 
"Well, let's see. The Confucianist, Desiccated Scholar is one who studies 
knowledge for the sake of knowledge, and who keeps what he learns to 
himself or to his own small group, writing pompous and pretentious papers 
that no one else can understand, rather than working for the enlightenment 
of others. How's that?". 
"Much better", said Pooh. 
- extract from The Tao of Pooh and the Te of Piglet by Benjamin Hoff. 
Abstract 
DNA methylation and its associated histone deacetylation and chromatin modification 
are global mechanisms that regulate gene expression. MeCP2 is an abundant mam-
malian protein that specifically binds the 5-methyl-CpG (mCpG) dinucleotide pair, 
represses transcription by recruiting histone deacetylases, and is essential for embry-
onic development. Mutations in the MeCP2 gene, which encodes the X-linked MeCP2 
protein, have been identified as the cause of the progressive, neurodevelopmental dis-
order, Rett syndrome (RTT, M1M312750). MeCP2 contains a methyl-CpG binding 
domain (MBD) and a transcriptional repression domain (TRD). The structure of MBD 
of MeCP2 has been solved and is found to adopt a novel fold forming a wedge shape. 
It consists of a four-stranded antiparallel /3-sheet, which forms one face of the wedge 
shape, a 3 turn a-helix and a single turn a-helix, which form the other face of the 
wedge. A long flexible loop between strands B and C (BC loop) forms the thin edge of 
the wedge and becomes structured upon binding to DNA. The BC loop together with 
residues in strands B, C, and D, and at the N-terminus of the larger a-helix, appear to 
form an interface with methylated DNA. The guanidyl sidechains of Arg 111 and Arg 
133 are also found to become structured upon binding to DNA and their mutation was 
found to inhibit binding. Thus they are believed to make direct contacts with DNA. 
The absence of symmetry in the domain implies that recognition does not exploit the 
symmetry of the binding site. 
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This PhD project was originally titled "Strategies for determining three-dimensonal 
structures on the basis of NMR data". There were two sets of data that were used; 
the data from the solved solution structure of the vaccinia virus complement control 
protein modules 3 and 4 (VCP34) [185] and a ' 3C-edited NOESY collected on MBD 
of MeCP2 (see later) with a few assignments graciously supplied by Dr Alice Soteriou 
who was working on the project. The ARIA protocol was the main focus of technique 
development in the first half of the first year of this project. The VCP34 data was used 
as a successful first test for ARIA. The MBD data's intended use was as a more conclu-
sive test and to develop understanding of the technique. However with the departure 
of Dr Alice Soteriou, I took over the MBD structure calculation project because i had 
made progress with the incomplete resonance assignment, and was familiar with the 
data as a structure calculation had already been attempted. And so the aim of my 
project changed, however the use of alternative new techniques were still used and with 
a large degree of success. This project was part of a collaboration, primarily with Dr 
Andrew Free who is a member of Prof. Adrian Bird's group in the Institute of Cell 
and Molecular Biology (ICMB) 
Almost all of the genes in the human genome, and many from microbial, plant and 
other animal genomes, have been sequenced. Two human chromosomes, 21 and 22, 
[67, 42] and the genome of Caenorhabditis elegans [158] have been sequenced. The 
next stage in this scientific advancement is to understand the mechanism that allows 
these genes to be selectively expressed. All genes are transcribed in an organism at 
1 
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some stage in its life, however a limited number are necessary for the differentiation of 
specialized cell types. And so it is essential to select the correct genes to switch on and 
those that need to be switched off. Many human diseases, including cancer [96] and 
neurodevelopmental diseases [5], are attributed to the inappropriate expression or lack 
of repression of certain genes. Among the mechanisms that stably inactivate genes, 
sometimes called gene silencing, is DNA methylation and the associated assembly of 
repressive heterochromatin. 
One of the main approaches to understanding mechanisms in biology is to study the 
molecular structure of the components. This has become an integral part of biological 
sciences, guiding other studies with the information it provides, and being directed 
by the findings of other experiments. To date, there are only two techniques that are 
feasible for determing the high resolution three-dimensional structure of biomolecules: 
X-ray crystallography and NMR spectroscopy. NMR spectroscopy is a powerful an-
alytical tool that is used widely across science. With advances in technology, it has 
been applied to the biological sciences and in particular is used to determine the three-
dimensional structure of biomacromolecules such as DNA or proteins. With the advent 
of methods to study proteins in solution came the ability to better understand their 
behaviour in vivo. 
1.1 DNA methylation 
It is well known that DNA consists of a long sequence of the four nucleotides; cytosine 
(C), guanine (G), thymine (T) and adenine (A), and that contained in these long 
tracts are genes which code for proteins that are involved in all biological systems. A 
dinucleotide sequence, i.e. just two of these bases, at first would be considered to be of 
no real significance as genes are usually many thousands of base pairs long. However 
the dinucleotide pair CpG is of considerable importance. 
The occurance of the sequence CpG in bulk vertebrate DNA is at one fifth of the 
expected frequency. Another feature of the CpG sequence that could be seen as unusual 
is that approximately 70% of all CpGs are methylated at the 5-position on the cytosine 
ring. Also levels of 5-methylCpG are higher in vertebrates than in invertebrates but 
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methylation of CpG is nearly always present in vertebrate genes. A third trait of this 
dinucleotide is that unmethylated CpGs are found clustered in discrete regions with 
relatively high guanine and cytosine content, known as "CpG islands". 
Within CpG islands the dinucleotide CpG occurs at the expected frequency and in this 
sense they are not "CpG" rich. It is, in fact, the bulk non-CpG-island DNA that is 
"CpG" poor [21]. This contrast between CpG islands and inter-island DNA and the 
general rarity of CpG in bulk DNA are a consequence of the methylation of cytosine. 
5-methyl-cytosine is susceptible to deamination which gives rise to thymine [37, 22], 
and can be missed by the DNA repair mechanism. The extent of CpG deficiency 
correlates well with the overall level of CpG methylation in various animal genomes 
and is inversely proportional with an excess of the expected products (TpG and CpA) 
of this process, providing evidence that this loss of CpG does happen and a general 
deficiency arises. This mutability of 5-methyl-cytosine is suspected of being the primary 
source of sequence divergence. 
5-methyl-Cytosine 	 Thymine 
Figure 1.1: The figure shows 5-methyl-Cytosine and Thymine with the correct ring 
numbering. Deamination of the 5-methyl-cytosine gives rise to thymine. 
Therefore, with cytosine methylation comes the consequence of increased mutability. 
Findings that show that some mutations causing haemophilia in man have arisen by 
the above mechanism[194] emphasize this point. Thus the sequence CpG is rare in 
non-CpG island DNA because of accelerated mutation due to methylation, and CpG 
islands have not lost CpG presumably because they are not methylated. There are 
approximately 45 000 CpG islands per haploid genome in humans and 37 000 in mice 
[6]. 
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1.1.1 CpG-islands and genes 
The interesting question is what is the importance of all this? It is well known that CpG 
islands are associated with genes and in particular with regions where transcription 
begins [20]. Approximately 60% of genes in man are asssociated with CpG islands [6]. 
CpG islands are also likely to contain promoters and 5' ends of genes. There are many 
examples that verify this finding, for instance, a detailed study carried out over thirteen 
years ago showed that all sequenced "housekeeping" genes that are transcribed by RNA 
polymerase II have CpG islands at their 5' ends [55]. Also many tissue-specific genes 
have CpG islands like the Thy-1 gene of mouse [90] and the human c-globin genes [22]. 
A more recent and important piece of work also found this to be true. In the DNA 
sequence of human chromosome 21 [67], it was found to contain a very low number of 
identified genes (225) compared with the 545 genes reported for chromosome 22 [42] 
and that there is a large 7-Mb region with low guanine and cytosine content which 
correlates with a scarcity of both Alu sequences 1 and genes. Only two known genes 
(PRSS7 and NCAM2) and five predicted genes were found in this region. Also it was 
found that there was a correlation between guanine and cytosine rich regions and gene 
density, and that CpG islands correlated well as indicators of the 5' ends of genes [67]. 
This was also found to be the case with human chromosome 22 [42]. 
CpG islands normally remain free of methylation in all types of cells, however there are 
circumstances where they are not. For example, CpG islands on the mammialian X 
chromosome have become methylated on the inactive homologue. In the developmental 
situation here the islands have become reproducibly methylated afresh or de novo 
[106, 86]. It was also noticed that active X chromosome was unmethylated. Sporadic 
de novo methylation has been seen on several occasions in cultured cell lines [21] and 
each time it has been associated with stochastic inactivation of a nearby gene. 
The biological interest of this dinucleotide sequence is in its widely recognized asso- 
ciation with condensed nuclease-resistant heterochromatin and silencing of gene ex- 
pression [122, 123, 13]. It plays a major part in repressing the expression of tumour 
Alu sequences - a family of 300 bp sequences occuring nearly a million times in the human genome. 
Many of these sequences contain a target site for the Alul restriction nuclease; hence their name 
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suppressor genes in cancer [79, 13, 96], X chromosome inactivation [6, 103, 102, 15], 
parential imprinting [102, 11, 76] and is vital for development [103, 134]. 
DNA methylation is associated with histone deacetylation and chromatin modification 
[123], and is a global mechanism that regulates gene expression. There are two families 
of proteins that are primarily involved with DNA methylation and gene silencing: DNA 
methyltransferase (DNMTs) and methyl-CpG binding proteins (MeCP or MBD). 
1.2 Histone deacetylation 
Histones are small basic proteins that bind tightly to eucaryotic DNA, and constitute 
about half of the mass of eucaryotic chromosomes. There are five types of histones: 
Hi, H2A, H213, H3 and H4. They package DNA into the form of chromatin, which is 
made up of repeating units called nucleosomes. A nucleosome core consists of 140 base 
pairs (bp) of DNA wound around a histone octamer of two of each H2A, H2B, H3 and 
H4. Histone Hi is located on the outside of the nucleosome, near the linker DNA of 60 
bp which joins adjacent nucleosomes to form the chromatin fiber, and interacts with 
H2A subunits of the nucleosomal core. Each type of histone can exist in a variety of 
forms because of post-translational modifications of certain sidechains. For example, 
Lys 16 in H4 is often acetylated [169]. 
CpG islands have a markedly open chromatin structure that contain nucleosomes en-
riched in acetylated forms of histones H3 and H4 [172]. Deacetylation of histones in 
nucleosomes is believed to alter the structure of chromatin - it adopts a more tightly 
packed structure that inhibits the access of transciption factors to their binding site. 
Hence a role for histone deacetylation in transcriptional silencing [64]. For example, 
in female mammals, the active X chromosome is associated with acetylated histones, 
whereas the inactive X chromosome significantly lacks histone H4 acetylation [78]. 
1.3 DNA methyltransferases 
Rather little is known of the cues that trigger de novo methylation. However, a family 
of enzymes have been identified that are responsible for the methylation of the 5-carbon 
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Figure 1.2: An overview of the mechanism by which DNA methylation and 
histone deacetylation repress transcription. The silencing of a transcriptionally 
active region first requires de novo methylation via DNA methyltransferases. The 
methyl-CpG binding proteins, associated co-repressors and histone deacetylases are 
recruited to 'cement' the promoter in the silent state. The deacetylated nucleosomes 
adopted a tightly packed structure that inhibits the access of transcription factors to 
their binding sites. 
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of the pyrimidine ring of cytosine, creating 5-methyl cytosine [17, 132]. There are four 
known members of this family of DNA methyltransferases (DNMT): DNMT1, DNMT2, 
DNMT3a and DNMT3b. They bear ten characteristic sequence motifs, referred to as 
motifs I - X [145, 99], six of which are strongly conserved. The catalytic mechanism 
of DNMTs involves first an addition of an enzyme cysteine thiolate, provided by motif 
IV that contains a conserved prolylcysteinyl depeptide [18], to the 6-position of the 
cytosine ring, producing a 4-5 enamine and protonation of the N3 position mediated 
by the highly conserved ENV tripeptide in motif VI [153, 34, 44]. Motifs I and X form 
a S-adenosyl-L-methionine (AdoMet) binding site, providing a methyl group which is 
covalently bonded to cytosine via a nucleophilic attack from the 4-5 enamine. After 
methyl transfer, removal of a proton from the 5 position could allow reformation of 
the 5-6 double bond and release of enzyme by 3-elimination (see figure 1.3). The 
DNA-DNMT1 co-crystal structure indicated that the target cytosine is inserted into 
the active enzymatic site to relieve any steric restraints [89]. 
NH2 
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Figure 1.3: The catalytic mechanism of DNA (cytosine-5) methyltrans-
ferases. Protonation of the N3 position is mediated by the highly conserved ENV 
tripeptide in motif VI. The base that extracts the 5-proton after methylation is not 
known in all cases. 
DNMT1 is a maintenance methyltransferase and has a preference for hemi-methylated 
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substrates in vivo [192]. It is recruited to replicating DNA to reproduce the methy-
lation pattern of the parental strands in the daughter strands [100]. Disruption of 
global methylation patterns is lethal to mammals, and mice deficient in DMNT1 are 
developmentally retarded and do not survive past mid-gestation, showing significantly 
reduced levels of DNA methylation [103]. 
DNMT1 has been shown to be associated with histone deacetylase activity in vivo [54]. 
It was found to contain a transcriptional repression domain that can bind to the histone 
deacetylase HDAC1. This domain encompasses a cysteine rich region (CxxC motif) 
and is homologous to the repressor domain of the trithorax- related protein, HRX. This 
suggests that DNA methylation mediated by DNMT1 may depend on or generate an 
altered chromatin state via histone deacetylation. 
The biological role of DNMT2 remains to be demonstrated in any species. Disruption of 
the DNMT2 gene had no obvious effects on genomic methylation patterns in embryonic 
stem cells, nor integrated retroviral DNA [133]. However DNMT2 may possibly play 
a role in some aspect of centromere function. 
De novo methylation of unmethylated and hemi-methylated DNA is performed by 
DNMT3a and DMNT3b. It has been shown that DNMT3a and -b are essential for 
embryonic development and are present at high levels in embryonic stem (ES) cells but 
at low levels in adult somatic tissue [134]. Disruption of the DNMT3a (Dnrnt3a/) 
or DNMT3b (Dnrnt3b/) genes in ES cells did not inhibit de novo methylation of 
introduced proviral DNA, however Dnrnt3a' and Dnmt3b' double mutants exhibit 
no de novo methylase activity. This indicates that both are required for de novo 
methylation. Different phenotypes are displayed by the different mutants in mice: 
Dnrnt3a' mice developed to term and appeared to be normal at birth, but became 
runted and died at 4 weeks of age; whereas Dnrnt3lr' mice died in mid-gestation. 
The double mutant mice failed to develop beyond gastrulation and so these enzymes 
have overlapping but distinct functions. 
Mutations of human DNMT3b affecting the catalyic domain of the enzyme have been 
identified in immunodeficiancy centromeric instability and facial anomalies (ICF) syn- 
drome [190, 134]. ICF syndrome is a rare autosomal recessive disease that causes 
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variable combined immunodeficiency, mild facial anomalies and extravagant cytoge-
netic abnormalities. The pericentric regions of chromosomes 1, 9 and 16 are affected, 
and the satelite DNA contained within them, normally heavily methylated, is nearly 
completely unmethylated in DNA of ICF sufferers [77]. However ther is no embry-
onic lethality in humans with these mutations of DNMT3b, perhaps because other 
functional regions of the enzyme are still present but are absent from the mice with 
the DNMTSb gene deleted. It is unclear why these enzymes appear to target partic-
ular regions of DNA as no mammalian DNA methyltransferase has been shown to be 
sequence specific. 
1.4 Methyl-CpG Binding Proteins 
Several proteins have been discovered that selectively recognise methylated DNA in-
cluding MeCP1 [112, 25, 38], MeCP2 [101, 119], MBD2, MBD3 and MBD4 [69]. Each 
contains a homologous methyl-CpG binding domain (MBD) which is the minimum 
length sequence that shows specific binding to methyl-CpG. The MBDs are 60 - 80 
residues long and show a 50 - 70 % level of sequence identity. Of these proteins, only 
the structures of the MBD of MBD1 [131] and of MeCP2 [181] have been solved, both 
by NMR spectroscopy. The MBD of MeCP2 is the protein of interest in this project 
and the structural studies on this domain, including the calculation of its solution 
structure by NMR, are discussed. 
1.4.1 MeCP2 
The methyl-CpG binding protein, MeCP2, is an abundant mammalian protein that 
binds specifically to methylated cytosine in the sequence 5' CpG [25, 26] and mediates 
DNA transcriptional repression [101, 119]. It consists of a single 482 residue polypep-
tide that contains a methyl-CpG binding domain (MBD) and a transcriptional repres-
sion domain (TRD) [120, 119]. Recombinant MBD of MeCP2, the focus of this project, 
is a 88-residue domain fragment which encompasses residues 77 - 162 of MeCP2, and is 
the minimum length sequence that has the capability to bind to a single symmetrically 
methylated CpG dinucleotide and binds to chromosomes at sites known to contain 
methylated DNA. The TRD of MeCP2 is contained between residues 207 and 310. 
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Figure 1.4: A schematic representation of MeCP2 and other members of the MBD 
family. Proteins are indicated by white rectangles extending from the amino terminus 
on the left. The locations of MBD domains, identified on the basis of sequence similarity 
(Hendrich & Bird. 1998), are indicated by the black boxes, and numerals indicate 
the boundaries in terms of residue number. The transcription repression domain of 
MeCP2 is indicated by a dark grey box. Two forms of MBD2 are shown corresponding 
to initiation of translation at either the first or second methionine codon (Hendrich 
& Bird, 1998). A multiple sequence alignment encompassing the MBDs from the 
five proteins is shown in one-letter code-. Numerals indicate the sequence number 
within MeCP2. Upper-case indicates a highly conserved (or conservatively substituted) 
residue (consensus sequence is shown below the alignment). The colour coding refers 
to the extent to which the amide chemical shifts are perturbed by the binding of DNA: 
green indicates no significant change, yellow indicates a small but significant change, 
and blue indicates a large change (more details in the legend to Figure 4). Black 
squares indicate residues whose side-chains contribute to the hydrophobic core. , The 
mouse version of MBD4 has a serine at this position. 
both the TRD and MBD have been shown to independently confer transcriptional 
silencing [120, 118]. 
MeCP2 specifically binds methylated DNA tightly both in vivo and in vitro via its MBD 
and only represses transcription from methylated promoters [120, 118]. Methylated 
genes can be transcribed as efficiently as non-methylated genes in the absence of MeCP2 
and other methyl-CpG binding proteins [119, 69]. MeCP2 (and MeCP1) can not bind 
hemi-methylated CpG sites, and will not bind significantly to DNA that contains 5- 
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methyl-cytosine in a sequence other than mCpG [112, 1011. 
It can bind tightly to preassembled chromatin containing methyl-CpG and displace 
histone Hi in order to access its binding site [119]. MeCP2 stably associates with 
nucleosomal DNA without major impediment, preferring maximally solvent exposed 
mCpGs [32]. Although substantial sequence selectivity in binding to DNA has been 
shown [29, 184], MeCP2 has the ability to recognise all mCpGs in the Xenopus bo-
realis 5S DNA fragment [32] thus selectivity is primarily determined by nucleosomal 
context. This capability to associate with methylated nucleosomal DNA without the 
requirement for disruption of the nucleosome ideally places MeCP2 within chromatin 
where it can recruit co-repressor complexes to repress transcription. 
MeCP2 recruits a co-repressor complex containg the transcriptional repressor mSin3A 
and histone deacetylases (HDAC)[117, 80]. A region of MeCP2 that localizes with 
the TRD associates with the catalytically active co-repressor complex. mSin3A is the 
prefered binding partner as HDACs have a much weaker affinity for MeCP2. Although 
it is possible that an unknown component of the translation lysate mediates indirect 
binding, there is probably a direct interaction between MeCP2 and mSin3A. Other 
regions of MeCP2 and other compounds involved in the identification assays were found 
not to attract any of the co-repressor proteins. Two regions of mSin3A are involved 
with the interaction with MeCP2: the N-terminal half of the HDAC-interaction domain 
(HID) of mSin3A and the C-terminal 200 amino acids of mSin3A. MeCP2 and the 
histone deacetylases seem to bind to distinct sites within the 375-residue HID region, 
as both can bind simultaneously [117]. 
As DNA methylation is associated with altered chromatin structures and the co-
repressor complex containing mSin3A and histone deacetylases (HDACs) is thought 
to exert its effects by modulating chromatin structure [95, 2, 66, 68], it is possible that 
a part of the MeCP2 mediated transcriptional repression involves altering chromatin 
structure. A component of repression by the TRD may be deacetylase-independent 
[117] which is consistent with the observation that mSin3A retains some ability to re-
press transcription in the absence of associated HDACs [95]. However TRD-mediated 
transcriptional repression was alleviated in vivo by the deacetylase inhibitor TSA (Tn-
chostatin A [193]), although not completely [117, 80]. This indicates that histone 
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Figure 1.5: Schematic diagrams of MeCP2 and mSin3A. Thick black lines indicate 
regions of strong interactions between the two proteins. mSin3A contains a HDAC-
interaction domain (HID) and 4 imperfect repeats of a paired amphipathic helix (PAH) 
motif. 
deacetylation is a critical component of the transcriptional repression mechanism of 
the TRD of MeCP2. Thus MeCP2 may provide a mechanistic bridge between DNA 
methylation and histone deacetylation, and the association of MeCP2 and the mSin3A 
and HDACs co-repressor complex may lead to local deacetylation of core histones and 
perhaps of other transcription related proteins leading to the consequential elimination 
of transcription [123, 117]. 
Deacetylase inhibitors do not completely relieve transcriptional silencing [117, 80], and 
inhibition of methyltransferase activity alleviates silencing of particular genes while 
inhibition of histone deacetylase in isolation has no effect [36, 30]. This indicates that 
MeCP2 may repress transcription through additional pathways [23]. The transcrip-
tional repression of methylated DNA templates was found to occur during preinitiation 
complex assembly [82], thus indicating that a component of the basal transcriptional 
machinery is prevented from functioning. In addition, it suggests that MeCP2 does 
not necessarily require chromatin assembly or abundant complex co-repressors. Also it 
was reported that MeCP2 interacts selectively with the initiation factor TFIIB, but not 
with TFIIA, TFIID, TFIIE, TFIIF and TFIIH [82]. The interaction was detemined to 
be with the TRD but not with the MBD of MeCP2, and so does not require binding 
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to DNA. This suggests that an additional component of MeCP2 mediated repression 
involves direct contact with the basal transcriptional machinery. 
It has been reported that the C-terminus of MeCP2 also facilitates DNA binding, 
both to naked DNA and in the nucleosome. However binding of the TRD alone to ei-
ther nucleosome or DNA cannot be detected [32]. Therefore the C-terminus of MeCP2, 
including the TRD, has multiple functions in establishing a repressive chromatin struc-
ture. 
MeCP2 has the ability to repress transcription at a distance of over 500 bp from the 
transcription start site [119, 82]. It is also broadly distributed throughout chromo-
some arms [119, 118, 101], and in particular, is linked to X-chromsome inactivation 
[40, 177]. The density of mCpG sites for MeCP2 to bind also influences repression 
[26]. Repression is not linearly dependent on mCpG density, but appears suddenly 
at between 0.5 and 1 methyl-CpG per 100 bp at 2 Mg MeCP2 [119]. In mammalian 
genomes, the average density of methyl-CpG lies within this range and there is an ex-
cess of binding sites over MeCP2 protein [118, 119, 101], thus it appears that MeCP2 
cannot saturate its available binding sites. The abundance of MeCP2 and the high 
frequency of its 2 bp binding site with the aforementioned evidence suggests a role as 
a global transcriptional repressor in vertebrate genomes [40, 119, 161, 1771. 
1.4.2 MBD1 
MBD1 contains a MBD-like motif located at its N-terminus. It can also bind specifically 
to one symmetrically methylated CpG dinucleotide pair in vivo via its methyl-CpG 
binding domain and repress transcription at methylated promoters [69, 38]. The struc-
ture of MBD1 has recently been solved by NMR spectroscopy [131] and is analogous to 
the MBD of MeCP2 [181] (see chapter 4). MBD1 also contains two or three cysteine 
rich domains (CxxC) that are related to those in DNA methyltransferase protein 1 
(DNMT1), and the mammalian trithorax-like protein HRX [38] and a TRD [124, 52]. 
It was originally thought to be a component of MeCP1 [38] but is now believed not to 
be a part of this repressor complex [124]. 
Apart from the TRD, the second CxxC domain can also repress transcription, however 
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neither the first nor third (only present in certain MBD1 isoforms [53]) CxxC domain 
could repress transcription [124, 52]. The CxxC domain of HRX could also repress 
transcription, whereas DNMT1 could not. It was suggested that inhibition by the CxxC 
domain can occur without binding to the reporter gene and may be non-specific [124]. It 
was found that MBD1 isoforms, of which there are at least five [53], can control the Spi 
- activated transcription from unmethylated, hypomethylated and hypermethylated 
promoters. The third CxxC domain is responsible for the repression of unmethylated 
promoters. MBD1v1 and -v3 preferentially repress transcription from sparsely and 
densely methylated promoters respectively [52]. 
1 	 700 (a.a.) 
I 	 I 	 I 	 I 
CXXC domains 
Figure 1.6: Schematic diagrams of MBD1 isoforms. The methyl-CpG binding domain 
(MBD), transcriptional repression domain (TRD), nuclear localization signal (NLS) 
and two or three CxxC domains are shown. MBD1v1 can repress transcription of 
unmethylated promoters, whereas MBD1v3 cannot repress unmethylated promoters. 
The TRD of MBD1 can efficiently repress transcription at a distance of over 2000 bp 
upstream of the transcription start [124]. This differs from MeCP2 which shows a 
significant reduction with distance in the efficiency of repression [119]. Repression by 
the TRD is sensitive to TSA, suggesting a role for deacetylation. However it is unlikely 
that MBD1 associates with known histone deacetylase complexes, and unlike MeCP2, 
HDAC1 is unlikely to be responsible for deacetylation. It also appears not to be as-
sociated with Mi-2/NuRD or sin3/SAP30 co-repressor complexes. The relatively non-
specific repression by the CxxC domain was not sensitive to TSA [124, 52]. Nonethe-
less, MBD1 repression in vivo depends on the TRD, promoter occupation through the 
contact between the MBD and methylated DNA, and deacetylation [69, 52, 124]. 
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MBD1 is a chromosomal protein that is enriched in hypoacetylated constitutive hete-
rochromatin. It resembles MeCP2 by being stably associated with chromosomes, even 
during mitosis, when many transcription factors are displaced [110, 124]. However 
distribution of MBD1 on the inactive X-chromosome was not significantly different 
from that seen on the active X-chromosome or the autosome [124]. It does bind to 
methyl-CpG sites in the genes for the tumour suppressors p16, VHL and E-cadherin, 
and in imprinted SNPRN genes. It also inhibits promoter activities of these genes in 
a methylation - dependent manner [53]. In addition, MBD1 localizes to the hyperme-
thylated region of chromosome 1q12 as well as DAPI (4'6'-diamidino-2-phenylindole) - 
brightened regions in the nucleus of human cells [53, 52]. This is in contrast to MeCP2 
which is distributed throughout the nucleus in human cells [119, 53]. Although both 
MeCP2 and MBD1 are chromosome associated, MeCP2 is usually present at low levels 
in cultured cells [23, 101]. 
Recombinant MBD of MBD1 was shown to efficiently bind to densely methylated DNAs 
[52], whereas MBD of MeCP2 was found to bind preferentially to a single mCpG din-
ucleotide pair [120]. Thus the MBD of these two methylated DNA binding proteins 
appear to be homologous in sequence and have similar structures, but are distinct in 
function. Whether the two proteins normally compete for the same site, have addi-
tional specificities that segregate them or contribute to each others repression remains 
undetermined at the present time. 
1.4.3 MeCP1/MBD2, MBD3 and MBD4 
MeCP1/MBD2 
MeCP1 is another protein that has been found to bind specifically to methylated 
DNA and inhibit transcription [112, 25]. In contrast to MeCP2, MeCP1 binds to a 
number of contiguous methyl-CpGs (> 10 bp) [170, 112] and has been shown to repress 
transcription of densely methylated promoters [25]. It is also capable of repressing 
transcription from sparsely methylated promotors, however the interaction is weak 
and can be overcome by the presence of an enhancer [26]. MeCP1 activity is absent in 
ES cells, but is ubiquitous in somatic cells and tissues. This makes MeCP1 more likely 
to be involved in methylation dependent repression of specific genes in somatic cells. 
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MeCP1 is actually a large protein complex of 400 to 800 kDa [38] that includes the 
methyl-CpG binding protein, MBD2, the histone deacetylases, HDAC1 and HDAC2, 
histone binding proteins, RbAP46 and RbAP48, the trancriptional repressor, Sin3A 
and its related proteins [125]. MBD2 can bind methylated DNA in vivo and in vitro. 
However unlike tightly binding MeCP2 that is believe to be involved with the long 
term silencing of methylated genes [101, 118], MBD2/MeCP1 is released from nuclei 
by low salt [112] and therefore suggests that it does not stably complex with DNA. 
The MeCP1 subset of the HDAC co-repressor complex may be a catalytic complex 
that alters methylated DNA-containing chromatin during a transient visit or has a 
regulatory role [125, 241. 
Mammalian cells have the potential to encode both long and short forms of MBD2, 
referred to as MBD2a and MBD2b [69]. MBD2b was proposed to have methyl-CpG 
demethylase activity [19] but recent reports have indicated no such activity exists, and 
instead implicated MBD2 in transcriptional repression [125, 179]. Indeed MBD2b has 
been found to contain a TRD, which overlaps with the MBD and binds directly to the 
transcriptional repressor Sin3A [24]. The MBD2 - interaction domain of Sin3A contains 
the PAH3 domain (see figure 1.7) and overlaps the first MeCP2 interaction domain of 
Sin3A (see figure 1.5). However the TRDs of MeCP2 and MBD2 are quite distinct in 
that the TRD of MeCP2 is well separated from the MBD, whereas in MBD2, the TRD 
encompasses part of the MBD. In addition, human MBD2 is identical to NY-CO-41, a 
human cancer antigen recognized by autoantibodies from colon cancer patients [154]. 
MB D3 
The function of MBD3 is unknown at the present time. MBD3 is highly related to 
MBD2 as it is 72% identical (see figure 1.8)[69, 195]. Two related complexes, called 
NuRd complex and Mi-2 complex, have been found to possess both nucleosome remod-
elling and histone deacetylase activities [180, 191] and both contain Mi-2, a member 
of the SW12/SNF2 helicase/ATPase family, MTA2, the metatasis-associated protein, 
and the HDACs, RbAP46, RbAP48 along with MBD3 [195, 179]. Two spliced forms 
of MBD3 were identified in the NuRD complex, MBD3a and MBD3b. The major form 
in the complex is MBD3b, which contains only a portion of the MBD [195]. There 
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Figure 1.7: A schematic diagram of Sin3A and MBD2b. The MBD2b binds directly to 
Sin3A. The interaction domains are indicated. Sin3A contains four paired amphipatic 
helix (PAH) domains. MBD2 contains a methyl-CpG binding domain and a coiled-
coil-like sequence at the C-terminus. 
are two forms of Xerzopus laevis MBD3, MBD3 and MBD3 LF. MBD3 LF is a longer 
form of MBD3 with a 20 amino acid polypeptide insertion in its MBD (see figure 1.8) 
[179]. The Mi-2 complex has also been shown to have ATPase activity that is stimu-
lated by nucleosomes but by not free histones or DNA [61]. This nucleosomal ATPase, 
although relatively inefficient, is essential for the translational movement of histone oc-
tamers relative to DNA and for the efficient deacetylation of the core histones within 
a mononucleosome. 
Human and mouse MBD3 have been shown to be unable to bind methylated DNA 
[69]. X. laevis MBD LF also fails to bind DNA, presumably due to the disruption 
to its MBD [179]. However X. laevis MBD3 resembles the MBD of MeCP2 in both 
affinity and relative preference for DNA. His 30 of human and mouse MBD3 could 
be responsible for this finding. The equivalent residue in the X. laevis variant and 
all other members of the MBD family are either lysine or arginine, e.g. Lys 119 in 
MeCP2 and Arg 30 in MBD1 [69, 179] (see figures 1.8 and 1.4). This mostly conserved 
residue has been found to be a part of the DNA binding surface of the MBD of MeCP2 
and MBD1, and its position within the domain indicates that it is important for DNA 
binding [181, 131]. Its mutation to alanine in both the MBD1 MBD and MeCP2 MBD 
seriously reduced their binding affinities [52, 49, 131]. This would suggest that this 
substitution seen only in the human and mouse variants might be responsible for the 
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Figure 1.8: The sequence alignment of human MBD2, Xenopus laevis MBD3 LF, 
Xenopus laevis MBD3 and human MBD3. MBD3 LF (long form) has a 20 residue 
insertion in its MBD which inhibits binding activity. Amino acids identical in all 
proteins are shaded. The methyl-CpG binding domain (MBD) is indicated. Arrows 
highlight difference of His 30 of human (and mouse) MBD3 which is lysine (or arginine 
in MBD1 and human MBD4) for all other proteins in MBD family. Mutation of this 
conserved residue in MBD1 and MeCP2 seriously reduced binding, therefore it is most 
likely to be responsible for the lack of binding activity in human and mouse MBD3. 
distinct lack of DNA binding activity in MBD3. 
In fact, MBD2 is able to interact directly with components of the NuRD complex. The 
NuRD, containing the human/mouse variant of MBD3, is tethered to methylated DNA 
via MBD2 and this interaction between NuRD and MBD2 stabilizes the MBD2-DNA 
protein complex [195]. The component of NuRD that interacts with MBD2 could be 
MBD3. It was found that MBD2a/b and MBD3 interact with each other in vivo and in 
vitro and and form homo- and heterodimers (or multimers)[171]. In the MBD2a-MBD3 
heterodimer, MBD2 and MBD3 can bind both fully methylated and hemi-methylated 
DNA, respectively, and simultaneously. However the MBD3 homodimer does not show 
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any DNA binding activity. Also MBD3 was found to have gene repressing capabilities 
following the formation of the MBD2a-MBD3 complex [171]. Therefore it is possible 
that each MeCP1, Mi-2 and NuRd complexes could contain multiple molecules of 
MBD2 or MBD3 [125,1711- 
In addition, MBD2 and MBD3 were co-localized with DNMT1 at replication foci in 
293 cell nuclei at late S phase (period of DNA synthesis in cell cycle). It was shown 
that DNMT1 forms a complex with MBD2 and MBD3. The abundance of 1\4BD3 and 
DN1\4T1 was highest in the late S phase, whereas the MBD2 level was largely constant 
throughout the cell cycle. This suggests that MBD3 may play an important role in the 
S phase. 
The last member of the MBD family, MBD4, also contains a methyl-CpG binding 
domain at its N-terminus and specificially binds methylated DNA [69]. However unlike 
the other MBDs, MBD4, also known as MED 1, was found to preferentially bind methyl-
CpG.TpG mismatches - the primary product of deamination at methyl-CpG [70]. Also 
MBD4 appears not to have an active TRD but rather a C-terminal region that is closely 
related to the glycosylase/endonuclease domains of bacterial repair proteins. The MBD 
and glycosylase-like domain are highly conserved between human and mouse variants 
(86% and 95% identical respectively), whereas the rest of protein is much less conserved 
(only 47.5 % identical). 
Instead of being a transcriptional repressor, MBD4 was found to be a thymine glycosy-
lase that removes thymine or uracil specifically from a mismatches CpG site. However 
it lacks endonuclease activity and does not cleave the phosphate backbone of DNA [70]. 
It also shows no sequence similarity to thymine DNA glycosylase (TDG) [152, 121], but 
shows very similar catalytic specificities to TDG [70]. MED1 (identical to MBD4) was 
shown to form a complex with the DNA mismatch repair protein, MLH1, implicated 
in mismatch repair [16]. It was proposed that the function of this enzyme is to mini-
mize mutation at methyl-CpG by initiating the conversion of mCpG.TpC mismatches 
back to M.CpG.CpG and could be responsible for maintenance of genome stability 
[70, 16]. Indeed MBD4/MED1 was reported to be mutated in human carcinomas, 
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which are thought to be caused by defects of mismatch repairs [9, 152]. This suggests 
that MBD4 has a role as a turmour suppressor gene. 
1.5 Rett Syndrome 
Rett syndrome [151] (RTT, M1M312750), named after Andreas Rett who first described 
the disese in 1966, is a progressive neurodevelopmental and X-linked dominant disorder. 
It is one of the most common causes of mental retardation and autistic behaviour in 
females affecting 1 in every 10 to 15 thousand females [62]. Rett syndrome sufferers 
appear normal until 6 - 18 months of age then undergo a period of regression with 
gradual loss of speech and purposeful hand use, deceleration of head growth and develop 
the stereotypical repetitive hand movement [63]. Apart form these symptoms, they can 
also develop gait ataxia and apraxia, autism, seizures, respiratory dysfunction (episodic 
apnoea and/or hyperapnoea) and have decreased somatic growth [43, 56, 116]. After 
the initial regression, the condition stabilises and female sufferers usually survive into 
adulthood [63]. Due to the X-linked dominant nature of this disorder, it is lethal to 
hemizygous males but heterozygous females survive [173, 5]. Cases of males born with 
Rett syndrome suffered severe neonatal encephalopathy and died in infancy [156, 155, 
173]. Brain imaging and neuropathologocal studies on Rett syndrome patients showed 
that their brains are smaller than normal, due to a reduction in individual neuronal size 
and increase in their packing density (number per 0.1 mm 3). Although there is some 
degree of localised cerebral atrophy, characterised by small neuronal size and reduced 
dendritic arborisation, there is no neuronal loss [12, 7, 8], which was an early indication 
that Rett syndrome was neurodevelopmental rather than neurodegenerative. 
As Rett syndrome almost exclusively occurs in females it was suggested that it caused 
by an X-linked dominant mutation which, as mentioned before, is lethal to hemizygous-
males [155] [156, 63, 173, 5]. Exclusion mapping studies using RTT families mapped 
the locus to Xq28 [5, 163]. By using a systematic gene screening approach, mutations 
in the gene (MECP2) encoding the X-linked methyl-CpG binding protein MeCP2 have 
been identified as the cause of most cases of Rett syndrome [5]. MECP2 maps be-
tween L1CAM and the RCP/GCP loci in Xq28 and undergoes X-inactivation, and it 
is encoded in 3 exons [40, 177, 173]. MECP2 mutations are found in at least 76% of 
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sporadic cases and 45% of familial cases. Prior to this discovery, there were no labora-
tory or pathological markers for RTT. Diagnosis of the disease had to be based solely 
on the presence or absense of the clinical features in a relatively advanced stage of the 
disease [173]. 
The Rett syndrome mutations have been shown to be de novo in sporadic cases. There 
were no abnormalities seen in the DNA from both parents for all parents analysyed [5]. 
A high proportion of mutations involve cysteine deamination transitions to thymine at 
CpG dinucleotides. These mutations recurred in unrelated patients and thus reflects 
the hypermutability of this site [4]. 
Three types of mutations have been found in Rett syndrome patients [5, 4, 173, 182, 
130, 65, 41, 135, 33]. These are 
Frameshift mutations generating truncations within DNA encoding the MBD, 
TRD and C-terminus of the methyl-CpG binding protein MeCP2. Frameshift 
mutations are either an insertion (A or T); 620insT, 677insA, 694insT, 710insT 
and 1193insT; or a deletion (G or C); 411delG, 450delC, 706delG, 770delG, 
771delC, 803delG, 806delG and 882delC; as well as larger deletions; 258-259delCA, 
407de1507ins8, 654del4bp, 829de14bp, 855de14bp, 1116del84bp, 1147dell70ins3bp 
and 1152del4lbp. The several small deletions ranging from 41 to 170bp be-
tween bp 1116 and 1152 are possibly due to a number of palindromic and quasi-
palindromic sequences within this region, which are believed to form secondary 
structures that render the sequence vulnerable to deletions. 
Nonsense mutations preceding and immediately downstream of the MBD and 
within the TRD; L138X, Y141X, R168X, Q170X, R198X, S204X, Q224X, R255X, 
K256X, R270X, R294X and R452X 
Of particular interest to this project (see chapter 6) missense mutations where one 
residue type is exchanged for another. These occur mainly in the MBD but a few 
are found within the TRD; D97E, P101R/T/H/L, R106W/Q, L124F, R133C/H, 
S134C, A140V, P152R, F155S/I, D156E, T158M, T203M, P225R, P302A/L/R, 
R306C, P322L/A and E397K. 











Figure 1.9: A map of MeCP2 mutations in RTT patients. Missense mutations are 
indicated below the schematic of MeCP2 in boxes. Nonsense mutations are above the 
schematic in ovals. Frameshift mutations are not shown. 
The Rett syndrome causing mutations would produce a partial inactivation of MeCP2 
which is predicted to cause inappropriate expression of its target genes during develop-
ment and in tissues where these genes are normally silenced. Most patients with classic 
RTT and known MECP2 mutations have random X-chromosome inactivation; how-
ever favourable non-random X-chromosome inactivation mitigates the conseqeunces of 
MECP2 mutations [173]. This leads to a broad array of phenotypes, ranging from 
neonatal encephalopathy in males to very subtle learning deficits in healthy adult fe-
males. 
Ballestar et al. [10] attempted to use circular dichroism to study the structural effects 
of four Rett syndrome missense mutations (11106W, R133C, F155S and T158M). They 
found that R106W, R133C and F155S had severe reductions in their binding affinities 
for methylated DNA. However it was claimed that the reduction in binding affinity seen 
in these mutants was due to a decrease of organized secondary structure i.e. unfolding. 
This was subsequently found to be true R106W and F155S in a study carried out as a 
part of the current studies, but not so for R133C which was seen to undergo very little 
structural change(see chapter 6) [49]. 
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1.6 Aims of project 
The methyl-CpG binding protein, MeCP2 is an abundant mammialian protein that 
binds specifically to methylated cytosine in the sequence 5' CpG and mediates DNA 
transcriptional repression. MBD is the minimum sequence of 88 residues (residues 
77 - 164) from MeCP2 (486 amino acids) that still shows specific binding to the 5-
methylCpC dinucleotide. The first aim of this project is to solve the NMR structure 
of the methyl-CpG binding domain (MBD) of MeCP2. A second aim is to try and 
determine the mechanism by which the domain interacts with DNA and how mutations 
seen in Rett syndrome affect this process. 
Chapter 2 
Nuclear Magnetic Resonance 
spectroscopy 
2.1 Basic NMR theory 
NMR spectroscopy is based upon phenomena that occur when a nucleus with a spin 
experiences a magnetic field, B0 . A property of nuclei is an intrinsic angular momentum 
referred to as spin, which is a vector quantity and the magnitude of which is quantized 
in units of h ( =). Every isotope of every element has a spin quantum number, I, 
which is determined largely by the number of unpaired protons and neutrons and may 
have the values, 




2,••• I = 	where n is an integer. 	 (2.1) 
Quantum numbers greater than 4 are quite rare. The magnitude of this spin angular 
momentum, I, is given as 
I = [1(1+ 1)]h 
	
(2.2) 
When a nucleus has a spin (I > 0), it also has a magnetic moment, i, which is directly 
proportional to and parallel to I 
24 
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i= 71 = 7h[I(I + 1)] 	 (2.3) 
where -y is the gyromagnetic ratio. Due to insufficient theories of nuclear structure, y is 
considered as an empirical quantity and cannot be reliably calculated. The generation 
of a magnetic moment can be considered as a rotation of charge. 
The number of allowed orientations that the angular momentum I of a spin-I nucleus, 
and hence the magnetic moment, may adopt on an arbitrarily chosen axis, e.g. the z 
axis, is given by 21 + 1. Therefore the z componenent of I, I is quantized by 
I = mih => 1z = mjh 	 (2.4) 
where m 1 is the magnetic quantum number and has 21 + 1 values in integral steps 
between +1 and -I. 
mj = 1,1— l,I-2, ... —I+l,—I. 	 (2.5) 
Therefore, the angular momentum of a spin-i nucleus, e.g. 'H, has only two permitted 
directions, i = ii h. If I > , the nucleus also has a nuclear quadrupole moment. 
The spin angular momentum can be measured by supplying a magnetic field B 0 with 
which it can interact, bearing in mind that the axis of quantization is arbitrary and 
normally the spin angular momentum of a nucleus has no preferred directions. 
In the absense of a magnetic field, all orientations of a spin-I nucleus are random and 
the spin states are degenerate. However when a magnetic field, 13 0 , is applied, the 
magnetic moment align parallel (cr) or antiparallel (3) with the magnetic field and the 
degeneracy is removed. The energy of a magnetic moment in a magnetic field is 
E= —p•B0 	 (2.6) 
and the quantized z axis is no longer arbitary but coincides with the direction of the 
field, so 
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from equation 2.4, 
E = —B0 	 (2.7) 
E = —ymjhB o 	 (2.8) 
and the energy of the nucleus has shifted by an amount proportional to the gyromag-
netic ratio and field strength. The 21+1 states for a spin-1 nucleus are equally spaced 
with an energy gap of hyB. 
1=1/2 
	








Figure 2.1: Energy levels for spin- i and spin-i nuclei in a magnetic field. The gyro-
magnetic ratio differs between nuclei, 7H for spin-! and 'y  for spin- 2 nu cleus, hence 
difference in splitting of energy levels for two nuclei 
The selection rule for NMR transitions is Lm + 1, therefore only transitions between 




Here 11 is the frequency of the applied electromagnetic radiation to induce a transition, 
27r 
(2.10) 
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For a proton, the above equation 2.10 predicts a resonance frequency of ii = 6 x 108 
Hz or 600 MHz for a magnet of 14.1 T. This is in the radio frequency region of the 
electromagnetic spectrum (A = 75cm) and the e.m. radiation required to induce NMR 
transition as a consequence is known as the radiofrequency field. 
2.1.1 Larmor Precession 
When placed in a magnetic field, the magnetic moment experiences torque given by 
Z x Bo and will align along the direction of the field. However, since the rotation gives 
rise to angular momentum on the nuclei, the situation is modified and the nucleus 
behaves like a gyroscope, resulting in the precession of the magnetic moments about 
B0 with a frequency of w0 known as the larmor frequency. 
Z 
Figure 2.2: Lamour precession of spin 1 nuclei in applied magnetic field, B 0 . Nuclear 
spins precess at Larmor frequency 
wo = yBo 	 (2.11) 
where -y is the gyromagnetic ratio and B0 is the applied field strength. 
2.1.2 Energy level populations and NMR signal 
Boltzmann law states; 
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— 	I _hvlower 	 { LE1 kT j exp 	fi 	(2.12) Tiupper  
where k is the boltzmann constant and T is temperature. 
Considering a spin- i nucleus e.g. 'H, there are two allowed transitions, m = 
m = - i.e from the lower energy level to the upper energy level and vice versa. 





m = +I!2 
lower energy level 
I= 1/2 
o Bo 
Figure 2.3: Energy levels and transitions for spin-i nuclei, e.g 1 H, in a magnetic field, 
B. a corresponds to absorption and b corresponds to emission of energy. 
The coefficients of probability of absorption and emission are equal for NMR transitions 
and thus there would be no net energy transfer from the radiation to the sample if the 
populations of the two states were the same. As the system is in thermal equilibrium, 
the Boltzmann distribution of energies applies (see equation 2.12), 
1ower - exp [ - 
h
kT I ' B0  flupper 	 (2.13) 
As the thermal energy term, kT, is much larger than the energy gap AE, equation 
2.12 will be very small and may be simplified, using the approximation e_x  1 - x, to 
lower - 	hv 
u 	
1 - 	 (2.14) 
pper 	kT 
and the normalized population difference can be described as 
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lower - upper - AE 
(2.15) 
lower + flapper - 2kT 
As with all forms of spectroscopy, e.m. radiation excites atoms, electrons and/or nuclei 
from one energy state to another according to its selection rules with the same prob-
ability as the reverse transition can be induced. Therefore the net energy absorption 
and hence the intensity of the spectroscopic transition is dependent on the difference 
in populations of the energy levels. In the case of 1 H, the difference between two en-
ergy levels. The NMR signal obtained is directly proportional to the number of nuclei 
producing it. 
2.2 Relaxation 
There are two relaxation processes that allow nuclear spins to return to thermal equi-
librium after being disturbed by irradiating at the resonance frequency, spin-spin re-
laxation and spin-lattice relaxation. These more subtle processes are very important 
to NMR spectroscopy and can determine whether spectra can be collected or not. The 
main application of relaxation in relation to this project was in the dynamics studies 
discussed in chapter 5. 
When carrying out a NMR experiment, the thermal equilibrium of a spin system is 
perturbed by a radiofrequency pulse. This 
• alters the population ratios 
• causes transverse magnetic field components (M and M) to appear 
After the radiofrequency pulse, the system relaxes back to thermal equilibrium. There 
are two different relaxation processes that allow this to happen; 
relaxation in the applied field direction, described by the spin-lattice or longitu-
dinal relaxation time, T1 
relaxation perpendicular to the applied field direction, described by the spin-spin 
or transverse relaxation time, T2 
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Relaxation of nuclear systems is very slow, especially for spin-i systems, taking sec - 2 
 minutes or sometimes even hours for relaxation to reach completion. Protons in 
high resolution NMR, as in this case, have T 1 's of the order of a second and do not 
vary greatly for protons in different bonding situations. 
2.2.1 Longitudinal relaxation, T 1 
As mentioned before, in a NMR experiment the equilibrium of the spin system is 
disturbed. The magnetization vector M 0 (which is initially equal to M) is rotated by 
a 90, pulse from the z-axis into the y-axis or by a 180, into the -z direction. Both 
cause a population change. The 90, pulse equalizes the populations of the energy levels 
whereas the 180, inverts the population ratio. Afterwards the equilibrium condition 
= M0 reasserts itself. T 1 determines the rate at which this happens as described 
by 
	
dM 	Me — Mo - - (2.16) 
dt T, 
Therefore the rate constant of this relaxation is T i 1  and so it's a first order process. 
Spin-lattice or longitudinal relaxation is associated with a change in the energy of a 
spin system, as energy is absorbed from the pulse and is transferred to its surroundings 
(or lattice which can actually mean neighbouring molecules in solution, the walls of the 
NMR tube etc.) , whose thermal energy will then increase. 
Contributions to spin-spin relaxation come from a variety of intra- and intermolecular 
interactions. Thus relaxation is explained by different relaxation mechanisms such as, 
dipole-dipole(DD) or dipolar relaxation 
spin-rotation (SR) relaxation 
relaxation caused by chemical shift anisotropy (CSA) 
relaxation due to spin-spin coupling (SC) 
electric quadrupolar (EQ) relaxation 
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6. relaxation caused by interactions with unpaired electrons in paramagnetic corn-
pounds. 
In diamagnetic compounds, the main contributor is the dipolar coupling (DD) which is 
manifested through NOEs. This interaction occurs because each nucleus is surrounded 
by other magnetic nuclei which are in motion. This motion causes fluctuating magnetic 
fields at the position of the nucleus being observed. If these fluctuating fields have 
components at the appropriate frequency, they can induce nuclear spin transitions. 
The relative translation of two molecules is not a significant factor in spin-lattice re-
laxation since the distances are large between the dipoles from different molecules. 
Vibrational motions are also quite ineffective because of their high frequencies. It is 
the rotational movement of molecules which generates fluctuating magnetic fields with 
the right frequency. The spin-lattice relaxation depends therefore on the size and shape 
of molecules as well as the magnitude of the external magnetic field. Dipolar relaxation 
especially is an effective relaxation mechanism for heteroatoms with hydrogen atoms 
directly bonded to them. 
Of the other mechanisms, the dipole-dipole interactions between the nuclei and un-
paired electrons in paramagnetic molecules is of special practical importance since the 
large magnetic moment on the electrons makes this interaction very strong, e.g. a 
high concentration of paramagnetic impurities in the sample causes the NOE to be 
completely lost, and also results in broad NMR signals. 
2.2.2 Transverse relaxation, T 2 
It is known that immediately after a 90, pulse the z-component of the magnetization 
vector is zero (M = 0). This can only happen if the populations are equal i.e. 	= 
Nupper 
1. Instead there is now a transverse magnetization, nuclear dipoles are precessing 
around the surface of the double cone with identical phase. This condition is called 
phase coherence. 
The magnetization M., is the sum of the y' components of all the individual spins. T2 
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determines the rate at which this magnetization decays by the equations 
d(Mi) - - 
dt 	- 	 T2 	 (2.17) 
and similarly 
d(M') - - 
- 	
(2.18) dt 	T2  
This means that the precessing nuclear spins which are bunched together lose their 
phase coherence i.e. spread out (see figure 2.4) 
Mz=M A... .... 
	(A) 
A Z 	(B) 
/ 





Figure 2.4: The components of the magnetic moments of the individual spins in the 
x', y' plane of the rotating frame only are shown. A. Magnetization M 0 is flipped 
90° to y' axis by 90, pulse. B. Nuclear dipoles bunched together in phase (Phase 
coherence). C. The net transverse magnetization decreases after a length of time as 
individual spins spread out as a result of phase changes. 
The My , magnetization becomes smaller as the precessing nuclear spins spread out and 
therefore so does the induced signal in the receiver coil. The energy of the spin system 
remains unaffected by spin-spin relaxation because the populations are not affected. 
Only the phase coherence between the precessing spins is lost, therefore this type of 
relaxation is occasionally described as an entropy process. 




This is so because it is possible for the transverse magnetization M y , to have already 
decayed away completely by relaxation before the longitudinal magnetization M has 
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reached the equilibrium value M 0 . However M cannot reach its equilibrium value M 0 
until the transverse magnetisation M y, has completely disappeared. 
2.3 Spin-spin coupling 
Another phenomenon that occurs in most NMR experiments and is a useful source of 
information about the system being studied is an interaction between nuclei known as 
spin-spin coupling. Spin-spin coupling (also referred to as scalar coupling or J-coupling) 
causes peaks in NMR spectra to split into two or more components. It is brought about 
by a magnetic interaction between individual atoms that is "conducted" by bonding 
electrons [50, 73, 51] 
There are a number of factors that determine the size of a coupling constant. They 
include: 
the hybridization of the atoms involved. 
bond lengths. 
the presence of neighbouring ir-bonds. 
the presence of neighbouring electron lone-pairs. 
effects of substituents. 
and most relevant in terms of biomolecular NMR and this project, bond angles 
and torsional angles (see section 2.3.1). 
Therefore interpreting the information that is derived from coupling constant is not a 
trivial task. As coupling occurs wherever there are atoms with I > 0 and in biomolecular 
NMR, these are 'H, ' 5 N and 13C, the majority of the spectra collected are decoupled. 
In a magnetic field, a spin-! i nucleus (I) aligns parallel or antiparallel to the direction 
of the field. Considering the parallel alignment to the field, if a neighbouring spin-1 2 
nucleus (5) is aligned parallel, the total effective field at S is slightly larger. Likewise 
if the neighbouring spin S is aligned antiparallel the effective field is reduced. 
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Figure 2.5: Figure illustrating effects of scalar coupling on energy levels. 
For example, the one bond 'H - ' 5 N coupling constant in 90 Hz. It is therefore necessary 
to remove this coupling from spectra to maximise sensitivity, resolve overlap, and make 
processing and assigning it far less troublesome. The basic principle of decoupling is 
to flip the non-observed nucleus during acquisition many times between the a and /3 
states. As a consequence, the observed nucleus has a neighbour that is in neither the a 
nor /3 states, i.e. neither up nor down in respect to the magnetic field, while the proton 
signal is being acquired, thus splitting cannot arise. There are a number of ways to do 
this, for example, by applying a continuous irradiation field B 2 at the exact resonance 
of the ' 5 N spin however this "stirring technique" rapidly becomes ineffective as B 2 is 
shifted from the exact resonance by as little as a few hertz. Now there are sophisticated 
decoupling sequences that are used as standard involving composite inversion pulses 
that only employ 1800  phase shifts e.g. WALTZ-16 [159, 160]. 
> 
a) 








90 	 180 
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The only coupling that has been measured in the course of this project is the vicinal 
coupling 3J(H,H) 
2.3.1 Vicinal coupling 
The most useful spin-spin couplings are those involving nuclei separated by three bonds, 
in particular 3JHNHa in the protein backbone. These coupling constants are found to 
vary with the dihedral angle between the N/HN plane and the Cc/Ho plane, based 
on calculations by Karplus [83] which concurs with empirical evidence [140, 178, 94]. 
This relationship, known as the Karplus realtion is given by 
J= Acos2 O+Bcos9+C 	 (2.20) 
and describes the Karplus curve plotted in figure 2.6. 
Figure 2.6: Figure showing typical dependence of a three bond coupling constant on 
the dihedral angle, 9. 
Although it is possible to calculate approximate values for the coefficients A, B and C, 
it is more practical to use empirically determined values (see section 4.3.3). Evidently 
the coupling constants are largest for 0 = 0°or180°, and smallest for 0 = 900. 
The two major secondry structure elements, helices and sheets have characteristic 
HNH dihedral angles of 	1201 and 	180° respectively. This equates to 3JHNHO, 
values to < 7 Hz (4 Hz) for a helical conformation and > 7 Hz (-'10 Hz) for 0-sheet 
conformations. 
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2.4 Chemical shift 
A good illustration of chemical shift can be seen in a simple 1D spectrum 
10 	 8 	 6 	 4 	 2 	 0 ppm 
Figure 2.7: 600MHz 'H spectrum of the Methyl-CpG Binding Domain (MBD) of the 
methylated-CpG binding protein, MeCP2 (section 1.4) in 90% H 2 0 and 10% D 2 0. 
The resonance frequency of a nucleus is determined by equation 2.10 where it is de-
pendent on the field strength, B 0 , and the gyromagnetic ratio, 7. However not all 
nuclei have the same frequency. If they did only one peak would be seen in the 1D 
spectrum in figure 2.7. The resonance frequency of a nucleus depends slightly on the 
"environment" that that nucleus experiences i.e. on the local electron distribution. 
This phenomenon is called chemical shift. 
Chemical shift arises because the effective field, B, experienced by by nucleus differs 
slightly from the applied external field, B 0 . This is due to the external field causing the 
electrons to circulate within their atomic orbitals, which creates a small magnetic field 
B' affecting the overall field 'felt' by the atoms. Thus the nucleus is shielded from the 
external field by its surrounding electrons. The lower the electron density, the smaller 
the shielding is. In a molecule, this leads to a variation in frequencies for each atom 
and therefore can be distinguished from each other. 
Obviously B' is proportional to B 0 and is normally about 10 4 - 10 5 times smaller. And 
so the field experienced by a nucleus is 
B=Bo —B'=B o (l—a) 	 (2.21) 
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where ci is the proportionality constant between B' and B0 and is known as the shielding 
or screening constant. As a result the resonance condition (equation 2.9) becomes 
= 'yB 0 (1 - ci) 	
(2.22) 
2ir 
In a practical sense, a generalisation can be made by saying that the more electroneg-
ative the neighbour(s) of a particular proton, the electron density around it decreases 
therefore shielding decreases and the chemical shift increases. 
2.4.1 Aromatics 
In most biological macromolecules, there are a large number of aromatic species. For 
example, in proteins there are tyrosines, phenylalanine and tryptophan which are aro-
matic amino acids and in DNA all of the four bases - guanine, cytosine, adenine and 
thymine (uracil in RNA) - are aromatic. These make an important contribution to 
structural studies because of their very distinguishable chemical shifts. 
Aromatic protons have a large chemical shift values that comes from effects caused by 
their aromatic ring currents. When an aromatic species is placed in a magnetic field 
the delocalised ir-electrons, which define the aromaticity and make the ring planar, 
form a ring current which in turn generates an additional magnetic field. This addi-
tional induced field, decreases the effective field above and below the aromatic ring and 
increases it in the plane of the ring. This then leads to areas of increased and reduced 
shielding in the vicinity of the aromatic ring. As for the aromatic protons, they are in 
a region of reduced shielding, thus the chemical shift increases. 
2.4.2 Referencing 
As the shielding constant a is an inconvenient measure of chemical shift, it is more 
practical to define the chemical shift in terms of the difference in resonance frequency 
between nuclei; 
= (i' - Vrejerence) x 106[PPM] 	 (2.23) 
VO 
where ii and v0 are the absolute frequencies of a proton signal and that of a standard. 
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Normally 'H NMR spectra are are referenced on TMS (tetramethylsilane, Si(CH 3 ) 4 ) 
but in biomolecular NMR, referencing is done on the water signal. The chemical 
shift of water protons (81-120) has a slight dependence on pH, temperature and salt 
concentration and is given by 
5H20 = 4.776 - 0.0119(T - 25) - 0.002(pH - 7.0) - 0.09[salt] 	(2.24) 
where T is temperature in celsius, pH is the pH of the sample and [salt] is the molar 
concentration of salt in the sample. The absolute frequency at 0 ppm for protons can 
be calculated from the frequency of water and the water proton chemical shift (eqn 
2.24) using equation 2.23, 
H 
H 	 'H20 
11 
= 1 + (6H2o x 10-6) 	
(2.25) 
The heteronuclear chemical shifts can be calibrated using 
C H7C 
110 _ - 110 - 	 (2.26) 
7H 
N_ HYN VON 	- 	 (2.27) 
7H 
where VOH I VOC  and 
VON  are the absolute frequencies at 0 ppm for 'H, 13 C and ' 5 N 
nuclei respectively. The chemical shift of the centre of the spectrum, i.e. the reference 
or carrier frequency, in the indiretly detected dimensions can be determined using an 
analogy of equation 2.23 
N 	N 
- 





Vrrier - 0 X 106 PPM (2.29) 
VOC 
where VIrier  and Vrrier are the carrier frequencies for the 'H, 15N and 13  C nuclei 
respectively, and VOC  and 
VON  are determined using equations 2.26 and 2.27 respectively. 
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These values were used to reference the spectra for use in AZARA and ANSIG by 
setting the central data point to these chemical shifts and the spectral frequency to v0 
of the appropriate nuclei relating to that dimension. 
2.4.3 The Chemical Shift Index 
There is a correlation between the proton chemical shift and the character and nature 
of protein secondary structure. In particular, the chemical shift of the Ha proton of 
all of the 20 naturally occuring amino acids experiences an upfield shift with respect 
to the random coil (i.e. when the protein is in an unstructured or denatured state) 
when those amino acids are in a helical configuration and a comparable downfield shift 
when in a 0-strand configuration. Combined with the chemical shifts, "Ca, ' 3 C 13 and 
carbonyl ' 3C (CO), it is possible to use chemical shift measurements to identify and 
locate protein secondary structure elements, without resorting to NOE data. 
A program is available for the calculation of chemical shift indices [186]. It uses the 
chemical shift of four atoms mentioned above Ha, Ca, C3 and CO and follows the 
protocol: 
It compares each chemical shift with a list of average random coil shifts (i.e. the 
chemical shifts of those atoms in unstructured proteins) with standard deviations. 
If the Ha, Ca or CO chemical shift is greater than the acceptable range for that 
type of amino acid, then that atom in that residue gets marked with a "1"; if its 
less than the range, it gets marked with a "-1"; and it is marked with a "0" if it 
is within the range. 
Using these chemical shift indices for each residue in the protein, the secondary 
structure elements can be inferred. For a particular atom in a residue, groupings 
of four or more 'l's not interrupted by a '-1' corresponds to a helix, any dense 
grouping of three or more '-l's' not interupted by a '1' corresponds to a 0-strand 
and anything else is designated as coil. 
When 70% or more of the chemical shifts used have values indicating a helix or 
a strand and obey the rule of at least four consecutive 'l's' for a helix and three 
for a /3-strand per atom, that residue (which actually would be a grouping of 
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Figure 2.8: The consensus chemical shift index of the methyl-CpG binding domain of 
the methyl-CpG binding protein MeCP2 unbound derived from 1 H, 13C&, 1300 and 
13C0 chemical shifts. The inferred secondary structure is illustrated by a spiral symbol 
for the helix and arrow symbols for the strands. As shown MBD contains one helix 
and four /3-strands forming a /3-sheet. 
three or more residues) get defined as whichever secondary structure element, 
otherwise that residue get defined as 'coil'. 
4. Termination points at either end of the secondary structure element can often 
be recognized by the appearance of chemical shift indicies that are opposite to 
those of the corresponding secondary structure element i.e. after a grouping of 
'l's' for a helix, a '-1' appears. If this is not the case, the termination point is 
marked be two consecutive '0's or coil indicating values. 
The protocol is slightly different when it comes to considering Co values because Co 
resonances shift in the opposite way from Ha, Ca and CO resonances and Co chemical 
shifts overlap considerably. As a consequence of this overlap problem with Co reso- 








Figure 2.9: The consensus chemical shift index of the methyl-CpG binding domain 
of the methyl-CpG binding protein MeCP2 bound to a 14 base-pair duplex derived 
from 111, 13  Ca and 13C 3 chemical shifts only. The observed secondary structure is 
illustrated by a spiral symbol for the helix and arrow symbols for the strands. As shown 
the MBD complex contains one helix and four 3-strands forming a /3-sheet, identical 
to MBD in an unbound state. 
nances, they can only be used to identify stretches of 0-strands. Therefore it is likely 
that some helices might not be identified. The protocol modification for C/3 chemical 
shift indices is as follows: 
A grouping of three or more consecutive 'l's' is a /3-strand. Anything else is 
designated as coil or not a /3-strand. 
When determining whether 70% or more of indices for a particular residue are 
defining a sheet, obviously the C/3 indicies are counted as 'l's' while the others 
are counted as '-l's' to designate residues as 0-strands. 
The termination points can only be recognized by the first appearance of two 
consecutive zero values. 
The CSI analysis was carried out for MBD of MeCP2, both free and bound to DNA, 
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on the basis of the completed resonance assignments. The chemical shift index showed 
that the protein consists of four /3-sheets and one ct-helix (figures 2.8 and 2.9) 
The consensus chemical shift index also showed that MBD did not lose any of its sec-
ondary structure elements when complexed with a 14 base pair long piece of methylated 
DNA, nor did it gain any new secondary structure elements. Therefore a reasonable 
conclusion to draw from this data is that MBD does not change its overall fold when 
it binds to methylated DNA. 
2.5 Nuclear Overhauser Effect 
The nuclear overhauser effect (NOE) is the primary source of raw data for current 
protein structure determing techniques. It is seen between two spins that have an 
appreciable dipolar interaction. The NOE and the dipole - dipole relaxation mechanism 
are intimately connected. 
Consider two inequivalent spin-! i nuclei, I and S, with no scalar coupling, i.e. Ji = 
0, but with a dipolar interaction, the S spins are saturated (i.e. equal populations 
by applying a weak r.f. field at the S resonance frequency during the recording of the 
spectrum. This would not only remove any NMR signal from S but would also affect 
the intensity of the I resonance. The signal from I would get either stronger, weaker 
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Figure 2.10: Energy level scheme for a two-spin system with J15 = 0. The probabil-
ities W for the six allowed relaxation transistions are shown. Those marked with 1 
correspond to single quantum transitions, while W 0 corresponds to a zero quantum 
transition and W 2 to a double quantum transition. The energy level populations are 
shown in accordance with equation 2.14. A = 
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The origin of the NOE can be explained by considering the energy level scheme for a 
pair of dipolar coupled spin-! nuclei, I and S, (figure 2.10). If zero energy is assigned to 
the ai/3s and 13i&s states, then ignoring the small chemical shift differences, the alas 
and /3i13s states have energies —hwo and hw0 respectively, where w0 = B0 . If the pop-
ulations of the aif3  and I3i cEs states is 1, then 1+2A and 1-2A are the populations for 
the aras and 13i13s states respectively, where A =. The four single quantum tran-
sitions, W i , constitute the spin-lattice relaxation processes. W 2 and W0 indicate the 
likelihood of the spin system relaxing via double or zero quantum transitions respec-
tively, i.e. Lm = 2 or 0, and are extra pathways that allow the spin state populations 
to return to equilibrium following some disturbance. Also they are not subject to the 
Am = +1 selection rule and therefore cannot be excited by electromagnetic radiation; 
they are spectroscopically forbidden and are not NMR observable. However both are 
allowed in relaxation, and are known as "cross-relaxation". 
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Figure 2.11: Changes in spin state populations in an NOE experiment. L = 
When the S transitions are saturated, the energy level populations of the as and 
)3s states are equalized. This would entail a number of spins in the as state spin- 
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flipping up to the 13s state, so that the populations of cas and ailis, and of I3ias 
and PIPS are equal (figure 2.11). The I transitions, i.e. a —* lu, are unaffected 
and their population difference remain 2L. If the W 2 cross-relaxation pathway was 
only available, the equilibrium populations (1+2A and 1-2) of the ajcs and 13i13s 
states respectively would be restored. As indicated in figure 2.11, this would leave the 
population difference between the I transitions approximately 3A and so the intensity 
of I has increased. Likewise if the dominant relaxation pathway was the W o cross-
relaxation process, the populations of the ai/33 and /31as states would be restored to 
their equilibrium values of 1 and the population difference across the I transition would 
be approximately L. Therefore the intensity of the I resonance would be reduced. The 
combination of these two opposing relaxation mechanisms determines the change in 
the signal intensity observed as the nuclear Overhauser effect. Whether the intensity 
of I is increased or decreased depends on the magnitudes of the contributions from W 2 
or Wo . 
The predominance of the W 2 or the Wo relaxation mechanism depends on the corre-
lation time, r, of the molecule. That is to say, W 2 predominates in small molecules 
with short correlation times and W 0 has greatest effect in macromolecules with long 
correlation times. This is due to the fiuctating magnetic fields needed to induce the 
double quantum transition requiring to contain frequencies near the sum of the larmour 
frequency of I and S, whereas much lower frequencies are needed for the zero quan-
tum transition. Therefore the NOE signal amplification depends on the magnetic field 
strength. Likewise the effect of these two pathways cancel at a relatively intermediate 
correlation time, r;' w, and no NOE effect is observed. 
The above account of the nuclear Overhauser effect is referred to as "steady state 
NOE" and is applicable to the heteronuclear NOE experiment described in chapter 
5. The NOESY experiments (see figure 2.12 for pulse sequence) still involve cross-
relaxation, but there is no saturation of spins. Instead the NOE arises when the phase 
coherence of a group of spins, precessing at one frequency during a period ti, migates 
via the cross-relaxation mechanism to another during a predisposed period known as 
the mixing time (t m ). 
The enhancement caused by the nuclear Overhauser effect can be quantified by a factor 
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Ti. When wçr << 1, known as the "extreme narrowing limit", the maximum NOE effect 




where -y is the gyromagnetic ratio of the nuclei I and S. When wore >> 1, in the slow 




It can also be defined in terms of the resulting intensity, I{S}, of spin I when spin S is 
saturated and its normal intensity Jo; 




The dipole-dipole relaxation mechanism is the most common source of cross relaxation. 
Most other relaxation mechanisms tend to restore the equilibrium population via the 
W 1 .pathways and so bypass the cross relaxation routes that cause NOEs. As the 
relaxation rate attributed to the dipolar mechanism is proportional to the square value 
of the local fluctating fields, which is comprised of the magnetic field, B, produced 
by a non-zero magneic moment, y. As B is proportional to the inverse cube (r 3 ) of 
the distance from IL, the relaxation rate of dipolar coupled nuclei is therefore inversely 
proportional to the sixth power of the internuclear distances (i.e. r— 3  squared). Thus 
NOEs can be used to estimate relative intermolecular separations if the nuclei are 
undergoing similar motions and if they have comparable contributions from the other 
relaxation mechanisms. 
2.6 Water signal and its suppression 
A major problem associated with water signal lies in its overlap with resonances from 
Ha protons. This is mainly limited to the 2D and 3D NOESY, 2D TOCSY and HCCH- 
TOCSY experiments. The only significant problem was with the NOESY spectra as no 
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data can be interpreted from or to Ha protons whose chemical shift values fall under 
the water signal. This results in no distance restraints being available for a number 
protons in the backbone and a lack of information for constraining the structure in 
those regions. 
As the 2D TOCSY experiments were mainly used to get aromatic shifts, the water 
signal is not a concern. Triple resonance experiments such as the HBHACONH can 
be used to obtain the resonance assignment of those Ha protons that water signal 
interferes with. Thus there are ways to get around masking by strong water signal and 
to obtain a resonance assignment. 
However it is still necessary to suppress water signal. This can be done simply by ap-
plying a weak irradiating field at the frequency of the water signal during the recording 
of the spectrum and the resulting saturation reduces the signal intensity. There are 
a number of other methods used to suppress water e.g. the WATERGATE sequence 
(Water suppression by gradient-tailored excitation) [143], DPFGSE (double pulsed 
field gradient spin echo) [74] and jump-return techniques [144]. 
2.7 NMR experiments 
The NMR experiments carried out use techniques which employ short r.f. pulses while 
the magnet field is kept stable and homogeneous. They consist of a sequence of pulses, 
which are calibrated to flip magnetization through 900  or 1800,  separated by set time 
delays to allow for free precession. The oscillating and exponentially decaying trans-
verse magnetization is detected by the NMR spectrometer via its receiver coil. The 
detected signal is the combination (superimposition and interference) of the individual 
signals from the various nuclei in the sample, each with its own characteristic offset 
frequency from chemical shift and couplings, amplitude and T 2 value, and it is known 
as the "free induction decay" (FID), denoted by a triangle (labelled t2 in figure 2.17) 
at the end of pulse sequences. It contains all the required information for obtaining a 
NMR spectrum. 
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G2 	H 	H 
Figure 2.12: Diagram of the NOESY pulse sequence with a WATERGATE sequence 
for solvent suppression. 
INEPT (Insensitive nuclei enhanced by polarization transfer) 
The INEPT sequence is a building block of HSQC-type experiments, including triple 
resonance and 3D experiments. It can achieve polarisation transfer using non-selective 
pulses. The basic sequence comprises a 90 pulse, a delay r, simultaneous 18O pulses 
in the 1 H channel and ' 5 N channel (or 13C channel) another delay of length r, followed 
by simultaneous 90 pulse in the 'H channel and a 90 pulse in the ' 5 N channel (or 
"Cchannel). The principle of the experiment can be explained using vector diagrams 
and product operators. The delay r is calibrated to be -j-  (2.78ms).NH  
9o'c 	 180 	 90 
1H Li 
1800 	 goox 
15 N 
Figure 2.13: Diagram of the INEPT pulse sequence. Flip angles and direction of pulses 
are indicated. r is set to 
In the vector model, a coordinate system x', y' and z', is used which is rotating at 
l(15NOH)+t(15N/3H) 
the larmor frequency of the amide protons ( vj-j = 	2 	). The first 901 
pulse flips the two magnetization vectors MN' H and MNH , protons coupled to "N in 
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the a and 3 states respectively, into the y'-axis. These vectors precess with frequencies 
Of VH - 






y ' y, 
Figure 2.14: Effects of 90° pulse along the x-axis. 
After T = 4J() seconds, the phase difference 0 = 27rJ(NH)r 900 . The 180 0 pulse 
along the x'-axis in the 'H channel rotates the y component of the spin from the 
+y' direction to the -y' direction. Meanwhile the 180° pulse in the ' 5 N channel will 
flip the magnetization MN from the +z direction to the -z direction which has the 
effect of inverting the 15 N and 15N populations and so swapping around M ° and 
M. After the second delay r (2.78 ms), the phase difference will increase by another 
27rJ(NH)7- ( 90 0 ) to a total of 180 0 . 
MNU 	
Na 











M 	 channel 
in15N 
Figure 2.15: Effects of delay r and 180 0 pulses in both channels. 
The last 90° pulse along the y'-axis in the 'H channel rotates the M ° in the x' 
direction to the z-axis and MN16in  the -x' direction to the -z direction which has the 
effect of inverting the populations of only the 0 state 15N nuclei and this rotates only 
the MN'ff vector through 180 '. There is now a population of Np 1 15 with Hp and N,, 
with 'Ha in the sample (figure 2.16, middle). Since this ' 5 N magnetization originates 
from excess of protons on the lower energy level, it is 2a times more populated than 
IN 
the natural ' 5 N magnetization. The final ' 5 N pulse along the x'-axis would flip the MN 
magnetization to y'-axis creating transverse magnetization which then can be collected. 








Figure 2.16: Effect of last 900  pulses along the y-axis in 'H channel (left) and and the 
x-axis in the ' 5 N channel (middle & right) and the resulting magnetization transfer. 
The INEPT sequence can also be explained using product operators. The angular 
momentum operators I, I,, and I which represent the x, y and z components of the 
spin angular momentum of the system, are employed as the basis operators although 
other basis sets, such as single element and spherical basis operators, can be used and 
are often required to describe other experiments.The evolution of the spin system after 
the INEPT pulse can be conveniently derived using certain rules for transformation of 
product operators, rather than laborious and cumbersome matrix calculations, essential 
when describing the experiment using the density matrix formalism [31, 138, 166, 174]. 
During periods of free precession, i.e. the delay r, the hamiltonian for evolution of a 
two spin system I and S under scalar coupling, i.e. Jis =' ('H'N) is 27rJJsIS, and 
so the magnetization evolves (only those applicable to this description are given) as 
2irJjsI Sz 
	
I,, 	—+ Icos(7rJIsr)-2ISsin(1rJIsi- ) 	 (2.33) 
2irJjsIz S 
2IS 	- 2IS cos(irJjsr) + I. sin(irJjsr) 	 (2.34) 
The first equation demonstrates that scalar couplings cause the evolution of in-phase 
magnetization into anti-phase magnetization. The hamiltonian expression for the ra-
diofrequency pulses are cJ or aI, for a pulse of flip angle ce along the x- or y-axis 
respectively. The transformations for a pulse is given by 
crI± 
I 	 I cos(c) j I, sin(&) 	 (2.35) 




Ix 	) Ix 
aI± 
1z 	Iz cos (&)+Ir sin (a) 
aI± 
ly 	) ly 
a 1± , 






The initial equilibrium magnetization is KjIz where K1 = Considering figure 
2.13 and I and S representing the 'H and 15 N spins respectively, the magnetization is 
transferred as follows 
Ix 
I 	 —I (2.41) 
—Icos(1rJNHr) +2Ix Sz sin (lrJjvHr) (2.42) 
xix 
>Iy cos(1rJNH7- ) + 2IS sin(lrJNjqr) (2.43) 
7rS 
Icos(irJNHr) - 2ISsin(1rJNHi- ) (2.44) 
Icos(21rJNHr) - 2ISsin(27rJNH7- ) (2.45) 
The last equation has been reduced using the trigonometric identities Cos 2 (X) - Sin 2 (X) 
= Cos(2X) and 2Cos(X)Sin(X) = Sin(2X). A 90 pulse is applied to the I spin, and a 
90 pulse is applied to the S spin. 
1r1 
	
IY cos(2JNHT) + 2ISsin(27rJNjqr) 	 (2.46) 
—+ Iycos(27TJNHT) - 2ISsin(27rJNH7 - ) 	 (2.47) 
If the delay r is set to -j-  (2.78 ms) then the final signal is Kr(-2IS).  The 
magnetization has been transferred onto the ' 5N spin and is scaled by the proton Kj 
factor, hence it has been successfully transferred from the sensitive proton nuclei to 
the less sensitive nitrogen-15 nuclei. 
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2.7.1 Multidimensional NMR 
An 1D NMR spectrum can be very complex, if the sample it was acquired from contains 
many protons as is the case with macromolecules like proteins. The complexity would 
be reduced if the data could be displayed on more than one axes and hence 2D and 
3D NMR spectra. 
The simplest 2D NMR pulse sequence consists of two 900  pulses separated by a delay, 
ti, followed by an aquisition time, t 2 , where the FID is collected. The second dimension 
is achieved by varying tj and collecting a FID for each such variation. This leads to a 
two dimensional set of NMR data as a function of ti and t2, with signal in t2 amplitude-
modulated as a function of t,. This technique can be extend to include a third time 
variant and thus add a third dimension to the NMR spectrum. 
More complicated pulse sequences are used such as those for TOCSY (TOtal Corre-
lation SpectroscopY) and NOESY (Nuclear Overhauser Effect Spectroscopy) exper-
iments. The NOESY experiment is of particular importance to biomolecular NMR 
because of its ability to identify pairs of spins that are separated by less than 6 A. The 
NOESY pulse sequence is illustrated in figure 2.12. 
The first part of the NOESY pulse sequence, i.e. a 900  pulse, t1 period and another 90 0 
pulse, frequency labels the proton spins and returns the magnetization to the z-axis. 
During the delay tm (mixing time), dipolar coupled spins undergo cross-relaxation and 
magnetization is transferred from one spin to another via the NOE. The final 90° pulse 
along the x-axis flips the magnetization from the z-axis to the y-axis where it becomes 
observable transverse magnetization. 
Two dimensional NMR does not always concern only protons, i.e. it isn't always 
homonuclear. The second dimension can correlate to other types of spin-i nuclei e.g. 
' 5 N and 13C, i.e. heteronuclear. Usually, at least one dimension in a 3D NMR exper-
iment concerns either 15 N or 13C spins. The most commonly used 2D heteronuclear 
experiment in biomolecular NMR, especially in the case of this project, is the ' 5 N 
HSQC (Heteronuclear Single Quantum Coherence) where every - coupled 'H-' 5 N 
species ('J'H15N = —90Hz) is represented by a peak at (5H,6iv)  where 5H  and SN are 
the amide 'H and ' 5 N chemcial shifts respectively. One axes of the spectrum gives 
(6.VIk\ 
180 	90 	 90 	180, 
15 N 
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' 5 N chemical shifts and the other givesb the 1 H chemical shifts (see figure 3.2). Each 
residue is represented in this spectrum except for prolines and in addition there are 
peaks representing side-chain amides, e.g. those in glutamates, asparates and arginines. 
90 	1800 	90, 	18O, 	90 	180 
INEPT 	 reversed INEPT 
fin 
Figure 2.17: Pulse sequence for the 15 N HSQC. A soft pulse watergate sequence used 
for water suppression was included during the refocusing period of the reversed INEPT. 
The INEPT components of the pulse sequence are indicated. 
The HSQC pulse sequence consists of an INEPT sequence, followed by a t1 evolution 
period and then a second INEPT sequence. The heteronuclear magnetization transfer 
is obtained after the first INEPT sequence where I spin polarization is transferred into 
antiphase heteronuclear single quantum coherence. The antiphase heteronuclear coher-
ence evolves during the subsequent t1 period. The 1800  pulse in the 111  channel dur-
ing t1 refocuses the proton- heteronuclear coupling evolution and so the heteronuclear 
coherence evolves only with the X-nucleus chemical shift hamiltonian. The second IN-
EPT sequence transfers the frequency labelled heteronuclear magnetization back onto 
protons where it is detected. 
The principle of combining polarisation transfer mechanisms in a single experiment, 
as illustrated above with the HSQC experiment, can be extended to create three di-
mensional experiments. Similarly, combined hetero- and homonuclear 2D experiments 
can be adopted to yield 3D experiments. For example, heteronuclear one-bond cor-
relation is combined with a NOESY transfer, for reduction of cross peak overlap in 
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a 2D homonuclear NOESY experiment. The introduction of another acquisition pe-
riod into a 3D ' 5 N HSQC - NOESY (also called a ' 5-edited NOESY) experiment will 
spread the NOE cross peaks of NH protons along a third dimension according to the 
' 5 N chemical shift of the nitrogens they are attached to. This gives a spectrum that 
is a cube where each peak at ( 8HN , 6H,6N) represents a NOE connectivity between a 
amide proton resonance and other protons in the sample. Indivual ' 5N planes of the 
3D NOESY spectrum contain much less overlap than the corresponding 2D spectrum. 
A variety of 3D experiments have been devised using this building block principle, e.g. 
3̀C edited NOESY and 3D TOCSY-HSQC. 
Triple resonance experiments transfer magnetization along the protein backbone using 
various coupling constants and pulse on three different frequencies ('H, 13 C, ' 5 N), hence 
the name. They belong to a class of techniques called out-and-back experiments. The 
magnetisation transfer pathway starts on the amide protons, moves via the amide 
nitrogen onto carbon atoms, whose chemical shifts are labelled during t1, t2 and t3 
acquisition periods, and back again to end up back on the amide protons. These 
experiments proved to be most useful for sequential assignment of doubly labelled 
proteins. Examples of triple resonance experiments with their magnetization pathways, 
as described by their name, are shown in figure 3.1 in chapter 3. 
2.8 Data acquisition 
The intensity of a one scan FID is usually weak and FT signals are very small compared 
with the noise. Therefore a time domain spectrum is an accumulation of a number 
of FIDs. The random electronic noises are partly averaged out, whereas the signals 
are combined constructively and so accumulate. The signal to noise ratio is directly 
proportional to the square root of the number of scans. 
The induced current picked up by the receiver coil during acquisition is digitalised by 
the receiver. The signal frequencies of the signals are measured as an offset from a 
reference frequency usually set to the middle of the frequency spectrum. The measure-
ments can be positive or negative depending on whether the resonance frequencies are 
greater than or less than the reference frequency. Quadrature detection is employed 
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Experiment Nuclei Sweep width Data points Processing Mixing Temj 
observed time 
MBD 
21) HSQC 8000.0/2015.0 2048 x 192 FFT - 18 ° 
21) HSQC 1 11/ 13 C 8000.0/12000.0 2048 x 256 FFT - 18 ° 
3D HBHA(CO)NR '14/'H/' 5 N 7679.8/3059.7/2015.0 1024 x 96 x 64 FFT/MEM - 18 ° 
3D HNCA 'H/ 13 C/ 15 N 7679.8/5934.7/2015.0 1024 x 64 x 64 FFT/MEM - 18 ° 
3D HN(co)cA 'H/ 13 C/ 15 N 7679.8/5934.7/2015.0 1024 x 96 x 64 FFT/MEM - 18 ° 
31) HNcAcB 1 H/ 13 C/ 15 N 7800.3/10559.7/2015.0 1024 x 128 x 64 FFT/MEM - 17° 
3D CBCA(CO)NH 'H/ 15 C/ 15 N 7679.8/10559.7/2015.0 1024 x 128 x 64 FFT/MEM - 18 ° 
3D H(C)(Co)NH-T0CSY 'H/ 1 H/' 5 N 7800.3/7199.4/2015.0 1024 x 128 x 64 FFT/MEM - 18 ° 
31) (H)C(CO)NH-TOCSY 'H/ 13 C/ 15 N 7799.6/10559.7/2015.0 1024 x 128 x 64 FFT/MEM - 17 ° 
31) HNCO 'H/ 13 C0/ 15 N 7679.8/2224.9/2015.0 1024 x 128 x 64 FFT 	- - 19 ° 
31) HCACO 'H/ 13 C/ 13 C0 3839.9/5934.7/2225.5 512 x 72 x 64 FFT - 18 ° 
3D HCCH-TOCSY 'H/ 13 C/ 13 C 4400.3/3800.1/5280.0 1024 )< 128 x 128 FFT/MEM 16 ms 18 ° 
3D (H)CC-TOCSY-CH3 'H/ 13 C/ 13 C(CF13) 8000.0/10559.7/6200.6 1024 x 128 x 96 FFT/MEM - 17 ° 
31) ' 3 C-edited NOESY-HSQC 'H/'H/ 13 C 7679.8/6478.8/3320.1 1024 x 192 x 64 FFT 80 mc 18 ° 
31) 15 N-edited NOESY-HSQC 'H/'R/' 5 N 5000.0/7000.0/2015.0 1024 x 320 x 64 FFT 75 ms 18 ° 
3D HNHA 'H/'H/ 15 N 9000.9/8000.0/1500.0 2048 x 156 x 64 FFT - 18 ° 
2D 1 H-'H COSY 'H/'H/ 8200.1/7400.6 4096 x 1280 FFT - 18 ° 
21) 111.114  NOESY 'H/'H/ 10000.0/7919.2 4096 x 1024 FFT 100 mc 18 ° 
2D TOCSY 'H/ 1 H/ 10000.0/7919.2 4032 x 1024 FFT 20 ma 18 ° 
2D TOCSY 'H/'H/ 10000.0/7919.2 4032 X 1024 FFT 50 mc 18 ° 
MBD-DNA complex 
2D HSQC 1 11/ 15 N 8000.0/1500.0 1024 x 192 FFT - 25° 
31) HBHA(CO)NH 'H/'H/' 5 N 8000.0/6199.6/1500.0 1024 x 120 x 64 FFT - 25 ° 
3D HNCA 'H/ 13 C/ 15 N 8000.0/5279.8/1500.0 1024 x 64 x 64 FFT - 25 ° 
3D HN(CO)CA 'H/ 13 C/ 15 N 7679.8/5934.7/2015.0 1024 x 96 x 64 FFT - 18 ° 
3D CBCA(CO)NH 1 H/ 13 C/ 15 N 7679.8/10559.7/2015.0 1024 x 128 x 64 FFT/MEM - 25 ° 
3D HCCH-TOCSY 1 H/ 13 c/ 13 C 7800.3/5280.0/6400.0 1024 x 112 x 96 FFT 16 mc 24 ° 
3D 13 C-edited NOESY-HSQC 'H/ 1 H/' 3 C 8000.0/6199.6/5609.3 1024 x 128 x 80 FFT 80 mc 24 ° 
3D CN-edited NOESY-HSQC 1 H/ 1 H/ 15 N( 13 C) 8000.0/6199.6/5609.3 1024 x 128 x 80 FFT 75 ms 24 ° 
3D (H)C(CO)NH-T0CSY 'H/ 13 C/ 15 N 7799.6/10559.7/2015.0 1024 x 128 x 40 FFT/MEM - 19 ° 
3D HNCO 1 1i/' 3 C0/' 5 N 7679.8/2224.9/2015.0 1024 x 64 x 64 FF'T - 19 ° 
DNA 
2D 'H- 1 H COSY 114/114/ 10999.6/8200.1 11008 x 4096 FFT - 18 ° 
2D 1j{114  NOESY 'H/'H/ 10999.6/8200.1 6976 x 1536 FFT 120 mc 18 ° 
2D 1 H-'H NOESY 'H/'H/ 12001.2/5200.2 4096 1< 1024 FFT 100 ma 25 ° 
2D '}i-'H NOESY 'H/'H/ 10999.6/8200.1 6976 1< 1536 FFT 40 ms 18 ° 
21) 1102-edited NOESY 'H/'H/ 10999.6/8200.1 1408 x 1024 FFT 100 mc 25 ° 
2D 1112-filtered NOESY 'H/ 1 H/ 10999.6/8200.1 2048 x 1024 EFT 100 mc 25 ° 
2D fl-filtered TOCSY 'H/'H/ 10999.6/8200.1 2048 x 1024 FFT 43 ms 25 ° 
MBD mutants 
21) HSQC 'li/ 15 N 8000.0/2015.0 2048 x 128 FFT - 18 ° 
31) ' 5 N-edited NOESY-HSQC 'H/'H/' 5 N 8000.0/6300.0/1277.0 1024 x 160 x 64 FFT 75 ms 18 ° 
Table 2.1: NMR experiments and acquisition parameters for studies on MBD. Dynamics experiments, 
WEX II-FHSQC and experiments on peptides are not included. Sweep width is in Hertz. Processing 
indicates whether only fast Fourier transformation (FFT) and/or Maximum Entrop Methods (MEM) 
were used. The G114P mutant was the only MBD mutant that a 3D 15 N-edited NOESY-HSQC was 
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to characterise the sign of the frequencies. This technique uses two phase sensitive 
detectors, one records the y-component of the magnetization and the other records the 
x-component of the magnetization, i.e. at a 900  phase shift to the y-component. This 
in essence records the sine and cosine components of a harmonic signal. The signal is 
sampled at evenly spaced time intervals as both a cosine modulated signal (real) and 
a sine modulated signal (imaginary), and is represented as complex data. 
2.9 X-filtered experiments 
The X-filtered or fl,f2-edited experiments are a series of isotope edited 2D NOESY 
experiments. They make use of uniform 13C and 15 N labelling of the protein or DNA 
and ' 3C and 15 N half filters to selectively observe components within biomolecular 
complexes. This technique has been applied to distinguish intra- and intermolecular 
NOEs of the MBD-DNA complex in which the protein is uniformly labelled and the 
DNA is not. 
In biomolecular complexes involving ' 3 C and 15 N doubly labelled molecules, three types 
of protons can be discriminated; 13 C-attached protons; ' 5 N-attached protons and the 
protons which are bound to ' 2 C and 14 N; through the use of simultaneous or "time-
shared" [ 13C, ' 5 N] isotope half-filters [164]. In practice, this can be acheived using 
the pulse sequence shown in figure 2.18 and use of the alternative combinations of the 
"WURST180" shaped pulses for the 13C istope half filter or the shaded 900  pulses 
for the ' 5 N isotope half filter [Dusan Uhrin, University of Edinburgh]. The collected 
FID was analogous to a 4D spectrum with the third and fourth dimensions containing 
2 data points each. They relate to the inclusion or exclusion of the fl editing and f2 
editing pulses. Each 2D plane was extracted from the processed time-domain spectrum, 
using the "extract" application from the AZARA package. It was found that each 2D 
spectrum required different phase corrections and the sign of the peaks varied in each 
plane as indicated in table 2.2. 
A short GF1 standard peptide (1 mM peptide in DMSO-D 6) , 8 residues long containing 
three isotopically labeled residues, 1 Tyr.Glyj15 N, 13 C]Gly-[' 5 N, 13 C] Phe- [15 N,' 3 C] Leu- 
Arg-Arg-Ile 8 (CiL, Massachusetts) was used as a test for the pulse sequence and to give 
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data for the purpose of determining a processing protocol for this experiment. 
TXI I I I I 
Dec ecoup 13C 
Wurst180 	 Wurstl80 
Dec2 llII_fl 	De 
Figure 2.18: Pulse sequence for the f1f2-edited NOESY experiment. It contains 
"wurst180" shaped pulse for 13C/ 12C selection and the shaded 900  pulses on 'Dec2' are 
for ' 5N/' 4 N selection. This pulse sequence was written by Dusan Uhrin, University of 
Edinburgh. 
Plane 'Highlighted pulses b H12 —H12 H 12 -4 H13 H 13 —* H12 H 13 —* H13 
1 fled n + + + + 
f2ed n 
2 fled n + - + - 
f2ed y 
3 fled y + + - - 
f2ed n 
4 fled y + - - + 
f2ed y 
Table 2.2: 	and 2nd  highlighted pulses for Fl and F2 editing respectively, a indicates 
which pulses are selected. b (+) and (-) show sign of peaks which then can be used to 
include or exclude certain NOEs. Indices 12 and 13 indicate protons attached to 12 C 
or 14 N and 13C or 15 N respectively. 
Spectra containing only certain NOES can be obtained from particular combinations 
of the 2D planes. This was achieved using the "combine" application from AZARA. To 
obtain a 2D noesy that only contains NOEs to and from protons bound to 12 C or 14 N, all 
four planes were combined together (table 2.3). A 2D spectrum only containing NOEs 
to and from protons bound to 13C or ' 5 N nuclei by adding the first and fourth planes 
(as numbered in table 2.2) and subtracting the second and third planes. Similarly a 
spectrum showing NOEs from protons bound to 12 C going to protons bound to ' 3C can 
be obtained by adding the first and third planes and subtracting the second and fourth 
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planes. The reverse, i.e. NOEs from ' 3C attached protons to ' 2 C attached protons, 
was obtained after adding the first and second planes and the subtraction of the third 
and fourth planes. This is summarised in table 2.3. 
Plane 1 	Plane 2 	Plane 3 	Plane 4 NOE 
+ + + + H12 —>1112 
+ 	- 	 - 	 + H13 	H13 
+ - 	 + - H12 H13 
+ 	+ - 	 - H13 	H12 
Table 2.3: Planes are as numbered in table 2.2. (+) and (-) indicates addition or 
subtraction of plane. H12 and H13 refer to 12 C (or ' 4 N) attached protons and 13C (or 
15 N) attached protons respectively. 
The X-filtered experiments were successfully run and collected on the MBD-DNA com-
plex, where all protons in the protein were 13 C or 15 N bound and DNA protons were 
12 or 14 N bound. This would ultimately lead to four 2D NOESY spectra: one of only 
the DNA molecule, one of only the protein molecule and two intermolecular NOESY 
spectra. Unfortunately the NOESY spectrum of the unlabelled DNA molecule showed 
only very broad peaks except for sets of peaks that were assigned to the terminal base 
pairs. However the spectrum which contained NOEs to and from protons attached to 
13C nuclei, i.e. the protein, displayed sharp peaks. There were no observable peaks in 
either intermolecular NOESYs. 
As this technique has been shown to be working, both with the aforementioned peptide 
and in literature [164], it was concluded that an effect at the DNA binding interface 
must be the cause of the peak broadening. Whether it is due to exchange, motion 
between the two molecules at the binding interface or some other reason remains un-
known. 
2.10 Spectral processing 
The FIDs recorded during a NMR experiment contains frequencies and intensities 
which are of interest. However this time domain spectrum can only be analyzed di- 
rectly if it contains a single resonance frequency. NMR spectra of small molecules 
let alone macromolecules very rarely contain a single resonance frequency so the fre- 
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quency domain spectrum, the characteristic NMR spectrum (examples given in figures 
2.7, 3.2, 3.4, 3.6, 3.7 and 6.3) used for interpreting the data it holds, has to be obtained. 
There were two methods employed to achieve this: Fourier transformation (FT) and 
Maximum entropy reconstruction (MaxEnt or MEM). 
2.10.1 Fourier transformation 
Fourier transform theory, a mathematical theory first postulated by Joesph Fourier 
in 1807, has many practical applications including NMR signal processing. Fourier's 
theorem states that certain periodic functions can be expressed as the sum of a number 
of sine functions of different amplitudes, phases and periods, and relates one function 
in the time domain, f(t), and another in the frequency domain, g(w), by 
	
g() = {f(t)} =1   f(t)e t dt 	 (2.48) 
where t is time (seconds) and w = 27rv (Hertz). 
The inverse Fourier transform is a linear operation and therefore 
t 
00 
1(t) = F 1 {g(w)} = i 
- J g(w)e'dw 	 (2.49) 2ir
-00 
The Fourier transform is a linear operation and therefore 
.T{af i (t) + bf2 (t)} = ag(w) + bg(w) 	 (2.50) 
where a and b are complex or real constants. The Fourier transform has a range of 
useful mathematical properties that are applicable to signal processing and can be 
found in most standard textbooks. 
The function of the frequency domain, g(w), is complex and can be represented as its 
real (gr (w) and imaginary (g2 (w)) components, 
= g, (W) + gj (w) 	 (2.51) 
The real part of the Fourier transform is the decomposition of the time domain function 
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1(t) cos (wt)dt 	 (2.52) 
co 
g' (LO) = 	
f(t) sin (t)dt 	 (2.53) 
-00 
The phases of the signal differ by 900,  and thus the first equation yields an absorptive 





Figure 2.19: (A) Absorptive and (B) dispersive Lorentzian lineshapes. The cusps 
of the dispersive lineshape are separated by exactly the linewidth of the absorptive 
lineshape. 
As the recorded FID is a digital sampling of the analog signal, the discrete Fourier 
transform is used to calculate the experimental frequency domain spectrum 
k 	 N—i 
= 	
= F{f(jzt)} = E s(jLt)e N 	 (2.54) 
j=o 
where N is the number of complex data points, it is the sampling interval, and k = 
0,. .., . In practice, the discrete Fourier transform is calculated using the 
fast Fourier transform (FFT) algorithm, which is an order N1092N  process, because it 
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is considerably faster than directly calculating the discrete Fourier transform, an order 
N 2 process. When the FFT algorithm is used, the number of data points must be 
an integral power of 2, i.e. N = r where n is a real positive integer. If the acquired 
number of data points does not fit this criteria, then the data is extended by zero-filling 
so that N = 2. 
2.10.2 Pre-transformation process 
Certain processes are required to be performed on the time domain spectrum before 
processing it. The optimal frequency domain spectrum is never obtaianed if these 
processes are not carried out before Fourier transformation. 
Zero-filling 
Zero-filling is the process of extending a collected FID with zero values so that the 
number of data points sampling the FID is an integral power of 2. This improves digital 
resolution proving the FID has decayed close to zero by the end of the acquisition time. 
Window functions 
Window functions are used to give desirable peak shape, better resolution, remove 
truncation artefacts and improve the signal to noise ratio. There are a range of available 
window functions e.g. exponential decay curve, Gaussian and Lorentzian-to-Gaussian 
functions. The most commonly used window function in this project was the sinebell 
squared function. 
They are applied by convoluting the spectrum with the desired function h(w) 
00 
h(w) ® g(w) =J f(t)h(t - s)ds 	 (2.55) 
-00 
where s is a dummy variable of integration. 
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2.10.3 Post-transformation process 
Phasing 
Phase corrections nearly always have to be made and are a fundamental part of pro-
cessing NMR spectra, because the spectrum displays frequency-independent as well as 
-dependent phase errors. The errors arise from mathematical properties of the rep-
resentation of the digitalized signal. The real part of the spectrum is a mixture of 
absorptive (A(w)) and dispersive (D(w)) lineshapes and mathematically these compo-
nents can be separated by constructing a new data set. 
However in practice an approximation is used so that spectra with multiple resonances 
can be handled, 
	
g'(w) = u(w) + iv(w) A(w) + iD(w) 	 (2.56) 
where 
u(w) = R{g(w)}cos(0w) + {g(w)}sin(0w) 	 (2.57) 
v(w) = {g(w)}cos(0w) - ll{g(w)} sin (0w) 	 (2.58) 
where 0(w) = 00 + 0 1 (w) is determined empirically to minimise the phase error; 0 0 is 
the zero-order phase correction and 01 (w) is the first order phase correction. 
Post-acquisition suppression of water signal 
Although water suppression techniques are efficient at removing water signal during 
the experiment, there is almost always some water signal remaining and it is often 
desirable to attempt to remove it post-acquisition. The convolution difference low-pass 
filter technique [85] is used to achieve this by filtering the low-frequency components 
from the signal by substracting the following from f(kz.t), 










where bj are filter coefficients and At is the sampling interval. Values of m are usually 
in the range of 8 to 64. 
2.10.4 Maximum Entropy reconstruction (MEM) 
As the time required to acquire a multidimensional NMR spectrum is proportional 
to the number of data points in the indirectly detected dimensions, the data for these 
dimensions is almost always truncated. In the case of 3D spectra, the truncation is quite 
severe. Often it is necessary to increase the resolution of 3D spectra especially since 
Fourier transformation of truncated time-domain interferograms can reduce resolution 
and produce truncation artefacts. Therefore it becomes necessary to use an alternative 
to Fourier transformation for processing the severely truncated indirectly detected 
dimensions. In the case of this project maximum entropy reconstruction (also called 
maximum entropy methods) [98, 71, 31]. 
An important point is that MEM processing cannot improve on the Fourier transform 
of the directly detected dimension (which is not truncated). MEM processing is done 
only on the truncated data, i.e. the indirectly detected dimension, after the complete 
directly detected FID has been been Fourier transformed. 
MEM reconstructs the frequency domain spectrum directly by determining the spec-
trum, g() for k = 0, 1, ..., N-i that maximizes the entropy function 
N-i 	k 	k 
S = 	 (2.60) 
k=O 
subject to the constraint 
N—i 
e = 	(f(j/.It) - j(jt))
2 
= M 	 (2.61) 
j=o 
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where M is the number of experimental time domain points, f(jLt) is the j 1h  exper-
imental time domain point, J(ji.t) = is the inverse Fourier transform of 
the reconstructed spectrum and
01
2  is the experimental noise level in the time domain 
data. 
The entropy and constraint equations can be combined into a single cost function, V, 
v=s+Ae 	 (2.62) 
where A is a Lagrange multiplier. The cost function is maximised by iteratively refining 
an initial guess for g() using standard numerical algoritms or search algorithms. 
2.11 Sample preparation 
Recombinant MBD protein samples were expressed and purified on a nickel-agarose 
column by Dr Andrew Free as described in [181]. The recombinant protein contained a 
6 histidine His tag (MHHHHHHAM) on the N-terminus for purification. The samples 
were uniformly labeled with ' 5 N and 13C by cell growth in defined medium enriched 
with [U- 13C]-glucose and [15 N]-(NH4 ) 2 SO4 (CiL, Mass.) [181]. The protein samples 
were received in a volume of 40 ml in a buffer consisting of 5 mM imidazole, 20 mM 
Tris (pH 7.9), 10 % glycerol, 0.1 % Triton X-100, 10 mM 0-mercaptoethanol and 0.5 
m or 0.75 M NaCl. The sample was first concentrated in a 4 ml or 15 ml Vivaspin 
concentrator with a 5kDa molecular weight cut-off (MWCO) from 40 ml to 1 ml and 
then buffer exchanged into a 50 mM sodium phosphate buffer (pH 6.0) containing 
0.01 % NaN3 and 1 mM PMSF (Aldrich). 1 mM DTT (Aldrich)was also added as 
a reducing agent to samples of Dr Xinsheng Nan's construct of MBD, however later 
this was not necessary as Dr Andrew Free modified the construct so as to remove 
the cysteine-containing C-terminus tag. Buffer exchange was accomplished by either 
iterative dilution and reconcentation of the sample or by use of a Vivaspin desalting 
cup. Finally the sample was concentrated down to 500-600 pl (a concentration of 1 
mM) and placed in a NMR tube with 10 % D 2 0. 
A couple of problems arose in preparing the sample for NMR. The first was due to the 
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use of Triton X-100, a detergent of a large molecular size, in the initial protein purifica-
tion. The sample was concentrated and buffer exchanged as described above however 
a 1D 'H spectrum revealed large quantities of a single "small" organic molecule. This 
turned out to be the Triton X-100, 4-(C8H 17 )C6H4 (OCH 2 CH2 )OH, with its chemically 
equivalent repeating units, being too large to pass through the filter of the concentra-
tor and causing the protein sample to precipitate out of solution. This problem was 
easily solved by removing the Triton X-100 from the eluting buffer for purification. 
The second problem took a while to discover. It involved the imidazole disolving the 
plastics of the Vivaspin concentrators although the manufacturers specifications stated 
that there was no effect (now corrected). It was noticed when a few samples were 
not being concentrated and were found in the collected flow through, that there was 
a correlation between this happening and whether the buffer contained significantly 
concentrated imidazole. This problem once discovered was very easily recitified by 
removing imidazole from the buffers used in the purification [49]. 
2.11.1 Formation of a MBD-DNA complex 
The key to forming a complex of MBD and methylated DNA is to have the DNA in 
slight excess. This procedure must be carried under cold conditions i.e. at 4°C or in 
the cold room since MBD is unstable at room temperature. Also to prevent two MBD 
molecules binding to one DNA molecule, the protein sample must be added to the 
DNA sample and not the other way round. 
Once a suitable DNA oligomer or "probe" has been designed and acquired, it needs 
to be annealed. The probes OUR-PROBE and OUR16_5 were purchased already 
purified from Oswel, Southampton (sequences in table 2.4). The annealing process 
turns single stranded DNA into a double helix. The first step is to accurately add 1 
ml of water (containing 0.01 % NaN 3 ) to the lyophilised oligonucleotide. This is to 
assist accurate concentration measurements. With the unannealled oligonucleotide in 
a sealed Eppendorf, it is heated to 80 - 90°C in a water bath and then left to cool slowly 
to room temperature. To check if the DNA has formed a duplex, the characteristic 
NOE crosspeaks should be observable in a 2D 1 H NOESY spectrum of the sample (see 
section 3.3). 
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The concentration of the DNA sample needs to be accurately measured. This was 
done using UV-Vis spectroscopy, by creating a lml solution that is 1 % of the original 
concentration. This was achieved by taking both 100 ILI of the original solution diluting 
up to 1 ml (10% of original solution), taking 100 p1 of that lml solution and diluting 
up to 1 ml (1 % of original solution); and by taking 10 pl of the original solution and 
diluting it up to lml (1 % of original solution). The UV-Vis absorption of these 1 % 
solutions was taken at a wavelength of 260 nm. This was repeated when necessary to 
obtain concordant results. An OD of 1 is approximately equivalent to 50 pg/ml for 
double stranded DNA. 
The concentration of the protein sample also needed to be accurately measured. Imida-
zole absorbs at 280 nm so has to be removed from the sample. There were two methods 
used in determining the protein concentration, both utilised UV-Vis spectroscopy. The 
absorption was measured at a wavelength of 280 nm, with 1 OD being equivalent to 
1.031 mg/ml (as determined by Dr Alice Soteriou [Unpublished data]). The second 
method involved taking 10 pl of the 1 ml stock solution and diluting it up to 1 ml (1 
% of original). The UV/Vis absorption was measured at wavelengths of 280, 320 and 
350 nm. The following formula was used to calculate the concentration; 
A280 - 10(2.51og(A320)1.51og(A350)) 
5540fl trp + 1480fltyr  + 134n3 _ 8 (2.63) 
where A280 , A320 and A350 are the UV/vis absorption at 280, 320 and 350 nm respec-
tively, and nt,p , ntyr and n 3 _ 3 are the number of tryptophan residues, tyrosine residues 
and disulphide bonds in the protein respectively [108]. The UV/Vis absortpion was 
measured and recorded on two separate samples until concordant results were obtained. 
Once concentrations have been determined accurately and therefore amounts of biomolecules 
in known volumes, a 1:1.1 protein/DNA complex can be made. As the protein precip- 
Sequence name 	5' 	 3' 
OUR-PROBE TATGTA5GTACATA 
OUR16-5 	CGCTGTC5GGACAGCG 
Table 2.4: Sequences of oligonucleotides used in MBD-DNA complexes. 5 indicates a 
5-methyl cytosine. 
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itates out and apparently resuspends back into solution in the reaction, the samples 
were diluted up to volumes of 3 - 4 ml each to minimise this. The diluted DNA sam-
ple was added, diluted to a sterilin universal vial with a small magnetic stirrer. The 
vial was placed in a large dish, supported by an amount of tin foil moulded around 
it with surrounding ice, all on top of a magnetic stirrer plate in the cold room. The 
protein sample was added in 50 - 100 jl aliquots whilst gently but firmly stirring 
the DNA sample i.e. no severe vortexing, with time intervals between additions that 
allowed complete mixing of the aliquot and DNA solution. After all of the protein 
had been added, the continuously stirred complexing solution was allowed to react 
overnight. The complex sample was concentrated to approximately 1 mM, exchanged 




Once the desired sample has been prepared for NMR spectroscopy and the relevant 
spectra collected, the next necessary step in the structure determination is to complete 
the resonance assignment. However this is not a trival task for a number of reasons: 
The lack of dispersion of peaks leading to overlap is the biggest problem. This 
also has major implication in interpreting data from NOESY spectra. 
The broadening of peaks due to inconvenient exchange rates. However some 
structural information can be acquired from this phenomenon as it is indicative 
of internal motion, for example. 
Inefficient magnetisation transfer can cause cross peaks that might be expected in 
a particular spectrum to be missing and leaves gaps in the resonance assignment. 
This can be caused by short T 2 values, i.e. shorter than the delays in the pulse 
sequence. 
Artefacts and water signal are a problem as they can mask true peaks or be 
misleading. However with a little experience its possible to recognise artefacts, 
which rarely cause problems. Water signal, especially in NOESY spectra, mainly 
masks Ha peaks. 
67 
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As a conseqeunce of the problems outlined above, the size of protein that may be 
studied by NMR is limited. Hence the application of a "divide and conquer" strategy, 
where larger proteins are split up and the individual parts studied separately, to struc-
ture determination projects. For example, NMR studies on MBD rather than on the 
too-large-for-modern-day-techniques MeCP2. 
Kurt Wüthrich was the first to lay out strategies and techniques for assigning NMR 
spectra of smaller proteins[189]. However as the technology advances with the devel-
opment of 3D and triple resonance experiments, larger proteins can be studied and 
have their structure solved. This does not mean that the original methods involving 
only 2D spectra are obsolete, but rather that they need adpating to incorporate newer 
techniques. 
3.2 Resonance assignment of MBD 
The spectra of MBD contain a disproportionate number of overlapping peaks consider-
ing the relatively small size of the protein. It was therefore necessary to resort to using 
a double labeled sample, and to collect triple resonance spectra, in order to obtain a 
sequential assignment. This entails greater expense both financially and in time to col-
lect spectra, but having the heteronuclear (i.e. 13C and 15 N atoms) chemical shifts (in 
the case of 15 N nuclei) are necesssary for dynamic studies and to utilise the ' 3 C-edited 
and ' 5 N-edited NOESY spectra. 
3.2.1 Backbone assignment 
The sequential assignment of the backbone atoms in MBD (by which is meant Ca, 
HN, Ha and C3 in this case, although CO is not strictly speaking a backbone atom) 
was completed using a 2D 15 N HSQC to direct peak-picking 'and the assignment of 
the triple resonance experiments; CBCA(CO)NH, HN(CO)CA, HNCA and HNCACB 
Peak-picking is the procedure of placing a point or marker on a peak. This is done because peaks in 
a processed spectrum are displayed as contours and it is necessary to know the chemical shift values 
at the apex of this contoured peak. This point is also used to define the volume of the peak when 
integrating the spectrum. Ansig macros can do peak-picking semi-automatically and integrate the 
peak whilst doing so since the algorithm finds the point of maximum volume and prompts for the 
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Figure 3.1: Outline of triple resonance experiments for backbone assignment. Path of 
magnetisation transfer is shown. Triangle indicates directly observed nuclei. Numbers 
indicate one-bond scalar coupling constants 
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[115, 84, 58]. These spectra had been processed using maximum entropy processing 
to increase spectral resolution. This alternative form of spectral processing (see sec-
tion 2.10) was necessary to complete the resonance assignment because of extensive 
overlapping. 
Assignment was carried out by identifying direct and relayed through-bond connectiv-
ities that are detected by the aforementioned experiments. "SEQ_PROB" [58] helped 
to achieve the sequence-specific assignment from sequential Ca/C13 chemical shifts and 
connectivities. The majority of the Hc and H3 assignments were deduced from 3D 
HBHA(CO)NH [57]. 
Each cross-peak in the 2D ' 5 N-HSQC spectrum correlates to a NH species in the pro-
tein. These include the backbone amides, NE/He of the arginine guanidyl sidechain, 
amide sidechain of glutamine (NE2/Hf21/HE22) and aspargine (N82/H521/H622), and 
N€1/H€1 of the tryptophan sidechain. Lysine amine sidechain, Ni7*/Hi7*  of the argi-
nine guanidyl sidechain group and histidine imidazole peaks are not normally seen 
due to NMR unfavourable exchange rates with water. Sidechain NH peaks are easily 
distinguishable from backbone peaks and do not cause problems. 
The 2D projection of a triple resonance experiment with 15 N and 'HN dimensions 
(see figure 3.1) is known as the HSQC plane and, if referenced correctly, will overlay 
exactly on the 2D ' 5 N-HSQC spectrum. Selecting a particular cross-peak in the HSQC 
spectrum and looking at the carbon/proton planes of the four overlaid triple resonance 
spectra (or proton/proton plane in the case of the HBHA(CO)NH) at the nitrogen shift 
of that particular peak, it is seen that there is a strip of normally four peaks (except in 
the case of glycine) in addition to the diagonal peak. Some peaks in different spectra 
will overlay and some do not. The ANSIG software colours the spectra differently so 
that distinguishing them from one another is trivial. Also it provides a facility to easily 
switch on and off spectra from view. 
The four separate peak positions in the ' 3C dimension correlate to the Ca and C3 of 
both the amino acid whose N and NH shifts are encoded in the HSQC cross-peak and 
of the preceeding residue. The cross-peak that is present in the HNCACB and HNCA 
spectra, but not in the HN(CO)CA and CBCA(CO)NH spectra correlates to the Ca(i) 
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Figure 3.2: The 2D ' 5 N-HSQC of MBD with full assignments. The sidechain assign-
ments are in italic with purple arrows. Tryptophan 28 sidechain NH is completely 
labelled. Of the arginine sidechains only the R35 H peak is marked. Note that all 
arginine Hc peaks are negative due to their folding in the spectra. Also note that R35 
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Figure 3.3: The 2D '5 N-HSQC of MBD in the MBD-DNA complex with full assign-
ments. The folding is different in this spectrum than the previous. The G38 peak is 
folded in at the bottom of the spectrum. Its correct 15 N chemical shift is 102.55 ppm. 
Note that the arginine Hf peaks are now more dispersed. The assignment for HE R15 
is slightly dubious. 
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atom. The cross-peak in the strip that appears in all four spectra will be the Ca(i-1) 
atom. Similarly the peak that is only seen in the HNCACB is the C/3(i) and the one 
that appears in both the HNCACB and CBCA(CO)NH is the Cfi(i-1). 
Once this prelimary assignment has been made, the next step is to find the correct 
connectivities to this strip, which will be refered to as strip n. This was aided greatly by 
macros in ANSIG that searched the peak-list' for matches in terms of chemical shifts. 
To achieve assignment the peaklist is searched until a strip is found whose Ca(i) and 
C/3(i) peaks match the Cc(i-1) and C/3(i-1) peaks of the first strip n, or likewise when 
a strip whose Co(i-1) and C/3(i-1) peaks match with strip n's Ca(i) and C3(i) peaks. 
These then can have the arbitary assignments of m and o respectively, as they refer to 
residues i-i and i+1 in respect to the "starting" strip n. This was repeated until the 
connectivities for a block of strips is made. 
The next step is to give the preliminary assigned strips and peaks in the HSQC 
sequence-specific assignments. This is initiated by finding strips relating to residue 
types with characteristic carbon chemical shifts (Appendix A has the average carbon 
chemical shifts for the 20 basic amino acids). The most distinct chemical shifts are 
those for alanine, glycine, serine and threonine. The C/i shift for alanine falls around 
19 ppm and no other C3 shifts falls near this. Glycine residues are also unmistakable 
with no C/I and a Ca shift that ranges from 42 - 47 ppm. An alanine or glycine strip 
is the preferential strip on which to start an assignment. The Gil  shifts for threonine 
and serine are around 72 ppm and 66 ppm respectively. They can be confused with 
one another in certain circumstances but this infrequently happens. 
The blocks of provisionally assigned strips were given sequential assignments, once the 
residue type of at least two strips has been identified, by checking the primary sequence 
of MBD for an alanine, threonine, serine or glycine separated by a particular number of 
(unidentifiable at this stage) residues from another alanine, threonine, serine or glycine. 
For example, an alanine strip was found to be connected along the sequence through 
six strips of ambiguous residue types to a glycine. Upon examination of the primary 
2  The peak-list is a database of peaks generated from the peak-picking procedure. Each point on 
a peak, i.e. peak-list entry, consists of an arbitary cross-peak number, volume, chemical shift 
coordinates, assignments for each dimension and the spectrum in which it was found. 
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Figure 3.4: Three strips of the overlaid triple resonance spectra, HNCA (black), HN-
CACB (positive peaks - magenta; negative peaks - orange), HN(CO)CA (light blue) 
and CBCA(CO)NH (dark blue). The connectivities and assignments are also shown. 
The strip for A64 clearly illustrates the characteristic C3 peak at 18.3 ppm.The strip 
for 163 also shows problematic overlapping of peaks within a spectrum. 
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sequence, only A64(A140) 3 is separated by six non-distinctive residues from a glycine, 
G70(G 146). Continuing along the connectivities, the glycine residue type was followed 
by a random residue type then by a threonine and a serine strip. This confirmed the 
assignment as only G70 is followed by a non-distinctive residue type, a threonine and 
a serine (D71, T72 and S73). Once the sequential assignment has been started it is a 
case of fitting the rest of the jigsaw pieces together. 
Prolines can cause a problem but once identified can be very useful in completing the 
sequence-specific assignment. Obviously, as they do not contain a NH species, they 
do not correspond to a cross-peak in the HSQC nor in the triple resonance experi-
ments. Their Cc and C/3 shifts are fairly unusual being around 64 ppm and 32 ppm 
respectively. Valine also has Cc and C/3 shifts that fall into this range but will have 
cross-peaks in the triple resonance and HSQC spectra. If a strip has Cc(i-1) and Q3(i-
1) peaks that fall into these ranges and no strips contains the corresponding Ca(i) 
and C/9(i) connectivities can be found, its is a safe bet to assume that residue i-i will 
correspond to a proline. 
Overlapping of peaks hindered this overall process however maximum entropy pro-
cessing, which gave greater spectral resolution, and the program "SEQ_PROB", which 
confirmed sequence-specific assignments and gave suggestions for assignments, was in-
strumental in overcoming this problem. 
3.2.2 Sidechain assignment - 13C and 'H 
With the sequence-specific backbone assignment completed obtaining the sidechain 
assignment is a matter of course. The majority of the 13 C chemcial shifts were obtained 
from the 3D (H)C(CO)NH-TOCSY experiment and most of the proton chemical shifts 
from the (H) C (CO) NH-TOCSY experiment. 
As the 15 N and 'FIN shifts are known, assigning these spectra is simply a case of 
working up the strip and matching carbon and proton shifts with the average chemical 
shift (with standard deviations) for the residues. A list of typical chemical shifts 
There are two numbering schemes for MBD. One is the natural sequence i.e. as it appears in the 
entire MeCP2 protein, given in brackets and the other is the recombinant numbering scheme where 
the first residue in the recombinant protein was numbered one. 
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for carbon-13 and proton was compiled from published resonance assignments [167, 
189], and later a statistical compilation of chemical shifts deposited in the BMRB 
(http://www.bmrb.wisc.edu/pages/)  was found and used. The HCCH-TOCSY and 
CC-TOCSY-CH3 were instrumental for confirming sidechain chemical shifts and for 
completing the resonance assignment. 
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Figure 3.5: The TOCSY spin-system patterns for the three aromatic amino acids is 
shown. Diagonal, symmetry related crosspeaks and chemically equivalent protons are 
illustrated. The nomenclature for the aromatic sidechains is given in greek characters 
on the molecular figures and roman letters on the spin-system diagrams. 
The aromatic sidechain proton shifts were assigned using 2D homonuclear TOCSY 
and NOESY experiments. This was achieved by identifying the aromatic spin-systems, 
which are distinctive by falling uniquely between 6.6 and 7.8 ppm. Tyrosine with only 
two chemically different protons has only one set of symmetry-related crosspeaks in 
the TOCSY ; phenylalanine with three chemically different protons has three pairs of 
symmetry related crosspeaks; and tryptophan has two spin-systems in its sidechain, 
one consisting of the Hcl and H62 protons and the other of four protons (H€3, H(3, 
H772 and H(2) which gives a set of six pairs of symmetry related crosspeaks (see figure 
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3.5). Fortunately the HEl proton (an amine) has a chemical shift of 10 - 11 ppm which 
makes the Hcl/H81 spin-system distinguishable from the tyrosine spin-system. The 
homonuclear NOESY can not only be used to confirm or identify aromatic spin-systems 
but was was used to find the through-space connectivities between the delta ring pro-
tons and the aliphatic beta protons, thereby finding the sequence-specific assignment 
for the aromatic ring. The 13C chemical shifts were obtained from the inter-residual 
NOEs observed in the 3D ' 3C edited NOESY spectrum. 
3.2.3 Sidechain assignment - ' 5N 
Not all 15 N sidechain groups are visible in NMR spectra of MBD. The lysine amine, 
arginine Hh protons and histidine imidazole HN protons were not seen in the HSQC 
of MBD alone. This is due to their rapid exchange with water broadening the peaks 
to obscurity. However in the HSQC of MBD complex, peaks appear in the position of 
the arginine Hh sidechain protons. 
The NMR visible 15 N sidechains; glutamine, asparagine, arginine HE, and tryptophan 
lid are easily distinguished. The tyrptophan Hd, as mentioned before, has a large 
chemical shift unlike any other in proteins. The arginine HE peaks are normally folded 
in as the ' 5 N€ chemical shift is approximately 85 ppm whereas backbone amides range 
from 100 - 130 ppm, therefore appear with negative volumes. The glutamine and 
asparagine NH 2 sidechain have characteristic "hatted" peaks. The "hats" on the peaks 
are due to splitting caused when one of the protons on the amide exchanges with 
deuterium. Figure 3.2 of a 2D ' 5 N HSQC has these sidechain peaks highlighted. 
The arginine HE can be assigned from a combination of the HNCA, HNCACB, ' 5 N-
edited NOESY, 15 N-edited TOCSY and NOE connectivities from CD/HD*  in the 13C_ 
edited NOESY. As the majority of the arginine sidechains are only solvent exposed, 
their chemical shifts overlap and the peaks are often broad. Thus all of the mentioned 
spectra were required to confirm the assignments. Only the HE peaks for R35(11111) 
were distinguishable from the others in the HSQC. However the HIE peaks in the HSQC 
of MBD-DNA complex were seen to be more dispersed, especially in the cases of 
R35(R111) and R57(R133) which were not overlapped at all. The sidechain HE peak 
for R35(11111) had an unusual 'H chemical shift in both HSQCs, it was not overlapped 
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in either spectra. 
The glutamate and asparagine sidechains were easily assigned using the HN(CO)CA, 
CBCA(CO)NH, HBHA(CO)NH, H(C)(CO)NH-TOCSY, (H)C(CO)NH-TOCSY and 
' 5 N-edited NOESY to find and double check the seen through bond connectivities to 
their respective aliphatic carbons and protons. The 13C and 'H chemical shifts for 
these residue types were reasonably dispersed and there was no overlapping problems. 
3.2.4 Extent of assignment 
MBD alone 
A total of 99.3% of the protons of the native sequence were assigned. The backbone 
resonance assignment was complete except for the ' 5 N chemical shift of Y19 (Y95). The 
Hn chemical shift of Y19 was assigned from NOESY spectra after structure calculations 
had been started and the resultant NOE violations had been analysed. The backbone 
amide of Y19 did not appear in the triple resonance spectra. The proton sidechain 
assignment was 98.7% complete. The gaps in the proton assignment were concentrated 
around P17 (P93) and M18 (M94) where peaks showed signs of exchange broadening 
due to internal motion on an intermediate time scale. The peaks arising from residues 1 
to 16 showed the characteristic broadness of peaks correlating to unstructured residues, 
as did the peaks of R39 (R115). 
Of the ' 3 C nuclei, 99.0% were assigned. Only three 13 C nuclei were not assigned. These 
were S4(S80) C/3, M18(M94) C7 and K31(K107) C8. The H6 protons of K31 were also 
not assigned. The peaks for both types of nuclei were broadened to obscurity, probably 
due to exposure to solvent and a resultant degree of motion in the long sidechain with 
respect to the overall tumbling of the molecule in solution. 
MBD-DNA complex 
The resonance assignment of the MBD-DNA complex is less complete than that of 
MBD alone because a number of the sidechain nuclei that are known to be in the 
intermolecular interface are broadened to obscurity. The backbone assignment was 
complete, except for the ' 5 N chemical shift of Y19, as was the case with MBD alone. 
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A total of 94.6% of the protons of the native sequence were assigned. Of the 13 C nuclei, 
92.6% were assigned. The gaps in the resonance assignment of MBD-DNA complex 
are almost entirely in arginine and lysine sidechains. 
3.3 Resonance assignment of deoxyribonucleic acids 
NMR spectra of DNA are relatively easy to assign compared with those of protein 
due to the simple fact that there are far less protons in a DNA macromolecule than 
in proteins. For example, the probe ouR16_5 a 16bp duplex with a molecular weight 
of 9.7 kDa, has only 348 distinct protons (counting methyl groups as one), and since 
this piece of DNA is palindromic there will be only half that number to consider in 
the NMR spectrum, whereas a protein of similar size on average will contain about 
700 assignable protons. However a common problem with DNA is the overlapping of 
peaks with similar chemical shift. There have been a number of statistical reports 
stating average chemical shifts and standard deviations of protein atoms [91, 93, 189] 
(BioMagResBank, http://www.bmrb.wisc.edu/)  and it is fairly obvious from these 
alone where possible problems can arise. So the first logical step to completing the 
resonance assignment of DNA was to obtain a list of average chemical shifts, to become 
familiar with DNA spectra, and to prepare for the occurrence of overlap. However there 
did not seem to be such a list available for atoms in DNA. 
A list of average chemical shifts of protons in DNA molecules with standard deviations 
was compiled using completed assignments deposited in the BMRB database (deposit 
numbers 4103, 4104 and 4235) and from publications [162, 109, 60, 189, 46, 48]. The 
results are given in table A.2. 
These chemical shift values were incorporated into ANSIG with the recommended 
nomenclature (see appendix D.1). It was seen that the chemical shifts of DNA protons 
are fairly well dispersed with ribose unit having chemical shifts ranging from about 2 
ppm to 6 ppm and the nucleic acid chemical shifts ranging from about 6 ppm to 14 
ppm. It is therefore possible to complete a resonance assignment of DNA using only 
2D homonuclear experiments, and this was done for the 14 bp double-stranded DNA, 
OUR-PROBE [TATGTA5GTATCATA] (see table 2.4), using only a 'H-'H NOESY 
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Spin-system Atom proton chemical shift standard deviation 
Adenine H2 7.462 + 0.258 
H8 8.066 ± 0.196 
HN61 7.213 ± 0.482 
HN62 6.450 + 0.325 
Guanine HN1 12.707 ± 0.213 
H8 7.686 + 0.152 
HN2* 6.602 + 0.224 
Thymine HN3 13.651 + 0.238 
H6 7.273 + 0.252 
H7* 1.393 + 0.185 
Cytosine H6 7.454 ± 0.206 
(h-bonded) HN41 8.131 ± 0.239 
HN42 6.429 ± 0.518 
(unmethylated) H5 5.474 ± 0.344 
(5-methyl-C) H7* as T H7*  ? 
Ribose Hi' 5.841 + 0.283 
H2' (A) 2.728 ± 0.154 
H2' (C) 2.208 ± 0.222 
H2' (G) 2.530 ± 0.152 
(T) 2.237 + 0.258 
H2" (A) 2.840 ± 0.081 
H2" (C) 2.387 ± 0.129 
H2" (G) 2.583 ± 0.165 
H2" (T) 2.440 + 0.133 
 4.843 ± 0.144 
 4.211 ± 0.136 
H5* 4.079 ± 0.140 
Table 3.1: Table of average chemical shifts for DNA 
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spectrum and a COSY spectrum. 
The first step in the sequential assignment was to identify the ribose spin-systems, 
Hi' -4 1­12' & 1­12" - H3' -4 H4' —* H5' & 1­15" 
and arbitrarily name them. e.g. letters of the alphabet, a, b, e2, o, v, etc. The Hi', 
H2' and 1­12" are the most important, in terms of being able to sequentially assign the 
chemical shifts. It is prudent to start in the Hi'- H2*  region of the spectra, especially 
as these peaks in both spectra are usually strong and their dispersion makes them easy 
to identify. 115' and 1 ­15" can be difficult to see due to overlapping with H4' peaks. 
In this case, a TOCSY experiment collected on the DNA could assist in resolving 
assignments. The next step is to locate guanine H8, adenine H8, thymine H6 and 
cytosine H6 strips in the spectra. There should be three distinct clusters of strips in 
the region 6.9 ppm - 8.5 ppm, which is roughly the aromatic region of a 1 H spectrum. 
The first cluster of strips will belong to adenine H8 which are found at approx. 8 - 8.5 
ppm, the second will be from guanine H8 which are found at approx. 7.5 ppm - 7.9 
ppm and the third will be thymine and cytosine H6 at approx. 6.9 ppm - 7.3 ppm. 
The NOE peaks from H8/H6 protons to the H2' and 1 ­12" protons of the ribose unit 
are strong (see figure 3.6). In this particular region, usually four NOEs are found per 
H8/H6 strip relating to 
• 1­18( 2 ) or 1­16() —* H2'() & 1­12"() 
• 1­18( 2 ) or 1­16(2 ) —* H2'(— l ) & H2" 
From these strips its now possible to obtain sequential assignment using the assumption 
that one of or both of H2*()  are closer in space than H2*(_1)  to 1­18() or 1 ­16() and 
thus the stronger NOE peak correlates to the former (see figure 3.6). There are also 
NOE peak from these base protons to the Hi'() and Hi'(_,) and usually to the other 
protons on the ribose units. 
It was also noticed that there are 4J-coupling COSY peaks between thymine's and 5- 
methyl-cytosine's H5 and H7*  protons as can be seen in figure 3.6. The cytosine HN4* 
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Figure 3.6: Overlay of 2D NOESY and COSY of a 14-mer DNA duplex. The NOESY 
spectrum is outlined in black. The COSY spectrum is blue and red. 
CHAPTER 3. RESONANCE ASSIGNMENT 	 83 
are distinguishable by the very strong NOE peak between themselves. Adenines are 
useful for obtaining cross-strand NOEs because the following peaks are usually seen 
• A(s ) H2 -+ H1'( 2 ) 
• A( 2 ) H2 -+ H1'( 2+ ,) 
• A(s ) H2 -+ 
• A(s ) H2 	H1'( + ,) 
Other cross-strand NOEs that should be visable are between the guanine HN1 and its 
conjugate cytosine HN4*,  and between the thymine HN3 and its conjugate adenine H2. 
These can also be used to check if the oligonucleotides have been annealed successfully 
to form a duplex. 
A complete resonance assignment and an assigned NOESY spectrum of DNA can 
easily be finished now with the consideration of Watson and Crick's structure of DNA 
determined in 1953 [183]. The completed resonance assignments for the DNA probes 
OUR PROBE can be found in appendix E.3. 
3.4 Chemical shift perturbations 
Changes in amide chemical shifts observed in the 2D 15 N-HSQC of MBD and of MBD 
bound to a 14 bp duplex containing the dinucleotide pair 5-methyl-CpG were used to 
explore the site of interaction between MBD and methylated DNA. The DNA-induced 
chemical shift perturbations were quantitatively calculated from the difference in the 
backbone chemical shifts of residues in MBD and MBD complex. The logic behind 
using this approach was based on the fact that chemical shift is dependent on local 
electron distribution, and when MBD is bound to methylated DNA, the local electron 
distribution on residues that are close to space to the DNA interface will be perturbed 
while the environment of residues that are relatively far from DNA will experience no 
perturbation in chemical shift. Although some backbone amide protons will experience 
chemical shift perturbations purely as a result of conformational change in the protein 
induced by binding, it is fair to assume that the majority of those amide protons 
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showing significant change in chemical shift upon binding are likely to be close to the 
intermolecular interface. 
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Figure 3.7: Overlay of 2D ' 5 N HSQC of MBD (red) and MBD bound to a 14-mer 
DNA duplex (blue). Shown are some backbone amide cross-peaks labelled according 
to residue. The green peak is folded, negative in the Fl dimension and belongs to 
R35(R111) sidechain HE nucleus when bound to DNA. The peak for R35 HE in unbound 
MBD has a proton chemical shift of 8.00 ppm and cannot be seen on this figure. 
It was seen that some backbone amide protons underwent a change in chemical shift 
upon addition of methylated DNA (up to 7.1 ppm for ' 5 N and 0.76 ppm for 'H) while 
other amide protons experience no significant change in chemical shift. This is consis-
tent with the theory behind the approach and the existence of a DNA-binding surface 
on the protein. It was not possible to compare these results and those from a control 
in which non-methylated DNA was used in the MBD-DNA complex because irrevsible 
precipitation occurs upon mixing the recombinant protein with non-methylated DNA 
of the same sequence as the methylated DNA used. 
The majority of the chemical shift perturbations were seen to be between strand B and 
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Figure 3.8: A plot of the DNA-induced perturbation of chemical shifts (8) versus 
sequence number. The difference is in Hertz is the sum of the difference in frequency 
for the amide 'H and ' 5 N in a particular residue. The green line defines the threshold 
above which M is considered large and the red line defines the value above which z8 is 
considered significant. The secondary structure elements are shown as predicted from 
the CS! plot. Numbering as for MeCP2. 
strand C, with the most strongly perturbed being the amide protons of G38 (G114) 
and A41 (A117). Also there are large chemical shift perturbations in strand D and 
the start of the a helix, and near the C-terminus. There are significant chemical shift 
perturbations in a polypeptide segment (IR.DRC) corresponding to residues 12 to 16 
(88 to 92 in the natural sequence) which are known to be disordered. This implies that 
this region might interact with DNA, especially as its positively charged residue i.e. 
arginine rich, a result which is consistent with the requirement of these residues within 
the minimal mCpC-binding sequence. These results can be mapped onto the tertiary 
structure and a picture of the DNA-binding face of MBD inferred(see section 4.5.2). 
The sidechain perturbations of NH containg sidechains observable in the 15 N - HSQC 
were also calculated. The most significant sidechain chemical shift perturbation was 
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the HE proton of R35 (Rill) whose 'H chemical shift had moved from 8.00 ppm to 
9.34 ppm upon binding to DNA. This indicates an important role for this residue in 
the functionality of this DNA-binding protein. 
Chapter 4 
Structure calculation 
The structure and consequently the function of biological macromolecules is a signif-
icant area of interest in science. Calculating the 3D structure of proteins and nucleic 
acids has been revolutionised with the advance of computer technology and the most 
time consuming step in a NMR structure determination is interpreting NOESY spec-
tra, i.e. NOE assignment. Assigning NOESY spectra is a laborious task and is rife with 
the problems already described in chapter 3, especially the problem of overlapping res-
onances. This then leads to ambiguities in distance restraints, which are difficult and 
time consuming to resolve. Sometimes NOEs are truly ambiguous, thus unambiguously 
resolving them is impossible. 
Although there is other data that determines NMR structures, NOEs is the most 
important [189]. Data such as coupling constants and proton exchange rates can be 
directly used in conjunction with NOEs, and is sometimes necessary for high resolution 
structures. 
4.1 The standard NMR structure calculation 
The standard NMR structure calculation consists of the following steps. 
Preparation of the sample including possible isotopic labelling. 
Running various NMR experiments and collecting data (see chapter 2). 
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Identification of spin systems and assignment of chemical shifts of the nuclear 
spins involved. (see chapter 3) 
Initial analysis of NOE measurements, i.e. the assignment of NOESY crosspeaks 
to pairs of spins and the conversion of quantified peak intensities into distances. 
Initial structure calculation in order to obtain starting structures consistent with 
NOE-derived distances and prior knowledge about the structure. 
Refinement of the structures. This involves assigning previously observed but 
unassigned NOESY crosspeaks and stereospecific assignments. 
However there are alternative methods for protein structure determination that deal 
with some of the problems described and automate some of the steps described above, 
e.g. ARIA. 
4.1.1 NMR data and distance restraints 
The two pieces of information concerning a NOE that are required for a structure 
calculation are the identity of the two spins defining the crosspeak and the measurement 
of the NOE intensity. A measurement of NOE intensities in a rigid two spin system is 
related to the distance, r 23 , between the two spins, i and j, by the relation; 
NOE oc r- 6 
	
(4.1) 
Unfortunately, significant errors can occur in the derivation of distances from NOE 
volumes due to overlap of crosspeaks, dynamic averaging and spin diffusion. Therefore 
NOE intensities are commonly classified as strong, medium, weak and very weak. 
Typically a strong NOE is assigned to an interproton distance below 2.7 A, a medium 
NOE to a distance below 3.3 A, a weak NOE to a distance below 5 A, and a very weak 
NOE to a distance below 6 A. 
The bounds for these distance ranges can be tightened or loosened if appropriate 
reference distances are available, and provided cross-relaxation rates are approximately 
constant, through the equation; 




where r 3 and oij are the unknown distance and cross-relaxation rate respectively, and 
rref and aref are the known distance and cross-relaxation rate respectively. 
The stereospecific assignment of prochiral groups such as methylenes, isopropyl groups 
of valines and leucines usually cannot be resolved until the latter stages of a structure 
calculation project. Thus the distance restraint is directed to a pseudoatom. Pseu-
doatoms are also used to describe unresolved NOEs, mainly protons that are equivalent 
due to motion e.g. methyl groups and aromatic rings. The pseudoatom has a theo-
retical position which roughly sits in between the atoms of the group concerned. A 





Figure 4.1: Distance r between a hydrogen H and the pseudoatom for a 0-methylene 
group. 
Pseudoatom corrections are typically set to 1 A for a methylene, 1.5 A for a methyl 
and 2 A for aromatics. Pseudoatom corrections are accumulative. 
Other examples of NMR data that can be included in a structure calculation are 
torsion angle restraints and hydrogen bonding restraints. Torsion angles are related to 
vicinal coupling constraints through the Karplus equation [83, 140]. A torsion angle 
restraint normally restricts the torsion angle to values between two boundaries. Several 
ranges of torsion angle may be consistent with a given coupling constant and thus the 
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conformation of the molecule is not uniquely determined. 
By measuring the exchange rate of amide protons in isotopically labelled solvent (e.g. 
deuterium oxide) it is possible to infer the location of hydrogen bonds in the molecule. 
The principle is that slowly exchanging amide hydrogens are more likely to be involved 
in a hydrogen bonds. The presence of a hydrogen bond is often included as a distance 
restraint between the donor and the putative acceptor. 
4.1.2 Simulated Annealing 
Simulated annealing (SA) is one of a number of calculation techniques, classed as 
'Local Search Algorithms', used to find the minimum or maximum values of a function 
containing many independent variables. This function is usually referred to as the 
target function in this application (sometimes as the 'cost' or 'objective' function), 
and is a quantitative measure of the "goodness" of some complex system. Its use is 
appropriate in protein structure calculations because it is feasible to assume that the 
true structure of a protein will be the structure with the lowest free energy. 
As its name suggests, simulated annealing is analogous to annealing, the process where 
a material such as steel or glass is heated and then cooled so that the structure of the 
material is rearranged into a structure of a lower free energy. By considering the target 
function as the potential energy of the system, the annealing process can be simulated. 
The reason that SA is utilised in combinatorial optimisation problems is that all exact 
methods known for determining an optimal solution require a computing effort that 
increases exponentially with size of the problem, e.g. the number of atoms to be posi-
tioned in a virtual space. Protein structure calculation is classified as a NP-complete 
(non-deterministic polynomial time complete) problem, as a result of this. It would 
be near-impossible to find methodically sample the structural energies of all possible 
conformations of a protein from consideration of the primary sequence and then pick 
the one with the lowest energy. However, it cannot be assumed that SA will reach the 
global minimum unless it is extended for an indefinite period [87, 59, 28]. 
The SA algorithm needs to create a Boltzmann distribution at a given temperature, 
T, and requires a sequence of temperatures, known as an annealing schedule, T1 = 
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T2 = . . . T, at which the Boltzmann distribution is completed. The choice of annealing 
schedule critically effects the success and efficiency of simulated annealing. There are 
a few mechanisms which are used to create the Boltzmann distribution (known as 
generation mechanisms) and they differ in the way they make a transition from one set 
of parameters to another. The most common generation mechanism is the molecular 
dynamics simulation [176, 59, 28], however the Metropolis Monte Carlo algorithm 
[113, 87, 59, 28] is also frequently used. 
4.1.3 Molecular Dynamics 
This generation mechanism couples the potential energy of the system to an energy 
bath, i.e. the system explores a potential energy surface (solution surface). The refer-
ence level of the bath is slowly lowered over the course of the molecular dynamics 
An appropriate set of atomic parameters can be considered as generalised coordinates 
that are propagated in time by the classical (Hamilton) equations of motion. By having 
these generalised coordinates represent the Cartesian X, Y and Z positions of the atoms 
of a molecule, the equations of motion can be reduced to Newton's second law; 
M, ( 
8r 
-)= —1E 	 (4.3) 
where M and r, are the masses and coordinates of atom i respectively, and E is the 
potential energy. However here E denotes the target function. 
The partial differential equation (equation 4.3) is normally carried out numerically by 
finite difference methods such as the Verlet algorithm [176]. The initial velocities are 
usually assigned from a Maxwellian distribution at the appropriate temperature 
For implementation of simulated annealing, it is necessary to be able to control the 
temperature during molecular dynamics. The three most commonly used methods are 
velocity scaling, Langevin dynamics and coupling to a heat bath. Without tempera-
ture control the particles would gain momentum and spend very little time near the 
minimum. The temperature control removes excessive kinetic energy and thus ensures 
a slower exploration of the minimum. 
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A simple but not necessarily optimal annealing schedule is 'slow-cooling' [87, 27]. When 
the system is in a critical state, fast-cooling might consequently trap the system in 
a metastable state, therefore the cooling rate at phase transitions is reduced. The 
temperature is decreased monotonically at a rate slow enough to ensure that the system 
reaches equilibrium at each stage of the annealing schedule. 
4.1.4 The target function 
The target function used in structure calculations normally depends on several atomic 
parameters, but most importantly on atomic coordinates. 
E = ECHEM + WNMRENMR 	 (4.4) 
where ECHEM describes empirical chemical information: it is a geometric function 
of all atoms consisting of terms for covalent bonds, bond angles, chirality, planarity 
and non-bonded repulsion. ENMR  represents the NMR data, describing the difference 
between observed and calculated data, and WNMR  is a weighting factor used to balance 
the gradients arising from the two terms. 
The empirical energy function can consist of a number of energy terms usually involving 
sets of two to four atoms. The parameters for covalent terms can be derived from 
average geometry and root mean square (rms) deviations observed in small molecules. 
The sum of energy terms is taken over all pairs of sets of atoms; 
N 
ECHEM = > {wb0 dEb0 d + wangieEangie + Wi mpr Eimpr + W v dw Ev dw } 	(4.5) 
P=1 
impr = chirality & planarity 
The Van de Waal's function (Ed) is normally formulated as a purely repulsive func-
tion. Electrostatic interactions and Van der Waal's attraction are usually not included 
in structure calculations. 
Ed = > C(Max(O kDmzn) - Rm) 	 (4.6) -" 
i3 
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where R is the distance between two atoms i and j, Rmin is the vdw radius for a 
particular atom pair, ij, C is a constant used to reduce the radii (C < 1) and m = 2 & 
n = 2 or m = 1 & n = 4. 
These empirical energy functions were not originally created for structure determi-
nation and sometimes it is desirable to modify them or include certain other energy 
terms. 
The most common form of ENMR  consists of NOE derived distance restraints and 
dihedral angle restraints derived from J-coupling constants. This function is often 
formulated as a flat-bottomed parabolic function; 
WNMRENMR = L'NOEENOE + WDIHEDRALEDIHEDRAL 	 (4.7) 
Id,I 	\2 ,J - upper) 	upper 
ENQE = ii 	0 	 diower <d < dupper 	 (4.8) 
NOE (diower - d" 2 d < diower ) 
( - 	
'2 
upper) 	I)upper < 
EDIHEDRAL = 	 1 0 lower < < upper 	(4.9) 
	
DIHEDRAL 1 (iower - ) 2 	< 01..er 
where the sum is carried out over all NOE-derived distances between spins, d is the 
distance between a particular pair of spins in the model, and diower  and dupper are 
the lower and upper bounds for the distance, 0 denotes the dihedral angle, cblower  and 
çbupper are the lower and upper bounds for the dihedral angle restraint derived from 
scalar J-coupling constant measurements and empirical Karplus relationships. 
Thus an energy penalty is given for a distance restraint that is violated by a model, 
and hence the structure that satisfies as many distance restraints as possible will have 
the lowest energy. ENQE  is often modified so that it becomes linear for large viola-
tions ("soft square" potential) because starting structures often contain very significant 
violations of experimental distance restraints. 
The complete energy function describes a N-dimensional solution or curve that will 
consist of a global and local minima. 
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4.2 ARIA 
ARIA is a fully automated iterative method that performs a series of tasks that are 
typically necessary in a protein structure calculation from NOE data. The main differ-
ence between ARIA and the more traditional manual method is the use of ambiguous 
distance restraints (ADR) (see section 4.2.1). 
Generally, this iterative method bases all operations in iteration n on the structures 
calculated in the previous iteration. For the initial iteration, there are three possibilities 
for starting structures; 
To generate a series of random structures. 
To calculate a set of structures based only on manually assigned data. 
To generate starting structures from sequence homology. 
Each following iteration begins with ordering the structures from the previous iteration 
with respect to the total energy of the structure and those with the lowest total energy 
are selected as the basis for interpreting the spectral data. 
The spectral data is first calibrated using average distances calculated from the selected 
structures. The frequencies of the peaks are matched up with the list of chemical 
shifts and an ADR (see section 4.2.1) is added to the restraints list. These restraints 
are analysed for restraint violations in the chosen structures. Any restraints that 
are systematically violated are removed from the virtual restraints list. This is done 
separately to each spectral data set, and restraint lists produced are merged together 
to avoid duplication of information. A new set of structures are calculated using 
simulated annealing. This process is repeated until structures and data sets do not 
change significantly. 
The final result consists of: 
Calculated structures, 
Assigned distance restraints, 
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3. Distance restraints that have been rejected because they are considered artefacts 
by the method. 
Manual inspection of the lists of rejected restraints and peaks is especially useful in 
finding errors. If necessary the final list of restraints is also inspected and modified by 
hand, and an ultimate set of structures is calculated. 
4.2.1 Ambiguous Distance Restraints (ADR) 
Although ambiguous NOEs are traditionally of no use, they still contain information 
and can now be converted into structural restraints. With the distance dependency of 
the NOE and the isolated spin pair approximation (ISPA), an ambiguous NOE depends 
on the sum of the inverse sixth power of the individual proton pair distances: 
NS 
NOEF1,F2 cx E d 6 	 (4.10) 
where a runs through all N6 contributions to a cross-peak at Fl and F2, and da is the 
distance between two protons of the a11 contribution. 
F2 ± 2 
Figure 4.2: ADR from a crosspeak. 
Thus the ambiguous NOE corresponds to a 'd 6-summed' distance D; 
NS 
D=(d;6y4  
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This distance can be calculated from a model structure. The calculation can now 
proceed as normal with the distance restraints, restraining D by means of a distance 
target function. This is analogous to a standard unambiguous distance restraint be-
tween atom pairs, and thus are known as ambiguous distance restraints [127]. 
4.2.2 The target function 
The target function is very similar to the conventional one; the distances in the struc-
ture are restrained to upper and lower bounds by 'flat-bottomed' potentials. It should 
be gradient bound and have an asymptotic region for large violations that are linear. 
The energy of a single distance restraint is 
(D—L) 2 	 D < L 
ENOE = KNOE 
o 	 L < D < U 	
(4.12) 
{ 
(U—D) 2 	 U<DU+a  
o!+/3 (D — U)+7(D — U) 1 D> U-t-a 
where D is the d 6-summed distance, IcN0E is the energy constant, and U and L are 
the upper and lower bounds. The parameter a determines the distance at which the 
potential switches from harmonic to asymptotic behaviour, 13 is the asymptotic slope 
and the coefficients c and y  are determined such that the potential is continuous and 
differentiable at U + a [127, 129]. 
4.2.3 Calibration 
The upper and lower bounds are estimated from the NOE build-up curves, or in many 
cases approximately from the NOE volumes, V; 
d 6 
U = ((L)V) + z 	 (4.13) 
Vr ej 
d 6 
L = 	 - 	 (4.14) 
Vr ej 
where A is the the error estimates and drej and Vr ej are known reference distance and 
volume. Short fixed distances such as between two protons of a methylene group are 
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not the best choice since both spin diffusion and and internal dynamics will decrease 
the NOE unless very long mixing times are employed. The structurally important 
NOE data frequently corresponds to distances greater than the reference, and could 
be increased by internal dynamics and spin diffusion. 
For this automated scheme, it is better to include long-range contacts in defining the 
reference distance drej. drej is calculated from the iteratively calculated structures as 
< d 6 >-61  average over all values for which the distance is smaller that a cut-off (3 - 
6 A); Vrej is then calculated as the arithmetic average of all corresponding volumes. 
If the same dref and Vrj are used for all protons, equations 4.13 and 4.14 convert 
the NOE into a distance irrespective of the NOE assignment, even if the NOE is 
ambiguous. Separate drej values can be used for different proton types to account for 
different internal correlation times or occupancies. Different exponents in the distance 
dependency of the NOE can be used to account for different internal dynamics. 
Proton-type dependent calibration can be applied to ambiguous NOEs as average 
weighted with estimated relative peak contributions. The use of pseudoatoms is un-
necessary because distance restraints can be directly derived from the peak volume via 
equation 4.13. Similarly, floating chirality assignments allows the direct conversion of 
NOE volumes into distances for unassigned pro-chiral groups. 
Errors in the distances estimated from the NOE are not random but systematic. There-
fore, the standard least-square treatment with simple harmonic error function is not 
valid, and hence the use of separate upper and lower, + and . These error esti-
mates are usually determined empirically in such a way that the cumulative error due 
to integration, spin diffusion and internal dynamics is included. A good estimate for 
the automatic calibration in ARIA is = = 0.125D2 [128, 129]. Varying the 
tightness of the distance bounds generally does not have a pronounced effect on the 
result, however the appropriate choice of A is very important, since restraint violation 
analysis is used for artefact recognition and/or peak assignment. 
CHAPTER 4. STRUCTURE CALCULATION 
4.2.4 Automated assignment 
When using ADRs, ambiguous NOEs need not be explicitly assigned because the as-
signment is done implicitly in the structure calculation. This is because the summed 
distance, D, is quite strongly weighted towards, and is always shorter than the shortest 
of contributing distances. The weighting is expected to be towards the dominating 
contribution of the NOE. 
However when starting from random structures this is not the case. Most of the initial 
implicit assignments are incorrect. Hence the path towards the final structure is much 
more difficult. During the calculation, the internuclear distances will change and with 
them the implicit assignment. Hence the ADRS are never explicitly assigned and every 
structure corresponds to an independent assignment. 
ARIA works by the following steps: 
Lists all possible assignments for each peak compatible with the resonances within 
a frequency range 5ppm if not done externally. 
Selects the lowest energy structures from the previous iteration, using them to 
interpret the spectra. 
For each assignment possibility in the structures, it extract a dmi n , or the average 
distance, dave . 
Uses the automated calibration to transform the peak intensities into distance 
restraints. 
Applies a criterion to discard assignment possibilities based on the distances, 
dmin or d ave . 
Calculates structures based on the new restraints. 
The actual assignment of NOEs is performed by comparing the possible assignments 
with corresponding distances in the structures. The criteria used is based on an esti-
mate of the relative peak contributions of different assignment possibilities to the peak 
volume. The contribution Cn of assignment n is estimated as; 
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C- 
- NS 	 (4.15) 
> d 6 a=1 
The assignment possibilities are then reordered according to the size of C, with n = 1 
as the largest contribution. The fewest number of contributions are chosen such that 
this condition; 
N 
Ca> P. 	 (4.16) 
is satisfied. The cut-off parameter, p, is varied for different iterations, usually starting 
at 1.0 and ending at about 0.8 [127, 128, 129]. 
4.3 Structure Calculation 
4.3.1 NOE restraint list 
A list of ambiguous or unambiguous NOE-derived distances between pairs of nuclei ( 1 H) 
constitute the bulk of the data restraining the structures formed during calculations, 
refered to as the NOE restraint list. The distance restraints were derived from three 
NOESY spectra: 3D ' 3C-edited NOESY; 3D 15 N-edited NOESY; and a 2D homonu-
clear NOESY. The restraints derived from the 2D homonuclear NOESY spectrum were 
found to be mostly ambiguous, and were duplicated in the two 3D NOESY spectra. 
Therefore they were not included in the refinement of the structure of MBD nor in 
the calculation of the structure of MBD-DNA complex. In addition, there was another 
problem with the 2D homonuclear NOESY of MBD-DNA complex - there were a lot 
of broad peaks masking a large proportion of the spectrum, believed to come from the 
DNA that MBD is bound to. This was also seen in the X-filtered experiments acquired 
for the purpose of obtaining protein-DNA NOEs and a 2D homonuclear NOESY of 
only the DNA in the complex. 
Once the desired NOESY spectra have been collected, processed and prepared for 
analysis in the prefered spectra viewing and assigning package (ANSIG in this project 
[91, 93]), the first step is to pick the peaks in the spectra. It is necessary to place 
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a point on the apex of each cross-peak so that assignments can be noted within the 
software and the limits of integration are defined. It is necessary to do this in a careful 
and methodical way for a number of reasons. Although a methodical peak-picking 
strategy takes longer, it saves time later because it avoids the picking of noise peaks, 
or duplicate peaks, and the subsequent laborious task of locating and removing them. 
Also there are usually NOE cross-peaks to water present in the spectra. These would 
give false distance restraints that are not always violated . These are recognizable as 
they always fall at the same chemical shift (in the case of this project, referencing of 
spectra is on the water signal at approximately 4.78 ppm) and normally appear slightly 
broad and strong. 
The method developed and employed, having experienced the problems outlined above, 
involved going through the two 3D NOESY spectra finding, picking and assigning the 
Fl and F3 dimensions (if applicable) one strip at a time. This is a fairly quick and 
simple process for the ' 5 N-edited NOESY as the Fl / F3 plane is a 2D ' 5 N-HSQC, 
previously assigned (see chapter 3). It is more laborious with the 13C-edited NOESY 
as this spectrum was folded and the 13C HSQC was not assigned. It was a case of, (i), 
selecting a particular carbon with a known chemical shift within a chosen residue, (ii), 
moving to the appropriate 'H / 'H plane (F2 / F3 in ANSIG; Fl / F2 with AZARA 
and vnmr) in the 3D spectrum, (iii), finding the correct strip relating to the chosen 
CH spin-system, and (iv), picking every real peak in that strip and assigning the Fl / 
F3 dimensions i.e. the dimensions relating to the nuclei in the CH species. If there was 
overlap with other peaks in both dimensions, then no assignment was made and it was 
necessary for these NOE peaks to become classified entirely ambiguous. It was found to 
be preferable to assign the Fl and F3 dimensions as this prevented ambiguous assigning 
by the automated chemcial shift matching and restraint list producing software when 
strips are close together or when there are mistakes in the chemical shift lists. It 
was also found to be good practice to unambiguously assign intra-residual NOEs at 
the same time, especially NOEs between geminal protons, as these will constitute 
almost all of the NOE volume, and contributions from any other NOE will in the vast 
majority of cases will be negligible. Leaving these cross-peaks unassigned will produce 
1  A NOE violation occurs when the distance between two nuclei in the calculated 3D structures is 
greater than that defined in the correlating distance restraint. 
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ambiguous distance restraints that are not necessary and can affect the calculation 
because too many unnecessary ambiguous distance restraints can define a solution 
surface with multiple minima or an improper description of the protein from an arising 
false minimum, even if the ADRs are all correct. For this reason and to generally speed 
up the structure calculation, it is prudent to assign the classic NOEs seen in secondary 
structure [189]. Their symmetry related NOE crosspeaks were also assigned to verify 
the NOE connectivity and assignment. 
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Figure 4.3: Schematic for the antiparallel 0-sheet and the associated NOE connectiv-
ities. Dashed lines indicate positions of hydrogen bonds. Double headed arrows show 
observed NOE connectivities in the NOESY spectra of MBD. The observed NOEs are 
typical of a /3-sheet. 
After the NOESY spectra have been peak-picked and these initial assignments have 
been made, the spectra have to be integrated so that the volume of the peaks can be 
determined and therefore inter-nuclear distances can be derived. The ANSIG software 
has the facility to integrate entire spectra which was used on the NOESY spectra. 
It is important when using this software, not to have any diagonal peaks picked, not 
only because its unnecessary and bad practice, but because the ANSIG software also 
calculates the relative volumes for each peak from the normalisation of the cross- 
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peak volumes, and the inclusion of diagonal peaks would give inaccurately low relative 
volumes for the NOE cross-peaks. The relative volumes are used to catagorise peak 
volumes into strong, medium, weak and very weak, and set corresponding inter-nuclear 
distances without having to calibrate them directly from the actual peak volumes in 
each different spectrum. 
Peak category maximum distance minimum distance relative volume cut-off 
Strong 2.7 A 0 A 3.0 
Medium 3.8 A 0 A 1.7 
Weak 5.0 A 0 A 0.3 
Very weak 6.0 A 0 A 0.0 
Table 4.1: Table of peak intensity category and relative volume to distance calibration 
used. 
The "connect" program, a part of the AZARA package, is used to create the restraint 
list from the chemical shift list and NOESY peak lists. The peak lists were extracted 
from the ANSIG cross peak file using the following programs on the UNIX command 
line; 
ansigBinary2rdb ANSIG cross-peak file> cross-peak file in RDB format 
row spectrum eq spectrum name < cross-peak file in RDB format > spectrum peak list 
The program "ansigBinary2rdb" converts the ANSIG cross-peak file into RDB format 
(RDB : Relational DataBase management system) and "row", a perl script that is 
part of the RDB package, extracts the chosen spectrum (spectrum name) as named in 
ANSIG. 
The chemical shift list was produced using series of shell scripts listed in order of use 





It was found that the shell script "makeShiftSummary" was inefficiently written and 
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had an unacceptably long run time, therefore it was deemed necessary to rewrite this 
program (see C.1.1 for code). Also the original version of "makeShiftSummary" cal-
culated the error bound for each chemical shift from the difference between the lowest 
and highest values. However the rewritten version allows the option for this method 
to determine the error bound or to take the standard deviation as the error bound. 
"Connect" matches the chemical shift values of the peak with any value in the chemical 
shift list that is within the error bound (normally set to 0.04 ppm minimum for proton 
and 0.35 ppm for carbon) to produce a restraint list that contains both ambiguous and 
unambiguous distance restraints. It also produces a table of cross-peaks that could not 
be matched to a nuclei. This arose for a number of reasons e.g. incomplete assignment 
(subsequently completed), or mistakenly picked coupling artefacts, noise signals and 
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Figure 4.4: Number of distinct NOEs used in structure calculation as a function of 
residue number. Black bars correspond to intraresidue NOEs; dark grey, sequential 
NOEs; light grey, short-range NOEs [i to i (2-4)]; white, medium and long-range NOEs 
[i to i (>4)]. Ambiguous NOEs in which one partner is identified are included, but not 
ambiguous NOEs in which neither partner was identified. 
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Spectrum no. of peaks excluded no matches Ambig Unambig 
MBD 
13C-edited NOESY 
15 N-edited NOESY 





























Table 4.2: Table of "connect" statistics for the final restraint list of MBD and MBD-
DNA complex. no. of peaks is the number of picked peaks in the spectrum given to 
the program. excluded is the number of peaks excluded from the restraint list because 
they fell within a pre-determined range; in this case on the water chemical shift. no 
matches indicates the number of cross-peaks that could not be matched to a nuclei. 
Ambig and Unambig are the number of ambiguous and unambiguous distance restraints 
respectively derived from the spectrum. 
4.3.2 Hydrogen bonds and exchanging amide protons 
A total of 14 hydrogen bonds between slowly exchanging amide protons and appropriate 
acceptors which were supported by local NOE data (see figure 4.3) were incorporated 
into the calculation once well-defined structures had been obtained. Donor protons 
to acceptor distances were restrained to be less than 2.3 A and donor nitrogen to 
acceptor distances were restrained to be between 2.5 A and 3.3 A so as to maintain 
an approximately linear geometry. These therefore accounted for an additional 28 
distance restraints to emulate the 14 inferred H-bonds. Only the hydrogen bonds in 
the /3-sheet were incorporated into the calculation and are between: 
Residues D21 and R30 
Residues T29 and 149 
Residues K31 and Y47 
Residues K33 and D45 
Residues R35 and K43 
Residues L48 and F56 
Residues N50 and K54 
11/2 11/2 
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The a-helix was seen to form early in the calculations from NOE data alone and thus 
it was deemed unnecessary to include these additional h-bond restraints. This was 
the case probably because the amide and alpha proton shifts were well dispersed for 
residues in the a-helix whereas there was an amount of overlapping in the /3-sheet. 
For example, the Ha chemical shifts for R30 and L48 are 5.425 ppm and 5.383 ppm 
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Figure 4.5: The WEX II-FHSQC sequences. Tm is varied from 5 to 60 ms. Contri-
butions of intramolecular NOEs (Has to HN5) can be estimated by the spin-echo filter 
inserted in the WEX II filter (bottom sequence). Te can be 40 - 60 ms. Last set of 
pulses (white boxes) were applied along the y-axis. Narrow boxes indicate 90° pulses 
and wide boxes 180 0 pulses. L and ö were tuned to get a JHN  evolutiuon period. 
Gradients, GI - G6, were 9.0, 0.1, 2.5, 0, 11 and 1.5 G/cm x ims respectively. 
The h-bond con nectivities were inferred from a 2D heteronuclear water exchange filter 
sequence (WEX II-FHSQC) [114]. This measures the exchange rate, k, of rapidly 
exchanging backbone amide protons with solvent water, i.e. k > 1.0s'. The WEX II-
FHSQC experiment is a combination of the WEX-11 filter and the FHSQC method and 
provides a well-defined mixing time, as the magnetization originating from water is the 
major source of signal at acquisition, minimizes cancellation errors, negates radiation 
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damping by using dephasing/rephasing gradients when water magnetization is in the 
transverse plane, and efficient water flip-back that avoids sensitivity loss due to water 
saturation. Also as there are contributions of intramolecular NOES (Ha to HN), it is 
necessary to measure them with spin-echo filtering. A clear definition of the mixing 
time, Tm is obtained between the first two hard pulses and is varied from 5 to 60 
ms. The exchange rates can be estimated from the signal by a two parameter fit of 
a function of the mixing time, Tm. The assumption that the molar fraction of water 
(XB) is much higher than the molar fraction of the protein (XA) so XB 1 and the 
effects of NOES are negligable. The function that relates the mixing time, Tm and the 
signal intensity, I is; 
I = 
	fXAk 	(exp_R1w0tTm - exp_(R1m01+k)Tm) 	(4.17) 
(R imol + k - Riwat) 
However the quantity !XA, where f is the proportionality coefficient between the molar 
fraction and the signal intensity, can be factored out by normalising I by Iref,  where 
'ref is the FHSQC signal intensity. Therefore, k and Rimoj + k were estimated using 




k - - exp_(R1m01+k)Tm) 	(4.18) 
Iref (R imo i + k) - Riwat 
where Rimoi  is the inverse of the T 1 of the protein, Riwat  is the inverse of the water Ti, 
and k is the normalised rate constant. Riwat was separately determined to be 0.393 
s, from a series of 1D spectra using a 10 s predelay and a pulsed field gradient to 
avoid radiation damping during the inversion delay. 
Magnetization transfer experiments are prone to artefacts from various sources of NOE 
effects, in this case the intramolecular NOES from Hce to HN excited by the first water 
selective excitation pulse. The contributions of these intramolecular NOES were esti-
mated by using the sequence where a spin-echo filter is inserted before the first hard 
pulse. The NOE contributions are included in the apparent exchange rates (NOE+k) 
and assuming linear evolution of exchange rates, NOE signals, and complete removal 
of the NOE effect after the spin-echo filter, the pure exchange rate (k) can be obtained 






(NOE+k) - 1—I s 
where I and I are peak intensities with and without spin-echo filter at Te and Tm 
values of 40 ms. Because NOE+k, 'Se,  I and f3 are known values, the pure exchange 
rate, k and the NOE contribution can be determined from the observation of the spin-
echo induced signal loss of amide protons which exchange rapidly enough for k to be 
dominant compared to the NOE contributions. f 5 was estimated by observing signal 
loss in glutamine and aspargine side chain amide protons, because these amide protons 
are usually well isolated from a protons. In these experiments carried out on MBD, f3 
was found to be 16.2%. 
Inaccuracies can arise from other sources such as spin diffusion or exchange from rapidly 
exchanging hydroxyl groups in proteins. Signals obtained from the spin-echo filtered 
experiment may still contain contributions from intermolecular NOEs i.e. from water 
protons to amide protons. 
Solvent exposed residues 
Strong signal was observed for residues 77 to 91 (the mobile N-terminal arm), 112 to 
117 (residues between strands B and C, referred to as the BC loop), 148 to 149 (flex-
ible turn after the C-terminus of the a-helix), and those in the C-terminal tag. This 
correlates with the dynamics result (chapter 5) and confirms the mobility of these re-
gions. Surprisingly peaks were observable for residues 97, 121, and 133. However they 
were found to arise from mainly from NOE contributions and therefore are not rapidly 
exchanging. The artefacts appear to originate from a nearby Ca proton close to the 
water resonance. For Asp97 (in the centre of strand A), this will be from Asp96 whose 
Ha proton resonates close to the water and so is consistent with the 0-strand confor-
mation (see figure 4.3). Likewise, the NOE contribution to the calculated exchange 
rate constant of Asp121 will come mainly from the Ha proton of Tyr120. However, 
Asp121's own Ha proton resonates at the water frequency and would contribute to its 
peak volume. In addition, the intensity of the peaks of Va1122 would comprise mainly 
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Residue Type Sec.Sta k0b3 (s_1)b calcd (s NOEd 
77 ALA 7.733 8.442 0.708 
78 SER 8.406 8.882 0.476 
79 ALA 5.077 6.062 0.985 
80 SER 7.311 8.228 0.917 
81 PRO NA NA NA 
82 LYS 2.391 2.700 0.309 
83 GLN 4.238 4.395 0.158 
84 ARC 11.305 11.947 0.643 
85 ARG 2.110 2.264 0.155 
86 SER 15.056 15.535 0.479 
87 ILE 2.436 2.721 0.285 
88 ILE 4.704 7.978 3.273 
89 ARG 4.266 4.866 0.600 
90 ASP 3.782 4.486 0.704 
91 ARG 4.258 4.854 0.597 
92 GLY 2.068 2.283 0.215 
93 PRO NA NA NA 
94 MET 1.161 2.216 1.055 
95 TYR 
96 ASP 0-sheet 
97 ASP /3-sheet 1.286 3.827 2.541 







105 THR /3-sheet 
106 ARG 3-sheet 
107 LYS 3-sheet 
108 LEU 3-sheet 
109 LYS 3-sheet 
110 GLN 11.713 13.981 2.268 
111 ARG 
112 LYS 21.112 24.720 3.606 
113 SER 8.904 9.200 0.296 
114 GLY 23.679 23.828 0.150 
115 ARG 52.547 55.578 3.031 
116 SER 31.862 32.502 0.640 
117 ALA 3.548 3.982 0.434 
118 GLY 4.178 5.510 1.331 
119 LYS 
120 TYR 1.041 1.118 0.076 
121 ASP 3-sheet 0.612 3.680 3.068 
122 VAL /3-sheet 
123 TYR /3-sheet 
124 LEU /3-sheet 
108 
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Residue Type Sec.Sta k0b8 (s_ 1 )b calcd (s_ NOEd 
125 ILE /3-sheet 
126 ASN 
127 PRO NA NA NA 
128 GLN 
129 GLY 
130 LYS /3-sheet 
131 ALA 3-sheet 
132 PHE 3-sheet 
133 ARG /3-sheet 0.363 2.333 1.970 
134 SER 
135 LYS a-helix 
136 VAL a-helix 
137 GLU a-helix 
138 LEU a-helix 
139 ILE a-helix 
140 ALA a-helix 
141 TYR a-helix 
142 PHE a-helix 
143 GLU a-helix 




148 THR 3.175 7.002 3.828 
149 SER 9.530 10.436 0.906 
150 LEU 
151 ASP 
152 PRO a-helix NA NA NA 
153 ASN a-helix 









163 GLY 15.506 15.625 0.119 
Table 4.3: Results from WEX II-FHSQC experiments, a Secondary structure elements 
as observed in tertiary structure and CSI plot. b k0b3  is the observed rate constant 
in s 1 after correction for NOE contributions. c Rate constants calculated from two 
parameter fit of peak volumes in s 1 . d Contributions from NOE in s 1 . Blank 
means that exchange rate was slower than detection limit (< 1.0s 1 ). NA means not 
applicable as there is no amide proton i.e. proline residues. 
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of this NOE contribution. However as there was overlap with the strong peaks from 
residues in the flexible N-terminal arm, and there was no strong peaks for Va1122, the 
exchange rate constant was not calculated. It is safe to assume that it was less than 1.0 
-• Similiarly, the NOE contribution to peaks relating to Arg133 would come from 
Phe132, thus confirming the existence of a /3-strand conformation. As Arg133 is on the 
boundary between strand D and the a-helix, its own Ha proton which resonates close 
to water is orientated out of the protein and (NOE) contributes, if at all, only to its 
own peak volume. The pure exchange rate, k 0b3 , values are less than 1.0 s_ i for Asp121 
and Arg133 but is not for Asp97. However the contribution from intramolecular NOEs 
makes up the majority of the calculated value (see table 4.3). 
Most other NOE contributions are are insignificant compared to the exchange rate con-
stant. It can generally be said that the origins of the larger NOE contributions (larger 
than 1.0 s 1 ) can be elucidated from the presence of nearby Ha protons resonating at 
the water frequency. The NOESY spectra can give an indication of the residue from 
which this originates. 
Of particular interest are the rate constants for residues around the C-terminal end of 
strand B and the N-terminus of strand C. It is clearly seen that there are no detectable 
exchange for Argill and Lys119, but rapid exchange for Gln 110, Lys112, G1y118 and 
Tyr120. This would suggest backbone hydrogen bonding between Argill and Lys119, 
especially as the NOE contribution to Gln 110 from the Ha proton of Lys109 indicates 
a 3-strand like conformation, and the characteristic peaks are seen in the NOESY 
spectra. 
The larger values for the exchange rate constants of GlnllQ and Lys112 (table 4.3) show 
that strand B is significantly more solvent exposed than strand C. This correlates with 
the fact that strand B consists mainly of arginine and lysine residues - some suspected 
to bind to DNA (section 3.4) - while strand C contains some hydrophobic residues. 
4.3.3 Dihedral angles 
A total of 45 3J(HNHa)  derived dihedral angle restraints were used in the calculation 
of the refined structures of MBD. These were obtained from a water-flip-back version 
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of the 3D HNHA experiment [94, 1781. The 3D HNHA spectrum yields diagonal peaks 
at (F 1 ,F2 ,F3) = (WHN,WN,WHN) and cross peaks at (F 1 ,F2 ,F3) = (WHa,WN,WHN), 
and providing that the ti acquisition period is much shorter than H1H'  the diagonal 
and cross peaks have identical line shapes [178]. The 3JHNHa  is extracted from the 
spectrum via the quantitative evaluation of the cross peak - diagonal peak intensity 
ratio by; 
Ix - = - tan 2 (27rJHNHa) 	 (4.20) 
ID 
where Ix  and 'D  are the intensities of the cross and diagonal peaks respectively, and 2 
is the JHNHa  de-/rephasing delay. The de-/rephasing delay can be determined from 
the experimental parameters BigT and Jxh (Varian) by; 
delay, 2 	
1 
= BigT + 	 (4.21) 
Jxh 
and in this case was found to be 0.01340954 seconds. 
The process of extracting the coupling constants from the spectrum required the writ- 
ing of a couple of ANSIG macros and programs (source in appendix C.2). After the 
spectrum had been picked, the assignment was greatly speeded up by the use of the 
Residue 3JHNH error Residue 3JHNHa  error Residue 3JHNH error 
S2 8.19 1.00 S4 7.29 1.00 SlO 6.47 1.00 
Ill 8.20 1.00 112 7.47 1.00 T23 7.86 1.00 
T29 9.61 1.56 L32 7.77 1.82 K33 9.25 1.00 
Q34 5.73 1.13 R35 6.65 1.00 S37 8.40 1.00 
S40 9.57 1.11 K43 6.72 1.00 D45 9.70 1.00 
Y47 7.38 1.05 L48 9.35 1.02 149 8.59 1.53 
N50 6.49 1.00 K54 7.92 1.00 A55 8.39 1.00 
F56 9.48 1.54 R57 8.23 1.20 S58 6.48 1.00 
V60 4.16 1.00 E61 5.23 1.00 L62 5.47 1.00 
A64 4.26 1.00 Y65 4.83 1.00 E67 5.25 1.00 
K68 4.76 1.00 V69 8.59 1.00 D71 7.02 1.00 
T72 9.02 1.00 L74 8.46 1.00 D75 7.95 1.00 
N77 6.43 1.00 D78 6.84 1.00 F79 8.63 1.00 
S88 7.32 1.00 S90 7.64 1.00  
Table 4.4: Table of HNHA derived 3JHNHa  coupling constants. The errors were cal-
culated from the r.m.s. noise and increased to a minimum of 1, if required. 
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"nuc_HNHA" macro which could distinguish between Ha and HN peaks (in the F2 
dimension, Fl and F3 dimensions should always be N and HN 2 in a 3D HNHA spec-
trum). These were distinguished them from the sign of the peak as the cross peak was 
positive and the diagonal peak was negative, so it was necessary to process the spec-
trum properly (or swap conditions in the macro). Integrating the spectrum was done 
with a purpose written macro "integr_vol", necessary to obtain accurate intensities. 
The normal integration macro was inadequate in this case as it would sample spec-
tral space around the desired peaks and give erroneous volumes, however was apt for 
NOESY, WEX II-FHSQC and dynamics spectra because catagorisation, curve fitting 
or simply the magnitude of the determined values negated this error. 
The "integrvol" macro works by first prompting the user to draw a box around the 
chosen peak in the F1/F2 plane, then switching to the F1/F3 (HSQC) plane and 
prompting for another box to be drawn around the peak in this plane. This gives 
a close fitting cuboid around the 3D peak from which an accurate sampling of the 
spectral data can be achieved from the integration and therefore an accurate peak 
volume can be obtained. 
Once assigned and integrated,the HNHA peaklist was converted to "rdb" format and 
submitted to the program "calculate _J", a shell script wrap for the program "calc_Jhnha" 
written in C, which produces a table of J-coupling constants in rdb format. The script 
"Jrdb2Jxplor" was used to convert this data into a X-PLOR digestable format. 
The JHNHa  values derived from equation 4.20 had to be multiplied by a correction 
factor of 1.11 to account for Ha spin-flips, assuming a Ha-selective Ti value of 100 
ms [178]. Uncertainities in the HNHA derived J values were estimated from the r.m.s. 
noise in the 3D specrum. The karplus curve parameters used were A = 6.51, B = -1.76 
and C = 1.72, 9 = torsion angle, 4 - 60 [178]. X-PLOR has the facility to accept 3J 
coupling constants into a calculation and so dispenses with the need to directly derive 
dihedral angle restraints from the 3JHNHO  coupling constants. 
2  These are the spectral dimensions as defined by ANSIG which puts the heteronuclear nuclei attached 
to the directly acquired proton in the Fl dimension and the directly acquired proton in the F3 
dimension regardless of the experimental definitions. 
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Figure 4.6: Plot of values for 3JHNHa  coupling constants calculated from the measured 
dihedral angles, 0, in calculated structures (without dihedral angle restraints) of MBD 
(diamonds). The karplus curve (solid line) parameters were A = 6.51, B = -1.76 and 
C = 1.72. 
4.3.4 Protocols 
Once the restraint lists had been prepared, they were used in two sets of SA protocols: 
ARIA (see section 4.2) and versions of the X-PLOR protocols rand.inp, rrsa.inp and 
reflne.inp, that had been modified to allow floating stereochemistry at, and to include 
active swapping of, prochiral centres in random order using a metropolis style accep-
tance criterion, refered to as "wrapper" [A.R.C. Raine, B.O. Smith and P.J. Domaille, 
unpublished data]. 
The wrapper protocols were used for the initial calculations and debugging of the 
restraint lists. Its minimization strategy consists of a sequence of simulated annealing 
stages. The separation into several stages makes calculations more efficient. The 
first stage (rand.inp) creates random starting structures that have an approximate 
conformation based on the ambiguous data. The next stage (rrsa.inp) regularizes the 
structures and is essentially a modernised DGSA.inp from the X-plor manual [27]. The 
initial simulated annealing temperature (2000 K) remained the same but the number 
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of steps is 4000 at high temperatures and 2000 steps are used during cooling. The 
refinement protocol (refine.inp) embodies two refinement stages, utilising data from 
ambiguous distance restraints. The number of steps at the high temperature is 10000 
with an initial temperature of 2000.01 K. The first cooling stage from 2000 K to 1000 
K is over 500 steps, and the second from 1000 K to 100 K is over 222 steps. Powell's 
conjugate gradient method [146] was used to minimize the total energy (equation 4.4) 
and the Verlet method for molecular dynamics was used. 
Initially, the wrapper protocols did not include the active swapping of prochiral centres, 
but when the root mean square deviation (r.m.s.d.) of backbone atoms for residue 19 
- 86 3 (it was known at this time that residues 1 - 18 were disordered) among the 
calculated strucutres were sufficiently low i.e. between 1.0 and 1.5 A, swapping of 
prochiral centres was allowed. The refined structures were calculated using ARIA [128]. 
The initial temperature was 2000 K with the number of step at the high temperature 
being 10000 for new structures and 2000 for kept structures. The first cooling from 
2000 K to 1000 K was done over 500 steps, and the second from 1000 K to 50 K 
over 210 steps. Powell's method for energy minimisation and the Verlet method for 
molecular dynamics was again used in ARIA. The error bounds, L+  and T, were set 
to 0.125 D 2 . 
4.4 NOE violations 
A structure calculation produces a set of structures that are described by restraint list. 
An energy is calculated for each structure using equation 4.4, and this value included 
by the SA protocols in the header of the PD13 4 file of each of the structures, along with 
the constituents of the total energy. One criteria used to decide whether a protein 
structure has in fact been solved is a low total energy. Assuming that there are no 
bugs in the SA scripts and protocols, the NOE energy term will be the main constituent 
of a large energy total (see section 4.1.4). 
As a violated distance restraint, or NOE violation incurs an energy penalty, it is es- 
3 95 - 164 natural sequence 
PDB - Protein Data Bank. The data base that contains the three dimensional structures of 
biomolecules in the format of x,y,z atomic coordinates 
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sential to find out why each violation has arisen and rectify the situation. Violations 
can arise for a number of reasons. For example, the restraint may come from an arte-
fact and therefore should be removed; or a missing assignment might have led to the 
incorrect matching of nuclei with chemical shift; or a value in the chemical shift list 
differed from the chemical shift of the NOE crosspeak by slightly more than the error 
bound which led to the wrong nuclei being matched to that peak - thus steps were 
taken to ensure that the appropraiate nuclei was included in the distance restraints 
either by the manual assignment of that peak or by appropriate adjustment of the 
listed chemical shift value, error bound or centering the cross-peak marker. Another 
sources of violations were peaks that had been put into too tight a distance category 
because their relative volumes fell close to the cut-off point, - these restraints had to 
be loosened. In the case of MBD-DNA complex, some NOE crosspeaks observed were 
to the DNA molecule and adjustments to the restraint had to be made accordingly. 
Finally it was often found that there was nothing wrong with the restraint and it had 
only been violated because other incorrect restraints had been satisfied instead pulling 
the structure into a "wrong" conformation. 
The elimination of violations was a lengthy and laborious process for free MBD but 
the methodology developed provided useful in expediting the structure calculation of 
MBD in the DNA complex. Once there were no more NOE violations and therefore 
zero contribution from the NOE energy term to the total energy, assuming that there 
are enough experimental restraints and the root mean square deviation of the backbone 
atoms among the ensemble of structures is sufficiently low i.e. less than 1.0 A, then 
the protein structure has been solved and all that is required is a final refinement. 
4.5 Protein Structure: PDB accession number 1QK9 
The CSI plot [186] for MBD indicates that the domain consisted of four /3-strands, 
A-D (A, residues 96-98; B, 104-109; C, 120-125; D, 131-134) and a three-turn a-
helix (residues 135-144) (see section 2.4.3). This was found to be consistent with the 
calculated structures. 
Natural MeCP2 (human) sequence numbering. The domain starts at Ala 77. 
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The results of the dynamics studies imply that the non-native residues at either end 
of the recombinant sequence are disordered in both MBD and MBD-DNA complex. 
Thus it maybe assumed that these are not involved in binding. The first 18 residues 
of the native sequence have heteronuclear NOEs of less than 0.6 indicating that this 
segment is mobile with respect to the overall tumbling of the molecule in solution. 
This is corroborated by an observed lack of NOEs in this region, and the broadness of 
cross-peaks in comparison with those from other residues. The gaps in the assignment 
were localized around Pro93 and Met94 where the peaks showed signs of exchange 
broadening on an intermediate timescale due to these two residues being the boundary 
between the mobile N-terminal segment and the structured domain. Also there were 
two other regions with low heteronuclear NOE values, residues 112- 119 and 148- 150. 
These correspond respectively to the loop between strands B and C (BC loop), and to 
a flexible turn beyond the C-terminal end of the a-helix. 
The final calculated structures had a r.m.s. deviation (backbone atoms) of 0.64 A 
in 28 structures out of 30 calculated. An overlay of these structures showed a good 
convergence of secondary structure elements but the position and conformation of a 
few loops and turns were not well defined by the experimental data. However there is a 
correlation between the r.m.s. deviation of specific residues in the calculated structures 
and the results from the dynamics studies. This implies, along with evidence from the 
measured proton exchange rates, that the ill-defined stretches are genuinely mobile, 
and their lack of structural definition is not due to experimental anomilies. 
The mean r.m.s deviation for the backbone (Ca, N & CO) of residues in the 3-sheet 
(strands B - D) and the a-helix is 0.36 A, while the equivalent value for all 69 residues 
of MBD (94-162) is 0.92 A. The least well defined regions are between residues 112 
- 119 and 148 - 150. However, strand A (residues 96 - 98, as predicted by the CSI 
plot), shows some limited disorder as the heteronuclear NOE of Asp97 is 0.71 and a 
low exchange rate constant is measurable for Asp97 and Thr99 whereas there were 
none detectable for the h-bonded residues in the other secondary structure elements. 
The r.m.s. deviation of Asp97 Ca and Pro 98 is 0.85 A and 1.8 A respectively, even 
though the resonance assignment for this region is complete. Thorough scrutiny of 
NOEs did not reveal any cis-proline conformations, but it is possible that some other 
134 
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Figure 4.7: Structure of the methylated DNA binding domain from MeCP2. A su-
perposition of backbone (Ca) traces for the 28 structures with lowest energy out of 
a set of 30 calculated. The 28 structures were selected by plotting total energy per 
structure against structure number in order of lowest energy. Structures lying where 
the gradient of the plot is almost zero and constant, were taken. Only residues 90 - 
164 are shown and superposition was on backbone atoms for residues 94 - 111, 120 - 
147 and 151 - 162, i.e. the segments of the domain where the heteronuclear NOE value 
is greater than 0.6 and is therefore structured. 
117 
144 
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Figure 4.8: A plot to show the r.m.s. deviation of the Ca atoms of residues 94-162 
as a function of residue number, based on a superposition of these Ca atoms from 28 
calculated structures. The grey striped block identicates the postition of the flexible 
N-terminal arm, residues 77 - 93 
slow conformational exchange is taking place. 
The calculated structures were submitted to the DALI server (http://www.ebi.ac.uk/dali/)  
[72] which was unable to find any similar folds in the database, and on the basis of 
this, MBD appears to have a novel fold. The tertiary structure of residues 94 - 161, 
which comprehensively includes the MBD consensus sequence, is approximately wedge-
shaped (see figures 4.9 and 4.10). This partly results from the a-helix not being par-
allel with the /3-sheet as the C-terminus of the helix is angled away from the plane of 
the 3-sheet by approximately 15°. One face of the wedge consists of a four-stranded 
antiparallel 0-sheet, while the other face is formed by the three turn a-helix and a 
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Medium range; i -* [i + (2 - 4)] 143 
Long range; i -+ [i + (> 4)1 368 
Root mean square deviations: 	 (SA) 	(SA)b 
For structured residues (94-111,120-147,151-162) 
Backbone atoms (Ca, N & CO) 	 0.639 	0.401 
Co atoms only 	 0.650 0.415 
From experimental restraints: 
Ambiguous NOEs(A) 0.024±0.009 0.013 
Unambiguous NOEs(A) 0.035+0.008 0.029 
J restraints for q5 (Hz) 0.97±0.06 0.87 
From idealised geometry: 
Bond lengths (A) 0.0035+0.0007 0.0023 
Bond angles (°) 0.49±0.06 0.40 
Final energy, Eq,, (kJmol 1 ) -217±17 -218 
Assessment of quality according to the Ramachandran 
plot (% residues) using PROCHECK [97]: 
Most favoured region 	 63.5 
Additionally allowed region 	 32.4 
Generously allowed region 4.1 
Disallowed region 	 0 
Table 4.5: Structural statistics for the 28 refined residues. (a) represents the average 
r.m.s. deviations for the ensemble of 28 structures. (b) represents values for the final 
structure that is closest to the mean. (c) The Lennard-Jones potential was not used 
at any stage in the refinement. 
C-terminal segment which includes a single turn of helix (residues 152 - 154) that runs 
parallel to the cr-helix. B-strands B and C project beyond strands A and D forming 
the thin end of the wedge which is further extended by a long loop between strands 
B and C. The BC loop is poorly defined by NOEs (see figure 4.4), is not well ordered 
according to the relaxation data and has backbone amide protons that are rapidily 
exchanging with water. Both faces of the wedge contribute hydrophobic sidechains to 
an elongated core. Figures 4.9 and 4.10 are the MOLSCRIPT [92] representations of 
MBD and are in the same orientation, and a 180° rotation as that in figure 4.7. 
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Figure 4.9: MOLSCRIPT representation of MBD (residues 94 - 164). The four /3-
strands forming the antiparallel 13-sheet are depicted by broad arrows pointing from 
the N-terminus to the C-terminus. The two helices (one has three turns and the other 
only one) are clearly indicated by the spiral ribbons. The colouring scheme is shaded 
blue at the N-terminus and red at the C-terminus. The orientation is the same as that 
in the previous figure. 
LeulOO, Trp104, Arg106, Leu108, Tyr120, Va1122, Leu124, Phe132, Leu138, Phe142, 
Leu150, Phe155, Phe157 and Va1159 comprise the hydrophobic core. The guanidyl tail 
of the Arg106 sidechain is solvent exposed at the turn between 13-strands A and B, 
the Thr120 hydroxyl group and a methyl group of Va1159 are exposed at the thin end 
of the wedge, and the 3-methylene of Phe157 is also exposed. Of the nine arginine 
and eight lysine residues within the protein, four arginines and one lysine lie within 
1 
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Figure 4.10: MOLSCRIPT representation of MBD (residues 94 - 164). The four ji-
strands forming the antiparallel /3-sheet are depicted by broad arrows pointing from 
the N-terminus to the C-terminus. The two helices (one has three turns and the other 
only one) are clearly indicated by the spiral ribbons. The colouring scheme is shaded 
blue at the N-terminus and red at the C-terminus. The orientation is at a 180° rotation 
to that in the previous figure. 
the mobile N-terminal segment ( residues 77 - 93) and three arginines and four lysines 
lie within a 14 residue long stretch situated in strand B and the BC loop. All of the 
positively charged sidechains are fully solvent exposed with the exception of Arg106. 
All of the negatively charged and polar sidechains are also solvent exposed. Proline 
and glycine residues are situated in turns or loops except for Pro98 which is in strand 
A. 
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4.5.1 Structural role of conserved residues 
Apart from Leu 108, Tyr120, Leu 150 and Va1159, all of the core residues are conserved 
in the MBD family (see figure 4.11). Leu108 is a valine in MBD4 but is a glutamate 
in the other family members. Tyr120 is a phenylalanine in MBD4 but is replaced by a 
serine in MBD1 and MBD2, and by an arginine in MBD3. Leu150 is partly conserved 
in the family with a valine replacement in MBD2, and a methionine in MBD3, but 
is substituted by a cysteine in MBD1. However the sequence alignments of the MBD 
family published by Hendrich and Bird [69] and Okhi et al [131] show this residue 
to be conserved in MBD1 and MBD4, conservatively substituted with a threonine in 
MBD3, but is replaced with a serine in MBD2. Again depending on the criteria for 
the sequence alignment, Va1159 is conserved in MBD4, conservatively replaced with 
threonine or is missing in MBD2 and MBD3 and is not conserved with a glutamate 
substitution or is missing in MBD1. Val159 has Tyr120 packed against one methyl 
group at the narrow end of the core, and has Leu108 packed against the other. 
Of the residues with exposed hydrophobic side chains, A1a117, Tyr123 and Tyr141 are 
conserved. 11e125 is conserved or conservatively substituted except in MBD1 where it's 
replaced with a glutamate. Tyr123 and 1le125 with the non-conserved A1a131 form a 
hydrophobic pocket near the centre of the 13-sheet face of the domain. 
There are three highly conserved asparate residues, Asp121, Asp151 and Asp156. 
Asp151 and Asp156 form part of a negatively charged surface on the helical face of 
the domain along with Asp147 and Asp154. The side chain of the conserved Asp121 
projects from the thin end of the wedge and forms an electrostatic interaction with 
Argill, although it was originally thought that this interaction could instead or also 
have been with Arg133. Argill and Arg133 are highly conserved residues. All prolines 
and glycines are conserved except for Pro156 which is replaced by leucine in MBD1, 
MBD2 and MBD3, and those in the mobile N-terminal segment, Pro8l and G1y93. 
4.5.2 The DNA binding interface 
As discussed in section 3.4, some backbone amide protons underwent DNA-induced 
changes in chemical shift. These measured changes were mapped onto the calculated 
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Figure 4.11: A sequence alignment of the MBD family. The numbering is the natural 
sequence of MeCP2. Capitals indicates a highly conserved residue. The consensus 
is given on the bottom line in bold italics. The asterisk in the consensus indicates 
multiple conservative substitutions. The colour coding refers to the chemical shift 
perturbation; Green indicates no significant change; yellow small but significant and 
blue large change. The colour coding is also mapped onto the side chains of the highly 
conserved residues in the two backbone traces of MBD at a 180° rotation from each 
other. 
structure (figure 4.12). Chemical shift perturbations are seen within residues 107 - 
123 which encompass the C-terminal half of strand B, the flexible BC loop and the 
N-terminal half of strand C. These all lie towards the thin end of the wedge-shaped 
domain. The most strongly perturbed are the amide protons of G1y114 and Arg117 
in the middle of the BC loop. Also strongly affected are amide protons of A131 and 
Arg 133 in strand D, Lys135 and Va1136 situated in the N-terminal end of the cr-helix, 
and Phe157, Thr160 and Arg162 which lie within the C-terminal stretch containing 
the single turn helix. 




Figure 4.12: Green indicates residues with no significant change in chemical shift; 
Turquoise indicates residues with a significant chemical shift perturbation; Blue indi-
cates residues with a large chemical shift perturbation. Argill and Arg133 are shown 
in sky blue. Both their backbone and side chain chemical shifts showed a large pertur-
bation upon binding to DNA. 
The surface electrostatic potential was mapped onto the molecular surface represen-
ation of MBD using GRASP [126]. This implied that MBD is positively charged on 
the face containing the two helices towards the thick end of the wedge shape. It was 
found that the positive potential is mainly situated on the residues that have shown 
DNA-induced chemical shift perturbations. This is consisent with the involvement of 
the 8-sheet fare and the thin end of the wedge-shaped domain in interactions with 
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DNA phosphate backbone. 
f 
41 
Figure 4.13: Molecular surface coloured by electrostatic potential (Blue is positive, red 
is negative) at ±5 eV using GRASP (Nicholls et al., 1993). 
There are also two hydrophobic pockets, one is formed by Tyr123, 11e125 and A1a131 
and the other by Val122, Phe157 and Val159 (see figures 4.15 and 4.16), that are 
solvent accessible. These hydrophobic pockes are surrounded by amide protons whose 
chemical shift is perturbed by the interaction with DNA. 
Also, a five residue peptide segment (residues 88 - 92) in the mobile N-terminal arm 
was observed to undergo chemical shift perturbations upon formation of the MBD-
DNA complex. As these residues and those in the BC loop displayed chemical shift 
perturbations upon binding to DNA, the collection and analysis of a heteronuclear 
NOESY of the MBD-DNA complex important (see chapter 5). The BC loop was 
found to become structured and had lost its flexibility. On the other hand, the mobile 
N-terminus was found to have remained disordered but to a significantly lesser extent. 
This presumably must at least be partially due to steric hinderance from the bulky 
DNA molecule. 
It was also noticed that two arginine guanidyl sidechains had become structured upon 
binding to DNA while the other guanidyl groups remained highly disordered. These 
are the sidechains of Argi 11 and Arg133, whose sidechain and backhon amide protons 
experience large DNA-induced chemical shift perturbations. The two guanidyl groups 
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are approximately 7.5 A apart and are oriented to project out of the identified DNA 
binding surface as illustrated in figure 4.12. 
4.6 MBD-DNA complex 
An ensemble of structures of the protein in the MBD-DNA complex have been calcu-
lated using the same methods employed for the structure determination of MBD alone. 
The mean r.m.s. deviation for backbone atoms in 9 out of 10 structures was 0.770 for 
all 69 residues (residue 94 - 162). An overlay of the structures (figure 4.14) showed a 
convergence of secondary structure elements that is consistent with the CSI plot (figure 
2.9) for DNA bound to MBD. MBD in its bound state still consists of 4 0-strands, 
forming an antiparallel /3-sheet, a three turn a-helix and a single turn helix. The mean 
r.m.s. deviation for the backbone of residues in strands B - D and the a-helix is 0.412 
(for comparison with MBD) and for all the secondary structure elements i.e. strands 
A - D and the a-helix is 0.428. The r.m.s. deviation of the structures from the mean 
structure varied from 0.456 to 1.113, indicating a lack of refinement in the structures. 
Only data from a 3D 13 C-edited NOESY and a ' 5 N-edited NOESY were used for this 
structure calculation, hence the higher r.m.s. deviation values compared to those for 
the structure of MBD alone. Also there is an imperfect convergence of the BC-loop 
which is known to become rigid upon binding to DNA, as well as of the other turns 
and loops. This can be accounted for by the lack of NOEs in the BC-loop region and 
the need for a final refinement step in the structure calculation involving other data 
such as dihedral angles. It was therefore hoped that data from X-filtered experiments 
improve the convergence in this region and correct any error in the conformation of 
the BC-loop and its orientation to strands B and C that could have arisen from the 
lack of experimental data in this region. 
The X-filtered experiments collected were a series of four 2D NOESY spectra in which 
different combinations of NOEs to and from protons on carbon-12 and carbon-13 in-
cluded and excluded (or nitrogen-14 and nitrogen-is). By the appropriate addition 
and subtraction of these 2D spectra it was possible to obtain 2D NOESY spectra that 
originated from one of the following: DNA, protein, connectivities between DNA and 
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protein. This was possible due to the protein being uniformly ' 3C and ' 5 N labelled 
while the DNA was not (see section 2.9). 
Figure 4.14: A superposition of backbone (Ca) traces for nine out often structures with 
the lowest energy. Only residues 90 - 162 are shown and superposition was on all shown 
residues. It clearly shows a convergence of structures, however further refinement is 
also required. 
The X-filtered experiments were successfully collected (by Dr Dusan Uhrin), however 
it was found that cross-peaks from DNA were very broad and so undistinguishable 
from one another. Therefore it was not possible to assign NOEs from the DNA in the 
complex or to perform a DNA structure calculation of the corn plexed DNA. The only 
cross-peaks that were assignable were those relating to the first and last base pairs. 
Upon scrutiny of the 2D NOESY of uncomplexed DNA, it was found that the end 
base pairs appeared to be missing certain cross strand NOEs and thus it was thought 
that the duplex might be frayed, especially as the end base pairs are A and T. It 
was subsequently reasoned that the broadness of the DNA crosspeaks might be due 
to bound DNA exchanging with free DNA molecules in solution, as the DNA was in 
excess. A new DNA sequence was designed which had a GC base pair at the ends to 
decrease fraying, a higher CC content, 16 bps instead of 14 bps and only one CpG 
(methylated) per strand (see table 2.4). This was found to bind more tightly than the 
CHAPTER 4. STRUCTURE CALCULATION 	 128 
original. Several sequences were tested (by Dr Andrew Free), which varied in length 
and GC content of the oligonucleotides. The X-filtered experiments were re-run on the 
new complex sample and unfortunately the same broadening effects were seen although 
it was known that this was a tighter complex. 
Inspection of the NMR data of the complex found that the gaps in the resonance assign-
ment appeared to be mostly at the tails of arginine and lysine residues, in particular of 
Argill, Lys119 and Arg133 - the residues believed to be directly involved with binding 
to DNA. Also "strips" for some arginine and lysine methylene carbons, e.g. -y  and 5 
methylene groups of Argill, Arg133 and Arg162, and 5 and E methylene groups of 
Lys109, Lys119, Lys130 and Lys135, were absent from the 13C-edited NOESY spectra. 
The HE strip of Argill was not observable at all in the 3D 15 N-NOESY. These could 
either be due to a broadening effect of NOEs at the DNA-protein interface or spectral 
anomalies. 
Whether this effect is due to exchange between free and bound DNA, movement of the 
bound protein along the surface of the DNA, NOE broadening due a dipolar interaction 
between the two biomolecules, or simply imperfect buffer and salt conditions remains 
unknown. A HSQC was collected on a sample of complex without sodium phosphate 
buffer. The peaks were very broad and became much sharper upon the addition of 
buffer. The pH of the buffer appeared to be optimal between 6 and 6.5 as , which 
was found to be concordant with work carried out by Dr Alice Soteriou (Edinburgh 
university). An interesting result, which casts doubt on the exchanging DNA molecules 
theory, was from an experiment to try to remove the DNA from the complex. This 
involved addition of benzonase, a DNA digesting enzyme, to the sample, giving the 
enzyme time to work and re-purifying the sample on a Ni-NIA (His band) superfiow 
column. The first wash was a sodium phosphate buffer adjusted to pH 7.5, i.e. the 
same buffer as used to dilute the sample initially. The second wash the same buffer 
but with 1 M NaCl, and the third was with both 1 M NaCl and 0.5 M imidazole. The 
HSQC of the re-purified protein still demonstrated that it was complexed to DNA. 
Unfortunately due to time limitations, it was not possible to complete the structure 
calculation on the MBD-DNA complex, nor find conditions to permit collection of the 
required spectra. The latter was also hindered by the fragility and instability of the 
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recombinant domain. Future work would involve completing the complex structure cal-
culation, entailing the collection of X-filtered experiments, a HNHA for dihedral angle 
data, possibly experiments giving other torsion angles and water exchange experiments. 
A couple of attempts on collecting a 3D HNHA on the complex were unsuccessful. Of 
low priority (but achievable at this present stage) is the completion of a resonance 
assignment of the new DNA sequence in an uncomplexed state and possibly a DNA 
structure calculation. This would allow the identification of the form of the unbound 
DNA, DNA chemical shift perturbations and structural changes caused by the domain, 
thus allowing a step towards understanding further the gene silencing mechanism of 
MeCP2. 
4.7 Discussion 
The solution structure of MBD1 was solved using NMR spectroscopy [131], shortly 
after MBD of MeCP2 was solved. It is similar to the MBD of MeCP2, as it consists 
of four 0-strands forming an antiparallel fl-sheet followed by an &-helix, that is angled 
away from the plane of the /3-sheet. It also appears to have a wedge shape with the 
thin end containing a disordered loop (called Li by Okhi et al.) between the second 
( )32) and the third (,33),3-strands, analogous to the BC-loop in MBD of MeCP2. There 
are a number of differences between the two MBD structures. The cr-helix is only two 
turns in MBD1. Although the twist in the 0-sheet is in the same direction, it is more 
pronounced in MBD1. In particular the first strand (01) is almost at a 900  orientation 
to strand /32. Also there is a hairpin loop at the C-terminus and no single turn helix. 
The backbone r.m.s. deviation of structured residues (residues 3 - 20 and 32 - 53 for 
MBD1, and residues 18 - 35 and 44 - 65 for MBD of MeCP2) between the structure 
of MBD of MeCP2 that is closest to the mean structure and that of MBD1 was 4.6 
A. The backbone r.m.s. deviation for the secondary structure elements between the 
MBD of MBD1 and MeCP2 was 3.27 A, while the r.m.s.d. for fl-sheets B - D (/32 - /34 
in MBD1 notation [131]) between the two MBD structures was 2.12 A. 
The structure of the uncomplexed transcriptional elongation factor TFIIS, which is 
a zinc containing DNA-binding motif, consists of three fl-strands forming an antipar- 
allel fl-sheet with a disordered loop between the first two longer strands [148] and is 
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analogous to strands B - Din MBD of MeCP2 and strands /32 - 04 in MBD1. Superim-
position of the similar /3-strands in mean structures MBD of MeCP2 and TFIIS showed 
that the twist in the 0-sheet was in the same orientation, however the r.m.s. deviation 
(Ca atoms) of the strands was 1.89 A for all three strands and 1.42 A between the 
second and third strands in TFIIS and strands C and D in MBD of MeCP2. 
The hairpin loop in MBD1 contains the conserved residues Phe62, Asp63 and Phe64 
(Phe155, Asp156 and Phe157 in MeCP2), and holds Phe64 (Phe157 in MeCP2) in 
a similar position adjacent to the C-terminal end of strand 04 (strand D) and the 
N-terminal end of the a-helix. Equivalent chemical shift perturbations of residues in 
MBD1 upon binding to DNA, to those in MeCP2 were also reported. These were in 
the C-terminal half of strand /32 (strand B), loop Li (the BC-loop), the N-terminal 
half of strand 33 (strand C), strand 04 (strand D), to the N-terminus of the a-helix 
and resiudes in the hairpin loop, the equivalent to the perturbed C-terminal stretch 
after the single turn helix in MBD of MeCP2. Also it was found that the loop Li, 
equivalent to the BC loop, became structured upon complex formation. Arg22, Asp32 
and Arg44 are orientated to project from the putative DNA binding face in a similar 
arranagement to Argiil, Asp121 and Arg133 in MBD of MeCP2. This illustrates 
common characteristics between MBD1 and MeCP2 and therefore supports the idea 
of similar mechanisms for methylated DNA recognition and binding between them. 
It would be fair to presume that the other members of the MBD family have similar 
characteristics and structure because of the coincidence of the well structured portion 
of MBD of MeCP2 and MBD1 and the extent of the MBD consensus sequence. Most of 
the residues within the consensus sequence defining MBDs are scaffold residues either 
involved in forming the hydrophobic core or occupying critical positions in turns or 
loops. The structure of MBD2 and MBD3 which will most likely resemble that of 
MBD1 in lacking the third turn of the a-helix and having a hairpin loop in the C-
terminal segment of the protein, while MBD4, with the extra residues, is likely to have 
a three turn helix. MBD4 is also likely to have the single turn helix, as in MeCP2, as 
only these two members of the family have a P(N/E)D sequence (residues 152-254 in 
MeCP2 and residues 128-130 in MBD4) which forms the single turn helix in MeCP2. 
Single crystal X-ray studies [lii] indicate that uncomplexed methylated DNA is likely 
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Figure 4.15: A space-filled representation of MBD of MeCP2. The hydrophobic pocket 
comprised of Y123, 1125 and A131 is indicated in green. Rill, R133 and D121 are 
also indicated coloured by atom type (nitrogen - blue; oxygen - red; carbon - grey; 
hydrogen - white). 
to be 13-form and the methyl groups of the methylated cytosine in the major groove are 
approximately 6.5 A apart . The recombinant MBD from MeCP2 has been reported 
[120] to bind as a monomer to a symmetrically methylated CpG flanked by at least six 
other base pairs. The structure of the MBD of MeCP2 indicates that it is monomeric, 
along with the existence of two surface accessible hydrophobic pockets which are be-
lieved to be involved in the recognition of the methylated cytosines by making Van de 
Waal's contacts with the methyl groups. There are also enough residues with DNA-
induced amide proton chemical shift perturbations that have the ability to hydrogen 
bond to phosphodiester oxygens. A review by Pabo and Sauer [137] found by exam-
ining published complexes that many different sidechains, and even protein backbone 
amides, can hydrogen bond to the phosphodiester oxygens. Mostly basic and neutral 
sidechains are involved, although less frequently because of their unfavourable electro-
static charge, aspartate and glutamate via bridging cations such as Mg2+  and  Ca2+  or 
water molecules. It appears unlikely that aspartates and glutamates in MBD are in-
volved in contact with DNA backbone, but there are 11 arginines and lysines (including 
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Figure 4.16: A space-filled representation of MilD of 1%,IeCP2. The hydrophobic pocket 
comprised of V122 (in green), F157 and V159 (in orange) is indicated. Rill, R133 and 
D121 are also indicated coloured by atom type (nitrogen - blue; oxygen - red; carbon 
- grey; hydrogen - white). 
Argill and Arg133), and a few short polar side chained residues with DNA-induced 
chemical shift perturbations. It is also suspected that Thr160 forms a contact with 
the DNA backbone, due to its position within the protein, i.e. projecting from the 
putative DNA binding face, and its observed chemical shift perturbation. Pabo and 
Sauer state that site-specific recognition always involves a set of contacts with the 
bases and DNA backbone, and a complex typically has 1 - 2 dozen h-bonds at the 
protein-DNA interface. The contacts with the DNA backbone usually involve h-bonds 
and/or salt bridges. MBD of MeCP2 appears have enough solvent-exposed residues 
with the potential to make contacts with the DNA to satisfy these general principles 
of site-specific recognition. 
Many DNA binding proteins (e.g. E.coli CAP protein [157], glucocorticoid receptor 
[107], 434 receptor [1], lambda repressor [14, 81], E.coli MetJ repressor [142, 165], 
E.coli Trp repressor [136], zif268 zinc fingers [141], lac repressor [35], Dead ringer [75], 
Murtl restriction endonuclease [39], Bacillus subtilis transition state regulator AbrR 
[175] and the arc repressor [150]) have hydrogen bonds with purine base, particularly 
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guanine, and this suggests that this may be especially important for recognition. This is 
consistent with the idea that Argill and Arg133 bond with guanine, in an arrangement 
previously observed in the DNA contacts made by zinc fingers [141, 45] (see figure 6.11), 
in the methyl-CpG dinucleotide pair. It is most probable that MeCP2 recognises and 
binds to methyl-CpG situated in a major groove of B-DNA, as is the case in the 
majority of DNA-binding proteins, because the major groove is larger, more accessible 
and has more potential sites for h-bonding and hydrophobic contacts. Major groove 
DNA recognition is frequently through contacts with a-helices, however there are a 
number of cases where /3-sheets and/or regions of extended polypeptide chain make 
the contacts [150, 149, 165, 187], as is suspected to be the case for MBD of MeCP2. A 
few base contacts occur in the minor groove such as those made by the N-terminal arm 
of the homeodomain, a DNA-binding motif that has a role in eukaryotic gene regulation 
[88, 188]. This therefore indicates that the role of the mobile N-terminal arm in MBD 
could be to make contacts with DNA in the minor groove, via arginine residues (Arg89 
and Arg9l: see figure 3.8) to the phosphate backbone. However, this is not a feature 
seen throughout the MBD family. This could be the reason that the minimum sequence 
that shows specific binding contains this long disordered polypeptide sequence. MBD1 
and MBD3 lack this N-terminal arm. The equivalent residues in MBD4 do not include 
any positively charged residues, but include polar side chains e.g. glutamate, serine 
and threonine, and therefore this does not discount the possibility of protein backbone 
amide contact with the DNA phosphate backbone. 
Although methylation of cytosine in the CpG dinucleotide pair appears not to cause 
deviation of the DNA structure from the canonical B-form, there remains the possibility 
that part of the transcriptional repression activity of MeCP2 could be to perturb the 
structure of methylated DNA using the MBD and/or the TRD. Whether MBD does 
have a role in altering the DNA structure can only be answered when the structure 
of the complex is solved. It is certainly possible that this is the case since MBD has 
a very direct contact with, and close proximity to, methylated DNA when MeCP2 is 
bound. 
It was noticed previously that the sequence of MBD of MeCP2 contains a pair of 
imperfect repeats based on A(F or Y)xxKV e.g. 131 AFRSKV 136 and 140AYFEKV145. 
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This gave rise to speculation [120] that the tertiary structure of MBD might feature 
two similar 5-methyl-cytosine recognition sites. However, the structure is lacking in 
symmetry and the repeated residues do not form similar substructures. Residues 131 
- 136 stretch from strand D to the N-terminual residue of the a-helix and are in the 
putative DNA-binding interface while residues 140 - 145, encompassed in the a-helix, 
are not. Thus it appears that MBD does not exploit the symmetry of the target 
for binding, unlike many prokaryotic DNA -binding proteins which bind as dimers. 
Upon binding, MBD will break the symmetry of the CpC binding site and this might 
have important consequences, since subsequent binding events could be directed in a 
downstream or upstream manner. 
The /3-sheet face of the domain is convex and because strands B and C are longer than 
strands A and D, it is four-stranded at the thick end of the wedge and two-stranded at 
the thin end. The conserved hydrophobic patch (Tyr123 and 11e125) and the potentially 
guanine binding arginine residue (Arg133) are situated on strands C and D of the /3-
sheet face at the point where it becomes two-stranded. This region could probably 
make contact with the edges of the methyl-CpG base pairs by insertion of one end 
of the sheet into the major groove. The lysine and arginine rich flexible loop could 
then follow the major groove for several more base contacts. This model is concordant 
with the pattern of perturbed amide chemical shifts and is not unprecedented, e.g. in 
the GCC-box binding domain [3] where three 0-strands have been observed to fit in a 
major groove without much widening , since at no point do the three strands fit side-
by-side at the centre of the major groove. Other proteins have recently been shown 
to interact with the major groove of DNA via a three-stranded antiparallel 0-sheet: 
the nuclear intron-encoded homing endonuclease; I-PpoI [47] and the Tn916 integrase 
[187]. 
Conclusion 
The MBD of MeCP2 has a novel wedge-shaped tertiary structure, but has certain 
attributes seen in other DNA-binding proteins. MBDs from other members of the 
family are likely to have a similar fold, as was the case with MBD1. However MBD2 
and MBD3 will probably exhibit local differences in structure, particularly at the thick 
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end of the wedge shaped domain, resembling those apparent in MBD1. On the basis 
of chemical shift perturbations, residues towards the thin end of the wedge-shaped 
domain and in the mobile N-terminal arm are likely to interact with methylated DNA. 
This concurs with data from the dynamics studies of the MBD of MeCP2 and the 
MBD-DNA complex. The structure has no internal symmetry, despite the symmetry 
of the methyl-CpG dinucleotide pair it binds to. There are highly conserved residues 
not required for the structural integrity of the domain. These include residues that 
are candidates for the recognition of the methyl-CpG sequence, and residues likely to 
be in contact with other domains within MeCP2 or the other proteins recruited in the 
transcriptional repression process. 
Chapter 5 
Dynamics studies on MBD 
Intramolecular motions of proteins are important for their biological activity e.g. en-
zyme catalysis, binding specificity and regulatory control. It is possible to study such 
internal motions with NMR spectroscopy. These motions occur with various temporal 
and spatial characteristics such as bond vibrations and rotations, vibrational motions 
of the protein backbone, local oscillations of small groups of atoms e.g side chain atoms, 
and the concerted segemntal motions of groups of residues, e.g. relative movement of 
domains or secondary structure [139, 168]. 
It was found that MBD has a degree of internal motion, with respect to its overall tum-
bling in solution, that broadened certain peaks and gave characteristics of unstructured 
residues. When regions of the protein structure failed to converge in the calculations 
although the given energies were low and the rmsd values due to a lack of NOE data, 
it was decided to embark on dynamics studies on MBD bound and unbound to DNA. 
5.1 Theory 
As mentioned in section 2.2, relaxation rates are governed by the internal motions 
and overall rotational motions of the molecule. Consequently the characterization of 
' 5 N heteronuclear relaxation can provide information about the internal dynamics of 
proteins on time scales faster than the rotational correlation time. The relaxation of 
heteronuclei is regulated by the dipolar interactions with the directly attached protons, 
and at high magnetic field strengths, also by chemical shift anisotropy. The longitudinal 
136 
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relaxation time , T, assuming other contributions are negliable, is given by 
1 	1 	1 
TiT?D+T?s4 	 (5.1) 
where TPD  and TfSA  are the dipolar and chemical shift anisotropy (CSA) longitudinal 
relaxation time respectively. Similarly the transverse relaxation time, T2 is given by 
1 	1  
T TDD T2 + CSA +Rex 	 (5.2) 
where TD  and TSA  are the dipolar and CSA transverse relaxation time constants 
respectively and Rex is the sum of the effective rate constants for other pseudo-first-
order processes that contribute to transverse relaxation, especially ' 5 N conformational 
change. 
For protonated '5 N nuclei in a uniformly labelled protein, the dipolar relaxation rates, 
T7  	T2 and 	are dependent on the spectral density function J(U) and are given by 
1 	1 2 




dH[4J(0) + J(WH - UN) + 6J(UH) + 3J(UN) + 6J(UH + UN)] (5.4) 
where WH and UN are the larmor frequencies of 'H and 15 N, and c/NH,  the heteronu-
clear dipolar coupling between the two spin-i nuclei, is given by 
dNH = h(LL2)yH7H(r) 	 (5.5) 4ir 	NH 
where h is Plank's constant 	, go is the permeability of free space, 7H  and 7N  are 27, 
the gyromagnetic ratios of 'H and 15 N, and rNH  is the N-H bond length (1.02 A) 
[139, 168]. The spectral density function, J(U), is the Fourier transform of the ori-
entational correlation function of a unit vector along the N-H bond and incorporates 
the dependence of the relaxation rates on molecular motion. The CSA relaxation rate 
constants, assuming an axially symmetric chemical shift tensor are 
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TfSA = wJ(alI - aj)
2
j (L,;N) 	 (5.6) 
TPA = 18 
1 	- crj ) 2 [4J(0) + 3J(UN)I 	 (5.7) 
where or1l and a1 are the parallel and perpendicular components of the chemical shift 
tensor. 
As well as the relaxation rates, the magnitude of the NOE enhancement can give insight 
into a protein's internal dynamics. The NOE enhancement, 77, is governed by the rate 
of movement of the species from which the NOE arises (see section 2.5). From equation 






where 'sat  and 'unsat  are the intensities of the resonances in the {'H}-' 5 N heteronu-
clear NOE spectrum obtained with and without saturation of proton magnetization 
respectively. The NOE enhancement can be defined in terms of the T 1 relaxation time, 
and spectral density functions [139, 1681 as 
NOE = Tld,H1 L[6J(wH + UN) - J(WH - UN)] 	 (5.9) 
7N 
The model-free formalism [104, 105] gives the spectral density function for the molec-
ular motions as 
J 	
- 2 [_S2Tm + ( 1 - S2)rl 	
(5.10) (w) 
- 5 1 + (wrm ) 1 + (wr)2]  
where T 1 = 7 1  + Te 1 , Tm 1S the overall rotational correlation time of the molecule, 
S is the generalised order parameter which measures the degree of spatial restriction 
of the unit bond vector, and r is the effective internal correlation time which is a 
measure of the rate of the internal motion of the unit vector. 
The motion dependent behaviour of T 1 and T2 is shown in figure 5.1 
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Figure 5.1: The effects of r on the T 1 and T 2 relaxation times. 
For rapidly tumbling molecules, where tumbling is fast compared to the resonance 
frequency, i.e. the extreme narrowing limit, oT, << 1, the '1 and '1' 2 relaxation 
become slower as the tumbling rate, r 1 , increases. The maximum relaxation rate 
or minimum T 1 occurs when r 1 matches the resonance frequency. However as the 
rotational correlation time increases and tumbling becomes slower, T 1 increases but 
T2 decreases. 
For an error estimation of the NOE values, the standard deviation in baseline noise, a, 
was determined using a function of the AZARA program "plot2". The error associated 
with the NOE value for peak j is then given by 





Iunsat 2  
- 'unsat 'sat 	
" 
j 'unsati ) 	
( 5.11) 
where Isatj  and lunsatj  are the intensities of peak j with and without saturation of proton 
magnetization respectively, and /M sat and LMunsat denote the standard deviations in 
volume for the spectra recorded with and without saturation of proton magnetization 
respectively. 
5.2 NMR experiments 
Uniformly 15 N-labelled protein samples of the MBD of MeCP2 were used to collect the 
spectra required for this dynamics study. Samples of the protein-DNA complex were 
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generated as described before. An approximately 1 mM NMR sample was prepared in 
50 mM sodium phosphate buffer set to pH 6.0 in 90% H 2 0 / 10% D 2 0. 0.01% w/v NaN 3 
and 2 mM PMSF were also added to prevent bacterial growth and inhibit proteolysis. 
A series of 15 N T 1 and T2 measurements and heteronuclear NOE experiments were 
collected on a Varian INOVA 600 MHz spectrometer, as described before, at 18°C for 
both unbound and bound MBD with the assistance of Dr Dusan Uhrin and Dr Brian 
0. Smith (University of Edinburgh). 
Figure 5.2 shows the pulse sequences used for the measurements of 15 N T 1 , ' 5 N T2 
and {'H}-' 5N NOE with 'H detection [168]. The experiments used for the T, and 
T2 measurements consist of a refocussed INEPT sequence to transfer magnetization 
from the amide protons to the amide ' 5 N nuclei, a variable relaxation period T, the 
evolution period ti, so the spectra are 2D, and a second INEPT sequence to transfer the 
magnetization onto the amide protons for detection. The {'H}-' 5 N NOE experiment 
consists of an initial relaxation delay (with or without proton saturation, i.e. the 
presence or absence of the heteronuclear NOE respectively), the t, evolution period 
and an INEPT sequence to transfer magnetization back onto the protons for detection. 
Harsh window functions were applied to separate peaks in crowded regions in the T 1 
and T2 spectra. However they were applied so that the first data point was unchanged, 
i.e. multiplied by 1. The window functions applied were gaussian, decay and sinebell 
squared at 90° in both dimensions. 
For measurements of T, and T 2 relaxation times, a number of approaches were at-
tempted to obtain a good data set. They involved different combinations of the T 
delay. Sets of 5 data points per residue collected for T 1 measurements had T delay 
times of 
• 12.2 ms and (4 x) 1091.3 ms. 
• 12.2 ms, 197.5 ms, 404.6 ms, 818.8 ms and 1636.3 ms. 
• 12.2 ms, (2 x) 437.3 ms and (2 x) 1145.8 ms. 
The sets of data points per residue obtained for T 2 measurements had T delay values 
of 
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Figure 5.2: Pulse sequences used for measurements of ' 5 N T 1 (top), T 2 (middle) and 
{'H}-' 5 N NOE (bottom). SL denotes spin-lock purge pulses for water suppression. 
The value of r was set to 4NH  (2.78 ms). 
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• 16.26 ms and (2 x) 130.05 ms. 
• 16.19 ms, 32.38 ms, 64.77 ms, 97.15 ms and 129.54 ms. 
• 16.19 ms and (4 x) 129.54 ms. 
It was found that there was a large error in the data points derived from the smallest 
T value spectrum when it was the first of the set to be acquired. Therefore the spectra 
were collected in a random order without the smallest T values being first. 
The longitudinal realaxation times, T 1 , were obtained by a three parameter fit of the 
equation 
T 
1(T) = I - [I - Io]ei 	 (5.12) 
where 1(T) is the intensity of the peaks, To  and I are the initial and final crosspeak 
heights respectively. The transverse relaxation times, T 2 , were obtained by the two 
parameter fit of the equation 
1(T) = I0 e 	 (5.13) 
where 1(T) is the intensity of the peaks, 1 0 is the initial crosspeak height [139, 168]. 
The Leven berg-Marq u ardt algorithm [147] was used for the curve fitting. This standard 
numerical algorithm minimizes the merit function x2  given by 
n 
X = 	




where 1(T 2 ) is the peak intensity, 1(T 2 ) is the predicted intensity derived from the 
variables in the model function at the ith  time point, or is the uncertainity in the data 
points and n is the number of time points. 
The measurement of the NOE enhancement was obtained from the ratio of intensities 
of peaks from the {'H}-' 5N NOE spectra with proton saturation over those without 
proton saturation. The {'H}- 15 N NOE ratio can range from one to approximately 
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minus four where any value under 0.6 can be considered to relate to a significant 
degree of internal motion. The uncertainity in the NOE ratio values were taken from 
the root mean square baseline noise in each spectra. 
5.3 Results and discussion 
T 1 , T2 and { 1 H}-' 5 N NOE measurements were taken for both MBD and MBD-DNA 
complex. It was found that the most accurate results were obtained for T 1 when the 
time points were duplicated (T = 12.2 ms, 2 x 437.3 ms and 2 x 1145.8 ms) and for 
T2 times when the time points were not duplicated (T = 16.19 ms, 32.38 ms, 64.77 
ms, 97.15 ms and 129.54 ms). Also more precise measurements were obtained when 
the peak heights rather than the peak volumes were taken to characterize the peak 
intensities. 
5.3.1 MBD 
The average T 1 for MBD in an unbound state is 788.8 ms with a standard deviation of 
67.7 ms. However there are T 1 values that exceed the average and standard deviation. 
The lowest value is 0.634 s for Ile 88 and the highest is 1.013 s for the cysteine in the 
C-terminal tag or 0.917 s for Thr 148. Values were not obtained for Arg 91, Tyr 95, 
Trp 104, Arg 106, Asp120 and Val 122. This was due to overlapping peaks affecting the 
peak height and therefore giving inaccurate values. Arg 115 had an usually high value 
of 1.414 s with an error of 1.307 s. It is unsure why these values were obtained but 
errors probably arise due to the broadness of the HSQC peaks of R115. The N-terminus 
of MBD appears to have average T 1 values of 0.80 s for the first four residues and then 
there is a drop to an average value of 0.68 s for residues 82 to 92 before returning to an 
average of 0.81 s. The drop in T 1 values corresponds to the flexible N-terminal arm of 
MBD except for the first four residues also in the N-terminal arm but not in the drop 
in T 1 . However these T 1 values are inconclusive and any suggestions of internal motion 
cannot be made from these results alone. The decay constants, T 1 , and uncertainties 
derived from curve fitting are plotted against residue number in figure 5.3. 
The T2 values were for the same residues of MBD as the T 1 values except for the 
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Figure 5.3: Ti values and uncertainties plotted for residues in MBD of MeCP2. 
exclusion of Glu 102 which had an anomalous value and large error and the inclusion 
of Arg 115. The T2 values for the first 15 residues average at 0.177 s with a standard 
deviation of 0.029 s, while the rest of the protein has an average T 2 of 0.073 ± 0.015 
s. The larger values correspond to the the disordered N-terminal arm. There is also a 
sharp increase in the T 2 values at the C-terminus. However this region is the C-terminal 
tag (SGSGC) which was later excluded from the expressed protein. It indicates that 
the C-terminal tag is disordered in relation to the the rest of the protein. There is a 
slight increase in T 2 values centering on Arg 115, the tail of the disordered BC-loop 
and a rise in values from residue 146 to 151 which encompasses the mobile turn after 
the c-terminal end of the ce-helix. Also the T 2 appears to be longer for Gin 128. The 
longer T2 values were found to coincide with the lower NOE ratios, thus regions of 
internal motion can be defined and excluded from the determination of the r.m.s.d. of 
the NMR structures. The decay constants, T 2 , and uncertainties derived from curve 
fitting are plotted against residue number in figure 5.4. 
The ' 5 N NOD values gave a direct indication of ordered and disordered residues within 
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Figure 5.4: T2 values and uncertainties plotted for residues in MBD of MeCP2 
the domain. The residues with a NOE ratio of less than 0.6 are considered to have 
a significant degree of mobility. It was found that the N-terminus from Ala 77 to 
Gly 92 had values much less than 0.6 and so it was concluded that this N-terminal 
arm was flexible. The first four residues had negative values suggesting that these are 
completely random coil, while the next eleven residues after Pro 81 are positive ranging 
from 0.061 to 0.43, generally increasing with residue number. This suggests that the 
residues at the N-terminus of Pro 81, i.e. Ala 77 to Ser 80 and the His tag (which 
also have negative values), have a larger degree of motion with respect to the overall 
tumbling of the molecule in solution than the eleven residues after Pro 81. The protein 
appears to become rigid, i.e. NOE ratios greater than 0.6, after Pro 93. Perhaps this 
is due to the restraining effects of proline residues, however it could be coincidental 
that Pro 81 and Pro 93 segregate a region of negative NOE ratios, positive but low 
values and the rest of the respectively rigid protein structure. The NOE ratio value for 
Asp 96 appears to be less than 0.6 at 0.560, however the large error on this peak and 
the fact that the observed peaks for this residue are often weak or broad in 2D HSQC 
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styled experiments gave the conclusion that this residue is most likely to be structured, 
especially as it is part of strand A, and the result was due to spectral or experimental 
anomalies. 
There were regions within the structured domain that had NOE values of less than 
0.6 and appeared to be disordered. These were the BC-loop (residues 112 - 119), the 
loop after the C-terminus of the a-helix and the C-terminal tag (later removed from 
the recombinant protein). Apart from the aforementioned regions, there are another 
two residues apparently with NOE ratios less than 0.6, Gin 128 and Phe 157. Gin 128 
is on the tip of the turn between strand C and strand D and therefore it is reasonable 
to assume that there is a small amount of movement or conformational change with 
this residue. The overlay of the structures (figure 4.7) also indicate that there could 
possibly be a couple of conformations for the turn between strand C and strand D 
(Pro 127 and Gln 128). The low value for Phe 157 is most probably due to spectral 
error since its amide peak in HSQC spectra is often weak or broad. Also, including its 
error bar, the NOE ratio would be above 0.6 and so Phe 157 was not considered to be 
mobile. 
The long loop between strands B and C consistently showed low NOE ratio values 
and therefore can be considered to have a significant degree of internal motion with 
respect to the overall tumbling of the molecule in solution. This is confirmed with the 
other evidence suggesting this, such as: the characteristic broad peaks at random coil 
chemical shift; the lack of inter-residual NOE cross-peaks; the water exchange data 
which shows that this region has rapidly exchanging amide protons (section 4.3.2); 
lack of evidence indicating any secondary structure in this region and the overlay of 
the structures (figure 4.7) shows that the BC-loop had numerous conformations, which 
is a result of the lack of data to constrain this region during the structure calculation. 
The turn after the C-terminal end of the a-helix, Thr 148, Ser 149 and Leu 150, 
also appear to be flexible. The calculated structures (figure 4.7) show a number of 
conformations for this region indicating motion within the turn. This is also consistent 
with this region's solvent exposure and its measured proton exchange rates which 
indicated rapid exchange between water and the backbone amide protons. Therefore 
it can be concluded that this turn and the BC-loop are flexing independently of the 
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Figure 5.5: { 1 H}-' 5N NOE values and uncertainties plotted for residues in MBD of 
MeCP2. Any values below the line at 0.6 are considered to be disordered. 
The heteronuclear NOE ratios and errors derived from baseline noise are plotted against 
residue number in figure 5.5. 
5.3.2 MBD-DNA complex 
The average T 1 for MBD bound to a 14 bp DNA duplex is 0.893 seconds with a 
large standard deviation of 0.233 seconds. The increase in average T 1 was anticipated 
because of the increase in size of the molecule. Although there is a lack of increase 
in T1 values for the molecules in the flexible N-terminal arm, no conclusions can be 
drawn from these results. The T 1 values and uncertainites derived from curve fitting 
are plotted against residue number in figure 5.6. 
The ' 5 N NOE data indicates that the BC loop has become rigid. This is likely to be 
mainly due to interactions between positively charged amino acid sidechains and the 
DNA molecule, and the steric hinderance of the DNA. However it is possible that it 
could be solely due to the latter. The turn at the C-terminal end of the of-helix , i.e. 
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Figure 5.6: T 1 values and uncertainties plotted for residues in MBD of MeCP2 bound 
to a 14 bp DNA sequence. 
resiudes 148 - 150, appear to have remained flexible. This is not surprising as this turn 
is positioned on the opposite side of the protein from the identified binding surface. 
Also, Gin 128 has apparently become more rigid. The NOE ratios for the N-terminal 
arm have increased with the first four residues now showing positive values and Asp 
90 having a NOE ratio of 0.6. This would suggest that this segment of the protein 
has become fairly structured and the N-terminal arm has lost some flexibility upon 
binding. However the N-terminal arm could still be considered flexible, as the general 
increase in the value of the NOE ratios may not be solely due to restraining effects of 
being bound to DNA. The heteronuclear NOE ratios and errors derived from baseline 
noise are plotted against residue number in figure 5.7. 
The T2  relaxation times for the MBD-DNA complex again reflect what was observed 
in the heteronuclear NOE data. For the majority of the bound protein, the T 2 values 
have practically remained the same. However the rise centering around Arg 115 is 
not present in the bound MBD T 2 data, which correlates with the observed change 
in NOE ratios for this region, i.e. the BC loop. The T 2 value for Gin 128 has also 
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Figure 5.7: { 1 H}-' 5N NOE values and uncertainties plotted for residues in MBD of 
MeCP2 bound to a 14 bp DNA sequence. Any values below the line at 0.6 are consid-
ered to be disordered. 
dropped which reflects the observation made with the heteronuclear NOE data. The T 2 
values and uncertainties derived from curve fitting are plotted against residue number 
in figure 5.8 
The main conclusion drawn from the backbone dynamics data is that the BC loop is 
mobile with respect to the overall tumbling of the molecule in solution when MBD is 
unbound but becomes rigid upon binding to methylated DNA. 
5.3.3 Sidechains 
Of the amide containing amino acid sidechains, only arginine sidechain data showed 
any significance. It was found as expected that the { 1 H}-' 5 N NOE ratio of the arginine 
sidechains were large and negative for MBD unbound, thus could be considered to be 
moving or rotating freely in solution. However the sidechain of Arg 111, whose peak 
appears apart from the cluster of other arginine H€ peaks in the HSQC, was seen to have 
a low but positive NOE value of 0.20. Figure 5.9 A & B show this region of the {'H}- 
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Figure 5.8: T 2 values and uncertainties plotted for residues in MBD of MeCP2 bound 
to a 14 bp DNA sequence. 
15 N NOE spectra without and with proton saturation respectively. This would suggest 
that the He of Arg 111 is experiencing a different environment to the other arginine 
sidechains, and having the only proton chemical shift that differs from the random coil, 
then it is fair to suggest that the sidechain of Arg 111 is interacting through its HE 
proton, probably via an electrostatic interaction (e.g. hydrogen bonding), with another 
residue. This was later determined to be Asp 121. 
The {'H}- 15 N NOE spectra of the MBD-DNA complex (figure 5.9 C-F) indicated that 
the sidechains of Arg 111 and Arg 133 had become well structured with NOE ratio 
values of 0.838 and 0.522 respectively. The other sidechains appear to have remained 
generally disordered. This suggests that these two arginines are directly involved with 
binding to DNA. It is unlikely that this finding is solely due to steric hinderance caused 
by the bound DNA molecule. 
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Figure 5.9: Figure of arginine sidechain region of ' 5 N heteronuclear NOESY spectra. 
Black peaks are positive and red peaks are negative. A NOE experiment on MBD 
without proton saturation. Arginine sidechain peaks are negative. B on MBD with 
proton saturation. Here, arginine sidechain peaks are positive so NOE ratio is negative 
and hence disordered. C,D NOE experiment on MBD-DNA complex without proton 
saturation. Note how sidechain of Arg 111 has significantly shifted and all arginine 
sidechain peaks are negative. E,F on MBD-DNA complex with proton saturation. 
Sidechain peaks of Arg 111 and Arg 133 have remained negative thus giving a positive 
NOE ratio and therefore are structured, while the other arginine sidechains remain 
Chapter 6 
Structural studies on mutations 
It has been shown that patients suffering from Rett syndrome have mutations in the 
MECP2 gene [5]. These include, amongst other types of mutations, missense mutations 
within the MBD and TRD domains (see section 1.5). This type of mutataion changes 
one residue type into another and the ones that occur in Rett syndrome appear to have 
a phenotypic effect. It was decided to determine the effects that these mutations and 
others have on the binding ability of MBD. 
This study consisted in part of electrophoretic mobility shift assays (EMSA) of binding 
by MBD and its mutants to DNA, carried out by Dr Andrew Free (Edinburgh), and 
of relevance to this thesis, NMR structural analysis [49]. In conjunction, fluorescence 
anisotropy analysis of DNA binding to MBD of MeCP2 and MBD2b were carried out 
by Dr David Dryden and here the NMR structure of MBD of MeCP2 was used as a to 
interpret results for MBD2b [Unpublished]. 
6.1 Sample preparation 
All MBD samples were cloned, expressed and purified by Dr Andrew Free [49]. The 
protein samples were only ' 5 N-labeled by supplementing the growth medium with 
0.4% w/v glucose and 1.5 g/l [15 N]-(NH 4 ) 2 SO4 . The samples were prepared for NMR 
spectroscopy as described in section 2.11. 
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6.2 Starting the study 
The EMSA analysis of wildtype MBD showed that it specifically binds to methylated 
DNA, with binding detectable at concentrations of 20 nM. Binding to unmethylated 
DNA was undetectable at protein concentrations as high as 20 MM. However there were 
apparent discrepancies between the results obtained and previously published results 
[120] which highlighted the point that these approaches may not reflect the true nature 
of MeCP2's in vivo activity. Nevertheless EMSA was used to check the binding of MBD 
mutants to methylated DNA. 
Based upon careful analysis of the NMR-derived solution structure of MBD of MeCP2 
(chapter 4)[181], a number of point mutated MBDs were generated and of those G114P, 
D121A, R111G, Y123A, R133C, R106W and F155S were found to have very marked 
reductions in binding activity. The aforementioned mutants were therefore studied by 
NMR spectroscopy. Of the other mutations made and not studied by NMR: K112M, 
S113A and S116R in the disordered B-C loop, Y141S and P127A had no significant ef-
fect on binding; A131E, K135Y and S134A (S134A was analogous to the Rett syndrome 
mutation S134C) had a reduced but significant binding while the K119A mutation al-
most abolished binding and the F157A mutation also had a severe effect on binding. 
The G114P mutation was created in an effort to constrain the mobile B-C loop as the 
flexibility of this disordered loop was suspected to be crucial for MBD's binding ability 
(section 5.3). This mutation had a major effect on DNA binding and considering that 
the other mutations made in the B-C loop, K112M, S113A and S116R, had no effect 
indicates that removing a degree of freedom from that conserved residue (i.e. G114) 
inhibits DNA binding. It was therefore important to measure the backbone dynamics 
of the B-C loop in the G114P mutant to assess the extent which the loop had been 
constrained. Only heteronuclear NOE experiments were used for this as they clearly 
showed a marked difference in BC loop mobility between MBD bound to DNA and 
unbound (section 5.3). 
Although not a Retts syndrome mutation, residue Rill was mutated to glycine, for a 
number of reasons. 
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Its backbone chemical shift is perturbed when bound to DNA, however this is 
thought to be mainly due to the effect of the conformational change and loss of 
mobility in the B-C loop upon binding. 
Its HE peak that is seen for all arginine residues in the 2D 15 N-HSQC of wildtype 
MBD unbound has an abnormal chemical shift in the proton dimension compared 
with the other arginine sidechain HE peaks (HE(111) has proton shift of 8.00 ppm 
Other arginine HE protons have chemical shifts of 7.16- 7.26 ppm). This would 
suggest that this sidechain is not just freely exposed to solvent. 
Upon analysis of the 2D 15 N HSQC of MBD bound to methylated DNA it was 
noticed that the HE peak had shifted considerably especially in the 1 H dimension 
(zöH = 1.34ppm). This says that the sidechain has had a major change in 
electronic environment e.g interacting with DNA. 
The dynamics studies on MBD unbound indicated that all the arginine sidechains 
were unstructured and freely rotating in solution. However the studies on MBD 
bound to methylated DNA showed that the Rill sidechain had become rigid 
and structured. The {'H}- 15 N NOE ratio for H€(R111) in unbound MBD was 
negative ( -1.0) i.e. very mobile, whereas it was +0.84 when bound (a similar 
value to those for the a-helix and 3-sheet). 
It also happens to be a highly conserved residue. 
It is orientated such that it projects from the face of the protein that has been 
recognised to bind to DNA and it is suggested that there might be mild electro-
static interactions with D121 that direct the orientation of the sidechain so that 
the guanidyl group can directly interact with DNA. Speculatively, this could be 
to make H-bonds with the edge of one or both of the two guanine bases in the 
mCpG dinucleotide pair or with phosphate group in the DNA backbone. 
Another arginine with suspected importance is R133, also a conserved residue. The 
mutation R133C occurs in Rett syndrome patients and was found to severely effect 
binding. This residue was also mutated to glycine which was found to have a less 
severe effect [49]. It was decided to study this mutation for similar reasons as those 
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for Rill. Its backbone chemical shift undergoes a large perturbation upon binding to 
DNA as does its sidechain chemical shift. However its sidechain He in a 15 N-HSQC 
of MBD unbound and bound is at the normal chemical shift for arginine sidechains 
exposed to solvent. Much more significantly, its sidechain becomes structured upon 
binding to DNA as with Rill but to a lesser extent ({'H}-' 5 N NOE ratio = +0.52). 
The position of R133 was important to the decision to study the effects of its substitu 
tion. It is situated between the end of strand D and the start of the a-helix at the thin 
end of MBD's wedge shape, projecting from the DNA binding face into solution and 
close to the disordered loop. In other words it is in the ideal position to be directly 
involved with binding to DNA. Also, as with Rill, it is suggested to be involved in 
electrostatic interactions with D121, however judging solely from the chemical shifts of 
HE(11133) it would probably be with guanidyl group as a whole rather than involving 
any h-bonding with the He. While speculating along these lines, the major change in 
chemical shift of the sidechain is in ' 5 N dimension. The proton shift change is far less 
than that of Rill. Although the evidence is not a strong as for Rill, R133 still seems 
to be a crucial residue for the functionality of MBD and probably interacts with DNA 
along with Rill. 
D121A and D121E were generated because, as mentioned above, D121 is suspected 
to interact with either or both Rill and R133. It is also a conserved residue. Both 
mutations of D121 had very marked effects on binding [49]. This is especially interesting 
as this aspartate residue was mutated to glutamate and thus the addition of a methylene 
group to the sidechain has the same effect on binding as removing the functional 
carboxyl group. This shows that D121 is in a vital position, shifting the sidechain 
even by 2 or 3 A has a serious effect, and is most likely to be interacting with the 
aforementioned arginine residues. 
The only hydrophobic residue to be studied by NMR spectroscopy was Y123. It is also 
a conserved residue (phenylalanine in MBD3 though), which is solvent exposed and 
forms part of a hydrophobic pocket set within the binding face of MBD. It has therefore 
been suggested that Y123 and the other residues that form the hydrophobic pocket 
(1125 and A131) have a role in making contact with a methyl group of the methylated 
cytosine, and thus have a role in the specificity of binding. Y123 is positioned close to 
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Figure 6.1: Schematic of MBD of MeCP2 showing position of mutated residues. R133 
was mutated to cysteine and glycine; 1125 and Y123 to alanine; D121 to alanine and 
glutamate; 11111 toglycine and G114 to proline. Only R133C is found in RTT patients. 
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Figure 6.2: Schematic of MBD of MeCP2 showing position of mutated residues. R106 
was mutated to tryptophan; F155 to serine; F157 to alanine and T158 to methionine. 
R106W, F155S and T158M are found in RTT patients. 
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D121 and R133, pointing in the same direction as them out of the binding face. The 
Y123A mutation had a noticeable effect on binding but activity was still seen and the 
backbone chemical shift of Y123 was not perturbed greatly upon binding, consistent 
with the conformational change of the B-C loop and the thin wedge end of the C-
strand. Also the mutation of the equivalent residue in MBD1, Y34, showed reduced 
binding to methylated DNA [131]. 
The last two mutations, F155S and R106W, studied by NMR are missense mutations 
found in cases of Rett syndrome. Neither residue showed significant chemical shift 
perturbation when MBD was bound to DNA. R106W was found to bind methylated 
DNA very poorly, whereas F155S binds to methylated DNA but doesn't shift the to 
completion [49]. Both are highly conserved residues and contribute to the hydrophobic 
core. R106 is the only arginine residue which is not completely exposed to solvent 
although its guanidyl tail is poking out on the helical face of the protein. It was 
suspected that these mutations, due to their structural role in MBD, might unfold the 
protein hence the need for their structural analysis. 
6.3 NMR experimental procedure 
The NMR studies consisted of collecting 2D ' 5 N-HSQC spectra of the MBD on a 
Varian INOVA 600 MHz spectrometer and comparing the amide ' 5 N and HN chemical 
shifts with those of the wildtype MBD, as was done in determining the DNA binding 
face (see section 3.4). The resonance assignments of the ' 5 N-HSQC of the mutants 
were obtained by overlaying them on the HSQC spectrum of the wildtype MBD whose 
assignment was previously completed as described in chapter 3. The chemical shift 
perturbations for assigned peaks were quantitatively measured using weighted average 
+ (41L)2 = 	
(6.1) 
where L6av is the weighted average shift difference and L6H and LSN are the differ-
ences in chemical shifts between wildtype MBD and mutant spectra of the amide proton 
and nitrogen respectively. Residues with large perturbations were not assignable with-
out data from further NMR experiments and therefore were noted accordingly (see 
figures 6.4, 6.5, 6.7, 6.8 and 6.10). 
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As a set of hetereonuclear NOE experiments were being run on the G114P mutant, it 
was necessary to complete the amide backbone assignment in this case. This was done 
by way of a 3D 15 N-edited NOESY and its comparison with one collected on wildtype 
MBD (both 75ms mixing times) and previously assigned. The hetereonuclear NOE 
experiments were collected under the same conditions as those collected on wildtype 
MBD and two sets of results were recorded on separate occasions to verify results. 
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Figure 6.3: Overlay of a portion of the 2D ' 5N HSQC of G114P (in blue) and that of 
wildtype MBD (in red). 
Chemical shift perturbations were used in the NMR structural analysis of the MBD 
mutants for the same reasons as for its use in analysing the structural differences 
between MBD in its bound and unbound states. As said before (sections 2.4 and 3.4), 
chemical shift is dependent on local electron distribution. It is reasonable to assume 
that regions of structural or conformational change would undergo a variation in their 
local electron distribution and thus a significant change in chemical shift. Also, regions 
within the mutants that are structurally identical to those in the wildtype should have 
similar chemical shifts. It was therefore decided that backbone amides with weighted 
average chemical shift perturbations greater than 0.04 ppm had significant structural 
changes. 
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As with the hetereonuclear NOE data on wildtype MBD bound and unbound (chapter 
5), the ratio of volumes in the spectra with a 3.01 ms NOE saturation pulse and without 
a saturation pulse with values less than 0.6 were considered to correlate to residues 
with a significant degree of mobility in relation to the overall tumbling of the protein 
molecule. 
6.4 Results and Discussion 
The 2D 15 N-HSQCs (not shown) of the missense mutations, F155S and R106W, found 
in Rett syndrome showed that the structure of MBD had indeed become unfolded 
in both cases. Repeat experiments with fresh samples verified and concluded this 
finding. This is consistent with the EMSA in the case of R106W but not entirely so for 
F155S. It is thought that a proportion of the F155S sample was unfolded or unfolding 
when added to the EMSA reaction but the not-yet-unfolded protein was stabilised in 
the assay by its target DNA, the presence of glycerol, the low temperature at which 
electrophoresis is carried out or the caging effect of the polyacrylamide gel [49]. In fact 
a study of the F155S mutation in the context of Xerzopus MeCP2 in which reactions 
in the gel mobility shift assay were carried out at 37°C failed to detect any binding, 
presumably because the MBD had unfolded at this higher temperature [10]. 
These findings are reasonable as presumably the instability of these mutants in vivo 
at 37°C will make them non-functional DNA binding proteins. Also replacing a long 
chained residue in a hydrophobic core i.e. R106 with a bulky aromatic residue like 
tryptophan could seriously distort the core, or replacing an hydrophobic residue in the 
core with a charged residue, with the likely effect of unfolding the protein. 
The other five mutants studied using NMR spectroscopy were all confirmed to be folded 
proteins. 
The Y123A mutation had no major effects on the structure of MBD, which is fairly 
consisent with its solvent-exposed location and relatively high DNA-binding affinity. 
Only L108 and V159 appeared to have strong chemical shift perturbations, probably 
due to the close proximity of their backbone amides to the bulky aromatic sidechain. 
There were other chemical shift perturbations greater than the significance value of 
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0.04 ppm however they were all less than 0.1 ppm. These were observed for D96, 
K107, K109-R111, D121, 1,124, R133-V136 and Y158. This can be accounted for 
easily as they are all close to Y123 and the replacement of an aromatic sidechain by 
a relatively small aliphatic group would not only remove the ring-current effect on 
chemical shift (section 2.4.1) but would also reduce steric hinderance due to the bulky 
sidechain and its ir-system, thereby allowing small conformational changes of nearby 
residues. Also the hydroxyl group on the tyrosine is possibly hydrogen bonded to the 
carboxyl sidechain of D121, and might assist that residue in its task of holding Rill 
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Figure 6.4: Chemical shift perturbation for the mutant Y123A. Blue line indicates the 
mutation. Orange lines mark residues with large chemical shift perturbations. Green 
dashed line is indicates the significance threshold of a difference of chemical shift of 
0.04 ppm. 
The hydrophobic pocket consisting of Y123, 1125 and A131 may be predicted to persist 
following the substitution of Y123 by another hydrophobic residue like alanine. The 
mutation of 1125 to alanine reduced methyl-DNA binding but to a lesser extent than 
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Y123A. The mutation of equivalent residue, i.e. from the sequence alignment of the 
members of the MBD family (see figure 1.4), in the MBD of MBD1 , Y34A, was re-
ported to have a marked effect on its ability to bind methylated DNA [52]. Mutating 
Y123 to a negatively charged residue such as aspartate caused a much more severe 
reduction, but binding could still be observed. This is consistent since the charged 
residue would disrupt the hydrophobic nature of the pocket, to the important D121 
residue nearby and by introducing a negative charge to the DNA binding face, and 
would potentially repel incoming backbone phosphates. However their individual con-
tributions appear to be fairly weak as specificity for methylated DNA is not removed 
when they each are. Although these residues forming a hydrophobic pocket do not have 
a major role in the recognition event, it is fair to suggest that specificity for the methyl 
groups of the methylated DNA may be a result of additive hydrophobic interactions 
within the protein-DNA interface. 
The results for the G114P mutation suggest an important role for the flexibility of 
the B-C loop. While several other mutations within this loop did not affect binding, 
G114P, predicted to constrain the conformational flexibility in this region, reduced the 
affinity for DNA substantially. Analysis of chemical shift perturbations show that only 
the B-C loop and connecting residues in the B and C strands (i.e. residues 109 - 121) 
were affected by this mutation (figure 6.5). 
This is consistent with the predicted constraining of the loop especially as the rest of 
the protein remained virtually unchanged. It was initially thought that this mutation 
might entirely restrain the B-C loop, however the heteronuclear NOE experiments 
showed that the B-C loop of the mutated protein is still disordered (see figure 6.6). 
The {'H}-' 5 N NOE ratio values (see figure 6.6) for this region do differ noticably 
between G114P and wildtype MBD; this with the chemical shift perturbation data 
suggests that the proline inhibits the loop from adopting certain conformations. 
The effect on the protein's DNA binding ability is most consistent with the idea that 
the B-C loop is flexible so that it can mold into a groove in the tertiary structure of 
the DNA. Hence by restraining conformation freedom of the disordered loop, binding 
activity is severely effected and the importance of its flexibility is highlighted. Also it 
is conceivable that this region's movement may bring into position the crucial Rill 
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Figure 6.5: Chemical shift perturbations for the mutant G114P. Further broadening 
of the backbone arnide peak for R115 observed in the HSQC of G114P prevented its 
resonance assignment. 
residue (see later) for binding. As the G 1 14P mutant still has some affinity for DNA and 
its effect is not as severe as the removal of R.111, it is likely that the positively charged 
residues in the loop play a non-specific role in interacting with negatively charged 
DNA, and that Rill is moved into a move energetically favourable conformation when 
binding rather than being moved into position. This certainly is more more consisent 
with the suggestion that D121 holds Rill in position. 
Upon mutation of Rill to glycine, there was no affinity for methylated DNA. This mu-
tant showed the most severe effects on binding for any single MBD missense mutation, 
indicating that the positively charged residue is vital for the interaction of the domain 
with DNA. Also it was found that R111G, unlike any other MBD mutant, bound very 
poorly to Fractogel SO resin during purification [49]. 
The NMR data indicated that the mutated domain was structured with only local 










Figure 6.6: Heteronuclear NOE data for the mutant G  14P. The two largely unstruc-
tured regions, the N-terminus and B-C loop, are highlighted in red. Values less than 
0.6 are considered to relate to regions with high mobility with respect to the overall 
tumbling of the molecule. The tip of the C-D loop around E128 and the turn after the 
helix around S149 are not rigid and have more than one conformation. 
perturbations in the vicinity of Rill and the B-C loop. As binding is completely 
abolished following this mutation, and considering the other information on this residue 
(e.g. the rigid sidechain when bound) it is fair to conclude that the functionality of 
R111'sguanidyl group is important rather than any contributions made by this residue 
to structural integrity of this domain. However in contrast to the perturbations caused 
by R133C, there appeared to be a number of disruptions in the region of the B-C loop 
and C strand, although Rill is projecting from the positive DNA binding face. The 
chemcial shift perturbations to the D121 residue and neighbouring residues is obviously 
caused by the removal of the interaction between D121 and Rill. The removal of this 
interaction could possibly free the flexible B-C loop from any resultant constraint, 
hence the large chemical shift perturbation seen in the loop. Also it is suspected that 
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Figure 6.7: Chemical shift perturbations for the mutant R111G. Blue line marks the 
mutation. Orange lines mark residues with large chemical shift perturbations. Green 
dashed line is indicates the significance threshold of a difference of 0.04ppm. 
MBD's DNA interaction involves K119 whose mutation to alanine seriously reduces 
the domain's binding affinity. K119 is orientated so as to project from the same face 
as Rill. However it probably has a less specific role in the binding mechanism than 
Rill. The close proximity of K119 to Rill would explain the large perturbation seen 
for it and neighbouring residues when Ri 11 is mutated to glycine. Also the equivalent 
MBD1 mutations, R22A and R30A, both showed large reductions in binding affinity 
[52]. 
The precise role of RI 11 will not be known for certain until the structure of the MBD-
DNA complex is elucidated. Nevertheless, it is known that it is an important residue 
in terms of the binding functionality of MBD and the suggestion that it is involved in 
recognizing one of the guanine bases in the mCpG dinucleotide pair would most likely 
hold true. 
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The second arginine mutation, R133C - Rett syndrome mutation - also caused a marked 
reduction in binding, concurrent with the loss of binding ability observed in the equiv-
alent MBD1 mutant R44A and this might underlie the phenotypic effects. There are 
some differences between the properties of R133C and the R111G mutant. Weak bind-
ing was observed with R133C at a concentration of 21iM whereas R111G showed none. 
The effects on the overall structure were minimal with only two residues, Y123 and 
S134, showing any chemical shift perturbation, which happens to be large in both 








80 	90 	100 	110 	120 	130 	140 	150 	180 
Residue 
Figure 6.8: Chemical shift perturbations for the mutant R133C. Blue line marks the 
mutation. Orange lines mark residues with large chemical shift perturbations. Green 
dashed line is indicates the significance threshold of a difference of 0.04ppm. 
The large perturbations seen for Y123 and S134 and the effects on DNA binding can be 
accounted for by their vicinity to R133 and the repulsive effects caused by changing this 
basic residue to a electronegative one i.e. cysteine. Although it is possible that Y123 
and/or S134 could be involved in an electrostatic interaction with R133 either to hold 
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it in a suitable conformation for binding or simply to prevent it from interacting with 
other electronegative amino acids e.g. D121, there is a lack of evidence to support 
this. What is rather interesting however is the relationship between charge on this 
residue and binding affinity i.e. the much less severe effects on binding observed with 
the R133G mutation and whether the large perturbations to Y123 and S134 would still 
be encountered. 
The NMR analysis of the R133C mutant, that has a Rett syndrome phenotype, showed 
that it is virtually identical to the wild-type protein, unlike the other Rett syndrome 
phenotypes studied (see figure 6.8). This fact, the large change in chemical shift of 
both its backbone amide and sidechain guanidyl group upon binding, and the loss of 
sidechain mobility upon binding indicates a major contribution to the binding action 
of MBD from R133, and a direct contact with DNA is made. As with Rill, the 
interaction of R133 with DNA is likely to be in the recognition of the sequence CpG, 
although it is difficult to say precisely where it interacts i.e. whether its the cytosine 
or the guanine it bonds to, maybe both or even the phosphate group. 
Another interesting mutation to study by NMR in the future, especially in light of the 
results for R133C, would be the Rett syndrome pheotype, S134(A/C). It would be safe 
to predict a similar lack of chemical shift perturbations with this mutant considering 
it is positioned next to R133 and that it is as equally solvent exposed. The question 
to ask is why does altering this serine residue to cysteine or alanine reduce the DNA 
binding affinity of MBD to produce a Rett syndrome phenotype. Unlike R133C, one 
cannot involve the loss of a positive charge. It may reflect a the difference in hydrogen 
bonding potentialities, and suggesting that S134 must be involved in a hydrogen bond-
ing interaction that contributes to the binding ability. This could involve the sidechain 
of R133 but seem unlikely as the sidechain's random coil chemical shift does indicate 
any interactions. Its therefore likely to be an interaction with DNA either by itself or 
a combined effort with another residue, maybe R133. Unfortunately due to the time 
limit on this project, it was not possible to study the structural effects of any other 
mutations. 
The 2D ' 5 N HSQC of D121A showed that the chemical shift of the Rill sidecahin 
He proton had moved from its relatively abnormal value to the region occupied by 
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Figure 6.9: Overlay of 2D ' 5 N HSQC of D121 (in blue) and that of wildtype MBD (in 
red). Note how the Hc sidechain peak for 11111 has been perturbed. 
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the other arginine Hc atoms (Figure 6.9). The backbone chemical shift perturbations 
observed by NMR for this mutation are in the B-C loop and the vicinity of D121 and 
Rill. There was significant change for neither the backbone nor sidechain chemical 
shifts of R133. This suggests there is a bridging interaction with Rill and not with 
R133. The effect of the D121(A/E) mutations on DNA binding would therefore be 
mainly due to the abolition of this interaction given the importance of Rill in DNA 
binding. As the equivalent MBD1 mutant, D32A, showed a marked loss of ability to 
bind methylated DNA [52], and both Rill and D121 are highly conserved residues 
throughout the MBD family [69], it is suggested that this interaction is a common and 
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Figure 6.10: Chemical shift perturbations for the mutant D121A. Blue line indicate 
position of the mutation. The asterisks (insted of bars, for clarity) indicate residues 
with large perturbations. The green dashed line is at 0.04ppm. 
It was also noticed that there are similarities between the chemical shift perturbations 
caused by D121A and those caused by R111G (see figures 6.10 and 6.7). The observed 
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chemical shift changes can be explained by the removal of this D121-R111 interaction, 
the subsequent loss of constraint on Rill, and local environmental change. Although 
it is ppssible that there is a hydrogen-bonding interaction between the hydroxyl proton 
on Y123 and the carboxyl group on D121, it is difficult to say whether this lies behind 
the large perturbation to Y123, or whether there are local changes in the electronic 
environment. Nevertheless there is emphasis on the D121-R111 bridging interaction 
and the role of D121 to position the basic arginine sidechain so it can interact correctly 
with DNA. 
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Figure 6.11: A possible mechanism for the interaction of D121 and Rill in the recogni-
tion of guanine in the sequence 5mCpG. It is commonly found in DNA binding proteins 
(Pabo and Sauer, 1992). 
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Figure 6.11 shows a suggestion for the mechanism for the bridging interaction between 
Rill and D121 and their role in the recognition of guanine in the dinucleotide sequence 
CpG. This mechanism is analogous to the base contacts made by arginine residues in 
the zif268 zinc finger-DNA complex [137]. 
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Appendix A 
Rough guides - 
A.1 to protein 13 C chemical shifts 
CA CB CG CD CE 
Gly 44f+48 
45.8 
Ala 51.49 	57.62 19.09 4- 	23.49 
54.56 21.29 
Val 59.87 -* 68.87 32.0 -+ 39.4 20.12 H 26.24 
64.37 35.7 23.18 
Leu 52.49 H 59.74 41.86 H 49.24 27.36 H 29.11 24.61 H 32.61 
56.12 45.55 28.24 28.61 
Ile 59.45 -+ 66.05 36.36 H 43.11 26.74 H 29.86 19.61 H 21.86 10.61 H 16.74 
62.75 39.74 28.30 20.74 13.68 
Ser 58.18 -+ 60.62 65.49 H 66.99 
59.40 66.24 
Cys 58.0 ox. 28.6 
red. 41.8 
Thr 60.37 H 69.43 70.36 H 74.93 19.49 H 24.12 
64.9 72.65 21.81 
Met 54.57 <-4 56.34 30.60 <-+ 32.80 33.01 55.46 31.70 
Phe 56.7 29.7 
Tyr 	58.6 	 38.7 
Trp 	57.8 	 28.3 
His 	55.8 	 32.0 
Lys 56.49 +-+ 62.11 31.24 <-+ 36.86 25.11 H 27.36 	30 H 32 	42.49 H 43.61 
	
59.8 	 34.05 	26.24 	31.00 43.05 
Ara 55.99 4-+ 61.49 30.74 H 35.24 27.37 H 29.99 44.74 H 45.24 
58.74 	32.99 	28.65 	44.99 
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CA CB CG 	 CD 	CE 
Asp 53.99 	59.87 41.99 4-+ 45.99 
56.93 43.99 
Glu 53.99 	61.12 28.49 -* 35.49 32.99 -* 39.12 
57.56 31.99 36.06 
Asn 51.04 -+ 53.18 37.49 -+ 40.04 
52.11 38.77 
Gin 55.99 -* 60.37 29.12 -* 37.29 33.99 +- 	35.74 
58.18 33.21 34.87 
Pro 63.74 	67.62 32.49 -+ 35.81 26.30 H 29.65 	51.49 H 53.05 
65.68 34.15 27.98 	52.27 
Table A.1: Table of typical ' 3C chemical shifts of atoms in protiens taken from pub-
lished resonance assignments. The average range of shifts is given for most residues, 
above the average value. Not to be taken as definitive, but as a useful rough guide 
for backbone assignment. For a larger statistical report of typical chemical shifts see 
BMRB website (http://www.bmrb.wisc.edu/pages/)  
A.2 to DNA proton chemical shifts 
ME APPENDIX A. ROUGH GUIDES - 
Spin-system Atom proton chemical shift standard deviation 
Adenine H2 7.462 + 0.258 
H8 8.066 + 0.196 
HN61 7.213 ± 0.482 
HN62 6.450 ± 0.325 
Guanine HN1 12.707 ± 0.213 
H8 7.686 + 0.152 
HN2* 6.602 ± 0.224 
Thymine HN3 13.651 + 0.238 
H6 7.273 ± 0.252 
H7* 1.393 ± 0.185 
Cytosine H6 7.454 + 0.206 
(h-bonded) HN41 8.131 ± 0.239 
HN42 6.429 ± 0.518 
(unmethylated) H5 5.474 + 0.344 
(5-methyl-C) H7* as T H7*  ? ? 
Ribose Hi' 5.841 + 0.283 
H2' (A) 2.728 + 0.154 
H2' (C) 2.208 ± 0.222 
H2' (G) 2.530 ± 0.152 
(T) 2.237 + 0.258 
H2" (A) 2.840 ± 0.081 
H2" (C) 2.387 ± 0.129 
H2" (G) 2.583 + 0.165 
H2" (T) 2.440 + 0.133 
 4.843 ± 0.144 
 4.211 ± 0.136 
H5* 4.079 ± 0.140 
Table A.2: Table of average chemical shifts for DNA 
Appendix B 
Programs written for ARIA 
B.1 "project.csh" 
This is the script written in C shell in the course of this project to run and control 
ARIA. It calls the bug fix "buggedawk". 
#!/bin/csh -f 
onintr close 
* This variable should be set to the name of your template file 
* If you use this script to create your template file, this variable 
U will be the name of template file. 
setenv TEMPLATE MBD_template.pdb 
U The PROJECT variable should be set to the path of your 
* project directory. 
setenv PROJECT /usr/nrnr/nessie/robertw/MBD+DNA/ 
* These don't need to be altered 
setenv PROTOCOL $PROJECT/protocol 
setenv TOPPAR $PROJECT/toppar 
setenv ASSIGN $PROJECT/assign 
setenv DATA $PROJECT/data 
setenv SEQUENCE $DATA/sequence 
* This should be set to the full path and name of Xplor that you use. 
setenv XPLOR /usr/progs/xplor3851/obj ect_library/xplor_ip25b.exe 
* Ignore this! 
setenv OMITNOE $DATA/omit_NOE. list 
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set filec 
if ( $#argv == 0 ) goto iterationO 
if ( $argv[1] == "setup" ) goto setup 
if C $#argv <= 1 ) goto iterationO 
if ( $argv[2] == 0 ) then 
goto iterationO 
else 





echo "Running Setup 
$XPLQR < generate.inp > generate.out 
echo "Generating template structure .. 
$XPLOR < generate_template.inp > generate_template.out 
goto exit 
# Initial iteration 
iterationO: 
setenv PREVIT $PROJECT/structures/it0 
setenv NEWIT $PROJECT/structures/it0 
if (-d $PRO.JECT/structures/itO == 0) mkdir $PROJECT/structures/it0 
touch $NEWIT/iteration. xplor 
echo 'evaluate ($iteration = 0)' > $NEWIT/iteration.xplor 
echo \"SEQTJENCE:"$TEMPLATE\" > $PREVIT/file.list 
# This bit checks for the existance of spectra_ass.list 
* and acts accordingly. 
cd $DATA 
if ( ! -e $DATA/spectra_ass.list ) then 
touch $DATA/spectra_ass . list 
foreach flsl ( * ) 
if ( -d $flsl && $flsl ! "sequence" && $flsl ! "ssbond") then 




* This bit checks fo the existance of spectruin.xplor 
* and acts accordingly. 
if ( -e $NEWIT/viols.exc) rm $NEWIT/viols.exc 
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touch $NEWIT/viols . exc 
foreach file ( * ) 
if ( -d $file && $file ! "sequence" && $file ! "ssbond") then 
if ( ! -e $DATA/$file/spectruin.xplor ) then 
touch $DATA/$file/spectrum.xplor 
echo 'evaluate ($spectruln = "'$file'")' > $DATA/$file/spectrum.xplor 
endif 
* This bit runs the calibration 
setenv SPECTRUM $DATA/$file 
set out 	"calib_$file.out" 
$XPLOR < $ASSIGN/calib.inp > $NEWIT/$out 
echo $SPECTRUN >> $NEWIT/viols.exc * Writes excluded violated 
nawk -f $ASSIGN/get_viols {$NEWIT}/{$out}>> $NEWIT/viols.exc * restraints to a fi 
endif 
end 
* Rob's fix 
* Bug in XPLOR program. Don't have access to source code as i'm only a 
* student. 
foreach ftbl ( $NEWIT/*.tbl ) 
if ($ftbl 	"ssbond.tbl") then 
nawk -f $ASSIGN/buggered_awk $ftbl 
my outlO_lO $ftbl 
endif 
end 
* Runs the merge script 
$XPLOR < $ASSIGN/merge.inp > $NEWIT/merge.out 
if ( ' -e $DATA/ssbond/ssbond.tbl ) touch $DATA/ssbond/ssbond.tbl 
if ( ! -e $DATA/ssbond/hbonds.tbl ) touch $DATA/ssbond/hbonds.tbl 
if (-e $NEWIT/ssbond.tbl) rm -f $NEWIT/ssbond.tbl 
if (-e $NEWIT/hbonds.tbl) rm -f $NEWIT/hbonds.tbl 
ln $DATA/ssbond/ssbond.tbl $NEWIT/ssbond.tbl >& /dev/null 
in $DATA/ssbond/hbonds.tbl $NEWIT/hbonds.tbl >& /dev/null 
* Rob's fix 
* Remove this section if the FORTRAN code has been corrected 
nawk -f $ASSIGN/buggered_awk $NEWIT/unambig.tbl 
my outlO_lO $NEWIT/unambig.tbl 
nawk -f $ASSIGN/buggered_awk $NEWIT/ainbig.tbl 
my outlO_lO $NEWIT/ambig.tbl 
* Omits restraints from calculation. 
* Never used it. Superfluous to needs. 
if (-e $OMITNOE != 0) then 
cd $NEWIT 
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nawk -v nof$OMITNOE -f $ASSIGN/comout_NOE.awk unambig.tbl > tmp 
my tmp unarnbig.tbl 
nawk -v nof$OMITNOE -f $ASSIGN/comout_NOE.awk anibig.tbl > tmp 
my tmp ainbig.tbl 
endif 
* The Simulated Annealing bit 
$XPLOR. < $PROTOCOL/re_l.inp > $NEWIT/re...l.out 
gzip -f $NEWIT/re_1.out 
cd $NEWIT 
* order the structures wrt energy. this script does not 
# 	work on alphas. 
awk ' /energies/ -(print "V" "PREVIT:" FILENAME \IIfl, II { tt , $3, "}"}' *.pdb I \ 
sort +2n >file.list 
nawk -f $ASSIGN/omitE file.list I sed 's/PREVIT:/NEWIT:/' > calcavefile.list 
$XPLOR < $ASSIGN/alice_average.inp > $NEWIT/ave.out 
goto iterationi 
iterationi: 
set iteration = 1 
if ($*argv < 1) then 
@ limit = 8 
else if ($*argv > 1) then 
@ limit = $argv[1] 
@ iteration = $argv[2] 
else 
@ limit = $argv[1] 
endif 
@ it = $iteration - 1 
setenv PREVIT $PROJECT/structures/it"$it" 
while ($iteration < $limit) 
if (-d $PROJECT/ structures/ it$ iteration == 0) mkdir $PROJECT/ structures/ it$ iterat 
setenv NEWIT $PROJECT/structures/it$iteration 
touch $NEWIT/iteration.xplor 
echo 'evaluate ($iteration = '$iteration')' > $NEWIT/iteration.xplor 
cd $DATA 
* Calibration part 
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if ( -e $NEWIT/viols.exc) rm $NEWIT/viols.exc 
touch $NEWIT/viols . exc 
foreach file ( * ) 
if ( -d $file && $file ! "sequence" && $file ! "ssbond") then 
setenv SPECTRUM $DATA/$file 
set out = "calib_$file.out" 
$XPLOR < $ASSIGN/calib.inp > $NEWIT/$out 
echo '$SPECTRUM" >> $NEWIT/viols.exc 
	
Writes excluded violated 
nawk -f $ASSIGN/getviols {$NEWIT}/{$out} >> $NEWIT/viols.exc # restraints to a i 
endif 
end 
* Rob's fix 
* Remove this section if the FORTRAN 
foreach ftbl ( $NEWIT/*.tbl ) 
if ($ftbi 	ssbond.tbl") then 
nawk -f $ASSIGN/buggeredawk $ftbl 
my outlO_lO $ftbl 
endif 
end 
code has been corrected 
* Runs merge script 
$XPLOR < $ASSIGN/merge.inp > $NEWIT/merge.out 
if (-e $NEWIT/ssbond.tbl) rm -f $NEWIT/ssbond.tbl 
if (-e $NEWIT/hbonds.tbi) rm -f $NEWIT/hbonds.tbl 
in $DATA/ssbond/ssbond.tbi $NEWIT/ssbond.tbl 
in $DATA/ssbond/hbonds .tbl $NEWIT/hbonds .tbl 
* Rob's fix 
nawk -f $ASSIGN/buggered_awk $NEWIT/unanibig.tbi 
my outlO_lO $NEWIT/unainbig.tbl 
nawk -f $ASSIGN/buggeredawk $NEWIT/ambig.tbl 
my out101O $NEWIT/ambig.tbl 
* Superfluous to needs. 
if (-e $OMITNOE != 0) then 
cd $NEWIT 
nawk -v nof$OMITNOE -f $ASSIGN/comoutNOE.awk unainbig.tbl > tmp 
my tmp unainbig.tbl 
nawk -v nof$OMITNOE -f $ASSIGN/comoutjWE.awk ainbig.tbl > tmp 
my tmp ambig.tbl 
endif 
* Runs simulated annealing protocol. 
$XPLOR < $PROTOCOL/rel.inp > $NEWIT/re_l.out 
gzip -f $NEWIT/rel.out 
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* Writes energies and pairwise average 
cd $NEWIT 
awk ' /energies/ {print "\" "PREVIT:" FILENAME "\", " { I' , $3, "}"}' *.pdb I \ 
sort +2n >file.list 
nawk -f $ASSIGN/omitE fiie.list I sed 's/PREVIT:/NEWIT:/' > calcavefiie.list 
$XPLOR < $ASSIGN/alice_average.inp > $NEWIT/ave.out 






echo 'project.csh interrupted.' 
* 
exit: 
B.2 XPLOR code bug fix - "buggedawk" 
This is written in the awk utility, a pattern-scanning and processing language. 
BEGIN{fig =01 
{ if (NF >= 2 && fig == 0) {print lin > "outlO_lO"; un = $0;next} 
if (NF == 1 && $1 == "OR" && fig == 0) 
{fig = 1; print "(",iin > "outlO_lO"; un = $0;next} 
if (fig == 1) {fig = 2 ;print un > "outlO_lO"; un = $0; next} 
if (fig == 2 && $1 == "OR" && NF == 1) 
{fig = 3; print un > "outlO_lO"; un = $0; next} 
if (fig == 2 && NF != 1) 
{fig = 0; print un,")" > "outlO_lO"; un = $0; next} 
if (fig == 3) 
{flg = 4; print un > "outlO_lO"; un = $0; next} 
if (fig == 4) 
{fig = 0; print un,")" > "outlO_lO"; un = $0; next} 
else {print un > "outlO_lO"; un = $01 } 
END { if (fig == 4 II fig == 2 ) print un,")" > "outlO_lO" 
else print un > "outlO_lO" } 
Appendix C 
Programs used in the structure 
calculation 
C.1 Scripts and programs written 
C.1.1 makeShiftSummary 
This is the much more efficient rewritten version. Its written in shell script, and writes 
only one set of files i.e. the final ones, rather than writing and re-reading numerous 
files. I/O processes are time consuming and are the main fault in many CPU intensive 
and excessively long run time programs. 
It calls an AWK program called "version 2.O.cs+sd". It also calculates the standard 
deviation of each chemical shift, which was not a feature of the original program. 
#!/bin/tcsh -f 
* uses tsch rather than csh in cases where the buffer size is too large 
* 
* WARNING!!! THIS PIECE OF EXTREMELY INEFFICIENT SCRIPT HAS BEEN MODIFIED 
* TO RUN 100 TIMES FASTER. It was pretty badly written before. However it 
* doesn't do the priority thing yet. 
* 
* 
* Takes output from makeShiftList which contains all assigned crosspeaks 
* Gives a summary table which has the mean chemical shift 
* and the spread of the chemical shifts. This table is then split into 
* two tables, one containing H shifts and their spreads, and one containing 
* N and C chemical shifts and their spreads: this two tables 
* are the input to the next script "makeConnectedShifts". 
* Also puts out a list of "offender" or 
* assignments with an unacceptable spread, in order of how bad they are. 
* This is extremely useful for checking assignments. Note that the priority 
* of the experiment is carried along. Priorities can also be given to dimensions 
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* and used to weight various parameters such as the tolerance given to a chemical 
* shift in the ambiguous treatment. 
********#Begin the script*#*****#**#*###******###*#*#*###**#**#*#*##*###*## 
* 
It Do All shifts 
It 
set SHIFT-TABLE = MBD_shifts_all_sorted.rdb 	*Generated from makeShiftList 
set SHIFT-SUMMARY-TABLE = MBD_shifts_sumxnary.rdb 
set SHIFT_SUMMARY_TABLE_H = MBD_shifts_summary_h.rdb 	*H atoms 
set SHIFT-SUMMARY-TABLE-NC = MBD_shifts_sununary_nc.rdb *N and C atoms 
set OFFENDERS_H = offenders_1_h.rdb 
set OFFENDERS-NC = offenders_1_nc.rdb 
* ********NEW CHOICE******** 
* If you want the standard deviation for the errors then set CHOICE to 1 
* otherwise set CHOICE to 0 (or whatever other number you feel inclined 
* to put in) for an error obtained from the difference between the highest 
* and lowest values for a particular shift. 
set CHOICE = 1 
It 
It 
set MAX-PRIORITY = 100 It Exclude shifts from indirect proton 
It dimensions in 4D spectra 
goto start 
start: 
nawk -f version2.0.cs+sd v offh$OFFENDERS_H v offnc$OFFENDERS_NC -v opt=$CHOL 
$SHIFT_TABLE > $SHIFT_SUMMARY_TABLE 
It Er, that's it! 
It 
It Split out a summary table for H 
It and a separate one for N and C 
It 
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row atname mat ''H'' < $SHIFT_SUNMARY_TABLE I \ 
sorttbl -r delta > $SHIFT_SUMMARY_TABLE_H 
row atname nmat 'H" < $SHIFT_SUMMARY_TABLE 
sorttbl -r delta > $SHIFT_SUMMARY_TABLE_NC 
version2.0.cs+sd 
NR > 2 && $2 > 0 && FILENAME == ARGV[11{ 
* Needs -v option to received variables offh, offnc and opt 
* which are the names of output files for offending proton shifts, 
* heavy atom shifts and an option of 1 or 0 for standard deviation or 
* difference between highest and lowest values for the error. 
res[$2] = $1 
for (i=1;i<=atom[0];i++) { 
if ($3 == atom[i]) {atref = i; break} 
else atref = 0 
} 
if (atref == 0) {atom{01++; atom[atom[O]]=$3;atref=atom[0]] -
for (s1;s<spec[0];s++) { 
if ($6 == spec[s]) {spref = s;break} 
else spref = 0 
} 
if (spref == 0) {spec[0]++;spec[spec[0]]$6;spref=spec[O]} 
* Data Structure is a 3 dimensional array 
* data [ residue, atname reference number, entry no. (1,2,.. 
* data [ resid, atref, 0 ] = no of entries 
data [$2,atref ,0]++ 
data[$2,atref,data[$2,atref,0]] = $5 
xpk[$2,atref,data[$2,atref,0]] = $7 
spectrum[$2,atref ,data[$2,atref ,0]] = spref 
sum[$2,atref] += data[$2,atref,data[$2,atref,0]] 
if ($2 > max) max=$2 
11 
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END {printf "resid\tresnaine\tatname\tshift\tdelta\n" 
printf N\tS\tS\tN\tN\ n u 
for (j=1;j<max;j++) { 
for (k=1;k<=atom[0];k++) { sumS2 = 0; mxval =0; mnval = 0 
if (data[j,k,O] < 1) continue 
mean[j,k] = sum[j,k]/data[j,k,O] 
for (11;1<data[j,k,0];1++) { 
if (mxval < (data[j,k,1]2Y0.5) mxval (data[j,k,1]2)'0.5 
if (mnval > (data[j,k,112Y0.5 II mnval == 0) mnval= (data[j,k,1] - 2) - 0.5 
suinS2 += ((data[j,k,1] - mean[j,k]) 	2) 
} 
# Find out what is causing the worst offenders 
delta[j,k] = mxval-mnval 
if (delta[j,k] > 0.0500 && substr(atom[k],1,1) == "H") { 
if (first0) { 
printf "resname\ts .resid\ts .atnaine\ts .shift\ts.delta\tshift\tspectrumVtxpk\n" > 
printf "S\tN\tS\tN\tN\tN\tS\tN\n" > offh 
first = 1 } 
for (ofhl;ofh<data[j ,k,0] ;ofh++) { 
printf "/s\t%d\t%s\th.4f\t%.4f",res[j] ,j atom [k] ,mean [j ,k] ,delta [j ,k] > offh 
printf "\t °h.3f\t%s\tY.d\n",data[j ,k,ofh] ,spec[spectrum[j ,k,ofhJ] ,xpk[j ,k,ofh] > 
} 
} 
if (delta[j,k] > 0.3 && substr(atom[k],1,1) ! "H") { 
if (second0) { 
printf ' 1 resname\ts .resid\ts .atnaine\ts. shift\ts .delta\tshift\tspectrum\txpk\n" > o: 
printf "S\tN\tS\tN\tN\tN\tS\tN\n" > offnc 
second = 1 } 
for (ofh=1;ofh<data[j,k,0] ;ofh++) { 
printf "/,s\t'/,d\t%s\t'/,.4f\t'/..4f",res[j] ,j, atom [k] ,mean [j ,k] ,delta[j ,k] > offnc 
printf "\t'/,.3f\t'/,s\t%d\n" ,data[j ,k,ofh] ,spec [spectrum [j ,k,ofh]] ,xpk[j ,k,ofh] > 
II 
# Calulate standard deviation in chemical shifts 
if (data[j,k,0] > 1 ) { 
S2 = suniS2 / (data[j,k,0] - 1) 
SD[j,k] = S2 	0.5 
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else SD[j,k] = 0 
* selects standard deviation or difference between max and min values 
* of chemical shift. Variable "opt" equal 1 or null/0 for SD or delta 
* values output respectively. 
if (opt == 1) { 
printf "7.d\t%s\t'/.s\t'/..4f\t'/..4f\n",j ,res[j] ,atom[k] ,mean[j ,k] ,SD[j ,k] 
:i 
else { 






This short simple shell script was written and used to easily create the X-PLOR di-
gestable restraints for /3-sheet h-bonb connectivies. The usage is simply 
make_H_bonds first-residue-number second-residue-number 
echo "assign (resid " $1 " and name 0 )(resid " $2 " and name HN ) 1.88 0.3 0.42" 
>> H_bonds.tbl 
echo "assign (resid " $1 " and name 0 )(resid 	$2 " and name N ) 2.3 0.1 1.0 11 \ 
>> H_bonds.tbl 
echo "assign (resid " $2 " and name 0 )(resid " $1 " and name HN ) 1.88 0.3 0.42" 
>> H_bonds.tbl 
echo "assign (resid " $2 " and name 0 )(resid " $1 " and name N ) 2.3 0.1 1.0" \ 
>> H_bonds.tbl 
C.1.3 calc_dist.pdb 
This program was found to be very useful in assigning NOEs and removing violations. 
It either finds the distance between two specified atoms or all those within a specified 
radius (default 6 A) and can filter the output. A help option is included. 
if [ $# = 0 ] 
then 
echo "Usage: $0 [-het -hi {pdb filename} (max dist) (min dist)" 
exit 1 
fi 
* option check 
* modify later - Rob 
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if [ $1 = '-h" ] 
then 
echo 
echo "This program will determine which atoms are within a definable distance" 
echo "from a desired atom in a structure described by a PDB coordinate file" 
echo "The default thresholds are 0 Angstroems for the minimum distance and 
echo "6 Angstroems for the maximum." 
echo 
echo "You can also narrow the search when prompted for a specific atom(s) by" 
echo "entering either the residue number, atom type or both. Put a space in if" 
echo "you enter both a residue number and an atom type - the order doesn't matt 
echo 
echo "Usage: $0 (-het) {pdb filename} (max dist) (min dist)" 
echo 
echo "Option -het will include heavy atoms in output, otherwise only protons" 
echo "will be considered. So there! What do you think about that then!?" 
echo 
echo "Examples of use:" 
echo "$0 random_file.pdb 	 (min0.0 max6.0)" 
echo "$0 random_file.pdb 4.3 	 (min=0.0 max=4.3)" 
echo "$0 random_f ile.pdb 5 2 (min=2.0 max=5.0)" 
echo 
echo "It uses PDB nomenclature and understands HB* & HG# type pseudoatoms." 
echo "What else can i say about it? Its not complicated." 
echo 
echo "Rob 2000" 
exit 1 
fi 




echo "looking for specific atom: \c" 
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read exc 
if [ $# = $cl ] 
then 
.0 11 
elif [ $# = $c2 ] 
then 
t=$2 





echo "theshold =11 $t "Angstroems" 
nawk -v exc " $exc " -v opt$opt -v a$atom -v r=$res -v thesmax=$t -v thesmin=$min 
BEGIN {print "Searching for",r,a " ... ' 
split (a, al, "*");split (al [l] ,a2, 11 # 11 ) 
ata2[1] 
printf " \n" 
k = split(exc,l," II) 
if (k == 2) {thesmax = 1e6; thesminO} 
if (k > 2) print "What ARE you trying to do?!? \ " exc " \ " eh?" 
for (m=1;m<=k;m++) { 
if (match("0123456789",substr(l[m] ,1,1))) nexc = l[m] 
else aexc = l[m] } 
if (k > 0) print "Matching any that fits with \" nexc, aexc"\" 
} 
{ if ($1 ! "ATOM") next 
if (first-line == 0) { 	 # finds start of coordin 
for (coord_start=1 ; coord_start<=NF; coord_start++){ 
fs = split($coord_start,fsa,".") 
if (match("0123456789",substr((fsa[1]2Y0.5,1,1)) 






if (opt ! "-het" && ! index($3,"H")) next 	 # ignores heteroatoms 
if (toupper(substr($3,1,length(at))) == toupper(at)){ 	# finds atom(s) of choi 
if ($(coord-1) == r) { 
found++ 
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x[found] = $coord ; y[found] = $(coord+1) ; z[found] = $(coord+2) 




atom[$2] = $3 	 # loads in coordinates 
res[$2] = $(coord-1) 
cooX[$2] = $coord 
cooY[$2] = $(coord+1) 
cooZ[$2] = $(coord+2) 
if ($2 > max) max = $2 
} 
END {if (found == 
print "Could not find",a,r,"in this file!" 
print "Check the name" 
exit } 
for (i=1;i<=max;i++) 
{ 	 # checking/matching nonsense 
if (atom[i] == ") continue 
xl = cooX[i] 
yl = cooY[i] 
zi = cooZ[i] 
for (j=1;j<=found;j++){ 
d = (((xl - x[j]Y2) + ((yl - y[j]Y2) + ((zi - z[j]Y2)Y0.5 
if (d <= thesmax && d >= thesmin) { 
if (toupper(substr (atom [i],1,length(aexc))) == toupper(aexc) II aexc== 11) pr 
if (res[i] == nexc 11 nexc == ") prt++ 
if (prt == 2) { 
printf "\t7,-4d'h-5s and %-3d%4s are 7.2.3f A apart\n", res[i],atom[i],r,atm[j], 
} 




} ' $file 
C.1.4 levels 
This short C code is for a program that produces the contour level values to be read 
into the program "contours" apart of the AZARA package. 
#include <stdio.h> 
#include <stdlib .h> 
#include <math.h> 
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/* Program by Robert Wakefield. 7/98. *1 
/* Do whatever you like to this */ 
/* but don't blame me 
void main (mt argc, char *argv[]) 
{ 
mt i, nol; 
long mt 1ev, lrob; 
float mul; 
if (argc < 3) { 
if (argc==2 && !strcmp(argv[1],"-h")) { 
printf("Usage %s 'starting-value' 'multiplier'", argv[03); 
printf(" 'number of levels'(optional, default 10)\n"); 
printf("or \nusage %s. Required parameters will be requested \n",argv[O]); 
exit(1); } 
printf ("Enter starting value: 
scanf ("Y,d", &lev); 
printf ("Enter multiplier value: 
scanf ("/.f", &mul); 
nol = 9; 
} 
else { 
1ev = atof(argv[1]); 
mul = atof(argv[2]); 
if (argc == 4) nol = atoi(argv[3]) - 1; 
else nol = 9; 
} 
for (i = 0; i <= nol ; i++ ) { 
lrob = ceil( lev*(pow(mul,i))); 




This short script simply finds the mean, sum and standard deviation of an inputted 
column of numbers. Its can have input piped in and is very useful. 
nawk '{ if ($1 ! " && index("0123456789",substr($1,1,1)) != 0) { 
sum += ($1'2)0.5 
n++ 
X[n] = ($12)0.5 
} 
} 
END { mean = sum / n 
for (j1;j<n;j++) { sumS2 + (X[j] - mean) - 2 } 
S2 = sumS2 / (n - 1) 
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SD = S2 	0.5 
print "Suxn:",suxn 
print "Mean:" ,mean 
print "Standard Deviation:",SD } ' $1 
nawk '{ if ($1 ! " && index("0123456789",substr($1,1,1)) != 0) { 
sum += ($1'2)0.5 
n++ 
X[n] = ($12)0.5 
} 
} 
END { mean = sum / n 
for (j=1;j<n;j++) { sumS2 + (X[j] - mean) -2 } 
S2 = sumS2 / (n - 1) 
SD = S2 	0.5 
print "Sum:',sum 
print "Mean: " ,mean 
print "Standard Deviation:",SD } ' $1 
C.1.6 stat.log 
This script is for summarising the output from the maxent function of "process" apart 
of AZARA. It was found to be very useful for MEM processing of spectra, as the output 
is normally quite lengthy. 
#! /bin/sh 
* by Rob 
if [ $* = 0 ] 
then 
file"max . log" 
else 
if [ 11 $1" = "-h' I 
then 





nawk ' { if ($1 == "working") { 
if ( $5 != 1 ) printf "\(/.d\)\n",it 
if (status != 0) printf "\tNo Convergence: status = '/,d\n",status 
if (omega > 1.1 II omega < 0.9) { 
if ( $5 != 1 ) printf "\tNo Convergence: omega = %1.3f\n",omega } 
printf "data number '/.d: ", $5 
old-omega = 0 omega = 0 
1 
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if ($1 == "iteration") { 
it = $2 
getline; omega = $6 
if ( omega >= old-omega) printf 
else printf "-" 
old-omega = omega 
getline; status = $3 
} 
} 
END { printf 	(/.d)\n",it } ' $file 
#!/bin/sh 
* by Rob 
if [ $# = 0 ] 
then 
file"max . log" 
else 
if [ 11 $1" = "-h" J 
then 





nawk ' { if ($1 == "working") { 
if ( $5 != 1 ) printf "\(%d\)\n",it 
if (status != 0) printf "\tNo Convergence: status = %d\n",status 
if (omega > 1.1 II omega < 0.9) { 
if ( $5 ! 1 ) printf "\tNo Convergence: omega = %1.3f\n",omega } 
printf "data number %d: ", $5 
old-omega = 0 ; omega = 0 
} 
if ($1 == "iteration") { 
it = $2 
getline; omega = $6 
if ( omega >= old-omega) printf 
else printf "-" 
old-omega = omega 
getline; status = $3 
} 
} 
END { printf " (70d)\n",it } ' $file 
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C.2 3JHNH  coupling constants 
C.2.1 calc_Jhnha.c 
This is the C source code for the program that calculates the J-coupling constants. 
It takes in its values from the command line and is controlled by the shell script 
"calculate-J" so that input and output formats can easily be changed. 
#include <stdio . h> 
#include <stdlib.h> 
#include <math.h> 
void main (mt argc, char *argv[]) 
{ 
irit res; 
float id, ix, noise, delay, correction; 
double 1, m , j , err-high, err-low; 
ix = atof(argv[1]); 
id = atof(argv[2]); 
res = atoi(argv[3]); 
noise = atof(argv[4]); 
delay = 0.01340954; 1* de- and rephasing delay in seconds */ 
correction = 1.11; /* correction factor */ 
/* 	printf ("Enter intensity of crosspeak: 
scanf ("/.g", &id); 
printf ("Enter intensity of diagonal: 
scanf ("Y.g", &ix);*/ 
j = 	( atan(sqrt( 	ix/id 	)) / ( 2*delay*M_PI) ) * correction; 
err-low = ( atan(sqrt((ix noise)/(id + noise))) / (2*delay*M_PI) ) * correcti 
err-high = C atan(sqrt((ix + noise)/(id noise))) / (2*delay*M_PI) ) * correcti 
printf ("/.i\t%g\t",res,j); 
printf ("%.5g\t'h.5g\t'/..5g\t%.5g\t'/..5g\n",err_high,err_high - j ,err_low,j - err-11 
err-high - err-low); 
} 
C.2.2 calculateJ 
This shell script controls the "calcjhnha" program. 
nawk ' NF == 19 {print $01 ' Icolumn residi atname2 intensity < $1 I \ 
headchg -del I\ 
nawk ' BEGIN {# noise-level = 59353.7 
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noise-level = 183837 } 
{if ($2 == "HA" ) {if ($3 < 0) Ix[$1] = -1*$3 
else Ix[$1] = $31 
else if ($2 == "HN") { if ($3 < 0) Id[$1] = -1*$3 
else Id[$1] = $31 
* Ignore Glycine relaxation screwy here 
* 	else if ($2 == "HAT') { if ($3 < 0) 1x2[$1] = -1*$3 
* else 1x2[$1] = $31 
if ($1 > max) max =$1 
} 
END{ 
print "echo \"Res 	J 	high 	high_J low 
print "echo \"N N N N 	N 	N 
for (i = 1; i <= max; i++) {if (Ix[i] != 0 && Id[i] 
print "calc_Jhnha",Ix[i] ,Id[i] ,i, noise-level } 
if (1x2[i] != 0 && Id[i] != 0){ 
print "calc_Jhnha" ,1x2[i] ,Id[i] ,i,noise_level } 
11 1 > tmp.file 




N\ 11 11  
o){ 
C.2.3 integr_vol 
This is the ansig macro for manual integration of crosspeaks. What is meant by 
manual integration in ANSIG is that the area that is integrated is defined by the 
user by drawing a box in one plane and then another in an alternative plane, thereby 
obtaining a user-defined cube. This is essential for obtaining the accurate volumes from 
the 3D HNHA spectrum that are required for calculating 3JHNHO  coupling constants. 
In initialise file (.ini): 
macro integr_vol 
variable cp ?crosspeak_? 
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echo old intensity: Intensity ($cp) 
crosspeak intensity $cp integrate-current (Spectrum ($cp)) 
echo new intensity: Intensity ($cp) 
variable cp 
end-macro 
Al procedure file: 
procedure cp_set_area (crosspeak cp) 
declare 
real A, iwl, 1w2,1w3, size; 
logical blah; 
begin 
Set (A, 0.22); 
Set (lwl, Linewidth (Spectrum (cp), Fl)); 
if Less (iwl, 0.0001) then Set (iwl, 0.3); end-if; 
Set (1w2, Linewidth (Spectrum (cp), F2)); 
if Less (1w2, 0.0001) then Set (lw2, 0.03); end-if; 
Set (1w3, Linewidth (Spectrum (cp), F3)); 
if Less (1w3, 0.0001) then Set (lw3, 0.03); end-if; 
Set (size, Ln (Abs (Relative-intensity (cp)))); 













Fl) , lwl) 
Fl), lwl), F3, 15N); 
F2), 1w2), 
1w2), Fl, 1H); 
1w3), 
F3), 1w3), F2, 1H); 
Gr_areaO; 
end-procedure 
procedure cp_set_area2 (crosspeak cp) 
declare 
real A, iwl, 1w2,lw3, size; 
logical blah; 
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begin 
Set (A, 0.22); 
Set (lwl, Linewidth (Spectrum (cp), Fl)); 
if Less (lwl, 0.0001) then Set (lwl, 0.3); end-if; 
Set (lw2, Linewidth (Spectrum (cp), F2)); 
if Less (1w2, 0.0001) then Set (lw2, 0.03); end-if; 
Set (lw3, Linewidth (Spectrum (cp), F3)); 
if Less (1w3, 0.0001) then Set (1w3, 0.03); end-if; 
Set (size, Ln (Abs (Relative-intensity (cp)))); 













(cp, Fl), lwl), 
(cp, Fl), lwl), Fl, 15N); 
(cp, F2), 1w2), 
(cp, F2), lw2), F3, 1H); 
(cp, F3), lw3), 
(cp, F3), lw3), F2, lH); 
Gr_area(); 
end-procedure 
procedure get_lw (spectrum sp) 
declare 












Now apply to spectrum linewidths 
Set_linewidth (sp, Fl, lwl); 
Set_linewidth (sp, F2, 1w2); 
Set_linewidth (sp, F3, 1w3); 
end-procedure 
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procedure get-1w2 (spectrum sp) 
declare 












Now apply to spectrum linewidths 
Set_linewidth (sp, Fl, lwl); 
Set_linewidth (sp, F2, 1w2); 





C.3 Scripts and programs available and utilised 
C.3.1 Chemical shift table 
There were a series of four shell scripts available for creating the chemical shift table 





makeShiftSummary was rewritten as the available script was inefficient and had an 
unacceptably long run time. 
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splitSpectra 




* Shell script to split one big ANSIG export xpk file into individual rdb tables 
* Uses FORTRAN executable ansig2rdb as well as rdb Perl operations 
* sorttbl, row, headchg, column 
* ***************************************************************************** 
* 
set XPK_FILE = . . /ANSIG/MBD+DNA.crp 
set XPK_TABLE = MBD+DNA.rdb 
if ( ! -d "spectra" ) then 
mkdir spectra 
endif 
# ANSIG export xpk file into rdb 
ansigBinary2rdb $XPK_FILE > $XPK_TABLE 
* make list of spectra 
sorttbl -u spectrum < $XPK_TABLE I column spectrum I \ 
row spectrum ne null > spectra.rdb 
* Split into separate files. ! per spectrum 
* S is the rdb designation for spectrum 
foreach S ('headchg -del < spectra.rdb') 
row spectrum eq $S < $XPK_TABLE I\ 
sorttbl residi atnainel resid2 atnaxne2 resid3 atnaine3 > spectra/$S.rdb 
end 
* this is just a 3D version 
make S hift List 
#!/bin/csh -f 
* makeShiftlist 
* Makes assignment tables of shifts based on the individual spectra 
* which have crosspeaks - they don't need to have assignments 
* The outputs are 
APPENDIX C. PROGRAMS USED IN THE STRUCTURE CALCULATION 213 
U 1) A table which summarizes unassigned atoms: $$_shifts_unassigned.rdb 
A table containing all the shifts entires which is sorted on the basis of re 
* 	atnam priority and shift: $$_shifts_all_sorted.rdb 
A unique table sorted on resid and atnam (sorted on the previous sort) which 
U 	contains only one entry for the chemical shift:$$_shifts_sorted.rdb. 
U The all-sorted table will be used for subsequent operations. 
U 
U 
* Priorities for selecting shift values: 
U Use HCCH_TOCSY = 99 
* Use 1 for rest 
U 
U 
set CNnoesy = 1 
set cbcaconnh99 = 1 
set cnoesy = 1 
set hbhaconnh99 = 1 
set hcch99 = 1 
set hnca99 = 1 
set hsqc221199 = 1 
* CNnoesy 
column -c resnamel resname -c residi resid -c atnamel atname \ 
-c atomTypel atomType -c shifti shift spectrum xpk -a priority N \ 
< spectra/CNnoesy.rdb I compute priority = $CNnoesy \; >! ./MBD_shifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a priority N \ 
< spectra/CNnoesy.rdb I compute priority = $CNnoesy 
headchg -del >> ./MBD...shifts.rdb 
column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a priority N \ 
< spectra/CNnoesy.rdb I compute priority = $CNnoesy \; 
headchg -del >> ./MBD_shifts.rdb 
U hsqc221199 
column -c resnainel resname -c residi resid -c atnamel atname \ 
-c atomTypel atomType -c shifti shift spectrum xpk -a priority N \ 
< spectra/hsqc221199.rdb I compute priority = $hsqc221199 
headchg -del >> ./MBDshifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a priority N \ 
< spectra/hsqc221199.rdb I compute priority = $hsqc221199 \; I \ 
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headchg -del >> ./MBD_shifts.rdb 
# cbcaconnh99 
column -c resnaznel resnaine -c residi resid -c atnainel atnaine \ 
-c atomTypel atomType -c shifti shift spectrum xpk -a priority N \ 
< spectra/cbcaconnh99.rdb I compute priority = $cbcaconnh99 
headchg -del >> ./MBDshifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a priority N \ 
< spectra/cbcaconnh99.rdb I compute priority = $cbcaconnh99 
headchg -del >> ./MBD_shifts.rdb 
column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a priority N \ 
< spectra/cbcaconnh99.rdb I compute priority = $cbcaconnh99 
headchg -del >> ./MBDshifts.rdb 
$ cnoesy 
column resnamel residi atnamel atomTypel shifti spectrum xpk -a priority N \ 
< spectra/cnoesy.rdb I compute priority = $cnoesy 
headchg -del >> ./MBDshifts.rdb 
column resnaine2 resid2 atname2 atomType2 shift2 spectrum xpk -a priority N \ 
< spectra/cnoesy.rdb I compute priority = $cnoesy \; 
headchg -del >> ./MBDshifts.rdb 
column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a priority N \ 
< spectra/cnoesy.rdb I compute priority = $cnoesy 
headchg -del >> ./MBD_shifts.rdb 
It hbhaconnh99 
column resnamel residi atnamel atomTypel shifti spectrum xpk -a priority N \ 
< spectra/hbhaconnh99.rdb I compute priority = $hbhaconnh99 
headchg -del >> ./MBDshifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a priority N \ 
< spectra/hbhaconnh99.rdb I compute priority = $hbhaconnh99 
headchg -del >> ./MBDshifts.rdb 
column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a priority N \ 
< spectra/hbhaconnh99.rdb I compute priority = $hbhaconnh99 
headchg -del >> ./MBDshifts.rdb 
It hcch99 
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column resnamel residi atnamel atomTypel shifti spectrum xpk -a priority N \ 
< spectra/hcch99.rdb I compute priority = $hcch99 
headchg -del >> ./MBD...shifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a priority N \ 
< spectra/hcch99.rdb I compute priority = $hcch99 
headchg -del >> ./MBD_shifts.rdb 
column resnaine3 resid3 atname3 atomType3 shift3 spectrum xpk -a priority N \ 
< spectra/hcch99.rdb I compute priority = $hcch99 
headchg -del >> ./MBD_shifts.rdb 
* hnca99 
column resnamel residi atnamel atomTypel shifti spectrum xpk -a priority N \ 
< spectra/hnca99.rdb I compute priority = $hnca99 
headchg -del >> ./MBD_shifts.rdb 
column resname2 resid2 atnaine2 atomType2 shift2 spectrum xpk -a priority N \ 
< spectra/hnca99.rdb I compute priority = $hnca99 \; 
headchg -del >> ./MBD.shifts.rdb 
column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a priority N \ 
< spectra/hnca99.rdb I compute priority = $hnca99 
headchg -del >> ./MBD...shifts.rdb 
# Save the unassigned shifts 
* Either residues with no assignements or crosspeaks with no 
* assignments 
row resid eq null or atnanie eq null < ./MBD_shifts.rdb \ 
> . /MBD_shifts_unassigned . rdb 
* now sort the table 
* Note the tee means that the uniqtable will be based on the sort 
* used to make the shifts-all table so that the entires in the unique table 
*(# ./MBD_shifts_sorted.rdb) will be the higest priority entry for a given 
* resid and atnam. 
#*** Change translate.rdb to translate_old.rdb to expand out pseudoatoms 
*#*# e.g. HB# to HB1 and HB2 
**#* However it can screw up mean chemical shifts and give huge errors. 
*#** Rob. 
*row resid ne null and atname ne null < ./MBD...shifts.rdb I\ 
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# 	sorttbl resnaine 
# jointbl resnaine=resname translate.rdb I\ 
U 	row atname eq new. atnaine 1\ 
* column resname resid -c old.atname atnaine atomType shift spectrum \ 
U 	 xpk priority I sorttbl resid atname priority shift I \ 
* tee ./MBD_shifts_all_sorted.rdb I\ 
* 	uniqtbl resid atname > ./MBD_shifts_sorted.rdb 
row resid ne null and atnaine ne null < ./MBD_shifts.rdb I\ 
sorttbl resnaine 
column resnaine resid atnaxne atomType shift spectrum \ 
xpk priority I sorttbl resid atnaine priority shift I \ 
tee ./MBD_shifts_all_sorted.rdb I\ 
uniqtbl resid atname > ./MBD_shifts_sorted.rdb 





* This script makes a master table of proton shifts and the 
* shifts of their attached heavy atoms, using the individual 
* _h and _nc tables output from the makeShiftSununary script. 
* 
* Requires the table conriected.rdb which is a list of what 
* H's are attached to what C's and N's. Also requires a 
* pdb file with no coordinates ( MBD_template.pdb which was 
* generated in xplor with the inp_file generate.inp) 
* Also requires the fortran program pdb2rdb. 
* 
* make template shift table with ALL nuclei. 
U 
* *###*##*###**##**#*##*#*###*#***#*#***##**###*#*###*#**#*#*#*#* 
* NOTE we should use the BMRB database values, with large delta's in the 
* template shift table. 
* See /zeus/arcrl/nxnrprogs/assign4d/newshifts.rdb as a first pass 
* at a list of these values. 
* ##**#**###*#**#**###*###**#*######*##*#*#####*##*#*###*****#*#* 
* 
* pdb2rdb takes an input pdb file with no coodinates and converts to rdb 
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* format. The point is to get all the atnames/renames/resids for the protein 
* of interest. Entries with C(CO), 0 and S are removed since they are not used 
* for the NMR constraints. A column shift is added and set to -99.0. A column 
* delta is also added --this can be made large where there are no assignments!!!! 
* The statement "\;resname = ucfirst \( lc \( resname \) \) \;" is a perl 
* operation which takes the first letter of resname and makes it uppercase (ucfir 
* and the rest lower case (lc). 
pdb2rdb < MBD_template.pdb I\ 
row atname ne C and atnaine ninat '"O" and atname ninat 'S"' I 
column resname resid atname -a shift N -a delta N 1\ 
compute shift = -99.0 \; resname = ucfirst \( lc \( resnaine  
> MBD_templateshifts . rdb 
* Now make H shift table starting with the summary table made from 
* the rdb script makeShiftSummary and with the template table 
* The summary table containing experimental shifts and deltas 
* set minimum delta 
sorttbl resname atnaine < MBD_shifts_suinmary.rdb I\ 
column resname resid atname shift delta I\ 
compute if \( delta lt 0.04 \) { delta = 0.04  
row atnaine mat 'H"' > t.rdb 
* Append the template table with shift-99.0 
sorttbl resname atname < MBD_template_shifts.rdb I\ 
column resname resid atname shift delta I\ 
row atname mat "H" I headchg -del >> t.rdb 
* Sort the combined table recursively based on resid and atname 
* and then recursively based on shift. Those with no assignments 
* will be given Shift-99.0 
* Note this table is sorted on the basis of resname which is 
* necessary to the last step where the H's and C's are connected. 
sorttbl resid atnaine -r shift < t.rdb I uniqtbl resid atname I\ 
sorttbl resname > MBDshiftsh.rdb 
* Now make NC shift table 
*Get all thr rows whose atname doesn't have H as the first letter "H" 
* set minimum heavy.delta 
sorttbl resname atname < MBD...shifts...suinmary.rdb I\ 
column resname resid -c atname heavy.atname -c shift heavy.shift -c delta heavy. 
compute if \( heavy.delta lt 0.35 \) { heavy.delta = 0.35 1 \; I\ 
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row heavy.atnaine nmat '"H" > t2.rdb 
#Append heavy atnaxn rows to the t2.rdb file. 
sorttbl resname atname < MBD_template.shifts.rdb I\ 
column resname resid -c atname heavy.atname -c shift heavy.shift -c delta heavy. 
row heavy.atname nmat '"H" I headchg -del >> t2.rdb 
* Sort the combined table recursively based on resid and atnarne 
* and then recursively based on shift. Those with no assignments 
* will be given Shift=-99.0. Note this table is sorted on the basis of 
* resid which is necessary to the last step where the H's and C's are connected. 
sorttbl resid heavy.atname -r heavy.shift < t2.rdb I uniqtbl resid heavy.atnaine 
sorttbl resid > MBD_shifts_nc.rdb 
* Join appropriate Hs to Ns or Cs 
* This is where the file connected.rdb is required which shows what C/N atoms are 
* connected to what H's. Note the connected and MBD_shiftsh have already been 
# sorted based on resname, and MBD_shifts_nc.rdb has already been sorted 
* based on resid. 
column resname -c atname c . atname -c heavy . atnaine c . heavy. atnaine < connected. rdb 
jointbl resnaxne=resname MBD_shifts_h.rdb I row c.atnaxne eq atname I\ 
column resnaine resid c.heavy.atname c.atname shift delta I \ 
sorttbl resid I jointbl resid=resid MBD_shifts.jic.rdb I\ 
row heavy.atnaine eq c.heavy.atnaine I\ 
column resname resid -c c.atnaine atnaine shift heavy.atnaine heavy.shift \ 
delta heavy.delta > MBD_HX_Shifts.rdb 
C.3.2 Referencing 
This is the script used to reference all the spectra used in the course of this project. 
*!/bin/nawk -f 
BEGIN { 
if (ARGC != 3) { 
printf"\nUSAGE: reference info-file procpar > out-file \n\n; 
printf"\nUse an info-file format:"; 
printf"\n path <full path for fid>"; 
printf"\n ndim <number of dimensions>"; 
printf"\n <dim_number> <nucleus> <offset or 0>"; 
printf"\n pH <pH>"; 
printf"\n salt <concentraton in mM > \n"; 
printf"\neg: path /usr3/somebody/NMR_DATA/010199.fid"; 
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printf"\n ndim 	2"; 
printf"\n 1 	1H 0"; 
printf"\n 2 	13C 	20067"; 
printf"\n salt 	200"; 




FILENAME == ARGV[1] { 
if ($1"path") 	{ fid = $2"/fid"; 
} else if ($1"pH") 	{ pH = $2; 
} else if ($1"salt") { salt = $2; 
} else if ($1=="ndim") { ndim = $2; 
} else if (($1"1") && ($2"1H")) { Hoffsetl$3; diml"lH"; 
} else if (($1"2") && ($2=="1H")) { Hoffset2$3; dim2"lH"; 
} else if (($1"2") && ($2"15N")) { Noffset=$3; dim205N"; 
} else if (($1"2") && ($2"130)) { Coffset=$3; dim2$2; 
} else if (($1"3") && ($2"15N")) { Noffset=$3; dim3"15N"; 
} else if (($1"3") && ($2"13C")) { Coffset$3; dim3=$2; 
} 
} 
FILENAME == ARGV[2] { 
if (p1 == "true") { sfrq = $2*1.e+6; 
} else if (p2 == "true") { dfrq = $2*1.e+6; 
} else if (p3 == "true") { dfrq2 = $2*1.e+6; 
} else if (p4 == "true") { temp = $2; 
} else if (p5 == "true") { sw = $2; 
} else if (p6 == "true") { swi = $2; 
} else if (p7 == "true") { sw2 = $2; 
} else if (p8 == "true") { np = $2; 
} else if (p9 == "true") { npl = 2*$2; 
} else if (pb == "true") { np2 = 2*$2; 
} 
if ($1"sfrq") 	 { p1 = "true"; 
} else if ($1"dfrq") { p2 = "true"; 
} else if ($1"dfrq2") { p3 = "true"; 
} else if ($1"temp") { p4 = "true"; 
} else if ($1"sw") 	{ p5 = "true"; 
} else if ($1=="sw1") { p6 = "true"; 
} else if ($1=="sw2") 	{ p7 = "true"; 
} else if ($1"np") { p8 = "true"; 
} else if ($1==40) 	{ p9 = "true"; 
} else if ($1=="ni2") { plO = "true" 
} else { 
p1"false"; p2="false"; p3="false"; p4="false"; p5"false"; 
p6"false"; p7"false"; p8"false"; p9"false"; p10"false"; 




t_coef = -0.0119; pH_coef = -0.002; s_coef = -0.009; 
ganunal5N = 0.1013291180; gammal3C = 0.2514495270; 
wppm = 4.776 + (temp-25)*t_coef + (pH-7.0)*pH_coef + salt/100.*s_coef 
freq_HOppm = Sf rq / (1 + (wppm * 1.e-6)); 
freq_Coppm = freq_HOppm * gainmal3C 
freq_Noppm = freq_Hoppm * gaimnalsN 
#print freq_Hoppm, freq_Coppm, freq_NOppm, Sf rq, dfrq, dfrq2; 
chl_carrier_ppml = -1.e+6 * (freq...Hoppm - (sfrq + Hoffsetl)) / freq_HOppm; 
chLcarrierppm2 = -1.e+6 * (freqHoppm - (sfrq + Hoffset2)) / freq_HOppm; 
ch2carrier_ppm = -1.e+6 * (freq...Coppm - (dfrq + Coffset)) / freq_Coppm; 
ch3carrier_ppm = -1.e+6 * (f reqNoppm - (dfrq2 + Noffset)) / freq_NOppm; 
sfrq = sfrq * 1.e-6; 
dfrq = dfrq * 1.e-6; 
dfrq2 = dfrq2 * 1.e-6; 
freq_Hoppm = freq_Hoppm * 1.e-6; 
freq...Coppm = freq...Coppm * 1.e-6; 
freq.NOppm = freqNoppm * 1.e-6; 
printf("ndim '/.d \n\nfile %s \n\nint\nvarian 2 \n\n', ndim, fid ); 
printf("dim 1 \nnpts %d \nsw '/.f\nsf %f \nrefppm %f \nnuc 1H\n\n", 
up, SW, freq.Hoppm, chLcarrierppml); 
if (dim2 == "lH") { 
printf("dim 2 \nnpts %d \nsw %f\nsf %f \nrefppm Y,f \nnuc 1H\n\n", 
npl, swi, freq...Hoppm, chLcarrierppm2); 
} 
else if (dim2 == '15N") { 
printf('dim 2 \nnpts '/.d \nsw %f\nsf %f \nrefppm %f \nnuc 15N\n\n", 
npl, swi, freq_Noppm, ch3...carrierppm); 
} 
else if (dim2 - "13C") { 
printf("dim 2 \nnpts '/.d \nsw '/.f\nsf %f \nrefppm %f \nnuc %s\n\n", 
npl, swi, freqCoppm, ch2carrier...ppm, dim2 ); 
} 
if (dim3 == 15Nt 1 ) { 
printf("dim 3 \nnpts '/.d \nsw %f\nsf %f \nrefppm Y.f \nnuc 15N\n\n", 
np2, sw2, freqNoppm, ch3carrierppm ) 
} 
else if (dim3 - "13C") { 
printf(dim 3 \nnpts %d \nsw %f\nsf %f \nrefppm '/.f \nnuc '/.s\n\n " , 
np2, sw2, freq..COppm, ch2_carrier....ppm, dim3 ); 
} 




D.1 ANSIG dictionary and DNA chemical shifts 
This should be appendixed onto the "dictionary" file as defined in the ANSIG control 
file (.ctr). It will then be possible to assign DNA spectra. 
residue Gua 	 !DNA guanine 
nuclei Cl' /13C , C2 /13C, C2' /13C, C3' /13C, C4' /13C, C5' /13C, C6 /13C, 
C8 /13C, Hi', H21' , H22 1 , H3' , H4' , H51' 
H52' , H8 , HN1 /labile, HN21 /labile, HN22 /labile, Ni /15N, N2 /iSN, 
N3 /15N, NT /15N, N9 /15N, P /31P 
group H5 1 # = H51 1 , H52' /dc 1.0 
group H2 1 # = H21 1 1 H22' /dc 1.0 
group HN2# = HN21, HN22 /dc 1.0 
chemical-shift Hi' = 5.853 /0.265, Ci' = 1.000 /1.000, 
H21' = 2.309 /0.300, H22' = 2.556 /0.221, 
C2' = 1.000 /1.000, 
= 4.849 /0.141, C3' = 1.000 /1.000, 
= 4.228 /0.129, C4' = 1.000 /1.000, 
H51' = 4.057 /0.131, H52' = 4.057 /0.131, 
C5' = 1.000 /1.000, 
Ni = 1.000 /1.000, HNI. = 12.762 /0.178, 
N2 = 1.000 /1.000, 
HN21 = 6.715 /0.007, HN22 = 6.602 /0.224 
N3 = 1.000 /1.000, 
N7 = 1.000 /1.000, 
N9 = 1.000 /1.000, 
C2 = 1.000 /1.000, 
C6 = 1.000 /1.000, 
C8 = 1.000 /1.000,H8 = 7.762 /0.188, 
P = 1.000 /1.000 
coupled 1J H3 1 /C3 1 , HN1/N1, HN2*/N2, H5'#/C5', H2'*/C2', 
222 
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H8/C8, H4'/C4', H1'/Cl' 
coupled 3J Hi'/H2'#, H2'#/H3', H3'/H4', H4'/H5'#, H51 1 /H52 1 , 
H21'/H22 1 , HN21/HN22 
end-residue 
residue Ade 	 !DNA adenine 
nuclei Cl' /13C, C2 /13C, C2' /13C, C3' /13C, C4' /13C, 
C8 /13C, H2 , H21' , H22' Hi' , H3' , H4' , H51' 
H52' , H8 , HN61 /labile, HN62 /labile, Ni /15N, 
N7 /15N, N9 /15N, P /31P 
group H5'* = H51 1 , H52' /dc 1.0 
group H2'# = H21 1 , H22' /dc 1.0 
group HN6* = HN61, HN62 /dc 1.0 
chemical-shift Hi' = 5.853 /0.265, Cl' = 1.000 /1.000, 
= 2.309 /0.300, 
= 2.556 /0.221,C2' = 1.000 /1.000, 
= 4.849 /0.141, C3' = 1.000 /1.000, 
= 4.228 /0.129, C4' = 1.000 /1.000 
H51' = 4.057 /0.131, H52' = 4.057 /0.131, 
C5' = 1.000 /1.000,N6 = 1.000 /1.000, 
HN61 = 7.213 /0.482, HN62 = 6.45 /0.325, 
statistical chemical shifts 
Ni = 1.000 /1.000, 
N3 = 1.000 /1.000, 
N7 = 1.000 /1.000, 
N9 = 1.000 /1.000, 
C2 = 1.000 /1.000, H2 = 7.462 /0.258, 
C6 = 1.000 /1.000, 
C8 = 1.000 /1.000, H8 = 8.076 /0.183 
p = 1.000 /1.000 
coupled 1J H3'/C3' ,H5'#/C5', HN6#/N6, H22'/C2 1 , 
H2/C2, H8/C8, H4 1 /C4 1 , H1 1 /C1 1  
Cs' /13C, C6 /13C, 
N3 115N, N6 115N, 
!limited resources for 
coupled 3.1 Hi'/H2'#, H2'#/H3', H3'/H4', H4'/HS'*, H51'/H52 1 , 
H21'/H22', HN61/HN62 
end-residue 
residue Cyt 	 !DNA cytosine 
nuclei Cl' /13C, C2 /13C, C2' /13C, C3' /13C, C4 /13C, C4' /13C, C5 /13C, 
CS' /13C, C6 /13C, H21' , H22' Hi' , H3' , H4' , HS 
H51' , H52' , H6 , HN41 /labile, HN42 /labile, Ni /15N, N3 /15N, 
N4 /iSN, P /31P 
group H5'# = H51 1 , H52' /dc 1.0 
group H2'# = H21 1 , H22' /dc 1.0 
group HN4# = HN41, HN42 /dc 1.0 
chemical-shift Hi' = 5.853 /0.265, Cl' = 1.000 /1.000 
H21' = 2.309 /0.300, H22' = 2.556 /0.221, 
C2' = 1.000 /1.000, 
C3' = 1.000 /1.000, H3' = 4.849 /0.141, 
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= 1.000 /1.000, H4' = 4.228 /0.129, 
= 1.000 /1.000, 
H51' = 4.057 /0.131, H52' = 4.057 /0.131, 
Ni = 1.000 /1.000, 
N3 = 1.000 /1.000, 
N4 = 1.000 /1.000, 
HN41 = 8.231 /0.275, HN42 = 6.667 /0.421, 
C2 = 1.000 /1.000, 
C4 = 1.000 /1.000, 
C5 = 1.000 /1.000, H5 = 5.497 /0.285, 
C6 = 1.000 /1.000, H6 = 7.447 /0.175, 
P = 1.000 /1.000 
coupled 1J H3 1 /0 1 , H5'#/C5', HN4#/N4, H2'#/C2', H5/C5, 
H6/C6, H4'/C4', H1'/C1' 
coupled 3J H1'/H2'*, H2'#/H3', H3 1 /H4', H4'/H5'*, H51'/H52', 
H21'/H22', HN41/HN42, H5/H6 
end-residue 
residue Thy 	 ! DNA thymine 
nuclei Cl' /13C, C2 /13C, C2' /13C, C3' /13C, C4 /13C, C4' /13C, CS /13C, 
C5' /13C, C6 /13C, C7 /13C, H21' , H22' Hi' , H3' , H4' 
H51' , H52' , H6 , H7# /3, HN3 /labile, Ni /15N, N3 /15N, 
P /31P 
group H5'# = H51 1 , H52' /dc 1.0 
group H2'# = H21 1 , H22' /dc 1.0 
chemical-shift Hi' = 5.853 /0.265, Cl' = 1.000 /1.000, 
H21' = 2.309 /0.300, H22' = 2.556 /0.221, 
= 1.000 /1.000, 
= 1.000 /1.000, H3' = 4.849 /0.141, 
= 1.000 /1.000, H4' = 4.228 /0.129, 
= 1.000 /1.000, 
H51' = 4.057 /0.131, H52' = 4.057 /0.131, 
Ni = 1.000 /1.000, 
N3 = 1.000 /1.000,HN3 = 13.701 /0.234, 
C2 = 1.000 /1.000, 
C4 = 1.000 /1.000, 
C5 = 1.000 /1.000, 
C6 = 1.000 /1.000, H6 = 7.300 /0.223, 
C7 = 1.000 /1.000, H7# = 1.393 /0.185, 
P = 1.000 /1.000 
coupled 1J H3 1 /C3 1 , H5'#/C5', HN3/N3, H2'#/C2', H6/C6, 
H4'/C4', H7#/C7, Hi'/C1' 
coupled 3J H1'/H2'#, H2'#/H3', H3'/H4', H4'/H5'*, H51'/H52', 
H21'/H22' 
end-residue 
residue m5C 	 !DNA(methylated) 5-methyl-cytosine 
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nuclei Cl' /13C, C2 /13C, C2' /13C, C3' /13C, C4 /13C, C4' /13C, C5 /13C, 
CS' /13C, C6 /13C, C7 /13C, H7# /3, Hi' , H21' , H22', H3' , H4' 
H51' 	, H52' 	, H6 , HN41 /labile, HN42 /labile, Ni /15N, N3 /15N, 
N4 115N, P /31P 
group H5'# = H51 1 , H52' /dc 1.0 
group H2 1 * = H21 1 , H22' /dc 1.0 
group HN4* = HN41, HN42 /dc 1.0 
chemical-shift Hi' = 5.853 /0.265, Cl' = 1.000 /1.000, 
H21' 	= 2.309 /0.300, H22' = 2.556 /0.221, 
= 1.000 /1.000, 
= 1.000 /1.000, H3' 	= 4.849 /0.141, 
= 1.000 /1.000, H4' 	= 4.228 /0.129, 
= 1.000 /1.000, 
H51' 	= 4.057 /0.131, H52' = 4.057 /0.131, 
Ni = 1.000 /1.000, 
N3 = 1.000 /1.000, 
N4 = 1.000 /1.000, 
HN41 = 8.231 /0.275, HN42 = 6.667 /0.421, 
C2 = 1.000 /1.000, 
C4 = 1.000 /1.000, 
C5 = 1.000 /1.000, 
C6 = 1.000 /1.000, H6 = 7.447 /0.175, 
C7 = 1.000 /1.000, H7# = 1.393 /0.185, 
P = 1.000 /1.000 
coupled 1J H3'/C3', H5'#/C5', HN4*/N4, H2'#/C2', H7#/C7, 
H6/C6, H4'/C4', H1'/Ci' 
coupled 3J H1'/H2'*, H2'*/H3', H3'/H4', H4'/H5'#, 	H51'/H52 1 , 
H21'/H22 1 , HN41/HN42 
end-residue 
residue GDP ! unlabelled 
nuclei HN1/labile, HN21/labile, HN22/labile, H8, 
Hi', 	H21 1 , 	H3', 	H4', 	H51 1 , 	H52' 
group HN2# = HN21, HN22 /dc 1.0 
group H5# = H51 1 2 H52' /dc 1.0 
chemical-shift HN1 = 12.0 /5.0, HN2# = 7.5 /3.0, H8 = 7.8 	/ 	1.0, 
Hi' 	= 5.8 /0.8, 	H21' 	= 4.5 /1.5, 	H3' 	= 4.5 	/1.5, 
H4' 	= 4.5 /1.5, H5# = 4.5 /1.5 
coupled 33 HN21/HN22, H1 1 /H21 1 , H21 1 /H3 1 , H3'/H4', H4'/H5# 
end-residue 
end-dictionary 
!residue RU 	 !RNA uracil 
nuclei H22' Hi' , C3' /13C, H3' , Ni 115N, N3 /15N, 
C5' /13C, H51' , C2' /13C, C2 /13C, C4 /13C, CS /13C, P /31P, 
H21' , C6 /13C, H52' , HN3 /labile, H5 , H6 , C4' /13C, 
H4' , Cl' /13C 





chemical-shift H22' = 	/ Hi' = 	I, 	C3' = I, H3' 	= 	I, Ni = 	I, 	N3 = I, 
Cs' 	= I, N5 = I, N6 = I, H51' 	= 	I, C2' 	= 	I, 	C2 = I, C4 = 
I, 
C5 = I, P = I, H21' 	= I, C6 = 	I, H52' = 	I, HN3 = I, H5 = 
I , 
H6= /,C4'= /,H4'= /,Ci'= / 
coupled iJ H3 1 /C3' H21 1 /02 1 , H5 1 /C5 1 , H3/N3, H22 1 /C2 1 , H5/C5, 
H6/C6, H4 1 /C4 1 , H1'/C1' 
coupled 3J 
!end-residue 
D.2 ANSIG al procedures 
D.2.1 nucHNHA 
For quick 3D HNHA assignment. Adjust accordingly! 




if Less (Dimensionality (cp),3) then 
Error ('Not 3D spectrum! F1N, F2=Ca if peak is +ve or Cb if -ye, F3=HN." 
else 
Echo (" This will set dl as N, d2 as Ha/HN and d3 as 
Echo (" Press q to quit macro"); 
if Less (Intensity (cp), 0.0) then Set (crb, "HN");end_if; 








For quick 15 N HSQC assignment. 
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Set (blank, " 
Echo (" Press q to quit macro"); 
if Equal (Nucleus (cp, Fl), blank) then 
Set-nucleus (cp, "N" , Fl); 
end-if; 
if Equal (Nucleus (cp, F2), blank) then 
Set-nucleus (cp, "RN", F2); 
end-if; 
if Equal (Dimensionality (cp),3) then 
if Equal (Nucleus (cp, F3), blank) then 





A very useful macro! This is a modified version that will assign the residue of all 
unassigned dimensions the same as the assigned dimensions. The priority goes Fl, F3 
then F2. 
procedure iii (crosspeak cp) 
declare 
string blank, seq; 
dimension list fdl; 
begin 
Set (blank, " 
Set (seq, blank); 
if Unequal (Dimensionality (cp),3) then 
Echo ("I hope you realise that the macro iii is meant for 3D expts"); 
Echo ("That's why its called iii cos' there's 3 dimensions and not ii"); 
Echo ("Luckily for you spacker, i'm smart and can cope."); 
end-if; 
Set (fdl, dimension-list (Dimensionality (cp))); 
First (fdl); 
Set (seq. Sequence (cp, Current (f dl))); 
if Equal (seq, blank) then 
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Last (f dl) ; 
Set (seq, Sequence (cp, Current (f dl))); 
end-if; 
if Equal (Dimensionality (cp),3) then 
if Equal (seq, blank) then 
Previous(f dl); 
Set (seq, Sequence (cp, Current (f dl))); 
end-if; 
end-if; 
if Equal (seq, blank) then 




while Defined (fdl) do 
if Equal (Sequence (cp, Current (f dl)), blank) then 






Another modified version of a useful macro. It will assign the residue of Fl and F3 to 
i and F2 to i-i, similiar to iii. It prioritizes F3, F2 and Fl for defining assignment to 
be copied through the unassigned dimensions. 
set sequence i in Fl and F3 dimensions, i-i in F2. 
believe F2 assignment 
procedure iimli (crosspeak cp) 
declare 
string blank, seq, next_seq; 
dimension list f dl; 




Set (blank, " 
Set (seq, blank); 
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if Unequal (Dimensionality (cp),3) then 
Echo ("Not a 3D expt"); 
return; 
end-if; 
Set (fdl, dimension-list (Dimensionality (cp))); 
Last (fdl); 	 ! This selects the F3 dimension as first priority 
while And (Defined (fdl), Equal (seq, blank)) do 
Set (seq, Sequence (cp, Current (fdl))); 
Set (pos, Position(fdl)); 
Previous (fdl); 	! Cycles through dimensions of spectrum 
end-while; 
if Equal (seq, blank) then 





while Defined (fdl) do 
if Equal (Sequence (cp, Current (f dl)), blank) then 
Convert (resid, seq, fail); 




if Equal (pos,2) then 
Set (next_resid, Next (resid)); 
else-if Equal(Position(fdl), 2) then 
Set (next_resid, Previous (resid)); 
else 
Set (next_resid, resid); 
end-if; 
end-if; 









This is an alternative macro for removing duplicate peaks. It was found that "del_duplictes" 
which appears to be a standard ANSIG macro is not so good, especially when one of 
the duplicates is unaliased and the other is not. At the moment it is set to display on 
' 5 N HSQC projections or spectra. It can handle two or three dimensional spectra, and 
considers the F2 and F3 (proton) dimensions of a 3D spectrum with the assumption 
that Fl is the heteronuclear dimension which can be frequently aliased. Savvy? Adjust 
accordingly. 
It'll give you a list of duplicates for each peak (one at a time) and ask if you want to 
delete them. So don't get carried away with clicking that mouse button! 
!uses yes-or-no from h1{lib}yes_or_no . a lH 
procedure annoying_aliased_duplicates (spectrum sp) 
declare 
crosspeak cp, bongo; 
crosspeak list cpl, cplist, dblist; 
logical abort, yes; 
real list coo; 




Set (cpl, Gr_loaded (sp)); 
First (cpl); 









Set (cplist, Crosspeaks (sp)); 
First (cplist); 
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while Defined (cplist) do 
Set (cp, Current (cplist)); 




Set (coo2,Convert(Coordinate(cp,F2) ,3,yes)); 
Set (coo3,Convert(Coordinate(cp,F3),3,yes)); 
end-if; 
if And ( Equal (coo2,r3), Equal (coo3,r4)) then 
Echo (Convert(cp)); 
Set (st,ConcatC' ,Concat(Sequence(cp,F1),Nucleus(cp,F1)))); 




Set (st,Concat( M ,Concat(Sequence(cp,F2) ,Nucleus(cp,F2)))); 
if Equal (st,' ") then 







if Equal(Dimensionality(sp) ,3) then 
Set (st,Concat(" ",Concat(Sequence(cp,F3),Nucleus(cp,F3)))); 





if Greater_equal(i,3) then 
Into (dblist,cp); 
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Remove (dblist ,bongo); 
First (dblist); 
while Defined(dblist) do 
Set (cp, Current (dblist)); 
yes-or-no (yes, Concat (Concat ("delete ",Convert (cp)) , "?") , abort); 












Chemical Shift Lists 
These tables of chemical shift values for spin- i nuclei as observed in the recombi-
nant protein, methyl-CpG binding domain of MeCP2, are the result of the resonance 
assignment (chapter 3) carried out in the course of this PhD project. 
E.1 MBD alone 
The entire chemical shift list for MBD alone has been deposited in the BioMagResBank 
or BMRB for short. The web site can be found at 
http://www.bmrb.wisc.edu/pages/  
The accession number is 4280 
E.1.1 Proton shifts 
Ala 1 HN HA HB# 
8.369 4.262 1.328 
Ser 2 HN HA HB# 
8.261 4.342 3.784 
Ala 3 HN HA HB# 
8.279 4.302 1.316 
Ser 4 HN HA HB# 
8.291 4.713 3.848 
Pro 5 HN HA HB1 H132 HD1 HD2 HG# 
8.291 4.342 2.275 1.880 3.810 3.706 2.007 
Lys 6 HN HA HB1 HB2 HD# HE# HG1 	H G 2 
8.334 4.182 1.790 1.732 1.664 2.994 1.443 	1.415 
Gin 7 HN HA HB1 HB2 HG# HE21 HE22 
8.275 4.222 1.978 1.969 2.343 7.523 6.867 
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Arg 8 HN HA HB# HD# HG1 HE 
8.408 4.238 1.756 3.177 1.575 
Arg 9 HN HA HB# HD# HG# HE 
8.423 4.302 1.777 3.185 1.622 
Ser 10 HN HA HB# 
8.382 4.382 3.784 
Ile 11 HN HA HB HD1# HG11 HG12 HG2# 
8.175 4.143 1.794 0.830 1.429 1.147 0.825 
Ile 12 HN HA HB HD1# HG11 HG12 HG2# 
8.210 4.063 1.754 0.814 1.458 1.156 0.857 
Arg 13 HN HA HB1 HB2 HD# HG# HE 
8.387 4.302 1.810 1.739 3.098 1.578 
Asp 14 HN HA HB1 HB2 
8.331 4.541 2.628 2.549 
Arg 15 HN HA HB1 HB2 HD# HG# HE 
8.327 4.307 1.906 1.707 3.167 1.657 
Gly 16 HN HAl HA2 
8.341 4.076 3.923 
Pro 17 HN HA H131 HB2 HD# HG1 HG2 
8.341 3.620 3.452 1.590 1.417 
Met 18 HN HA HB1 HG1 HG2 HE# 
8.316 4.336 2.078 1.808 
Tyr 19 HN HA HB1 HB2 HD# HE# 
7.962 4.147 3.086 2.690 7.154 6.675 
Asp 20 HN HA HB1 HB2 
7.596 4.868 2.624 2.448 
Asp 21 HN HA HB1 HB2 
8.765 5.250 2.950 2.150 
Pro 22 HN HA HB1 HB2 HD1 HD2 HG1 	HG2 
8.765 	4.564 	2.320 	2.011 	4.011 	3.671 	2.027 1.900 
Thr 	23 	HN HA HB HG2# 
8.354 	4.238 	4.211 	1.112 
Leu 	24 	HN HA HB1 HB2 	HG 	HD1# 	HD2# 
6.900 	4.056 	1.623 	1.361 1.615 1.039 0.826 
Pro 	25 	HN HA HB1 HB2 	HD1 	HD2 	HG# 
6.900 	4.297 	1.944 	1.757 2.447 3.143 2.444 
Glu 	26 	HN HA HB1 HB2 	HG# 
8.362 	4.060 	2.060 	1.950 2.294 
Gly 	27 	HN HAl HA2 
8.904 	4.322 	3.671 
Trp 	28 	HN HA HB1 	HB2 	HD1 	HE3 	HH2 	HZ2 	HZ3 	HE1 
8.457 	5.156 	3.470 3.183 7.237 7.383 6.639 7.766 	6.680 	10.715 
Thr 	29 	HN HA HB 	HG21 	HG22 	HG23 
9.166 	4.672 	4.060 1.125 1.125 1.125 
Arg 	30 	HN HA HB1 	HB2 	HD# 	HG# 	HE 
8.375 	5.425 	1.859 1.671 3.097 1.490 7.160 
Lys 	31 	HN HA HB1 	HB2 	HD1 	HD2 	HE# 	HG# 
9.450 	4.827 	1.709 1.559 2.828 1.335 
Leu 	32 	HN HA HB1 	HB2 	HG 	HD1# 	HD2# 
9.056 	5.317 	1.623 1.448 1.521 0.514 0.452 
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Lys 33 HN HA HB1 HB2 HD# HE# HG# 
8.984 4.802 1.950 1.748 1.551 2.725 1.360 
Gin 34 HN HA HB1 HB2 HG1 HG2 HE21 	HE22 
9.209 4.191 1.827 1.624 1.880 1.559 7.218 6.837 
Arg 35 HN HA HB1 HB2 HD# HG# HE 
8.795 4.262 1.825 1.750 3.176 1.625 7.961 
Lys 36 HN HA HB1 HB2 HD# HE# HG# 
8.869 4.330 1.861 1.716 1.647 2.953 1.394 
Ser 37 HN HA HB1 H132 
7.918 4.587 3.820 3.769 
Gly 38 HN HAl HA2 
8.606 4.136 3.877 
Arg 39 HN HA HB1 H132 HD# HG# HE 
8.775 4.167 1.884 1.836 3.176 1.610 
Ser 40 HN HA HB# 
8.458 4.470 3.855 
Ala 41 HN HA HB# 
7.572 3.780 1.230 
Gly 42 HN HAl HA2 
8.515 4.133 3.614 
Lys 43 HN HA HB# HD# HE# HG# 
7.954 4.372 1.762 1.630 2.957 1.347 
Tyr 44 HN HA HB1 HB2 HD# HE# 
8.619 4.931 2.717 2.596 6.896 6.765 
Asp 45 HN HA HB1 HB2 
8.944 4.962 2.611 2.455 
Val 46 HN HA HB HG1# HG2# 
8.320 4.325 2.070 0.734 0.734 
Tyr 47 HN HA HB1 HB2 HD# HE# 
8.961 5.230 3.008 2.596 6.946 6.706 
Leu 48 HN HA HB1 HB2 HG HD1# HD2# 
9.071 5.383 1.880 1.565 1.350 0.705 0.267 
Ile 49 HN HA HB HD1# HG11 HG12 HG2# 
9.550 5.015 1.852 0.675 1.308 0.989 0.746 
Asn 50 HN HA H131 H132 HD21 HD22 
8.427 3.130 2.158 1.558 6.880 6.675 
Pro 51 HN HA HB1 HB2 HD# HG# 
8.427 4.143 2.360 1.687 3.130 2.107 
Gin 52 	HN HA HB1 HB2 H  H  HE21 HE22 
6.889 4.252 2.220 1.970 2.453 2.247 7.575 6.904 
Gly 53 	HN HAl HA2 
8.098 4.033 3.317 
Lys 54 	HN HA HB1 HB2 HD1 HD2 HE1 HE2 	HG1 	HG2 
7.701 3.901 1.186 1.186 1.373 1.223 2.870 2.640 	0.975 	0.629 
Ala 	55 	HN HA HB# 
7.904 5.077 1.144 
Phe 	56 	HN HA HB# HD# HE# HZ 
9.599 4.890 3.082 7.156 6.725 5.768 
Arg 	57 	HN HA HB1 HB2 HD1 HD2 	HG# 	HE 
9.340 4.824 1.770 1.720 3.026 2.967 1.406 7.260 
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Ser 58 HN HA HB1 HB2 
7.244 3.462 3.838 3.640 
Lys 59 HN HA HB# HD# HE1 HE2 HG# 
8.460 3.670 1.715 1.725 3.047 2.900 1.406 
Val 60 HN HA HB HG1# HG2# 
7.602 3.612 1.918 0.975 0.925 
Glu 61 HN HA HB# HG# 
7.372 4.135 2.360 2.340 
Leu 62 HN HA HB# HG HD1# HD2# 
7.482 3.359 1.333 0.814 -0.054 -0.101 
Ile 63 HN HA HB HD1# HG11 HG12 HG2# 
8.371 3.472 1.737 0.855 1.725 1.076 0.920 
Ala 64 HN HA HB# 
7.511 4.178 1.510 
Tyr 65 HN HA HB1 HB2 HD# HE# 
7.740 4.387 3.350 2.886 7.050 6.922 
Phe 66 HN HA HB1 HB2 HD# HE# HZ 
8.748 4.417 3.623 3.199 7.184 7.028 6.718 
Giu 67 FIN HA H131 HB2 HG1 HG2 
8.275 4.066 2.160 2.060 2.437 2.198 
Lys 68 HN HA HB1 HB2 HD# HE# HG1 	HG2 
7.806 4.023 2.025 2.025 1.728 3.001 1.494 1.398 
Val 69 HN HA HB HG1# HG2# 
7.970 4.247 2.264 0.710 0.770 
Giy 70 HN HAl HA2 
7.753 3.939 3.809 
Asp 71 HN HA HB1 H132 
8.070 4.740 2.606 2.390 
Thr 72 HN HA HB HG2# 
8.420 4.460 4.497 1.064 
Ser 73 HN HA HB# 
8.624 4.220 3.834 
Leu 74 HN HA HB1 HB2 HG HD1# HD2# 
7.626 4.354 1.095 0.926 1.571 0.938 0.768 
Asp 75 HN HA HB1 HB2 
8.829 4.922 3.030 2.399 
Pro 76 HN HA HB1 HB2 HD# HG1 HG2 
8.829 4.322 2.120 1.940 4.120 2.187 2.026 
Asn 77 HN HA HB# HD21 HD22 
8.797 4.479 2.731 8.146 7.021 
Asp 78 HN HA HB# 
8.312 4.469 2.496 
Phe 79 HN HA HB1 H132 HD# HE# HZ 
7.075 3.897 2.813 2.089 6.859 5.959 6.341 
Asp 80 HN HA HB1 HB2 
8.933 4.542 2.811 2.408 
Phe 81 HN HA HB1 HB2 HD# HE# HZ 
9.084 4.358 3.496 2.712 7.139 7.023 6.665 
Thr 82 HN HA HB HG2# 
8.991 4.477 4.266 1.299 
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Val 83 HN HA HB HG1# HG2# 
9.044 3.352 2.068 1.111 0.714 
Thr 84 HN HA HB HG2# 
7.920 4.172 4.297 0.980 
Gly 85 HN HAl HA2 
7.391 4.363 3.872 
Arg 86 HN HA HB# HD# HG# 	HE 
9.322 4.104 1.719 3.093 1.594 7.205 
Gly 87 HN HA# 
8.634 3.982 
Ser 88 HN HA HB# 
8.290 4.350 3.833 
Gly 89 HN HA# 
8.467 3.905 
Ser 90 HN HA HB# 
8.205 4.423 3.837 
Gly 91 HN HA# 
8.532 3.949 
Cys 92 HN HA HB1 HB2 
7.860 
E.1.2 Carbon-13 and nitrogen-15 shifts 
Ala 1 CA CB N 
52.807 19.422 125.59 
Ser 2 CA CB N 
58.347 63.981 114.94 
Ala 3 CA CB N 
52.414 19.681 125.75 
Ser 4 CA CB N 
56.592 116.63 
Pro 5 CA CB CD CG 
63.692 32.282 50.882 27.620 
Lys 6 CA CB CD CE CG N 
56.811 33.074 29.430 42.337 25.141 120.75 
Gin 7 CA CB CG N NE2 
56.033 29.757 34.023 121.01 112.41 
Arg8 CA CB CD CG N NE 
56.445 30.970 43.501 27.162 122.83 
Arg9 CA CB CD CG N NE 
56.345 31.143 43.506 27.164 122.36 
Ser 10 CA CB N 
58.429 63.937 117.86 
Ile 11 CA CB CD1 CG1 CG2 N 
61.335 38.912 13.298 27.543 17.768 122.58 
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Ile 12 CA GB CD1 CG1 CG2 N 
61.217 38.510 12.854 27.595 17.763 125.26 
Arg 13 GA GB CD CG N NE 
56.154 31.217 43.488 27.161 125.63 
Asp 14 GA GB N 
54.474 41.309 121.54 
Arg 15 GA GB CD CG N NE 
56.290 31.173 43.568 27.356 121.24 
Gly 16 GA N 
44.510 109.59 
Pro 17 GA GB CD CG 
62.871 32.000 49.740 27.183 
Met 18 GA GB GE CG N 
55.348 32.714 17.011 122.54 
Tyr 19 GA GB GD1 GD2 GEl GE2 N 
61.244 39.111 133.032 133.032 117.771 117.771 119.938 
Asp 20 GA GB N 
52.863 44.169 115.81 
Asp 21 GA GB N 
50.335 42.553 118.85 
Pro 22 GA GB CD CG 
63.700 32.561 51.345 26.797 
Thr 23 GA GB GG2 N 
62.351 69.190 21.880 110.25 
Leu 24 GA GB GD1 CD2 CG N 
53.586 42.101 26.667 24.891 27.527 123.98 
Pro 25 GA GB CD CG 
62.364 31.416 50.014 27.774 
Glu 26 GA GB CG N 
58.518 29.900 36.098 120.50 
Gly 27 GA N 
45.679 114.21 
Trp 28 GA GB GD1 GE3 CH2 GZ2 GZ3 	N 	NE1 
57.648 30.161 127.264 120.200 124.486 114.635 122.092 	112.85 	130.97 
Thr 29 GA GB GG2 N 
61.080 72.998 22.538 112.85 
Arg 30 GA GB CD CG N NE 
54.844 34.019 44.096 27.500 120.22 
Lys 31 GA GB CD GE CG N 
54.864 36.365 42.172 25.170 124.82 
Leu 32 GA GB GD1 GD2 CG N 
54.174 43.725 25.799 25.900 29.525 126.01 
Lys 33 GA GB CD GE CG N 
55.068 36.084 29.540 42.058 25.182 122.37 
Gin 34 GA GB CG N NE2 
56.058 30.062 34.223 127.20 111.53 
Arg 35 GA GB CD CG N NE 
56.529 30.906 43.319 27.510 126.81 84.84 
Lys 36 GA GB CD GE CG N 
56.500 34.107 29.093 42.226 24.235 123.88 
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Ser 37 CA CB N 
57.454 65.041 113.78 
Gly 38 CA N 
45.356 109.51 
Arg 39 CA CB CD CG N NE 
57.724 30.056 43.160 27.172 120.82 
Ser 40 CA CB N 
57.691 63.240 114.54 
Ala 41 CA CB N 
53.584 18.596 123.11 
Gly 42 CA N 
45.153 109.76 
Lys 43 CA CB CD CE CG N 
56.083 33.898 29.738 42.783 25.274 120.69 
Tyr 44 CA CB CD1 CD2 CE1 CE2 N 
58.262 41.559 133.074 133.074 117.913 117.913 118.73 
Asp 45 CA CB N 
53.921 44.294 120.46 
Val 46 CA CB CG1 CG2 N 
62.575 33.604 21.613 21.613 121.76 
Tyr 47 CA CB CD1 CD2 CE1 CE2 N 
56.076 40.732 132.746 132.746 117.937 117.937 124.01 
Leu 48 CA CB CD1 CD2 CG N 
53.593 43.290 23.625 26.034 28.252 121.90 
Ile 49 CA CB CD1 CG1 CG2 N 
59.389 38.673 13.300 27.935 17.650 123.96 
Asn 50 CA CB N ND2 
51.119 36.638 126.69 108.81 
Pro 51 CA CB CD CG 
65.308 31.443 50.293 27.800 
Gin 52 CA CB CG N NE2 
56.354 28.709 35.068 112.42 112.35 
Gly 53 CA N 
45.439 108.28 
Lys 54 CA CB CD CE CG N 
55.716 32.432 28.714 42.294 24.862 123.29 
Ala 55 CA CB N 
50.402 22.421 125.30 
Phe 56 CA CB CD1 CD2 CE1 CE2 CZ 	N 
57.442 43.951 131.957 131.957 130.350 130.350 128.739 	119.84 
Arg 57 CA CB CD CG N NE 
55.320 32.286 43.280 27.143 119.80 84.22 
Ser 58 CA CB N 
56.165 66.241 111.50 
Lys 59 CA CB CD CE CG N 
59.589 32.249 29.803 42.143 25.442 122.01 
Val 60 CA CB CG1 CG2 N 
66.458 32.010 22.085 21.321 116.76 
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Glu 61 CA GB CG N 
59.217 31.193 37.031 119.73 
Leu 62 GA GB CD1 CD2 CG N 
57.876 42.663 25.250 24.570 25.633 121.50 
Ile 63 GA CB CD1 CG1 CG2 N 
65.820 38.819 14.419 30.415 17.217 118.22 
Ala 64 GA GB N 
54.963 18.322 119.79 
Tyr 65 GA GB GD1 GD2 GEl GE2 N 
61.538 39.387 133.569 133.569 118.001 118.001 120.35 
Phe 66 GA GB GD1 GD2 GEl GE2 GZ 	N 
58.270 36.667 130.073 130.073 130.184 130.184 129.299 	118.52 
Glu 67 GA GB CG N 
59.200 29.799 36.824 118.09 
Lys 68 GA GB CD GE CG N 
59.335 32.603 29.294 42.381 25.000 121.03 
Val 69 GA GB GG1 GG2 N 
61.918 31.985 21.270 19.334 110.12 
Gly 70 GA N 
46.771 111.82 
Asp 71 GA GB N 
53.862 42.121 119.98 
Thr 72 GA GB GG2 N 
60.801 68.911 21.423 116.43 
Ser 73 GA GB N 
60.474 64.333 118.90 
Leu 74 GA GB GD1 GD2 CG N 
53.756 44.285 26.752 23.253 26.800 123.17 
Asp 75 GA GB N 
50.318 42.380 122.81 
Pro 76 GA GB CD CG 
64.993 33.057 51.237 27.951 
Asn 77 GA GB N ND2 
55.421 38.291 114.56 115.63 
Asp 78 GA GB N 
55.263 40.554 118.88 
Phe 79 GA GB GD1 CD2 GEl CE2 GZ 	N 
57.755 39.430 131.610 131.610 129.831 129.831 84.996 119.10 
Asp 80 GA GB N 
53.430 41.535 124.45 
Phe 81 GA GB GD1 GD2 GEl GE2 CZ 	N 
59.048 39.837 132.084 132.084 130.316 130.316 128.181 	125.25 
Thr 82 GA GB GG2 N 
62.344 70.429 22.434 113.19 
Val 83 GA GB GG1 CG2 N 
67.010 32.643 21.611 21.473 123.33 
Thr 84 GA GB GG2 N 
62.260 69.994 21.904 105.66 
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Gly 85 CA N 
44.598 111.184 
Arg 86 CA CB CD 	CC 	N 	NE 
57.383 30.900 43.700 	27.201 	123.75 
Cly 87 CA N 
45.429 109.80 
Ser 88 CA CB N 
58.785 64.082 115.69 
Gly 89 CA N 
45.436 110.68 
Ser 90 CA CB N 
58.576 64.088 115.40 
Gly 91 CA N 
45.649 111.18 
Cys 92 CA CB N 
11 59.594 29.255 122.52 
E.2 MBD-DNA complex 
E.2.1 Proton shifts 
Ala 1 HA HB# HN 
4.324 1.399 8.396 
Ser 2 HA HB# HN 
4.422 3.863 8.253 
Ala 3 HA HB# HN 
4.382 1.391 8.273 
Ser 4 HA HB# HN 
4.713 3.842 8.244 
Pro 5 HA HB1 HB2 HD1 HD2 HG# 
4.397 2.289 1.896 3.805 3.723 1.999 
Lys 6 HA HB# HD# HE# HG# HN 
4.225 1.755 1.681 3.000 1.439 8.348 
Gin 7 HA HB# HB1 H132 HG# HN HE21 	HE22 
4.303 2.001 2.062 1.986 2.346 8.301 6.883 	7.537 
Arg 8 HA HB# HD# HG# HN HE 
4.311 1.805 3.192 1.645 8.439 
Arg 9 HA HB# HD# HG# HN HE 
4.370 1.817 3.205 1.665 8.469 
Ser 10 HA HB# HN 
4.467 3.859 8.431 
Ile 11 HA HB HD1# HG11 HG12 HG2# HN 
4.207 1.898 0.869 1.475 1.188 0.910 8.225 
Ile 12 HA HB HD1# HG11 HG12 HG2# HN 
3.979 1.875 0.891 1.508 1.140 0.900 8.332 
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Arg 13 HA HB# HD# HG# HN 	HE 
4.283 1.810 3.112 1.554 8.327 
Asp 14 HA HB# HN 
4.564 2.717 8.202 
Arg 15 HA HB1 HB2 HD# HG# 	HN 	HE 
4.443 1.993 1.792 3.186 1.708 7.991 
Gly 16 HAl HA2 HN 
4.205 3.990 8.203 
Pro 17 HA HB1 HB2 HD# HD1 HD2 HG1 HG2 
3.582 1.042 	0.734 	3.480 	3.492 	3.446 1.546 1.313 
Met 18 HA HB# HE# HG# HN 
4.390 1.607 1.866 2.453 8.375 
Tyr 19 HA HB1 HB2 HD# HE# 	HN 
4.204 3.162 2.740 7.241 6.763 8.350 
Asp 20 HA HB# HB1 HB2 HN 
4.980 2.592 2.678 2.535 7.597 
Asp 21 HA HB1 HB2 HN 
5.353 3.027 2.190 8.814 
Pro 22 HA HB1 HB2 HD1 HD2 HG# HG1 HG2 
4.656 2.395 	2.116 	4.082 	3.740 	2.037 2.083 1.965 
Thr 23 HA HB HG2# HN 
4.330 4.260 1.160 8.423 
Leu 24 HA HB1 HB2 HD1# HD2# HG HN 
4.094 1.688 1.399 1.100 0.862 1.671 6.893 
Pro 25 HA HB1 HB2 HD1 HD2 HG1 HG2 
4.361 2.300 1.852 3.192 2.525 1.559 1.190 
Glu 26 HA HB# HB1 HB2 HG# HN 
4.118 2.047 2.122 2.011 2.345 8.364 
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Gly 27 HAl HA2 HN 
4.383 3.746 8.923 
Trp 28 HA HB1 HB2 HD1 
5.240 3.510 3.227 7.288 
Thr 29 HA HB HG2# HN 
4.776 4.136 1.220 9.214 
Arg 30 HA HB# HB1 HB2 
5.370 1.887 1.929 1.806 
Lys 31 HA HB# HB1 HB2 
4.911 1.805 1.885 1.741 
Leu 32 HA HB# HD1# HD2# 
5.507 1.706 0.676 0.480 
Lys 33 HA HB# HB1 HB2 
4.869 1.980 2.058 1.978 
Gin 34 HA HB# HB1 HB2 
4.711 1.914 1.917 1.548 
Arg 35 HA HB# HB1 HB2 
4.434 1.854 1.906 1.752 
Lys 36 HA HB# HD# HE# 
4.458 1.934 1.728 3.085 
Ser 37 HA HB# HN 
4.794 3.864 8.298 
HE3 HH2 HZ2 HZ3 HN HE1 
7.434 	6.627 7.800 6.719 8.509 10.740 
HD1 HD2 HG# HN HE 
1.556 8.455 
HD# HE# HG1 HG2 HN 
1.693 2.884 1.494 1.320 9.615 
HG HN 
1.628 9.127 
HD1 HD2 HE# HG# HN 
2.845 1.480 8.903 
HG1 HG2 HN HE21 HE22 
1.914 1.278 9.043 7.324 6.816 
HD# HG1 HG2 HN HE 
2.924 9.198 9.500 
HG1 HG2 HN 
1.622 1.495 9.251 
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Gly 38 HAl HA2 HN 
4.466 3.877 8.112 
Arg 39 HA HB# HD# HG# HN 
4.136 1.966 3.292 1.765 8.881 
Ser 40 HA HB# HB1 HB2 HN 
4.391 3.574 4.160 3.587 8.632 
Ala 41 HA HB# HN 
3.349 1.087 6.886 
Gly 42 HAl HA2 HN 
4.452 3.401 8.302 
Lys 43 HA HB# HB1 11132 HD1 
4.337 1.801 1.972 1.802 
Tyr 44 HA HB# HB1 HB2 HD# 
5.311 2.897 2.917 2.666 7.045 
Asp 45 HA HB1 HB2 HN 
5.080 2.573 2.155 8.818 
Val 46 HA RB HG# HN 
4.315 2.154 0.781 8.552 
HE 
7.360 
HD2 HE# HG1 HG2 RN 
2.879 1.568 1.477 7.892 
HE# HN 
6.813 	8.925 
Tyr 47 HA HB# HB1 HB2 RD# HE# RN 
5.314 3.019 3.021 2.745 7.059 6.766 8.911 
Leu 48 HA HB# HB1 H132 HD1# HD2# HG RN 
5.460 1.557 1.952 1.595 0.809 0.309 1.396 9.170 
Ile 49 HA RB HD1# HG11 HG12 HG2# RN 
5.088 1.996 0.744 1.381 1.190 0.833 9.633 
Asn 50 HA HB1 11132 RN HD21 HD22 
3.215 2.228 1.656 8.485 7.018 6.420 
Pro 51 HA HB1 11132 RD# HD1 HD2 HG# 
4.248 2.418 1.759 3.181 3.176 1.864 2.174 
Gin 52 HA H131 HB2 HG1 RG2 HN HE21 HE22 
4.305 2.281 2.038 2.520 2.318 6.952 6.906 7.569 
Gly 53 HAl HA2 HN 
4.150 3.407 8.142 
Lys 54 HA HB# HD# HD1 RD2 
4.061 1.304 1.487 1.479 1.257 
Ala 55 HA HB# FIN 
5.123 1.257 8.096 
Phe 56 HA HB# HD# HE# HZ 
4.957 3.178 7.295 6.800 5.813 
Arg 57 HA HB# HB1 HB2 HD# 
4.945 1.918 1.925 1.745 3.160 
Set' 58 HA HB1 11132 RN 
3.342 4.161 3.692 7.299 
Lys 59 HA RB# HD1 RD2 HE# 
3.869 1.935 3.158 
Val 60 HA RB HG1# RG2# RN 
3.738 2.144 1.117 1.007 7.770 
Glu 61 HA HB# HG1 HG2 RN 
4.229 2.478 2.541 2.413 7.385 
Leu 62 HA RB1 HB2 HD1# RD2# 
3.462 1.651 1.068 0.145 -0.1319 
HE1 RE2 RG1 RG2 HN 
2.946 	2.623 0.987 0.631 7.740 
RN 
9.693 
HG1 HG2 RN HE 
9.532 7.340 
HG# HG1 HG2 RN 
1.577 	1.596 1.483 9.071 
HG RN 
1.135 	7.437 
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Ile 63 HA HB HD1# HG11 HG12 HG2# HN 
3.559 1.856 0.919 1.815 1.142 0.991 8.290 
Ala 64 HA HB# HN 
4.245 1.583 7.581 
Tyr 65 HA H131 HB2 HD# HE# HN 
4.452 3.471 2.939 7.130 7.011 7.838 
Phe 66 HA H131 HB2 HD# HE# HZ HN 
4.521 3.733 3.241 7.247 7.083 6.706 8.972 
Glu 67 HA HB# HB1 HB2 HG1 HG2 HN 
4.147 2.187 2.237 2.134 2.503 2.282 8.248 
Lys 68 HA HB# HD# HE# HG# HG1 HG2 HN 
4.125 2.087 1.796 3.083 1.549 1.607 1.457 7.856 
Val 69 HA HB HG1# HG2# HN 
4.318 2.355 0.847 0.753 8.041 
Gly 70 HA# HAl HA2 HN 
3.943 4.026 3.897 7.793 
Asp 71 HA HB1 HB2 HN 
4.841 2.702 2.456 8.156 
Thr 72 HA HB HG2# HN 
4.534 4.553 1.131 8.428 
Ser 73 HA HB# HN 
4.292 3.890 8.656 
Leu 74 HA HB# HB1 HB2 HD1# HD2# HG HN 
4.410 1.038 1.092 0.966 0.977 0.817 1.628 7.667 
Asp 75 HA HB1 HB2 HN 
5.018 3.095 2.463 8.842 
Pro 76 HA HB1 HB2 HD1 HD2 HG1 HG2 
4.372 2.233 2.027 4.197 4.135 2.256 2.062 
Asn 77 HA HB# HN HD21 HD22 
4.553 2.791 8.810 7.015 8.181 
Asp 78 HA HB# HB1 HB2 HN 
4.537 2.587 8.358 
Phe 79 HA HB1 HB2 HD# HE# HZ HN 
3.970 2.910 2.161 6.954 6.054 6.388 7.139 
Asp 80 HA HB1 HB2 HN 
4.539 2.883 2.454 8.922 
Phe 81 HA HB1 H132 HD# HE# HZ HN 
4.474 3.579 2.941 7.200 7.091 6.700 9.383 
Thr 82 HA HB HG2# HN 
4.611 4.531 1.423 9.100 
Val 83 HA HB HG1# HG2# HN 
3.326 2.231 1.179 0.713 9.514 
Thr 84 HA HB HG2# HN 
4.215 4.298 1.062 8.156 
G!y 85 HAl HA2 HN 
4.459 3.969 7.372 
Arg 86 HA HB# HD# HG1 HG2 HN HE 
4.159 1.747 3.142 9.340 
G!y 87 HA# HN 
3.714 8.134 
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E.2.2 Carbon-13 and nitrogen-15 shifts 
Ala 1 CA CB N 
52.824 19.422 125.501 
Ser 2 CA CB N 
58.347 63.864 114.815 
Ala 3 CA CB N 
52.509 19.599 125.707 
Ser 4 CA CB N 
56.349 63.321 116.400 
Pro 5 CA CB CD CC 
63.589 32.222 50.829 27.593 
Lys 6 CA CB CD CE CC N 
56.629 33.058 29.308 42.310 24.992 120.972 
Gin 7 CA CB CG N NE2 
56.031 29.553 33.880 121.030 111.999 
Arg 8 CA CB CD CG N NE 
56.305 30.892 43.546 27.301 122.927 
Arg 9 CA CB CD CG N NE 
56.330 31.043 43.717 27.163 122.400 
Ser 10 CA CB N 
58.453 63.658 117.107 
Ile 11 CA CB CD1 CG1 CG2 N 
61.692 38.822 13.114 27.808 18.033 122.800 
Ile 12 CA CB CD1 CG1 CC2 N 
62.229 38.264 12.725 18.034 124.289 
Arg 13 CA CB CD CG N NE 
56.984 30.472 123.549 
Asp 14 CA CB N 
55.035 40.872 118.807 
Arg 15 CA CB CD CG N NE 
56.329 32.178 119.108 
Gly 16 CA N 
44.170 108.988 
Pro 17 CA CB CD CG 
62.829 31.942 49.561 27.184 
Met 18 CA CB CE CC N 
54.616 33.076 17.064 32.306 123.102 
Tyr 19 CA CB CD# CE# N 
61.518 39.251 132.716 117.817 
Asp 20 CA CB N 
52.798 44.260 115.576 
Asp 21 CA CB N 
50.252 42.599 118.980 
Pro 22 CA CB CD CC 
63.597 32.484 51.353 26.780 - -- 
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Thr 23 CA GB CG2 N 
62.303 69.215 21.902 110.359 
Leu 24 CA CB CD1 CD2 CG N 
53.699 41.990 26.950 24.945 27.660 123.985 
Pro 25 CA CB CD CG 
62.375 31.400 49.990 27.867 
Glu 26 CA GB CG N 
58.526 29.948 36.075 120.619 
Gly 27 CA N 
45.653 114.486 
Trp 28 GA GB GD1 CE3 CH2 CZ2 	CZ3 	N 	NEI 
57.529 30.259 127.017 120.085 124.327 114.452 	122.049 	122.312 	131.0 
Thr 29 CA GB CG2 N 
61.280 72.992 22.625 113.147 
Arg 30 CA GB CD CG N NE 
54.606 33.986 27.878 121.017 
Lys 31 GA GB CD GE CG N 
55.187 36.305 29.546 42.173 25.302 126.365 
Leu 32 GA GB CD1 CD2 CG N 
54.224 44.020 25.961 26.281 29.799 127.315 
Lys 33 CA GB CD GE CG N 
55.520 36.494 25.703 122.158 
Gin 34 GA GB CG N NE2 
54.772 31.080 34.039 126.529 112.194 
Arg 35 GA GB CD CG N NE 
58.016 30.650 127.767 131.306 
Lys 36 GA GB CD GE CG N 
57.117 35.005 29.137 42.367 25.109 124.435 
Ser 37 GA GB N 
57.768 65.965 115.812 
Gly 38 GA N 
44.184 102.942 
Arg 39 CA GB CD CG N NE 
59.154 29.991 43.813 27.733 122.243 109.492 
Ser 40 CA GB N 
57.598 63.214 111.670 
Ala 41 GA GB N 
54.527 18.180 123.511 
Gly 42 GA N 
44.601 111.244 
Lys 43 GA GB CD GE CG N 
56.676 33.706 25.554 122.222 
Tyr 44 GA GB GD# GE# N 
58.123 41.756 132.752 117.656 120.219 
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Asp 45 CA CB N 
53.739 45.498 118.233 
Val 46 CA CB CG# N 
62.386 33.419 22.083 121.252 
Tyr 47 CA CB CD# CE# N 
56.066 40.965 132.850 118.002 123.910 
Leu 48 CA CB CD1 CD2 CG N 
53.464 43.244 23.721 26.257 28.180 122.578 
Ile 49 CA CB CD1 CG1 CG2 N 
58.981 38.251 12.952 27.764 17.627 124.401 
Asn 50 CA CB N ND2 
51.398 36.706 126.703 108.589 
Pro 51 CA CB CD CG 
65.314 31.419 50.249 28.130 
Gin 52 CA CB CG N NE2 
56.303 28.612 35.091 113.010 111.848 
Gly 53 CA N 
45.483 108.560 
Lys 54 CA CB CD CE CG N 
55.442 32.559 28.643 42.278 24.883 124.013 
Ala 55 CA CB N 
50.664 22.162 126.135 
Phe 56 CA CB CD# CE# CZ N 
57.469 43.285 131.590 130.179 128.394 119.767 
Arg 57 CA CB CD CG N NE 
55.203 32.715 118.611 83.720 
Ser 58 CA CB N 
56.335 66.491 112.286 
Lys 59 CA CB CD CE CG N 
59.529 32.360 25.419 121.850 
Val 60 CA CB CG1 CG2 N 
66.388 31.839 22.972 21.508 118.240 
Glu 61 CA CB CG N 
59.210 31.186 37.008 119.985 
Leu 62 CA CB CD1 CD2 CG N 
57.791 42.146 26.301 23.735 26.196 120.559 
Ile 63 CA CB CD1 CG1 CG2 N 
65.957 38.820 14.420 30.432 17.315 118.603 
Ala 64 CA CB N 
54.893 18.424 120.103 
Tyr 65 CA CB CD# CE# N 
61.577 39.600 133.043 117.943 120.684 
Phe 66 CA CB CD# CE# CZ N 
58.227 36.647 129.891 129.876 127.523 118.590 
Glu 67 CA CB CG N 
59.275 29.660 36.630 118.445 
Lys 68 CA CB CD CE CG N 
59.340 32.687 29.777 42.316 25.157 121.354 
Val 69 CA CB CG1 CG2 N 
61.928 31.963 19.333 21.221 110.097 
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Gly 70 CA N 
46.767 112.189 
Asp 71 CA CB N 
53.747 42.243 120.351 
Thr 72 CA CB CG2 N 
60.940 68.907 21.480 116.500 
Ser 73 CA CB N 
60.425 64.324 119.131 
Leu 74 CA CB GD1 CD2 CG N 
53.797 44.183 26.583 23.311 26.602 123.256 
Asp 75 CA CB N 
50.156 42.523 122.930 
Pro 76 CA GB CD CG 
64.999 33.142 51.331 28.118 
Asn 77 CA GB N ND2 
55.464 38.423 114.481 115.345 
Asp 78 GA GB N 
55.338 40.626 119.072 
Phe 79 GA GB GD# GE# GZ N 
57.865 39.412 131.231 129.522 128.104 119.506 
Asp 80 GA GB N 
53.676 41.830 124.973 
Phe 81 GA GB GD# GE# CZ N 
58.950 40.293 131.839 129.847 127.508 125.971 
Thr 82 GA GB GG2 N 
62.450 70.584 22.761 113.508 
Val 83 GA GB GG1 GG2 N 
68.069 32.051 24.784 21.677 124.736 
Thr 84 GA GB GG2 N 
62.507 70.046 22.043 105.692 
Gly 85 CA N 
44.360 111.885 
Arg 86 CA CB CD CG N NE 
57.001 31.184 123.498 
Gly 87 GA N 
46.274 115.469 
248 
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E.3 DNA (OUR PROBE) 
P urine and pyrimidine chemical shifts 
Base Type HN1 HN3 HN41 HN42 H2 H5 H6 H8 117* 
1 Thy 7.257 1.487 
2 Ade 7.755 8.394 
3 Thy 13.274 7.159 1.359 
4 Gua 12.335 7.756 
5 Thy 13.329 7.153 1.321 
6 Ade 7.294 8.219 
7 m5C 8.261 6.029 6.974 1.467 
8 Gua 12.562 7.645 1.304 
9 Thy 13.373 7.147 1.305 
10 Ade 7.236 8.180 
11 Cyt 8.063 6.494 5.236 7.203 
12 Ade 7.573 8.146 
13 Thy 7.076 1.415 
14 Ade 7.469 8.146 
Ribose chemical shifts 
Base Type Hi' H21' H22' 1-13' 1-14' H51' 1152' 	H5'# 
1 Thy 5.730 2.143 1.724 4.588 3.938 3.580 
2 Ade 6.277 2.950 2.804 4.959 4.387 4.054 3.982 
3 Thy 5.694 2.411 2.098 4.809 4.184 
4 Gua 5.890 2.686 2.513 4.865 4.319 4.100 
5 Thy 5.638 2.390 2.028 4.809 
6 Ade 6.137 2.855 2.559 4.947 4.336 4.102 4.021 
7 m5C 5.425 2.244 1.956 4.720 4.181 4.080 
8 Gua 5.799 2.626 2.459 4.824 4.255 4.048 4.002 
9 Thy 5.635 2.392 2.028 4.807 
10 Ade 6.098 2.795 2.602 4.949 4.340 4.099 4.024 
ii Cyt 5.426 2.263 1.914 4.728 4.090 
12 Ade 6.101 2.737 2.497 4.896 4.288 4.082 4.024 
13 Thy 5.766 2.181 1.823 4.731 4.023 
14 Ade 6.213 2.587 2.383 4.627 4.122 
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The methyl-CpG binding domain (MBD) of the tran-
scriptional repressor MeCP2 has been proposed to rec-
ognize a single symmetrically methylated CpG base pair 
via hydrophobic patches on an otherwise positively 
charged DNA binding surface. We have tested this bind-
ing model by analysis of mutant derivatives of the 
MeCP2 MBD in electrophoretic mobility shift assays 
complemented by NMR structural analysis. Exposed ar-
ginine side chains on the binding face, in particular 
Arg.111, were found to be critical for binding. Mg-ill 
was found to interact with the conserved aspartate side 
chain Asp-121, which is proposed to orientate the argi-
nine side chain to allow specific contacts with the DNA. 
The conformational flexibility of the disordered B-C 
loop region, which forms part of the binding face, was 
also shown to be important. In contrast, mutation of the 
exposed hydrophobic side chains had a less severe effect 
on DNA binding. This suggests that the Arg-iii side 
chain may contribute to sequence-specific recognition 
of the CpG site rather than simply making nonspecific 
contacts with the phosphate backbone. The majority of 
missense mutations within the MBD found in the human 
genetic disorder Rett syndrome were shown or pre-
dicted to affect folding of the domain rather than the 
DNA recognition event directly. 
Methylation of cytosine residues in the dinucleotide se-
quence CpG within mammalian DNA is associated with tran-
scriptional repression. A family of methyl-CpG binding pro-
teins, which are thought to mediate the biological consequences 
of DNA methylation, has been identified and characterized (1), 
of which the founder member is the transcriptional repressor 
MeCP2. These proteins contain a conserved ethyl-CpG bind-
ing domain (MBD), 1 which is 70-75 amino acids in length and 
exhibits 50-70% similarity between the proteins. The MBD of 
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MeCP2 is necessary and sufficient for DNA binding in vitro and 
allows MeCP2 to recognize a single symmetrically methylated 
CpG dinucleotide in diverse sequence contexts (2). Of the other 
MBD-containing proteins, MBD1 and MBD2 also bind to single 
symmetrically methylated CpG dinucleotides in vitro and act 
as transcriptional repressors (3, 4). Repression by MeCP2 can 
act at a distance from a promoter and involves the targeting of 
histone deacetylases via a C-terminal transcription repression 
domain, which interacts with the corepressor mSin3 (5), al-
though a deacetylase-independent mechanism may also con-
tribute to repression (5-7). Targeting of histone deacetylases is 
probably also important in transcriptional repression by MBD1 
and MBD2 (3, 4). Mammalian MBD3 is found in a histone 
deacetylase complex, the Mi-2 or NURD complex (8), but does 
not bind specifically to methylated DNA in vitro and is not 
localized to methylated chromosomal regions in vivo (1). MBD4 
is probably a methyl-CpG-TpG mismatch-specific glycosylase 
(9). 
Recently, an indication of the role of MeCP2 in human de-
velopment has been provided by the linking of mutations in the 
MeCP2 gene to the human neurodevelopmental disorder Rett 
syndrome (10). This disorder is a childhood-onset regressive 
disease that causes loss of speech and hand movement, coupled 
with autistic behavior, microencephaly, and growth retarda-
tion and affects one in every 10,000-15,000 live female births 
(11, 12). Mutations found in the DNA of Rett syndrome patients 
include frameshift mutations generating truncations within 
the MBD, the transcription repression domain, or the C termi-
nus of MeCP2, nonsense mutations preceding and immediately 
downstream of the MBD or within the transcription repression 
domain, or most interestingly, missense mutations within the 
MBD and transcription repression domain domains (10, 13-
18). It is of particular interest to determine what effects this 
latter class of mutations might have on the ability of the 
MeCP2 protein to carry out its functions of methylated DNA 
binding and transcriptional repression. 
We have recently solved the solution structure of the MeCP2 
MBD by NMR spectroscopy (19). The domain has a novel fold 
that forms a wedge-shaped structure, comprising an N-termi-
nal four-stranded anti-parallel $3-sheet on one face of the wedge 
and a C-terminal a-helix and small turn on the other face. At 
the thin end of the wedge, a large, flexible loop region (the B-C 
loop) between the second and third $3-strands appears, together 
with the exposed faces of the second, third, and fourth 
$3-strands (strands B, C, and D), to form a binding surface for 
methylated DNA. Based on this information and the surface of 
the DNA binding region mapped by NMR studies, a model was 
proposed in which a conserved solvent-accessible hydrophobic 
patch composed of the side chains of Tyr-123, Ile-125, and 
possibly Ala-131 might recognize the methyl groups of the 
methylated cytosine residues in the major groove (19). A second 
NMR study on the MBD of the related repressor MBD1 (20) 
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revealed a highly similar fold, suggesting that all the MIBD-
containing proteins are likely to recognize DNA in an equiva-
lent manner. These authors also proposed a similar model for 
DNA recognition and confirmed that mutations in the con-
served tyrosine and charged side chains within the binding face 
affected methyl-DNA recognition in mobility shift assays. 
In this study, we have employed rationally designed site-
directed mutant proteins in quantitative mobility shifts to test 
more thoroughly the model for DNA recognition by the MBD 
domain of MeCP2. In particular, we have defined the critical 
role of surface-exposed residues and the large flexible loop on 
the DNA binding face of the protein in recognition of methyl-
ated DNA. In contrast, we find that the conserved hydrophobic 
side chains in the binding face play a less crucial role in the 
interaction. We have also investigated the effects that certain 
missense mutations within the MeCP2 MBD associated with 
Rett syndrome have on the folding of the domain and on DNA 
binding and have used our structural information on the MED 
to account for the phenotypic effects of a number of such mu-
tations. This leads us to propose that the majority of missense 
mutations within the MeCP2 MBD associated with Rett syn-
drome affect the ability of the domain to interact with methy-
lated CpG dinucleotides via a disruption of the domain fold 
rather than direct mutation of side chains involved in DNA 
recognition. 
EXPERIMENTAL PROCEDURES 
Cloning and Site-directed Mutagenesis—The MeCP2 MBD was 
amplified from the plasmid pET6HMBD (21) using the primers 5'-CT-
AGCAGCCATGGCCTCTGCTTCTCCCAAACA-3' and 5'-CTAGCAGG.. 
ATCC'N'ACCCTCTCCCA(YVTACAGTGA-3', and the resulting amplifi-
cation product was digested with NcoI and BamHI and cloned into 
NcoI-BamHI-digested pET6H to generate pAFB 105. This plasmid 
therefore encodes residues 77-164 of MeCP2 with the heterologous 
N-terminal sequence MHHHHHHAM. The portion of MeCP2 encoded 
is that previously defined as the minimum required for recognition of 
methyl-CpG (2) and is identical to that used for determination of the 
NMR structure of the MED (19) except that it lacks the heterologous, 
unstructured C-terminal residues GSGC. To generate site-directed mu-
tants of the MBD, the QuikChange kit (Stratagene) was employed with 
20-25-mer primers and pAFB105 as a template, according to the man-
ufacturer's instructions. 
Protein Expression—An overnight culture of a fresh transformant of 
Escherichia coli BL21 (ADE3)/pLysS was diluted 1:100 into 1 liter of LB 
medium and grown at 37 C to an A 6. of 0.5, whereupon the cells were 
induced with 0.5 mat isopropyl-(3-D-thiogalactoside and grown for 3 h 
more. Cells were harvested, resuspended in 50 mm HEPES, 0.1 M NaCl, 
harvested again, and resuspended in binding buffer (5 aim imidazole, 20 
mm Tris-HCI, pH 8.0, 0.25 at NaCl, 10% glycerol, 0.1% Triton X-100, 10 
mm /3-mercaptoethanol). Cells were lysed by sonication, and debris was 
removed by centrifugation at 16,000 rpm for 20 mm. Clarified super-
natants were loaded onto 10 ml nickel-nitrilotriacetic acid Superflow-
agarose columns (Qiagen) equilibrated with binding buffer, washed 
with 2 x 10 ml binding buffer plus 30 mm imidazole, and eluted with 5 
ml of binding buffer plus 0.5 M imidazole. Elution fractions were loaded 
onto 10 ml Fractogel EMD SO 650(M) columns (Merck), washed with 
2 x 10 ml binding buffer, and step-eluted with 5 ml of binding buffer 
plus 0.25 M NaCl followed by 5 ml of binding buffer plus 0.5 M NaCI; the 
majority of the protein eluted in the first of these fractions. The pooled 
eluates were dialyzed against 2 liters of 100 mm NaCl, 10% glycerol, 
0.1% Triton X-100, and the resulting material was >95% pure as judged 
by SDS-polyacrylamide gel electrophoresis. Proteins were quantified by 
the Bradford assay kit (Bio-Rad). For the production of labeled protein 
for NMR spectroscopy, cells were grown instead in M9 medium supple-
mented with 0.4% (wlv) glucose and 1.5 g/liter [15N1(NH4)2SO4 and 
induced as above. Protein from the harvested cells was purified as 
above, except that binding buffer lacking both Triton X-100 and imid-
azole was used. The eluates from the Fractogel column were buffer-
exchanged into 50 mm sodium phosphate, pH 6.0, 50 mat NaCl and 
concentrated to a final concentration of 1 mat. 
Electrophoretic Mobility Shift Assay—A double-stranded 27-mer oli-
gonucleotide pair, symmetrically methylated (mC) at a single site on 
each strand (5'-TCAGArFCGCGCmCGGCTGCGATAAGCT-3' and its 
reverse complement; Ref. 1) was end-labeled with digoxygenin-dideoxy- 
TABLE I 
Mutations in the MBD of MeCP2 and DNA binding abilities of the 
mutants 
N/A, not applicable. 
Residue Structurl location Conserved 
Chemical 





1(107(M) Strand B No ++ 90 
K1 12(M) B-C loop Poorly ++ 91 
S113(A) B-C loop Yes ++ 85 
G114(P) B-C loop Yes ++ 12 
K119(A) Strand C Yes ++ 14 
D121(AIE) Strand C Yes ++ 12111 
P127(A) C-D turn Yes N/A 90 
A131(E) Strand D No + 39 
R133(G)* Strand D Yes + + 57 
S134(A)* D-helix turn Yes - 34 
K135(Y) a-Helix Yes ++ 51 
Y141(S) a-Helix Yes - 70 
F157(A) Core Yes ++ 23 
R162(G) C-terminus No ++ 73 
Amino acids mutated in the initial screen are indicated by their 
single letter codes with numbering for full-length MeCP2. Substituted 
amino acids are indicated in parentheses, and those residues mutated 
in cases of Rett syndrome are indicated by asterisks. 
6  The location of the residues within the NMR-derived structure of 
the MBD is indicated; side chains that contribute to the hydrophobic 
core are denoted by 'core." 
"Conservation of the amino acid within the MBD family is indicated. 
The chemical shift change of the corresponding backbone amide in 
the MeCP2 MBD upon interaction with DNA (19). 
DNA binding is quantified as the percentage of bound DNA at a 
protein concentration of 30 nM as determined by EMSA. 
IJTP using an oligonucleotide end-labeling kit (Roche Molecular Bio-
chemicals) according to the manufacturer's instructions. An unmethylated 
version of the same oligonucleotide pair was labeled similarly. Purified 
proteins were incubated with 2 nM labeled duplex oligonucleotide plus 50 
ng4d poly[d(A-T)] (Roche Molecular Biochemicals) as a nonspecific compet-
itor in 20 mm HEPES, pH 7.61 1 mm EDTA, 10 mm (NH4)2S041  1 mm 
dithiothreitol, 0.2% Tween®20, 30 mat KC1 in a final volume of 30 ,.d at room 
temperature for 15 mm. Loading buffer (60% 0.25X Tris-borate EDTA 
(TEE), 40% glycerol; 7.5 0) was added, and the samples were electrophore-
sed on pre-run 0.25X TEE, 6% polyacrylamide (37.5:1 acrylamide-bisacryl-
ainide) gels at 250 V for 3.5 h in 0.25X TBE buffer at 4 "C. Gels were blotted 
onto Hybond-N (Amersham Pharmacia Biotech) in 0.25X TEE buffer over-
night, and the membranes were fixed by UV cross linking followed by 
baking at 80 "C for 10 mm. Digoxygenin-labeled probes were detected using 
a nonradioactive DNA detection kit (Roche Molecular Biochemicals) accord-
ing to the manufacturer's instructions, followed by exposure to Hyperfllm 
ECL (Amersham Pharmacia Biotech). Scanned images were quantified us-
ing ImageQuant software (Molecular Dynamics). 
NMR Spectroscopy—Spectra were collected on a 1 mat sample in 90% 
H20 1  10% D20 at 18 "C in a 50 mm sodium phosphate buffer adjusted to 
pH 6.0. Two-dimensional ' 5N-HSQC and three-dimensional ' 5N-edited 
nuclear Overhauser effect spectroscopy (NOESY) spectra were recorded 
on a Varian INOVA 600 MHz spectrometers using 5-mm probes. All 
NMR data were processed with the AZARA package (see the CCPN 
website at the University of Cambridge) with the application of an 80' 
sinebell-squared window function. ANSIG (22, 23) was used to display 
spectra and maintain cross-peak lists for resonance assignment. The 
resonance assignment for wild-type MBD of MeCP2 was described 
previously (19). By overlaying two-dimensional ' 6N-HSQC spectra col-
lected on mutant MeCP2 MBD proteins, it was possible to assign the 
majority of peaks. Backbone 1HN and ' °N atoms of the G114P mutant 
were sequence-specifically assigned from three-dimensional ' 5N-edited 
nuclear Overhauser effect spectroscopy (NOESY) experiments (75-ms 
mixing time) on the mutant. The chemical shift perturbations for as-
signed peaks were quantitatively measured using weighted averaging 
8/tv = ([8H + ON/5)21'), where 8Av is the weighted average shift 
difference, and &H N and 6N are the differences in ppm between wild-
type and mutant chemical shifts. The ratio of ' °N heteronuclear nuclear 
Overhauser effects obtained from experiments with a 3.01-ms satura-
tion pulse and without a saturation pulse was used to probe the back-
bone dynamics of the G114P MBD mutant (24). 
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FIG. 1. Effects of the GI 14P mutation on DNA binding and structure of the MBD. A, binding of the wild type (wt) MeCP2 MBD and its 
G1 14P mutant derivative to a methylated 27-mer duplex oligonucleotide (see "Experimental Procedures") measured by EMSA. Concentrations of 
the proteins used were 0.25, 0.5, 1.0, 2.0, 4.0, 8.0, 16.0, 32.0, 64.0, and 128.0 nM. The EMSAs from which the binding curves were derived are shown 
to the right of the graph. B, chemical shift perturbation for the backbone amides of the G114P mutant compared with wild type as measured by 
two-dimensional 16N-HSQC NMR spectroscopy. Significant perturbations are those greater than 0.04 ppm, as indicated by the horizontal dotted 
line. The G1 14P mutation is indicated by the vertical dashed line, and a schematic of the regular secondary structural features of the MBD is shown 
above the graph (arrow, 13-strand; coil, a-helix). The backbone amide of Arg-1 15 could not be unambiguously assigned in this spectrum. C, value 
of 1 H,'5N-NOE ratio as a function of residue number for the G114P mutant. Significant disorder is indicated by values below the horizontal line 
(0.6). A schematic of the regular secondary structural features of the MBD is shown above the graph (arrow, (3-strand; coil, a-helix). 
RESULTS 
EMSA Analysis of DNA Binding by MeCP2 MBD Mu-
tants—We generated a set of point mutations within the MBD 
that included solvent-exposed charged and hydrophobic resi-
dues, core residues, and side chains predicted to be important 
for the conformation of the peptide backbone within the domain 
(Table I). These mutant proteins were assayed for binding to a 
methylated 27-mer duplex oligonucleotide containing a single, 
symmetrically methylated CpG dinucleotide (see "Experimen-
tal Procedures") at fixed protein and DNA concentrations of 30 
and 2 nr, respectively. At this protein concentration, the wild-
type MBD is >80% bound. As quantified in Table I, the mutant 
proteins exhibited a range of binding activities from severely 
compromised to wild-type affinity; none of the mutants nor the 
wild type showed any affinity for the unmethylated oligonu-
cleotide under these conditions (data not shown). Of the muta-
tions causing a significant reduction in DNA binding, the 
G114P and D121A or D121E mutants were of particular inter-
est. Gly-114 is located at the tip of the disordered B-C loop, 
which otherwise seems fairly amenable to substitution (see 
K112M and S113A, Table D. Residue Asp-121, which we had 
previously predicted to be involved in bridging interactions 
with arginine side chains on the DNA binding face (19), was  
shown to be critical for binding, as its mutation to alanine or 
even glutamate severely affected the DNA interaction. The 
mutation S134A was also seen to cause a moderate reduction in 
binding affinity. Ser-134 was found to be mutated to cysteine in 
cases of Rett syndrome (14, 16), and the reduction in binding 
affinity caused by mutating this residue may thus contribute to 
the pathology. 
Constraining the B-C Loop by a G1I4P Mutation Severely 
Compromises Binding—As noted above, a mutation of residue 
Gly-114 within the disordered B-C loop region to proline had a 
major effect on DNA binding (Table D. This is in contrast to the 
mild effects of other mutations within this loop examined, 
including the adjacent S113A. The replacement of the flexible 
residue glycine with a structurally constrained proline is pre-
dicted to preclude certain conformations of the B-C loop when 
the MBD domain binds to DNA. To quantify the magnitude of 
the effect of this change on binding, we carried out a quantita-
tive EMSA analysis with the G114P mutant (Fig. IA). Minimal 
binding (10%) was detectable at the highest protein concentra-
tion used (128 nM), indicating that binding was 25-fold 
weaker than that of the wild-type MBD, which showed 10% 
binding at ""'5 nai protein under these conditions. Thus it ap-
pears that flexibility in the B-C loop region is a critical compo- 
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nent of DNA recognition by the MBD, possibly reflecting the 
ability of this region to fit into the major groove of DNA and 
make multiple contacts with the phosphate backbone (19). 
Two-dimensional '5N-HSQC NMR analysis of the structure of 
the GI 14P mutant indicated major changes in the loop region 
from residues 110-121, consistent with the structural con-
straint of this loop as a result of the mutation (Fig. IB). In 
contrast, the structure of the rest of the MBD remained unaf-
fected, indicating that the overall fold remained intact as pre-
dicted. However, analysis of the backbone dynamics of the loop 
region in the G1 14P mutant revealed that it is still relatively 
disordered (Fig. 10, suggesting that the proline substitution 
precludes specific conformations rather than imposing a gen-
eral reduction in flexibility. It is also possible that the proline 
substitution introduces a steric clash with the DNA in the 
mutant. Either possibility is, however, inconsistent with "dock-
ing models" that show a lack of close contact between the B-C 
loop and the target DNA (20, 25). Instead, we suggest that an 
induced conformational change in this region of the protein 
upon DNA interaction contributes to the binding affinity. 
Structural Analysis of the D121A Mutant—Because the mu-
tagenesis screen suggested that residue Asp-121 was particu-
larly critical for DNA binding and it had previously been sug -
gested that this side chain might form an important bridging 
interaction with the Arg-111 or Arg-133 side chains (19), the 
D121A mutant was compared with the wild-type domain by 
two-dimensional 15N-HSQC NMR spectroscopy. An analysis of 
the backbone amide chemical shift differences between the 
wild-type and mutant proteins for residues throughout the 
domain (Fig. 2A) showed that this mutation causes significant 
changes in the environment of the B-C loop region and toward 
the C terminus of the domain, which folds on top of strand C, of 
which Asp-121 is a part. Moreover, the Arg-111 backbone am-
ide could not be assigned in the mutant by two-dimensional 
' 5N-HSQC, whereas the Arg-133 chemical shift was not greatly 
affected. Likewise, the Arg-111 side chain H atoms were sig-
nificantly perturbed by the D121A mutation and moved from 
an abnormal chemical shift to a position in the spectrum occu-
pied by the majority of arginine side chain H. atoms (Fig. 2B). 
This suggests that the primary interaction of Asp-121 is with 
Arg-111 and that the effect of the D121A and D121E mutations 
on DNA binding may largely be due to the abolition of this 
interaction given the critical role of Arg- 111 in DNA binding 
(see below). It seems probable that the Asp-121–Arg-111 inter-
action positions the basic arginine side chain so that it can 
interact correctly with the DNA target. 
Crucial Role of the Arg-111 Side Chain in DNA Binding—We 
mutated the Arg-111 residue of the MeCP2 MBD to glycine 
(Table II) and examined the effect of the mutation on DNA 
binding. The mutant protein exhibited no affinity for methyl-
ated DNA at the concentrations tested (Fig. 3A), although the 
mutated domain remained structured with only local pertur-
bations in the vicinity of Arg-111 and the B-C loop (Fig. 3B). We 
also observed that the mutant protein, unlike all other MBD 
derivatives tested, bound very poorly to Fractogel SO resin 
during purification (data not shown). These are the most severe 
phenotypes seen for any single MBD missense mutation and 
indicate that the positive charge provided by the Arg-111 side 
chain is crucial for the interaction of the domain with both 
DNA and the negatively charged resin. It also suggests that the 
reduced binding affinities seen for the D121A and G114P mu-
tants (above) may in part be due to their disruptive effects on 
the environment of this arginine side chain. A second arginine 
side chain, that of Arg-133, also projects from the DNA binding 
face of the domain, is conserved in the MBD family, and un-
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FIG. 2. Structural effects of the D121A mutation. A, chemical 
shift perturbation for the backbone amides of the D121A mutant com-
pared with wild type as measured by two-dimensional ' 5N-HSQC NMR 
spectroscopy. Significant perturbations are those greater than 0.04 
ppm, as indicated by the horizontal dotted line. Amides that could not 
be unambiguously assigned in the spectrum of the mutant protein are 
indicated by asterisks, and the D121A mutation is indicated by the 
vertical dotted line. A schematic of the regular secondary structural 
features of the MBD is shown above the graph (arrow, 13-strand; coil, 
a-helix). B, a portion of the two-dimensional ' 5N-HSQC NMR spectrum 
for the D121A mutant overlaid with that of the wild-type MBD. Back-
bone amides are indicated for the wild-type (blue) and mutant (red), and 
arginine H. atoms are indicated for the wild-type (magenta) and mutant 
(green). The large chemical shift change for the Arg-111 H. atoms 
caused by the D121A mutation is indicated. 
This latter residue is found mutated (to cysteine) in a case of 
Rett syndrome (10). We made a mutant MBD containing the 
R133C mutation (Table II) and compared its effect on binding 
to that of R111G. Unlike the Arg-111 mutant, R133C showed 
weak binding to methylated DNA at a concentration of 2 ii 
(Fig. 3A) and had minimal effects on the overall structure of the 
domain (Fig. 30. Also unlike the R111G mutation, the R133C 
mutation did not affect the chemical shift of the Asp-121 back-
bone amide, confirming that Asp-121 interacts with Arg-11 1 
rather than Arg-133. We also observed that mutation of Arg-









DNA binding by arginine, hydrophobic patch, and Rett syndrome- 
associated mutants of the MeCP2 MBD 
Residue' St.ructurl 	Conserved 	s Chemical 	ns 	DNA location hift changed protein 	binding 
% bound 
Wi 20 61 
200 97 
2000 99 
R106(W) 5 Core Yes - 	 20 11 
200 21 
2000 31 
R111(G) B-C loop Yes ++ 	20 0 
200 0 
2000 3 
Y123(A) Strand C Yes + 	 20 19 
200 52 
2000 61 
Y123(D) Strand C Yes + 	 20 14 
200 28 
2000 38 
1125(A) Strand C Yes - 	 20 11 
200 76 
2000 71 
R133(C)* Strand D Yes ++ 	20 7 
200 8 
2000 18 
F155(S)5 Core Yes - 	 20 50 
200 61 
2000 61 
T158(M)5 C-terminus Yes - 	 20 60 
200 70 
2000 71 
"Amino acids mutated are indicated by their single letter codes with 
numbering for full-length MeCP2. Substituted amino acids are indi-
cated in parentheses, and those residues mutated in cases of Rett 
syndrome are indicated by asterisks. 
' The location of the residues within the NMR-derived structure of 
the MBD is indicated; side chains that contribute to the hydrophobic 
core are denoted by "core." 
Conservation of the amino acid within the MBD family is indicated. 
d  The chemical shift change of the corresponding backbone amide in 
the MeCP2 MBD upon interaction with DNA (19). 
DNA binding is quantified as the percentage of bound DNA at the 
protein concentrations indicated, as determined by EMSA. 
cysteine substitution at this position (Table I), suggesting that 
the positive charge of this arginine side chain does not contrib-
ute substantially to the DNA interaction. Thus, although the 
reduced binding affinity of the R133C mutant probably ac-
counts for its phenotype as manifested in Rett syndrome, this 
side chain is not of comparable importance to Arg-111 in bind-
ing DNA. 
Effects of Mutations in the "Hydrophobic Patches" Tyr-123 
and lie- 125—It is interesting to note that the only significant 
change in a backbone amide chemical shift remote from the 
mutated residue in the R133C mutant was manifested in the 
strand C residue Tyr-123 (indicated by an asterisk in Fig. 30. 
In the HSQC spectrum of R133C, the cross-peak due to the 
Tyr-123 amide was not detectable at or near its position in the 
spectrum of the wild type. Therefore it had either shifted sig-
nificantly or become broadened due to a substantial change in 
local relaxation properties. In either case, it is apparent that 
changing Arg-133 to Cys significantly perturbed residue 123. 
This (with Ile-125) is one of two semi-conserved hydrophobic 
side chains within the putative DNA binding face of MED 
proteins that we proposed earlier to form an interaction site for 
the methyl groups of a methylated CpG dinucleotide (19). Mu-
tation of Tyr-34, the equivalent of Tyr-123 in MBD1, to alanine 
reduces methyl-DNA binding (20), although Ile-125 is replaced 
by a glutamme m the latter protein. The chemical shift of 
Tyr-123 may be affected by the R133C mutation due to the 
spatial proximity of the two side chains. In MeCP2 only, the 
Ala-131 side chain also contributes to the second hydrophobic  
patch (19), and we observed that mutation of this side chain to 
glutamate reduced the DNA binding affinity (Table I). We 
therefore mutated Tyr-123 and Ile-125 of MeCP2 to alanine 
(Table II) and analyzed the binding of the mutant proteins to 
methylated DNA (Fig. 3A). Both mutant proteins exhibited 
reduced binding affinity, although in each case this was only 
–10-fold lower than the wild-type affinity, and the majority of 
the probe was bound at the higher concentrations used (200 nM 
and 2 ). Neither mutant had as severe an effect on binding as 
either of the arginine mutants R111G or R133C. Mutating 
Tyr-123 to a negatively charged residue, aspartate, instead of 
the hydrophobic alanine caused a more severe effect on bind-
ing, but interaction with methylated DNA was still observed 
(Table II). The Y123A mutation had no significant structural 
effects on the domain according to two-dimensional '5N-HSQC 
NMIR (data not shown), consistent with its solvent-exposed 
location and relatively high binding affinity. Thus, it seems 
reasonable to conclude that, although the Tyr-123, Ile-125, and 
Ala-131 side chains contribute to the interaction with methyl-
ated DNA, there is redundancy in this component of the recog-
nition event. The role of basic side chains such as Arg-111 and, 
to a lesser extent, Arg-133, together with the flexibility of the 
B-C loop is more important in contributing binding energy to 
the reaction. How exactly the methylated cytosines interact 
with the residues in the DNA binding face and determine the 
specificity for methylated DNA is a question to be addressed by 
the structure of the MBDDNA complex. 
Missense Mutations Found in Rett Syndrome Cases Affect the 
Structure of the MBD—As noted above, the R133C mutation, 
which has a significant effect on DNA binding affinity, is found 
in cases of Rett syndrome. We examined three other missense 
mutations within the MBD identified in the initial study of 
MeCP2 mutations in Rett syndrome (Ref. 10; Table II) to see if 
they also affected DNA binding. Amino acids Arg-106 and 
Phe-155 have side chains that both contribute to the hydropho-
bic core of the MBD domain (19) and are mutated to tryptophan 
and serine, respectively, in specific Rett syndrome cases. Fur-
ther occurrences of the R106W mutation have since been iden-
tified (13, 16, 18), and R106Q and F1551 mutations have also 
recently been found in Rett syndrome patients (14, 18). The 
R106W protein was found to bind methylated DNA very poorly, 
whereas the F155S mutant, although forming a complex at 
fairly low protein concentrations, did not shift the probe to 
completion (Fig. 4). The latter result suggested that a propor-
tion of the F155S protein added to the reaction may have been 
unfolded, and indeed two-dimensional 15N-HSQC NMR spec-
troscopy of both of these mutant proteins showed the domain 
structure to be unfolded, preventing re-assignment of the back-
bone amides. It is likely that the F155S mutant in particular 
may be stabilized in the EMSA assay by the presence of its 
target DNA and of glycerol, by the low temperature at which 
the electrophoresis is carried out and by the caging effect of the 
polyacrylamide gel. Indeed, a recent study of the F155S muta-
tion in the context of the intact Xenopus MeCP2 protein in 
which mobility shift reactions were incubated at 37 'C failed to 
detect any binding activity of the mutant protein, presumably 
because the MBD became unfolded (25). The presumptive in-
stability of the R106W and F155S proteins in vivo at 37 'C is 
likely to make them nonfunctional in DNA binding, accounting 
for the observed phenotype. In contrast, a third mutation, 
T158M, which has been found repeatedly in Rett syndrome 
cases (10, 13, 14, 16, 18), had near-wild-type affinity for the 
methylated oligonucleotide (Fig. 4; Table II). This has also been 
shown in the context of Xenopus MeCP2 (25) and is perhaps 
unsurprising as the Thr-158 side chain is on the opposite side 
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FIG. 3. Conserved arginine and hydrophobic side chains are important for DNA binding by the MED. A, binding of the Ri 1 iG, Y123A, 
1125A, and R133C mutants to the methylated 27-mer, as measured by EMSA. Concentrations of the proteins in nri are shown above the panel. B, 
chemical shift perturbation for the backbone amides of the R111G mutant compared with wild-type as measured by two-dimensional 15N-HSQC 
NMR spectroscopy. Significant perturbations are those greater than 0.04 ppm, as indicated by the horizontal dotted line. Amides that could not 
be unambiguously assigned in the spectrum of the mutant protein are indicated by asterisks, and the R111G mutation is indicated by the vertical 
dotted line. A schematic of the regular secondary structural features of the MBD is shown above the graph (arrow, 13-strand; coil, a-helix). C, 
chemical shift perturbation for the backbone amides of the R133C mutant compared with wild type as measured by two-dimensional ' 5N-HSQC 
NMR spectroscopy. Significant perturbations are those greater than 0.04 ppm, as indicated by the horizontal dotted line. Amides that could not 
be unambiguously assigned in the spectrum of the mutant protein are indicated by asterisks, and the R133C mutation is indicated by the vertical 
dotted line. A schematic of the regular secondary structural features of the MBD is shown above the graph (arrow, fl-strand; coil, a-helix). 
role in either structure or function. Instead, Thr-158 may be 
involved in interactions between the MBD and other domains 
of MeCP2 or other proteins, which could affect the function of 
the intact protein. 
DISCUSSION 
In this study we have investigated those amino acid side 
chains within the previously suggested DNA binding face of the 
MeCP2 MBD that could make an important contribution to the 
recognition of methylated DNA. It is apparent from our EMSA 
assays that the arginine residue 111, which is absolutely con-
served in the MBD family, plays a critical role in DNA binding, 
as its mutation results in an MBD which, although still struc-
tured, has no detectable affinity for DNA. Arg-1 11 appears to 
be involved in an interaction with the conserved aspartate side 
chain Asp-121, which is also very sensitive to mutation, and as 
was previously speculated (19), this interaction may orientate 
the arginine functional group so that it is in the correct position 
to bind DNA. Given the severe effect of mutating Arg-111, it is 
likely that its DNA interaction is a specific one involving a 
guanine in the methylated CpG recognition sequence rather  
than a nonspecific one with the phosphate backbone. Recogni-
tion of guanine bases via a "buttressed arginine" of this type is 
an important component of DNA binding by the zinc fingers of 
the Zif268 protein (26). In contrast, mutation of Arg-133 to 
cysteine, found to occur in cases of Rett syndrome, produced an 
MBD with low but detectable affinity for methylated DNA, 
whereas a glycine substitution at position 133 had only a mild 
effect on DNA binding. 
We have also defined an important role for flexibility in the 
disordered B-C loop region in DNA binding. Although several 
mutations within the loop region do not affect binding, a GI 14P 
mutation, which is predicted to restrict the conformational 
flexibility in this region of the protein, reduces its affinity for 
DNA substantially. The mutation is seen by NMR spectroscopy 
to affect the environment of the loop as expected but to leave 
the overall structure of the MBD unaltered. This is consistent 
with the idea that the B-C loop may move to fit into the major 
groove of the DNA as the protein binds. One residue that may 
be brought into position by this movement is the critical side 
chain of Arg-111, although the restriction of movement in the 
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loop does not have such a severe effect as the removal of the 
arginine, since the G114P mutant still has affinity for DNA at 
protein concentrations of greater than 100 rim. It is more likely 
that a general nonspecific interaction is made with DNA by 
positive charges in the loop region such as Arg-115 and Lys-
119, whereas Arg-111 has a more specific role to play. 
The hydrophobic residues exposed on the DNA binding face, 
Tyr-123, Ile-125, and Ala-131 in MeCP2, have been shown to 
contribute to the affinity of binding to methylated DNA. How -
ever, in contrast to predictions from the original MBD-DNA 
interaction model (19, 20), their individual contributions ap-
pear to be fairly weak, and specificity for methylated DNA is 
retained when they are removed. More severe effects on bind-
ing can be obtained when negative charges, which will repel the 
phosphate backbone, are introduced at these positions (the 
Y123D and A131E mutations), although binding is still not 
completely abolished. This suggests that specificity for the 
exposed methyl groups in the major groove of the DNA may be 
a result of additive hydrophobic interactions within the pro-
tein-DNA interface. Given this and the observation that a 
charged residue, Arg-111, seems to be more critical for DNA 
binding, it is also possible that the aliphatic portion of the 
arginine side chain may contribute directly to recognition of the 
methylated base. 
Finally, we have considered the effects that Rett syndrome-
associated missense mutations within the MBD have on its 
DNA binding ability. In general, these were found to lead to a 
reduction in binding affinity, but in only one case was this a 
direct effect of mutating a residue implicated in protein-DNA 
interactions. This mutation, R133C, is unique among the Rett 
syndrome mutations tested (Figs. 7 and 8) in affecting binding 
without any structural effect on the domain. A study of the 
R133C mutation in the context of Xenopus MeCP2 has sug-
gested that it may cause an altered protein structure (25), but 
the circular dichroism analysis used in that study does not 
permit a precise determination of structural changes. In con-
trast, our NMR analysis of the R133C mutant MBD shows very 
limited changes in the chemical shifts of backbone amides 
throughout the domain, indicating that it is structurally virtu-
ally identical to the wild-type protein. Unlike R133C, the 
R106W and F155S mutations both affect the structure and 
stability of the domain, causing it to unfold under NMR condi-
tions, as expected for side chains that contribute to the hydro-
phobic core. However, F'155S in particular retained DNA bind-
ing activity in the EMSA assay, indicating that the domain is 
not completely unfolded under these conditions. The S134A 
mutation, analogous to S134C found in a Rett syndrome case,  
also caused a reduction in DNA binding affinity, but a fifth 
mutation, T158M, which has been found in several Rett pa-
tients, did not seem to affect DNA binding affinity significantly. 
The most likely explanation for the Rett syndrome phenotype 
of this mutation is that the Thr-158 side chain, which is on the 
opposite side of the MBD domain from the DNA binding sur-
face, is important for interactions between this domain and the 
rest of the intact MeCP2 protein. 
Since this study commenced, several other Rett syndrome-
associated mutations have been found within the MBD. These 
include changes at two proline residues, 101 (to Thr, His, or 
Leu) and 152 (to Arg) (13, 15, 16), which probably have struc-
tural effects on the domain given their locations between the A 
and B strands and at the terminus of the a-helix, respectively. 
Subtle aspartate to glutamate mutations at positions 97 (with-
in strand A) and 156 (at the C terminus of the domain) have 
also been found in Rett patients (13, 18); although the latter 
residue is well conserved in the MBD family, neither mutation 
is predicted to have a particularly severe effect on the proper-
ties of the domain itself. In contrast to previous statements 
(13), Asp-156 is not implicated in any way in DNA binding. 
Instead, the interfaces between the MBD and other domains of 
the protein (or other proteins) could be affected by the D97E 
and D156E mutations. It seems that in general, the missense 
mutations found in Rett syndrome may result in structural 
changes in the domain rather than specifically targeting side 
chains involved in DNA recognition, the exception being the 
R133C mutation. However, it must be remembered that the 
mutation frequency at different sites within the DNA encoding 
the MBD probably varies widely, with many of the mutations 
identified so far being at highly mutable CpG sites. It would be 
interesting to determine the phenotypes caused by some of the 
DNA-binding site mutations constructed in this study, such as 
the loop mutation G114P and the severe R111G change, in an 
in vivo model system. 
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the mCpG-binding domain (MBD) from MeCP2 has been solved and the 
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DNA-binding surface of the domain mapped using NMR spectroscopy. 
Residues 95-162 of MeCP2 adopt a novel fold forming a wedge-shaped 
structure. An N-terminal four-stranded antiparallel j3-sheet forms one 
face of the wedge, while the other face is formed mainly by a C-terminal 
helical region. The thin end of the wedge is extended by a long loop 
between 3-strands B and C containing many basic residues. The B-C loop 
together with residues in strands B, C and D, and at the N terminus of 
the ct-helix, appears to form an interface with methylated DNA. Unstruc- 
tured residues at the NH 2 terminus of the domain are also involved in 
formation of the complex. The presence of numerous arginine and lysine 
side-chains on the DNA-binding surface of MBD is consistent with the 
requirement for the mCpG site to be flanked by non-specific sequences of 
base-pairs. The absence of symmetry in the domain implies that recog- 
nition does not exploit the symmetry of the binding site. A conserved 
hydrophobic pocket containing the side-chains of Tyr123 and 11e125 on 
the positively charged n-sheet face is a candidate for the region of contact 
with the methyl-groups of the modified cytosine residues. 
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the 5-position of cytosine in cytidine-guanosine 
(CpG) dinucleotide pairs. Because of its ability 
to repress transcription, methylation of CpG 
sequences has been implicated in stable modu-
lations of gene expression in a cell-type-specific 
manner during development (Bartolomei & 
Tilghman, 1997). Mice lacking maintenance DNA 
methyltransferase (DNMT) are developmentally 
retarded and die at mid-gestation (Li et al., 1992). 
While certain invertebrate genomes have a 
pattern of DNA methylation characterised by 
methylation-rich and methylation-free regions, the 
somatic genomes of vertebrates are consistently 
methylated except for regions known as "CpG 
islands" (Bird, 1986). CpG islands are coincident 
with the promoters of nearly two-thirds of human 
genes transcribed by RNA polymerase II 
0022-2836/99/351055--11 $30.00/0 	 © 1999 Academic Press 
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(Antequera & Bird, 1994). DNA methylation can 
repress transcription at a distance (Cedar, 1988; 
Kass et al., 1993), and repression of methylated 
transgenes requires prior assembly of chromatin 
(Buschhausen et al., 1987). Silencing of genes by 
methylation at CpG islands has been observed in 
the inactive X-chromosome (Riggs & Pfeifer, 1992), 
in genomic imprinting (Neumann & Barlow, 1996; 
Razin & Cedar, 1994), and in transformed cell-lines 
and tumours (e.g. Bird, 1996). 
A family of five mammalian proteins, MeCP2, 
MBD1, MBD2, MBD3 and MBD4, has been ident-
ified (Hendrich & Bird, 1998, and references there-
in) as being of likely importance in interpreting the 
signal that methylation of DNA represents. Each 
member has a stretch of 60-80 residues displaying 
a high level of similarity (50-70 %) between all five 
proteins (Figure 1). In MeCP2, this region has been 
identified as necessary for binding directly to 
methyl-CpG (mCpG, Nan et al., 1993), and it has 
been termed the mCpG-binding domain (MBD). 
MBD2 and MBD4 bind specifically to methylated 
DNA in vitro (Hendrich & Bird, 1998). Both pro-
teins co-localise with foci of heavily methylated 
satellite DNA in mouse cells and localisation is dis- 
rupted in cells deficient in CpG methylation 
(Hendrich & Bird, 1998). MBD2 has been reported 
to possess demethylase activity (Bhattacharya et al., 
1999) and MBD4 is probably a novel repair 
enzyme (Bellacosa et al., 1999). MBD3 apparently 
lacks specific methylated DNA-binding activity, 
although it has a high degree of sequence simi-
larity with MBD2 (Figure 1). MBD1 and MeCP2 
bind specifically to methylated DNA in any 
sequence context and inhibit transcription (Meehan 
et al., 1989; Lewis et al., 1992; Boyes & Bird, 1991; 
Nan et al., 1997). 
MeCP2 is capable of binding to a single, symme-
trically methylated CpG dinucleotide and binds to 
chromosomes at sites known to contain methylated 
DNA (Nan et al., 1996). MeCP2 (Figure 1) contains 
both an MBD and a transcriptional repression 
domain. It is able to recruit histone deacetylases 
(Nan et al., 1998; Jones et al., 1998), and to displace 
histone Hi from preassembled chromatin that con-
tains methylated DNA. Its localisation is disrupted 
in embryonic stem cells (ES) lacking a functional 
DNMT gene (Nan et al., 1996). Like DNMT-
deficient ES, MeCP2-deficient ES grow normally in 
culture but are incapable of supporting embryonic 
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Figure 1. A schematic representation of MeCP2 and other members of the MBD family. Proteins are indicated by 
white rectangles extending from the amino terminus on the left. The locations of MBD domains, identified on the 
basis of sequence similarity (Hendrich & Bird, 1998), are indicated by the black boxes, and numerals indicate the 
boundaries in terms of residue number. The transcription repression domain of MeCP2 is indicated by a dark grey 
box. Two forms of MBD2 are shown corresponding to initiation of translation at either the first or second methionine 
codon (Hendrich & Bird, 1998). A multiple sequence alignment encompassing the MBDs from the five proteins is 
shown in one-letter code. Numerals indicate the sequence number within MeCP2. Upper-case indicates a highly 
conserved (or conservatively substituted) residue (consensus sequence is shown below the alignment). The colour 
coding refers to the extent to which the amide chemical shifts are perturbed by the binding of DNA: green indicates 
no significant change, yellow indicates a small but significant change, and blue indicates a large change (more details 
in the legend to Figure 4). Black squares indicate residues whose side-chains contribute to the hydrophobic core. 
The mouse version of MBD4 has a serine at this position. 
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development (Tate et al., 1996). On the other hand, 
MeCP2-deficient somatic cells are viable and 
MeCP2 may be responsible for genome-wide tran-
scriptional repression or "transcriptional noise 
reduction" (Bird, 1995), but may also effect sup-
pression of specific genes. 
The boundaries of the minimal domain of 
MeCP2 necessary and sufficient for binding mCpG 
were defined empirically using mutagenesis and 
band-shift assays (Nan et al., 1993). While residues 
98-161 encompass the consensus MBD residues in 
MeCP2 (Figure 1), additional residues within 
MeCP2 at either the COOH or the NH, terminus 
of the consensus sequence are required for binding. 
The minimum length mCpG-binding sequence in 
MeCP2 consists of amino acid residues 78-162. A 
recombinant fragment corresponding to this 
sequence was shown to bind to a single CpG site 
with an affinity in the order of 1 nM, and as a 
monomer (Nan et al., 1993). Symmetrically methyl-
ated CpG in the context of double-stranded - DNA, 
flanked by non-specific sequences of no less than 
six base-pairs is a requirement of the target (Nan 
et al., 1993). 
Given that the MBD is pivotal to the biological 
manifestation of the methylation signal in eukary-
otic DNA, its structure-function relationships are 
of interest. Here, the solution structure of a recom-
binant fragment of MeCP2 encompassing its MBD, 
and capable of recognising mCpG is described, 
and on the basis of chemical shift perturbations, 
the DNA-binding surface of the domain is ident-
ified. 
Results 
Secondary structure and 
conformational mobility 
A recombinant fragment of MeCP2 encompass-
ing residues 77-164, and having the non-native 
sequence MHHHHHHAM at its NH2 terminus 
and GSGC at its COOH terminus, was soluble at 
1 mM (at pH 6.0), and appeared to be stable for 
many days providing the temperature of the 
sample remained below 20°C; therefore NMR data 
were collected at 18°C. Using a 13C,15N-labelled 
sample it was possible to assign backbone atoms in 
all residues of the native sequence, some residues 
of the NH2-terminal poly-His tag, and all of the 
extra COOH-terminal residues. A total of 98.5 % of 
the protons of the native sequence were assigned. 
The gaps in the proton assignment are concen-
trated around Pro93 and Met94 where the peaks 
show signs of exchange-broadening. Of the side-
chain 13C nuclei, 98.7% were assigned. The chemi-
cal shift data were used to construct a CSI-plot 
(Figure 2(a); Wishart & Sykes, 1994) which is con-
sistent with four short p-strands, A-D (A, residues 
96-98; B, 104-109; C, 120-125; D, 131-134), followed 
by three-turns of CL-helix (residues 135-144). 
Heteronuclear 1 H-15N nuclear Overhauser effects 
(NOEs) were measurable for the backbone amides  
of 75 residues (Figure 2(b)). The non-native resi-
dues at either end of the recombinant sequence 
have negative or very small heteronuclear NOEs, 
implying that these residues do not adopt an 
ordered structure. The first 18 residues of the 
native sequence have heteronuclear NOEs of less 
than 0.6, which indicates that this segment is also 
disordered. The next 69 residues (94-162), which 
encompass the MBD consensus residues (Figure 1), 
have an average heteronuclear NOE of 0.69. There 
are two places between residues 94 and 161 where 
consecutive backbone amide protons have hetero-
nuclear NOEs below 0.6, namely 112-119, and 148-
150. These correspond, respectively, to the loop 
between strands B and C, and to a region beyond 
the C-terminal end of the cat-helix. In general, resi-
dues within defined elements of secondary struc-
ture in MBD have higher values of heteronuclear 
NOEs than residues in the connecting loops. 
Beyond residue 161, the values of the NOE fall off 
and therefore the backbone is probably poorly 
structured. 
Tertiary structure 
Calculated structures were derived from a data-
set consisting of 45 I(HN-H)  coupling constants, 
1550 distinct NOE-derived unambiguous distance 
restraints, and 317 ambiguous restraints. Of the 
unambiguous restraints, 647 were intraresidue (the 
NOB list was not filtered to remove restraints of no 
structural value), 392 were sequential and 511 
were longer-range (see Table 1). A reasonably con-
sistent density of NOEs was identified throughout 
the central region of the sequence with most NOEs 
arising from n-strands B, C and D, the tx-helix, and 
a C-terminal segment (Figure 2(c)). Residues at the 
NH2 terminus (<94) and at the COOH terminus 
(>161) do not participate in any long-range NOEs. 
An additional 28 NOEs were used to emulate 14 
inferred H-bonds. 
An overlay of 28 structures out of 30 calculated 
(Figure 3(a), and Table 1) reveals that convergence 
of secondary structural elements is generally good, 
but that the positions and conformations of several 
loops and turns are not defined by the experimen-
tal data. On the whole there is a good correlation 
between the value of the root-mean-square (r.m.s.) 
deviation of specific residues in the calculated 
structures (Figure 2(d)) and their disorder accord-
ing to heteronuclear NOEs, implying that the ill-
defined stretches are genuinely mobile, and that 
their lack of structural definition is not an exper-
imental artefact. Thus the mean r.m.s. deviation for 
backbone (heavy-atoms only) of residues of 3-
strands B, C, and D and the cL-helix is 0.36 A, while 
the equivalent value for all 69 residues of the MBD 
(94-162) is 0.92 A. As might be expected from the 
heteronuclear NOEs, the least well-defined regions 
are 112-119 and 148-150. However, strand A (resi-
dues 96-98, as predicted by the CSI-plot), is an 
exception in that the heteronuclear NOB of Asp97 
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Figure 2. Summary of homonuclear and heteronuclear NOEs, the CSI and r.m.s. deviations. (a) A CSI-plot (Wishart 
& Sykes, 1994) for MBD. (b) Value of 1 H-15N NOE as a function of residue number - error bars correspond to uncer-
tainty derived from noise in the spectrum. (c) Number of distinct NOEs used in structure calculation as a function of 
residue number. Black bars correspond to intraresidue NOEs; dark grey, sequential NOEs; light grey, short-range 
NOEs [i to i + (2-4)]; white, medium and long-range NOEs [i to i + (>4)]. Ambiguous NOEs in which one partner is 
identified are included, but not ambiguous NOEs in which neither partner was identified. (d) A plot to show the 
r.m.s. deviation of the C atoms of residues 94-162 as a function of residue number, based on a superposition of these 
C' atoms from 28 calculated structures. 
r.m.s. deviation of its C atom is 0.85 A, and the 
r.m.s. deviation of the C atom of Pro98 is 1.8 A. 
Resonance assignment for the amino acids in this 
region is complete. Scrutiny of NOEs did not 
reveal any cis X-Pro conformations here, but it is 
possible that some other slow conformational 
exchange event is occurring. 
On the basis of the inability of the program 
DALI (Holm & Sander, 1993) to find any similar 
folds in the database, MBD appears to have a 
novel fold. Residues 94-161 (which encompasses 
the MBD consensus sequence) adopt a tertiary 
structure that is approximately wedge-shaped 
(Figure 3(b)). One face of the wedge is contributed 
by the NH2-terminal two-thirds of the MBD 
sequence which forms a four-stranded, up-and-
down, antiparallel 3-sheet. The other face is formed 
by the three-turn a-helix and a COOH-terminal 
stretch that is for the most part extended but 
includes a single turn of helix (residues 150-152). 
The wedge-shape results, in part, from the a-helix 
not being parallel with the 13-sheet; rather the C ter- 
minus of the helix is angled away from the plane 
of the 13-sheet by approximately 150.  At the thin 
end of the wedge-shape, 13-strands B and C project 
beyond strands A and D, and the domain is further 
extended by a long loop between strands B and C. 
The B-C loop is poorly defined by NOEs, and not 
well-ordered according to the relaxation data. The 
thick end of the wedge is formed by the COOH 
terminus of the helix, and a subsequent, poorly 
structured peptide segment that directs the main-
chain back, down into the body of the domain. The 
turns between 13-strands A and B and 13-strands C 
and D also contribute to this end of the wedge-
shaped molecule. Both faces of the wedge contrib-
ute hydrophobic side-chains to an elongated core. 
The side-chains of LeulOO, Irp104, Arg106, 
Leu108, Tyr120, Val122, Leu124, Phe132, Leu138, 
Phe142, Leu150, Phe155, Phe157, and Va1159 com-
prise the hydrophobic core (Figure 3(c)). Of the 
core side-chains, the guanidyl moiety of Arg106 is 
solvent-exposed on the helical face, the hydroxyl 
group of Tyr120 and one of the methyls of Va1159 
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Table 1. Structural statistics for the 28 refined structures 








Medium-range; i -+ [i + (2 to 4)] 143 
Long-range; i -.* [i + (>4)] 368 
Root mean square deviations: (SA)' 	(SA),L 
For structured residues (94-111, 
120-147,151-162) 
Backbone atoms (Ca, N & CO) 0.639 	0.401 
C atoms only 0.650 0.415 
From experimental restraints: 
Ambiguous NOEs (A) 0.024 ± 0.009 	0.013 
Unambiguous NOEs (A) 0.035 ± 0.008 0.029 
J restraints for <t (Hz) 0.97 ± 0.06 	0.87 
From idealised geometry: 
Bond lengths (A) 0.0035 ± 0.0007 	0.0023 
Bond angles (°) 0.49 ± 0.06 0.40 
Final energy, EL - 	(kJ mo! -1 ) —217 ±17 	—218 
Assessment of quality according to the Ramachandran 
plot' (% residues) in: 
Most favoured region 63.5 
Additionally allowed region 32.4 
Generously allowed region 4.1 
Disallowed region 0 
Represents the average r.m.s. deviations for the ensemble of 
28 structures. 
b  Represents values for the final structure that is closest to 
the mean. 
'The Lennard-Jones potential was not used at any stage in 
the refinement. 
d  Using PROCI-IECK (Laskowski et al., 1993). 
are exposed to solvent at the thin end of the 
wedge, and the 13 methylene of Phe157 is exposed 
on the helical face of the wedge. The side-chains of 
Va1136, 11e139, and A1a140 are all mainly exposed 
on the helical face, while Tyr95, Tyr123, 1le125 and 
A1a131 are mainly exposed on the 3-sheet face. At 
the thick end of the wedge, the side-chains of 
Tyrl4l and Va1145 are solvent-accessible, while at 
the thin end, within the long disordered B-C loop, 
Alal 17 is exposed to solvent. Three out of the five 
arginine residues within the MBD sequence, and 
four of the seven lysine residues lie within the 14-
residue stretch 106RKLKQRKSGRSAGK 119 which 
encompasses 13-strand B and the B-C loop, at the 
thin end of the wedge-shaped domain. With the 
exception of Arg106, all of the positively charged 
side-chains within this stretch are fully exposed on 
the domain surface. The side-chains of Lys130 and 
Lys144 are solvent accessible at the thick end of 
the wedge, while Lys135 projects into the solvent 
from the N terminus of the ce-helix. Arg133 is also 
solvent-exposed at the thin end of the wedge, close 
to the disordered B-C loop. All of the negatively 
charged and neutral polar side-chains are solvent-
accessible. Proline and glycine residues lie in turns 
or loops. 
Role of residues conserved in the MBD family 
Of the core residues, all are conserved or conser-
vatively substituted throughout the family with 
the exception of Leu108, Tyr120, Va1159 and 
Leul50. Position 120 is occupied by a Phe in 
MBD4, but by a Ser in MBD1 and MBD2, and an 
Arg in MBD3. In MeCP2, the aromatic ring of 
Tyr120 is partly exposed but packs against one of 
the methyl groups of Va1159 at the narrow end of 
the core. This valine residue is present in MBD4 
but missing in MBD1, MBD2 and MBD3. The other 
methyl group of Va1159 packs against Leul08. 
Leu108 is conservatively replaced by a Val residue 
in MBD4, but this position is occupied by a Glu in 
MBD1, MBD2 and MBD3. Therefore, in MeCP2 
and MBD4 a cluster of hydrophobic residues (Leu, 
Tyr and Val in MeCP2; Val, Phe and Val in MBD4) 
forms the narrow end of the hydrophobic core, but 
this is absent in the other members of the family. 
Leu150 is conservatively replaced in MBD2, MBD3 
and MBD4, but is substituted by a cysteine residue 
in MBD1. However, in MBD1, MBD2 and MBD3 
this region is likely to have a significantly different 
local structure, since these MBDs appear to have 
deletion in the third turn of the c-helix. 
Of the exposed hydrophobic side-chains, Alall7, 
Tyr14l and Tyr123 are conserved (Tyr123 is con-
servatively replaced by a Phe in MBD3). 11e125 is 
conserved or conservatively replaced in all mem-
bers with the exception of MBD1 where it is a Gin 
residue. Tyr123 and 11e125 form a hydrophobic 
pocket (together with the non-conserved residue, 
A1a131) at the approximate centre of the 13-sheet 
face of the domain. 
There are three highly conserved Asp residues. 
The conserved C-terminal aspartate residues, 
Aspl5l and Asp156 form part of a contiguous 
negatively charged surface feature on the helical 
face of the domain along with Asp147 (which lies 
in a highly mobile loop) and Asp154. The side-
chain of the conserved Aspl21 projects from the 
thin end of the wedge and could form an electro-
static interaction with either or both of the two 
conserved arginines at positions 111 and 133, since 
it occupies a position between these two side-
chains. The third conserved arginine residue, 
Arg106, is partly buried as described above. 
Mapping the interface with DNA 
The surface electrostatic properties of the MBD 
from MeCP2 are noteworthy (Figure 3(d)). The 13-
sheet face presents a large positively charged sur-
face. The helical face is positively charged towards 
the thin end of the wedge-shaped domain, but 
negatively charged towards the thick end. This pat-
tern of positive and negative charges is consistent 
with the involvement of the 13-sheet face, and the 
thin end of the wedge-shaped domain in inter-
actions with the DNA phosphate backbone. 
To explore further the likely site of interaction 
between MBD and DNA, an equimolar quantity of 








Figure 3. Structure of the methylated DNA binding domain from MeCP2: (a) Stereo-pair representation of a super-
position of backbone (Crn') traces for the 28 structures with lowest energy out of a set of 30 calculated. The 28 
structures were selected by plotting total potential energy per structure against structure number, with structures 
numbered in order of increasing energy; structures lying beyond the gradually rising part of the resulting curve were 
rejected. Only residues 90-164 (heteronuclear NOEs above 0.4) are shown. Superposition was performed on the basis 
of backbone (heavy) atoms of the following residues: 94-111, 120-147 and 151-162 (see Table 1). Other residues were 
not used in the superposition since their heteronuclear NOEs were less than 0.6 and therefore they are unlikely to be 
well-ordered. (b) MOLSCRIPT (Kraulis, 1991) representations of MBD (residues 92-164); the representation on the left 
is in the same orientation as in (a); the one on the right is rotated 180 degrees. (c) Stereo-pair showing the 14 side-
chains which contribute to the hydrophobic core (see Figure 1). The side-chains of the 28 accepted structures are 
drawn, based on a superposition of backbone atoms as shown in (a). A C trace of residues 92-161 of a typical 
structure is shown to provide orientation. The Phe side-chains are coloured blue; Leu, orange; Arg, brown; Vat, red; 
Tyr, cyan; and Trp, magenta. (d) Molecular surface coloured by electrostatic potential (blue is positive, red is nega-
tive) at ±5 keV using GRASP (Nicholls et al., 1993). The same two views as used in Figure 3(b) are shown. 
an appropriately methylated 14 bp oligonucleotide 
was titrated into the NMR sample. Subsequently it 
was possible to re-assign 94% of the amide protons 
and 15N nuclei in the MBD. While some backbone 
amide protons undergo a change in chemical shift 
(6 ) upon addition of methylated DNA (up to 7.1 
ppm for ' SN, and 0.76 ppm for 1 H), other amide 
protons experience no significant change in 6 
(Figure 4(a)). This observation is consistent with 
the formation of a specific protein-DNA complex 
in the NMR tube. Unfortunately it was not possible 
to compare the results of this experiment to a con-
trol in which non-methylated DNA was used for 
formation of complex, since irreversible precipi-
tation occurs upon mixing the recombinant protein 
with non-methylated DNA of the same sequence 
as the methylated DNA. 
Although some backbone amide protons will 
undergo DNA-induced changes in chemical shift 
purely as a result of a conformational change in 
the protein induced by binding, it is a reasonable  
assumption that the majority of those amide pro-
tons showing significant change upon binding are 
likely to be close to the intermolecular interface; 
this allows the mapping of the DNA-binding sur-
face of the domain. Changes of both the 'H 6 and 
the ' 5N 6 were measured (in Hz) for 76 residues, 
then summed and plotted as a function of 
sequence number (Figure 4(a)). A polypeptide seg-
ment (IRDRG) in the unstructured NH,-terminal 
tail shows significant changes in shift, implying 
that this region might interact with DNA, a result 
which is consistent with the requirement of these 
residues within the minimal mCpG-binding 
sequence. The 6 values of residues within the C-
terminal half of strand B, throughout the poorly 
structured B-C loop, and in the N-terminal half of 
strand C, are also perturbed by DNA binding 
(Figure 4(b)). These all lie towards the thin end of 
the wedge-shaped domain. Most strongly per-
turbed are the amide protons of G1y114 and 
Argll7 in the middle of the B-C loop. Also 
a 
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Figure 4. Residues implicated in DNA-binding on the basis of chemical shift changes upon complex formation. (a) 
An overlay of equivalent portions from the 'H,'N HSQC spectrum of the free protein (red) and of the protein bound 
to methylated DNA (blue). Shown are some backbone amide cross-peaks labelled according to residue. The green 
peak is folded and negative. (b) A plot of the DNA-induced perturbation of chemical shifts (i.e. l) versus sequence 
number. The value on the Y-axis is the sum, in Hz, of Al for the amide H and 'N in a particular residue. The 
lower horizontal dotted line represents the value above which Aó is considered significant, and the upper horizontal 
dotted line defines the threshold above which A6 is considered "large'. A schematic representation of CSI-predicted 
secondary structure is inset. (c) The location of perturbed amide protons in the structure. A grey ribbon is used to 
indicate the path of the backbone, and the amide nitrogen atoms (blue) and protons (white) are shown either as lines 
(no significant As), rods (small but significant ), or spheres (large M). The view on the left is the same as the 
right-hand image in Figure 3(b) and (d). In the view on the right the molecule has been rotated 90 about its vertical 
axis. Also shown (magenta) are the side-chains Tyr123 and llel25, and their solvent-accessible surface (generated in 
INSIGHT, Biosym). 
strongly affected are amide protons of alternating 
residues in strand D (A1a131, Arg133) and Lys135 
and Val136 which initiate the or.-helix. Finally, the 
values of several amide protons (Phe157, Thr160 
and Arg162) within the COOH-terminal extended 
strand are altered by complex formation. The pos-
itions of all the significantly affected amide protons 
are indicated in Figure 4(c) (and summarised by 
the colour-coded sequence in Figure 1). They are 
clustered towards the thin end of the wedge, and 
are predominantly on the 3-sheet face and in the 
B-C loop. Figure 4(c) also includes a representation 
of the surface-accessible atoms of Tyr123 and 
11e125, and illustrates that this hydrophobic pocket 
is surrounded by amide protons whose 6 is per-
turbed by interaction with DNA. 
Discussion 
On the basis of single crystal X-ray studies (e.g. 
Mayer-Jung et al., 1997) the uncomplexed DNA is 
likely to be B-form, with the methyl groups of 
methyl-C in the major groove, at a distance of 
approximately 6.5 A from one another. The MBD 
from MeCP2 has been reported (Nan et al.. 1993) to 
bind as a monomer to a symmetrically methylated 
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CpG site flanked by non-specific sequences of at 
least six base-pairs. 
It was noticed previously that within the 
sequence of MeCP2 MBD there are a pair of imper-
fect repeats based on A(F or Y)xxKV, e.g. 
3̀ AFRSKV 13 ' and ' 4°AYFEKV' 45 . This gave rise to 
speculation (Nan et al., 1993) that the tertiary struc-
ture of MBD might feature two similar methyl-C 
recognition sites. However, the structure appears 
to be lacking in symmetry and the repeated resi-
dues do not form similar sub-structures: e.g. 
Phe132 is buried in the core while Tyr141 is a sur-
face residue distal to the putative DNA-binding 
interface. Thus it appears that MBD does not 
exploit the symmetry of the target for binding, 
unlike many prokaryotic DNA-binding proteins 
(which bind as dimers). Upon binding, the MeCP2 
MBD will break symmetry and this might have 
important consequences, since subsequent binding 
events could be directed in a downstream or 
upstream manner. 
The exposure to solvent of Tyr123 and 1le125 in 
a groove or pocket set within the face of MBD 
likely to interact with DNA (Figure 4(c)), is sugges-
tive of a role for these residues in making van der 
Waals' contacts with the methyl groups of the 
modified cytosine residues. These amino acids are 
conserved, although in MBDI, 11e125 is replaced 
by a Gin residue. In MeCP2, but in no other MBD, 
a third hydrophobic side-chain (Alal3l) also con-
tributes to this hydrophobic patch. At the surface, 
Tyr123 is contiguous with the highly conserved, 
charged residues Asp121 and Arg133. Argill (also 
a consensus residue) is nearby. It is possible that 
Aspl21 forms an electrostatic interaction with one 
or other of these arginine residues, directing the 
orientation of the flexible arginine side-chain so 
that the guanidyl group can make critical H-bonds 
with the edge of one of the two guanine bases in 
the mCpG site. Such a buttressed arginine residue 
arrangement first predicted by Seeman et al. (1976) 
is seen, for example, in the DNA contacts made by 
zinc-fingers (Pavletich & Pabo, 1991; Fairall et al., 
1993). In support of this hypothesis, if Asp121 is 
changed to a glutamate residue, then binding to 
DNA is indeed disrupted (A.F. & A.P.B., unpub-
lished). 
The 13-sheet face of the domain is convex, and 
because strands B and C are longer than strands A 
and D, it is four-stranded at the thick end of the 
wedge-shaped domain and two-stranded at the 
thin end. The conserved hydrophobic patch 
(Tyr123, llel25) and the potentially buttressed argi-
nine residue (133) are situated on strands C and D 
of the 13-sheet face at the point where it becomes 
two-stranded. This region could probably make 
contact with the edges of the mCpG base-pairs by 
insertion of one end of the sheet into the major 
groove. The lysine and arginine-rich flexible B-C 
loop could then follow the major groove for several 
more base-pairs. This model is in agreement with 
the pattern of perturbed amides (Figure 4(b)), and 
is not unprecedented, e.g. in the GCC-box binding  
domain, three 13-strands have been observed to fit 
in a major groove (Allen et al., 1998) without much 
widening, since at no point do the three strands fit 
side-by-side at the centre of the major groove. Two 
other proteins have recently been shown to interact 
with the major groove of DNA via a three-stranded 
antiparallel 13-sheet: the nuclear intron-encoded 
homing endonuclease, I-PpoI (Flick et al., 1998), 
and the Tn916 integrase (Wojciak et al., 1999). 
The coincidence of the well structured fraction of 
the recombinant peptide and the extent of the 
MBD consensus sequence (Figure 1) indicates that 
other MBDs will have a broadly similar tertiary 
structure. Most of the residues within the consen-
sus sequence defining MBDs are scaffold residues, 
either involved in forming the hydrophobic core 
(summarised in Figure 1) or occupying critical pos-
itions in turns and loops. Others are solvent-acces-
sible and probably do not have a structural role. 
For example, at the thick end of the wedge-shaped 
domain Tyrl4i is surface-exposed. It is highly con-
served, but on the basis of changes in chemical 
shift, neither this residue nor the underlying struc-
tural elements at this end of the wedge appear to 
be involved in the binding of DNA. This end of the 
MBD is therefore implicated in a critical interaction 
with another domain within MeCP2, or with a 
different protein, and Tyr141 is a good candidate 
for a mutagenesis experiment. The structures of 
MBDs in MBDI, MBD2 and MBD3, which might 
lack the third-turn of -helix contributing to the 
thick end of the wedge-shaped structure, are likely 
to diverge significantly from the structures of 
MBDs of MeCP2 and MBD4 in this region. These 
structural differences presumably reflect the fact 
that this end of the domain is distal to the DNA in 
the complex and has different functions in different 
protein contexts. It may also be related to the fact 
that while in MeCP2 and MBD4, there is scope for 
an NH,-terminal domain preceding the MBD, in 
MBD1, MBD2b and MBD3 the MBD occupies an 
NFL-terminal position. It is worth noting that there 
must also be differences in structure at the 
"business end" of the domain, since the hydro-
phobic trio (Leu108, Tyr120, Va1159) which forms 
the narrow end of the core (Figure 3(c)) is absent in 
MBDI, MBD2 and MBD3. The two conserved 
aspartic acid residues at positions 151 and 154 are 
unlikely to interact directly with DNA because 
they are on the "wrong" face of the sheet. A role 
for these residues might be to help the domain 
become orientated appropriately on the DNA by 
repelling the backbone; alternatively, they too 
might be involved in contacting another domain or 
protein. 
The apparent involvement of the unstructured 
residues prior to the MBD consensus sequence 
in mCpG recognition by MeCP2 is intriguing. 
This sequence includes four Arg and a lysine 
residue as might he expected, but it also 
includes a pair of isoleucine residues whose 
potential role is less obvious. The minimal 
sequence of MeCP2 required for DNA recog- 
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nition did indeed involve these 18 residues, but 
extra amino acids at the COOH terminus were 
able to compensate for their absence. The 18 
residues in MBD2 prior to the MBD consensus 
sequence (Figure 1) include three Arg residues 
and are almost certainly unstructured, since they 
are rich in prolire and glycine residues. In 
MBD4, the equivalent residues do not include 
any positively charged side-chains. MBDI and 
MB133 lack any NI-1 2-terminal residues. The 
involvement of an extended NH,-peptide in a 
protein-DNA complex has been observed in the 
case of the homeodomain (Wolberger, 1996) 
where the peptide fits in the minor groove and 
arginine residues make electrostatic contacts with 
the phosphate backbone. 
In summary, the MBD of MeCP2 has a novel, 
wedge-shaped tertiary structure. MBDs from other 
proteins are likely to have a similar fold, although 
MBDI, MBD2 and M13133 must exhibit local differ-
ences in structure, particularly at the thick end of 
the wedge-shaped domain. On the basis of chemi-
cal shift perturbations, residues towards the thin 
end of the wedge-shaped domain and in an NH, 
terminal flexible region, are likely to interact with 
methylated DNA. The structure has no internal 
symmetry, despite the symmetry of the mCpG it 
binds to. The structure reveals highly conserved 
residues not required for structural integrity of the 
domain. These include residues that are candidates 
for recognition of the mCpG sequence, and resi-
dues likely to be in contact with other domains 
within MeCP2 or other proteins. 
Materials and Methods 
Protein expression 
Recombinant, His-tagged MBD from MeCP2 
(MHHHHHHAM-77-164-SGSGC) was expressed in 
Esciterichia coli BL21(DE3)LysS from plasmid pET6HMBD 
(Cross et al., 1994). The sequence was based on a pre-
vious study (Nan et al., 1993) that defined the minimal 
protein fragment required to recognise methylated-CpG. 
The poly-His tag does not interfere with binding. An 
overnight culture was diluted 100 times and incubated 
at 37 C to A,, E  = 0.3, before induction with isopropyl - 
thiogalactoside. Cells were grown in defined medium 
enriched with 4 g 1' [U- 13C]glucose and 5 g 1' 
F ' 5N](NH.,) 2SO4. Harvested cells were resuspended in 
MA (50 mM sodium phosphate (pH 7.0), 50 mM NaCl), 
combined with five volumes of MA plus 5 M urea (due 
to the protein being expressed in an insoluble form), 
sonicated and pelleted. The supernatant was loaded onto 
a cation-exchange column which was washed sequen-
tially with MA plus 5 M urea, MA plus 0.25 M NaCl 
and 3.75 M urea, and MA plus 0.4 M NaCl and 3 M 
urea. The protein was eluted in MA plus 1 M NaCl. The 
material was purified further on a nickel-agarose 
column. The purity of the protein was —98 % (as judged 
by SDS-polvacrylamide gel electrophoresis) and the yield 
was 10 - 40 mg l' of culture. All operations were per-
formed at 4 C. 
NMR spectroscopy 
Spectra were collected on a 1 mM sample in 90')/o 
H2O, 10°o 2H2O at 18 C in buffer MA adjusted to 
pH 6.0. Samples of the protein-DNA complex were gen-
erated by mixing the protein with an equimolar quantity 
of the double-stranded oligonucleotide 5'-TATGTAmCG-
TACATA-3' (Oswel, Southampton, UK). Mixing of the 
protein with non-methylated DNA of the same sequence 
resulted in precipitation. The following proved useful for 
resonance assignment: 2D "N HSQC, ' 1C HSQC; 2D 
homonuclear COSY, TOCSY (mixing times 20 ms and 
50 ms), NOESY (100 ms); 3D HCCH-TOCSY (Kay et al., 
1993), HNCACB, CBCA(CO)NH (Muhandiram & 
Kay, 1994), HBHA(CO)NH (Grzesiek et al., 1993), 
HNCA (Kay et al., 1994), HN(CO)CA (Grzesiek & Bax, 
1992), H(C)(CO)NH-TOCSY and (H)C(CO)NH-TOCSY 
(Grzesiek et al., 1993; Logan et al., 1993). All spectra were 
recorded on Varian [NOVA 600 MHz spectrometers 
using 5 mm probes and sensitivity-enhanced pulsed-
field gradient methods were used for all NH-detected 3D 
experiments. Multidimensional NMR data were pro-
cessed with the AZARA package (http://www.bio. 
cam.ac.uk/azara)  making use of maximum entropy 
methods to process the 3D experiments. 
Resonance assignment 
ANSIG (Kraulis, 1989; Kraulis et al., 1994) was used to 
display spectra and maintain cross-peak lists for reson-
ance assignment. The 2D ' 5N HSQC spectrum was used 
to direct peak-picking of spectra using 'peak_find' from 
AZARA. SEQ_PROB (Grzesiek & Bax, 1993) helped to 
achieve sequence-specific assignments from sequential 
C/C connectivities. The majority of the H and H" 
assignments were deduced from 315 HBHA(CO)NH. The 
13C side-chain assignments were obtained from 3D 
(H)C(CO)NH-total correlation spectroscopy (TOCSY) 
and most of the proton side-chain assignments were 
acquired from 3D H(C)(CO)NH-TOCSY and HCCH-
TOCSY. Aromatic proton spin systems were assigned 
using the homonuclear spectra. Backbone 'N and 
'C' atoms were assigned for all residues of the natural 
sequence, some residues of the N-terminaltag and all of 
the extra C-terminal residues. A total of 98.5 % of 'H res-
onances of the native sequence (residues 77-164) and 
98.7% of side-chain 'C resonances were assigned. The 
'H, ' 3C and 'N chemical shifts for MBD have been 
deposited in BioMagResBank, accession number 4280. 
Structure calculations 
A total of 3500 MOE restraints from 3D 'C-edited, 3D 
"N-edited and 2D 'H NOESY spectra (this number 
includes degenerate restraints), and 45 3JHN41.  (extracted 
from a 3D 1-INHA (Kuhinowa et al., 1994) spectrum) 
were incorporated into structure calculations carried out 
using X-PLOR (Brunger, 1992). The X-PLOR protocols 
used for the initial structure calculations and debugging 
were versions of the standard rand.inp, rrsa.inp and refi-
ne.inp, modified to allow floating stereochemistry at, 
and to include active swapping of, prochiral centres in 
random order using a metropolis-style acceptance cri-
terion (ARC., Raine, B.O.S & P.J.Domallie, unpublished 
results). Initial calculations used a list of restraints that 
were assigned on the basis of chemical shift using "con-
nect" from AZARA. Relative peak intensities in each 
spectrum were mapped into four distance classes of less 
than 2.7 A, 3.8 A, 5 A and 6 A, for strong, medium, 
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weak and very weak intensities, respectively. Sub-
sequently a proportion of the NOEs were at least par-
tially assigned on the basis of the initial calculations 
giving 1464 unambiguous and 1920 ambiguous restraints 
(restraints were not filtered to remove redundancies aris-
ing from the use of mutiple spectra as input). ( y )_l( 
averaging was used throughout. Once the well-defined 
structures had been obtained, 14 H-bonds between 
slowly exchanging amide protons and appropriate 
acceptors which were supported by local NOE data were 
incorporated. Donor proton to acceptor distances were 
restrained to be less than 2.3 A and donor nitrogen to 
acceptor distances were restrained to be between 2.5 A 
and 3.3 A so as to maintain an approximately linear geo-
metry. The refined structures were calculated using 
ARIA (Nilges et al., 1997), where the ambiguous cut-off 
point was decreased to 90% over 10 iterations (30 struc-
tures calculated in each iteration). Filtering, calibration of 
distances and removal of duplicate restraints as carried 
out by ARIA resulted in 1550 unambiguous and 317 
ambiguous restraints in the last iteration from which the 
final structures were taken. 
Protein Data Bank accession number 
Atomic co-ordinates have been submitted to the 
Protein Data Bank with accession number 1qk9. 
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